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Abstract 
 
The current study builds upon existing QoL research in children with psychopathology to 
begin examining resilience processes in this population of youth. Although available 
research suggests that psychiatric disorders and levels of psychopathological symptoms 
predict worse QoL, there is evidence that some who experience high levels of 
psychopathology also demonstrate high QoL. Using 2 years of data from the 
Longitudinal Assessment of Manic Symptoms (LAMS) study, the current work sought to 
identify specific demographic, parental/familial, and individual protective and resiliency 
factors that buffer the negative impact of psychopathological symptoms on parent- and 
youth-reported QoL. At baseline, data were available for 685 6- to 12-year-old children 
and one of their parents or guardian. Multilevel modeling was used to examine potential 
moderating effects of time-varying and time-invariant covariates on the time-linked 
relationship between symptom severity and QoL. Changes in the number of inpatient 
psychiatric hospitalizations, stressful life events, and total effect of life stress across time 
were found to moderate the severity-QoL relationship. Specifically, increasing number of 
inpatient psychiatric hospitalizations and total effect of life stress across time were found 
to reduce the negative effect of symptom severity on parent-reported QoL. Increasing 
number of youth-reported stressful life events and total effect of life stress also reduced 
  
iii 
 
the negative effect of symptom severity on youth-reported QoL. Additional factors such 
as social support, physical health concerns, parental psychopathology, parental and 
familial  psychiatric histories, suicidality, and insurance status, while not found to 
moderate the severity-QoL relationship, uniquely predicted QoL. The current study also 
examined concordance rates between parent- and youth-reported QoL. While there was 
significant agreement in parents’ and youth’s ratings, levels of agreement differed across 
domains and over the course of the longitudinal study. Implications of current results for 
intervention approaches and treatment development work are discussed, and suggestions 
for future studies of resilience processes in youth with psychopathology are offered. 
Despite limitations of the current study due to its exploratory nature, this work offers 
reasons for optimism that youth experiencing increasing psychopathological symptoms 
over time are not necessarily “doomed” to synchronously worsening QoL, and provides 
important insights into the dynamic and interactive processes that give rise to better-than-
expected outcomes among youth with psychopathology.  
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Chapter 1: Introduction  
 
 What distinguishes youth who fare well despite experiences of adversity in their 
lives from those who are vulnerable to such experiences? What are the processes by 
which successful adaptation to adversity take place? What is meant by “experiences of 
adversity”, and what constitutes “good” or successful functioning when such untoward 
events or circumstances are encountered? For the past several decades, such questions 
have been examined by researchers who strive to elucidate factors that correlate with and 
predict resilience, explain how processes of resilience unfold, and delineate strategies that 
may foster resilience in youth (Luthar, Cicchetti, & Becker, 2000; Masten, 2001; Masten, 
2011; Rutter, 2012). Much resilience research has focused on children and adolescents; 
although recent years have witnessed increased work with adults as well (Luthar & 
Brown, 2007). In the current study, I examine resilience among children and adolescents 
with various forms and severity of psychopathology, by elucidating factors that predict 
adaptive outcomes despite expression of psychological symptoms.  
Historical and Current Conceptualizations of Resilience 
 Before providing an overview of resilience research, it is appropriate to pause and 
consider how the definition and conceptualization of the construct of resilience has 
evolved and been refined over the years and by different researchers. Early on, the term 
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“invulnerable” was used to describe children who functioned well despite experiencing 
considerable adversity (Anthony, 1974). This term is now considered misleading, as it 
connotes a sense of absolute resistance to risks and suggests that adaptive functioning in 
spite of stress is a trait or characteristic that resides exclusively in the child (Luthar et al., 
2000). This does not seem to be the case. The term “stress resistance”, initially used by 
Garmezy (e.g., Garmezy et al., 1984), also suggests a complete immunity to stress which 
has not been supported. Similarly, describing children as “resilient” can also be 
misleading, for this term again seems to convey an internal trait or attribute that exists 
apart from the influence of external events (Luthar et al., 2000; Masten, 1994, 1999; 
Rutter, 1999; Rutter, 2000). Rather, researchers have recommended a careful choice of 
terminology when describing these phenomena. The term resilience may be best defined 
as the following: a dynamic, interactive process that is inferred when, within the context 
of adversity, an individual exhibits adaptive functioning exceeding that which would be 
expected given his or her experience of such adversity (Luthar & Cicchetti, 2000; Luthar 
et al., 2000; Masten, Best, & Garmezy, 1990; Masten & Coatsworth, 1998; Rutter, 1987; 
Rutter, 1999; Rutter, 2013). In other words, resilience is effectively a two-part construct, 
involving a consideration of both: (1) exposure to adversity, and (2) adaptive functioning. 
This conceptualization of resilience will be adopted herein.  
Risk and Protective Factors, Vulnerability and Resiliency 
As accentuated by some researchers (e.g., Rutter, 1985),  resilience research 
necessarily goes beyond identifying predictors of positive outcomes, but involves 
identifying factors and characteristics that allow individuals to display adaptive outcomes 
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in the face of adversity and stressors. Given the centrality of risk and protective factors in 
understanding resilience processes, a further discussion of their definitions and 
implications is important. Risk factors have been defined as those antecedent variables 
that carry increased likelihood of predicting maladjustment or maladaptive outcomes 
(Kraemer et al., 1997; Luthar, 2006). When placed in the context of the two-part 
conceptualization of resilience, risk factors can be considered as the adversity that 
individuals encounter or are exposed to. Protective factors are those characteristics that 
modify negative effects of risk factors to reduce the likelihood of negative outcomes and 
increase the prospect of positive adaptation (Luthar, 2006; Luthar & Cicchetti, 2000). To 
distinguish protective factors, which some argue necessitates the presence of adversity, 
from factors that predict positive outcomes regardless of level of risk, researchers have 
opted to use the terms promotive factors, resources, or assets to describe these latter 
attributes (Masten, 2011; Rutter, 2012; Sameroff, 2000). Moreover, Rutter (1987) 
underscores the idea that resilience processes do not entail an avoidance of risk, but 
rather, successful adaptation to adversity is what characterizes resilience. Akin to the 
biological processes related to immunization, the protective effects of receiving vaccines 
comes not from avoiding infectious agents, but rather from coping adaptively to noxious 
agents similar to the target agents. On the other hand, vulnerability factors are those that 
modify the negative effects of risk factors by way of increasing the likelihood of negative 
outcomes, and have been defined as more biologically-based characteristics that 
exacerbate risk situations (Luthar, 2006; Rutter, 1987). As with vulnerability factors, 
resiliency factors are considered to be personal or constituent variables. However, they 
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differ in that resiliency factors enable individuals to flexibly adapt to situational demands 
(Luthar, 1996), and thus may foster resilient outcomes, while vulnerability factors 
adversely impact outcomes. Unlike the process of resilience, the term resiliency itself 
does not require exposure to risk or adversity, though may contribute to resilient 
outcomes. Throughout the current work, both protective and resiliency factors will be 
discussed where appropriate and feasible.   
Resilience and the Developmental Psychopathology Perspective 
 While a full discourse on the key concepts of developmental psychopathology is 
available elsewhere (e.g., Beauchaine & Hinshaw, 2013; Cicchetti & Cohen, 2006; Mash 
& Dozois, 2003; Rutter & Sroufe, 2000; Sameroff, Lewis, & Miller 2000) and is 
therefore not provided herein, it is important to note that resilience as a construct 
occupies a central place in the developmental psychopathology perspective. To succinctly 
summarize, the developmental psychopathology perspective emphasizes the importance 
of examining both normal and pathological development and functioning, assessing 
continuity and discontinuity in behavioral patterns and disorders across development, 
integrating research across multiple levels of analysis, interweaving work from various 
disciplines, incorporating transactional models or emerging psychopathology, 
illuminating the role of contextual variables in shaping behavioral and emotional patterns, 
and understanding the role of risk and protective factors in affecting impairment and 
functioning (Hinshaw, 2013). This last aim invites careful, thoughtful research on 
resilience. Resilience illustrates the concept of multifinality, or processes through which 
individuals who experience similar environmental insults arrive at different outcomes. 
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Beginnings of Resilience Research 
One of the earliest findings that propelled resilience research was the observation 
that a subset of children of mothers with schizophrenia demonstrated adaptive 
functioning and showed few signs of psychopathology despite their vulnerability 
(Garmezy, 1974; Garmezy, Masten, & Tellegen, 1984; Garmezy & Streitman, 1974). 
This prompted researchers to search for factors that protect children from such 
environmental and genetic risks, and lead to what Garmezy initially termed “stress 
resistance”. Garmezy (1985) postulated that three categories of factors would serve to 
promote children’s adaptation to stressful life situations: those of the individual (e.g., 
reflectiveness, responsiveness to others, intelligence – resiliency factors), those of the 
family (e.g., familial warmth, cohesion, parental concern, presence of supportive adults in 
the absence of responsive parents – protective factors), and other support factors (e.g., 
presence of supportive individuals and social structures – protective factors). Later work 
confirmed the protective nature of these characteristics. Rutter (1979), who attempted to 
identify factors that increased risk for later development of psychiatric disorders among 
underprivileged children living in an inner London borough, found significant marital 
conflict, low socioeconomic status (SES), large family size, parental criminality, maternal 
psychopathology, and involvement of foster care to be associated with worse mental 
health outcomes. The greater the number of these factors present, the higher the 
likelihood of developing a psychiatric disorder. Such findings underscore the effects of 
cumulative stressors, and support the importance of familial factors in promoting or 
hindering adaptive functioning in the face of adversity.   
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An influential article by Rutter (1987) highlights the importance of considering 
interaction effects when discussing resiliency. For example, being female is a protective 
factor in contexts of exposure to family discord. Males exhibit significantly greater 
emotional and behavioral problems than females in such settings. In addition, children 
with a more positive temperament (compared to those with more difficult temperament 
features), and those with at least one good relationship with their parents were protected 
from the development of psychiatric disorders when experiencing family discord. Hence, 
it appears that sex, temperament, and parent-child relationship characteristics may play 
important roles in resilience processes. Furthermore, Rutter illustrates four possible 
pathways through which risk can be altered in resilience processes: (1) reducing effects 
of risk by altering experiences of risk or exposure to risk; (2) reducing negative chain 
reactions that perpetuate effects of risks; (3) increasing self-esteem through positive 
relationships and task accomplishments; and (4) opening up new opportunities and 
turning points in individuals’ lives. These postulations serve to emphasize the crucial 
point that resilience is a set of dynamic processes, influenced by multiple factors in 
multiple domains and in multiple ways. 
In a pioneering longitudinal study carried out by Werner et al., the Kauai 
Longitudinal Study (Werner, Bierman, & French, 1971; Werner & Smith, 1982), 698 
children born in Kauai were followed from birth to adulthood in order to examine the 
longitudinal course of offspring who experienced prenatal and perinatal complications 
and unfavorable rearing conditions. Werner was particularly interested in those who 
exhibited adaptive functioning despite adverse circumstances. Across development, 
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factors that promoted resiliency included: temperamental characteristics (being 
affectionate, good-natured), skills and values that promoted efficient use of abilities, 
being reared by competent and organized parents, exposure to supportive and caring 
adults outside of the family, and availability of new opportunities that occur at major life 
transitions (Werner, 1989, 1992, 1993).  
Another body of work that characterized early resiliency research was the Project 
Competence Study, launched by Garmezy, which was later expanded to the Project 
Competence Longitudinal Study (Garmezy et al., 1984; Masten & Tellegen, 2012). This 
study examined: (1) a community cohort of 200 8- to 12-year-old children, (2) a group of 
32 children with a life-threatening heart condition, and (3) a group of 29 children with a 
severe physical handicap (Garmezy et al., 1984). Focusing specifically on the community 
cohort, Garmezy and colleagues found that high SES, female sex, and high intelligence 
were predictive of high school-based competence regardless of stress levels. However, 
they also reported a significant interaction. Children with high intelligence displayed high 
competence at both high and low stress levels, whereas those with low intelligence 
showed lower competence at high stress compared to low stress levels. Over the course 
of a 10-year follow-up period, better intellectual functioning and parenting quality 
predicted academic, social, and behavioral competence at both mid-to-late-adolescence 
and late-adolescence-to-early-adulthood, even among those who experienced significant 
adverse life events (Masten et al., 1999). Participants were also divided into “competent” 
(low adversity, high competence), “resilient” (high adversity, high competence), and 
“maladaptive” (high adversity, low competence) groups based on standard scores (e.g., 
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standard scores above half a standard deviation on adversity measures indicate high 
adversity; standard scores above half a standard deviation on the majority of competence 
areas indicate high competence). Profiles of individuals in the “competent” and 
“resilient” groups were remarkably similar (i.e., characterized by average or higher 
intelligence, parenting qualities, and psychological well-being measured by a symptom 
checklist), while those in the “resilient” group significantly differed from those in the 
“maladaptive” group in that “maladaptive” individuals had fewer protective resources 
and had higher levels of negative emotionality. These findings further support the idea 
that even in the face of significant adversity, some children and adolescents can emerge 
with positive adaptation and competence.  
In a 20-year follow-up when participants were entering emerging and young 
adulthood, this research group examined factors that predicted stability and change in 
resilience status in the 10 years between emerging and young adulthood (Masten et al., 
2004). Those who changed from “maladaptive” to “resilient” status had greater adaptive 
resources with regard to achievement motivation, autonomy, and supportive relationships 
with adults, compared to those who remained in the “maladaptive” group.  Nevertheless, 
those in the newly resilient group had lower adaptive resources in childhood compared to 
those who showed stable competent and resilient status, particularly in domains of 
parenting quality, SES, and intelligence.  
Resilient Outcomes, Protective Factors, Resiliency Factors: “Ordinary Magic” 
The second part on the resilience conceptualization requires a definition of 
adaptive functioning. In various studies of resilience, positive adaptation is defined as 
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behavioral manifestation of competence, a group of related constructs that is associated 
with successful adaptation in key developmental tasks or more narrowly-defined (e.g., 
academic or social) domains of achievement (Luthar, 2006; Masten, Burt, & Coatsworth, 
2006; Masten & Coatsworth, 1995, 1998). For example, given exposure to adversity, 
secure attachment with caregivers, good academic functioning, positive relationships 
with teachers and peers, prosocial behaviors, few behavioral problems, and low levels of 
psychological symptoms and disorders (e.g., Bolger & Patterson, 2003; Cicchetti & 
Rogosch, 1997; Cicchetti, Rogosch, Lynch, & Holt, 1993; Luthar, 1991; Masten & 
Coatsworth, 1998; Masten et al., 1999; Yate, Egeland, & Sroufe, 2003) have served as 
indicators of resilience. Selection of adaptive outcomes in resilience studies warrants 
careful thought. Whereas some researchers use composite functioning indices created by 
combining standardized scores across multiple domains (e.g., academic, social, 
behavioral, emotional), others assert that choosing specific domains that are postulated to 
be directly relevant to particular risks exposed by study participants (e.g., absence of a 
depressive disorder in children of parents with depression) is more appropriate (Luthar, 
2006; Luthar et al., 2000; Luthar & Zelazo, 2003). Whichever method researchers 
choose, one must consider that competence or positive adaptation in one domain does not 
necessarily translate into competence or positive adaptation in another. For example, 
those who show competence in academic and social domains may nevertheless 
experience significant emotional distress (Luthar, 1991; Luthar & Brown, 2007). 
Accordingly, researchers must consider carefully and describe the types of outcomes they 
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wish to examine, and when a comprehensive depiction of resilience is intended, then 
exploration of multiple outcomes may be most useful.  
Perhaps not surprisingly, resilience has been studied in children and adolescents 
exposed to a wide range of adverse events. For example, low SES (Cicchetti, Rogosch, & 
Sturge-Apple, 2007; Garmezy, 1991; Werner, 1992; Werner & Smith, 1982), childhood 
maltreatment (Bolger & Patterson, 2003; Cicchetti & Rogosch, 1997; Cicchetti et al., 
1993; Cicchetti, 2012; Kim, Cicchetti, Rogosch, & Manly, 2009; Williams & Nelson-
Gardell, 2012), urban stressors and community violence (Cowen et al., 1997; Luthar & 
Goldstein, 2004; Wyman et al., 1999; Wyman, Cowen, Work, & Parker, 1991), parental 
psychopathology (Beardslee & Martin, 2010; Beardslee & Podorefsky, 1988; Jaffee, 
2005; Mordoch & Hall, 2002; Tebes, Kaufman, Adnopoz, & Racusin, 2001), parental 
separation (Hetherington & Stanley-Hagan, 1999), chronic illness (Fee & Hinton, 2011; 
Im & Kim, 2012; O'Dougherty & Wright, 1990), traumatic life events (Agaibi & Wilson, 
2005; Bonanno & Diminich, 2013; Bonanno & Mancini, 2008), and combinations of 
multiple risk factors such as parental psychopthology, absence of father, and SES 
(Fergusson & Lynskey, 1996; Sameroff, Gutman, & Peck, 2003; Seifer, Sameroff, 
Baldwin, & Baldwin, 1992) have been examined. Remarkably, studies of resilience 
across multiple types of adversity have converged on a consistent “short list” of 
protective factors (Masten, 2007; Radke-Yarrow & Brown, 1993).  
Both variable-based and person-based approaches have been utilized to identify 
protective and resiliency factors in resilience research (Cicchetti, 2010; Luthar, 2006; 
Masten, 2001; Masten, 2011). With variable-based analyses, which focus on 
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understanding relations among variables of interest, main effects of key variables can be 
identified (e.g., predictors of competent outcomes), and effects of hypothesized protective 
factors can also be determined by examining interaction effects with the adversity in 
question. Person-based techniques, on the other hand, involve forming categories of 
children based on their levels of risk exposure and competence and comparing variables 
of interest among the groups. Masten and colleagues’ (1999, 2004) longitudinal study 
described above utilized the latter approach. By categorizing participants into 
“competent”, “resilient”, and “maladaptive” groups, Masten et al. were able to compare 
profiles of individuals in each of these categories to determine potential risk and 
protective factors that predicted group membership in the context of adversity.  
Using both variable-based and person-based analytic techniques, and by 
comparing children and adolescents who are exposed to various forms of risk, certain 
family factors and community factors have emerged as protective for children and 
adolescents. With regards to family factors, secure attachment, sharing a close 
relationship with at least one parent, competent parenting characterized by 
responsiveness, support, warmth, appropriate control, and monitoring, and the presence 
of supportive grandparents and competent siblings are associated with positive adaptation 
among youth exposed to adversity. Factors in the community that are protective include 
high quality child care, supportive relationships with teachers at school, mentors, or other 
caring adults, positive and satisfying friendships with prosocial peers, religious affiliation 
and participation in religious activities, engagement in organized activities in 
neighborhoods, and opportunities for making major life changes. With regard to 
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resiliency factors at the individual level, high intelligence (though findings are not 
unequivocal), “easy-going” temperament, competent self-regulation, effective coping 
abilities, adequate problem-solving and planning skills, high self-esteem and self-
efficacy, and internal locus of control have demonstrated beneficial effects in various 
studies of resilience. Finally, as discussed below, genetic factors such as those implicated 
in MAOA activity and serotonin transporter genotypes, as well as regulation of stress-
responsive hormonal levels, have begun to emerge as resiliency factors (Cicchetti, 2010; 
Cicchetti & Rogosch, 2007; Cicchetti et al., 2007). 
As one considers this “short list” of protective factor consistently revealed in 
numerous studies, it may seem apparent that the majority of these factors are not 
“extraordinary” characteristics that are possessed and experienced by few. In fact, this 
very point led Masten (2001) to coin the phrase “ordinary magic” in describing the 
resilience phenomenon. She writes:  
The great surprise of resilience research is the ordinariness of the phenomena. 
Resilience appears to be a common phenomenon that results in most cases from 
the operation of basic human adaptational systems. If those systems are protected 
and in good working order, development is robust even in the face of severe 
adversity; if these major systems are impaired, antecedent or consequent to 
adversity, then the risk for developmental problems is much greater. (p. 227) 
Certainly, some of these protective characteristics may be less frequently 
observed in those experiencing significant adversity. For example, although competent 
parenting is beneficial for all children regardless of risk, it is reasonable to presume that 
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maintaining positive parenting in the face of significant adversity is especially difficult 
(Luthar, 2006). The presence and preservation of otherwise ordinary factors and 
processes in contexts of adversity appears to be critical in facilitating resilience 
phenomena. Related to the above discussion regarding the importance of considering the 
level of exposed risk when selecting and defining adaptive outcomes, it is worth 
remembering that as with protective and resiliency factors, resilient outcomes need not be 
“extraordinary”. By definition, so long as outcomes are “more positive” than would be 
expected given the level of encountered risk, resilience processes may well be at work.   
Genetic and Biological Factors in Resilience 
 Although the focus of early resilience research was on identifying psychosocial 
factors associated with resilience, researchers have cautioned against neglecting genetic 
and biological variables in the study of positive adaptation in the context of adversity 
(Cicchetti, 2010; Cicchetti, 2012; Curtis & Cicchetti, 2003; Luthar & Brown, 2007; 
Rutter, 2007, 2012, 2013; Rutter, Moffitt, & Caspi, 2006). As highlighted by studies 
illustrating Gene x Environment interaction effects (e.g., genetic factors moderating the 
effect of environmental effects on outcomes and vice versa), resilience processes involve 
factors at the genetic level and transactions across multiple levels of analysis in 
generating outcomes. Based on data obtained from the Dunedin Multidisciplinary Health 
and Development Study, Caspi and colleagues (2002) examined the effects of childhood 
maltreatment on subsequent antisocial behavior in adulthood, and found that among 
maltreated males, those who carried a specific polymorphism of the monoamine oxidase 
A (MAOA) gene associated with high MAOA activity showed lower levels of antisocial 
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behavior compared to males with the polymorphism associated with low MAOA activity. 
Caspi and colleagues (2003) also found that a polymorphism of the promoter region of a 
serotonin transporter gene moderated effects life stress on depression in adulthood, such 
that individuals who experienced high life stress but had two long alleles exhibited 
reduced depression compared to those with one or two short alleles.  
Examining such Gene x Environment interactions among adolescents with low 
SES and a history of maltreatment, Cicchetti and colleagues (2007) obtained similar 
findings. Among maltreated youth, those with polymorphisms associated with high 
MAOA activity showed greater self-coping strategies, which were related to fewer 
depressive symptoms. Those with low MAOA activity exhibited increased depressive 
symptoms. In addition, those who experienced sexual abuse who also had two short 
alleles of the serotonin transporter gene experienced greater symptoms of depression, 
anxiety, and somatic complaints. In a study focusing on both maltreated and non-
maltreated low-income children, Cicchetti and Rogosch (2007) examined the influence of 
two stress-responsive adrenal steroid hormones, cortisol and dehydroepiandrosterone 
(DHEA), on resilient functioning. Among children who were victims of physical abuse, 
high morning cortisol was associated with greater ego resiliency and ego control (i.e., the 
ability to regulate impulses and affect), in contrast to findings among non-maltreated 
children, for whom low morning cortisol was associated with adaptive outcomes. Only 
among maltreated children who showed resilient outcomes was a unique increase in 
DHEA from morning to afternoon observed. In another study of 8- to 12-year-old 
children from low SES neighborhoods, high levels of respiratory sinus arrhythmia, a 
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positive indicator of emotion regulation, partially protected children from developing 
depression in the context of maternal melancholic depression (Shannon, Beauchaine, 
Brenner, Neuhaus, & Gatzke-Kopp, 2007). Low levels of maternal melancholic 
depression also partially protected children from depression in the context of paternal 
antisocial behavior. In addition, children with high electrodermal responding were 
partially protected from developing conduct problems in the presence of paternal 
antisocial behavior.  
Neurobiological stress reactivity has also been implicated in resilience processes. 
Boyce and Ellis (2005; Ellis & Boyce, 2008) proposed a curvilinear, U-shaped model of 
the development of biological sensitivity to context (BSC), such that early exposure to 
both intensely supportive environments and significantly adverse environments may lead 
to the development of high stress reactivity. On the one hand, high sensitivity to 
protective environments are postulated to allow for increased absorption of their 
beneficial effects; on the other, high sensitivity to adverse environments mobilizes one to 
cope with threatening circumstances. Boyce and Ellis use the analogy of dandelions and 
orchids to illustrate their theory. The “dandelion child” is one who exhibits the low-
reactive phenotype, maintaining stable or optimal functioning regardless of how 
supportive or adverse his or her environment may be. Put in the context of the current 
research, the “dandelion child” is one who exhibits resilient outcomes. The “orchid 
child”, however, is one who exhibits the high-reactive phenotype and whose functioning 
is linked with the environmental context. Specifically, the “orchid child” is hypothesized 
to flourish under supportive environments while succumbing to negative effects of 
  
16 
 
harmful environments; in other words, not exhibiting resilience outcomes. In addition, 
genetic contributions to children’s reaction norms also influence one’s expected level of 
stress reactivity.    
 Hence, it appears that genetic and biological factors, though historically neglected 
in the resilience literature, play important roles in explaining the process of resilience in 
youth. These studies highlight the importance of considering multiple levels of analysis 
when exploring resilience in children and adolescents exposed to adversity. In addition to 
identifying factors that predict positive or negative outcomes, it is critical to examine how 
variables at the individual, family, and social levels interact to moderate effects of risks 
on subsequent functioning. Nevertheless, the call for increased focus on genetic and 
biological factors must be supplemented with an important caveat: one must be wary of 
concluding that because genetic factors play a role in contributing to resilience processes, 
resilience is a trait that simply resides in an individual in the form of a specific genetic 
polymorphism. As has been reiterated throughout this document, such a conclusion is 
inaccurate and not warranted. While genetic and factors are implicated, it is likely that a 
cascade of effects involving variables both internal and external to an individual 
contributes to resilient outcomes. Providing individuals who may or may not possess 
specific resiliency trait or characteristics with external supports that have been suggested 
as protective, may foster desired resilience outcomes in the context of risk and adversity. 
Resilience reflects a set of dynamic processes across multiple levels of analysis. Thus, 
one must be intentional in avoiding exclusive focus on any one level of analysis when 
attempting to provide a comprehensive explication of resilience processes.  
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Resilience in the Context of Psychopathology 
 In the foregoing literature review, I have described research conducted in 
populations exposed to various forms of adversity (e.g., socioeconomic disadvantage, 
childhood maltreatment, parental mental illness). However, examining resilience 
processes among individuals with existing signs of psychopathology has not been a prime 
focus in the resilience literature. Although the absence of psychopathology or other 
emotional and behavioral maladjustment has frequently served as an outcome measure 
(e.g., the functioning component of resilience) in research with these high-risk groups, 
few studies have considered the presence of psychopathology in children and adolescents 
as vulnerability they experience per se, and relatedly, few have examined resiliency and 
protective factors that may enable these youth to sustain positive functioning despite their 
emotional and behavioral disturbances.  
Conceptualizing Adaptive Functioning 
The study of resilience in such populations is complicated by the nature of 
classifying mental disorders according to systems such as the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR; American 
Psychiatric Association [APA], 2000) and the recently released DSM-5 (APA, 2013). 
Specifically, the DSM nosology requires that mental disorders be associated with distress, 
impairment, or significantly increased risk for distress or impairment. In the DSM-5 
(APA, 2013), mental disorders are said to be “usually associated with significant distress 
or disability in social, occupational, or other important activities” (p. 20). When 
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attempting to examine resilience processes among those with diagnosed mental disorders, 
however, this definition poses a challenge, particularly in delineating the two components 
of resilience (namely, adversity and adaptive functioning), for inherent in this definition 
is the necessary presence of both adversity and maladaptive functioning. Does this imply 
that one can never observe resilience in the context of psychopathology?  
Although not exclusive to the study of resilience, the concept of functional 
impairment and its role in classification of psychopathology has gained interest of many 
researchers. Wakefield (1992a, 1992b) introduced the term “harmful dysfunction” to 
emphasize that mental disorders comprise both dysfunction of some internal process or 
natural mechanism and harm or negative consequences to the individual or society. Not 
only has the DSM been criticized for inadequately incorporating and describing these two 
presumably requisite aspects of dysfunction, the utility of the explicit criterion that 
mental disorders be “clinically significant” has been questioned. As one example, Spitzer 
and Wakefield (1999) suggested that for some disorders, such as conduct disorder or 
selective mutism, the presence of symptoms in the diagnostic criteria intrinsically implies 
impairment (e.g., it is difficult to imagine that one who pervasively acts aggressively 
towards others and destroys others’ property, or one who consistently fails to speak in 
social situations where speech is expected, would not experience significant impairment 
in social functioning). Yet for other disorders, such as separation anxiety disorder or 
generalized anxiety disorder, the explicit clinical significance criterion may serve to 
reduce the number of false positive cases (e.g., one may worry about an excessive 
amount of events but yet does not experience significant distress about those worries). 
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Still for other disorders such as Tourette’s disorder or substance dependence, the clinical 
significance criterion may increase the number of false negatives (e.g., one who shows 
severe dependence on alcohol yet experiences little distress and is able to fulfill 
responsibilities in social roles may be classified as not having a disorder). The 
relationship between experiences of psychological symptoms and impairment or 
functioning is certainly complex.  
The Global Assessment of Functioning (GAF) scale on Axis V that was present in 
the DSM-IV also attempted to capture aspects of harm and functional impairment 
(Masten & Obradovic, 2006). However, since raters are asked to consider both social and 
occupational functioning and symptom severity, and to choose the lower of two levels 
(e.g., “worse” functioning), using the GAF as an indication of overall impairment further 
blurs the boundary between experiences of symptoms and functional impairment. The 
Children’s Global Assessment Scale (CGAS; Shaffer et al., 1983) is a similar measure as 
the GAF and also requires raters to consider both symptoms and impairment, but 
provides anchors appropriate for children and adolescents. Hence, similar problems in 
delineating symptoms and functioning arise when using the CGAS. On the other hand, 
the International Classification of Diseases (ICD-10) by the World Health Organization 
(WHO, 1992) uses the Disability Assessment Schedule (WHODAS) to assess functional 
impairment. Focusing solely on functioning without consideration of symptoms, the 
WHODAS attempts to provide a “pure” assessment of one’s level of functional 
impairment. With the multiaxial system removed in the DSM-5, the GAF is also no 
longer included (APA, 2013). Instead, the DSM-5 has adopted the use of the WHODAS 
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as a recommended tool for assessing functional impairment. Given its ability to assess 
functioning in the domains of cognition, physical well-being, self-care, interpersonal 
relationships, and engagement in responsibilities and other activities, the WHODAS may 
serve as a functional outcome measure in future resilience research. 
Quality of Life (QoL) – Indicator of Resilience in the Context of Psychopathology 
Returning to my earlier point that the inherent functional impairment 
characteristic of mental disorders complicates conceptualization of resilience among 
youth with psychopathology, it is appropriate to shift attention to the discussion of 
another construct that is beginning to be studied in children and adolescents with 
psychological disorders, and serves as a suitable construct in the study of resilience 
among these youth. Quality of Life (QoL) has been defined by the WHO as “individuals’ 
perception of their position in life in the context of the culture and value systems in which 
they live and in relation to their goals, expectations, standards and concerns” (World 
Health Organization Quality of Life [WHOQOL] Group, 1995, p. 1405). The term 
health-related QoL (HRQoL) has been used to describe QoL associated with health 
conditions, and HRQoL will be subsumed under the broader term QoL throughout this 
document (Coghill, Danckaerts, Sonuga-Barke, & Sergeant, 2009; Eiser, Mohay, & 
Morse, 2000; Spieth & Harris, 1996; Wallander, Schmitt, & Koot, 2001).  
Although there is not yet consensus regarding specific components required in a 
definition of QoL, it is commonly conceptualized as a broad, multidimensional construct 
that encompasses physical well-being, psychological domains, social functioning, and a 
cognitive domain (Coghill et al., 2009; Eiser & Morse, 2001b; Harding, 2001; Spieth & 
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Harris, 1996; Titman, Smith, & Graham, 1997; Wallander et al., 2001). Coghill and 
colleagues (2009) delineate QoL from other related constructs such as functional 
impairment, which is described above and defined by these authors to be the objective 
effect of symptoms on functioning, and health status, considered as the presence or 
absence of symptoms. Further, QoL differs from these constructs in that it requires a 
subjective evaluation of individuals’ perceptions of their current situation in life. Whereas 
individuals’ functional impairment or health status can and are often assessed and 
determined by clinicians, QoL by definition is an assessment of individuals’ own 
perceptions of their well-being.  
When considering assessment of QoL in children, however, relying exclusively 
on their subjective reports of well-being may not yield a complete representation of QoL; 
proxy ratings commonly provide by children’s parents or caregivers may be important 
sources of information (Coghill et al., 2009; Eiser et al., 2000; Spieth & Harris, 1996; 
Theunissen et al., 1998; Vogels et al., 1998; Wallander et al., 2001). For one, limitations 
in children’s language development (e.g., difficulty in accurately interpreting items on 
questionnaires), lack of long-term perspective (e.g., focusing primarily on short-term 
goals and wishes), difficulties with recall (e.g., reporting QoL based on most recent 
events only), low levels of insight, and social desirability biases (e.g., not wanting parents 
to know their dissatisfaction with their current life) may yield unreliable QoL indices. 
Among severely ill children, particularly those with physical illnesses, it may not be 
possible to obtain their subjective reports of well-being. Further, although parents’ 
assessment of children’s QoL may be influenced by their own biases (e.g., how their 
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child’s condition has affected them) and the nature of their interactions with their child, 
their proxy report is nevertheless valuable, for they are generally not limited by some of 
the aforementioned developmental issues and may provide a broader appraisal of their 
child’s well-being than children’s own subjective reports. In addition, given children’s 
dependency on their parents and caregivers regarding healthcare decisions, obtaining 
proxy reports from such individuals is appropriate and may also reveal additional targets 
of treatment or concern.  
It is also important to mention that as with ratings of behavioral and emotional 
symptoms, concordance rates between parents and children in their reports of QoL is far 
from perfect and varies across domains (Eiser & Morse, 2001a; Theunissen et al., 1998; 
Verrips, Vogels, den Ouden, Paneth, & Verloove-Vanhorick, 2000; Vogels et al., 1998). 
For example, greater agreement is noted for more overt and observable domains such as 
physical functioning, whereas agreement in more covert domains such as emotional and 
social QoL appears lower. There is also some evidence that children and parents may rate 
QoL in some domains as higher or lower than that reported by the other informant. 
Therefore, it appears that in addition to obtaining children’s subjective reports of their 
QoL in various domains of functioning, incorporating proxy reports from key informants 
who are knowledgeable of children’s well-being may provide unique perspectives on 
children’s overall QoL.  
Another issue discussed in the QoL literature pertains to whether disease-specific 
or more generic measures should be used (Eiser & Morse, 2001b; Ravens-Sieberer et al., 
2006; Spieth & Harris, 1996). Generic QoL measures allow for assessment of functioning 
  
23 
 
across a broad range of domains regardless of the type of condition a child may have, 
which allows for comparisons of QoL across populations of health conditions or between 
children with and without health conditions (physical or psychological). Disease-specific 
QoL measures, on the other hand, focus on populations with specific diagnoses. These 
allow for meaningful aspects of conditions to be included in QoL measures and may be 
better positioned to detect important therapeutic outcomes. However, disease-specific 
measures do not permit comparisons of QoL among populations of children with 
different conditions, and is also not suited for comparisons of QoL between affected and 
healthy children. Although some may argue in favor of one or the other, the selection of 
QoL measures ultimately rests on the type of questions or goals researchers or clinicians 
aim to address and achieve. Further, regardless of whether generic or disease-specific 
measures are chosen, one must consider developmental differences in markers of QoL 
(Coghill et al., 2009; Eiser & Morse, 2001b; Wallander et al., 2001). For example, issues 
such as body image and autonomy may be critical domains to assess among adolescents 
but not among younger children, and researchers and clinicians desiring to examine such 
age-specific indices of QoL may choose to use measures sensitive to these developmental 
differences. Moreover, identifying key QoL components that are valued by children and 
families may lead to treatments incorporating strategies to foster well-being in QoL 
domains, thereby promoting broader and perhaps more long-lasting positive changes in 
children.  
As medical advances started to increase survival rates of youth with physical 
illnesses that were previously deemed terminal, assessment of QoL in these children and 
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adolescents began to receive growing attention. It is critical to examine and assess the 
broader well-being of these children who will survive with their physical illnesses for the 
rest of their lives. However, the study of QoL in children and adolescents with 
psychological disorders has largely been neglected, and it is only in very recent years that 
interest in examining QoL in children with mental disorder has surfaced (Bastiaansen, 
Koot, & Ferdinand, 2005b; Bastiaansen, Koot, Ferdinand, & Verhulst, 2004; Coghill et 
al., 2009; Sawyer et al., 2002). QoL research in this latter population of children is 
unquestionably important. Specifically in the domain of treatment research, including 
QoL as a key variable can shift clinicians’ and researchers’ focus from exclusively 
symptom reduction to improvement in broader well-being and psychosocial functioning 
(Coghill et al., 2009). Relatedly, the focus can widen from reduction of functional 
impairment (supposedly via symptom reduction) to include fostering of global life 
satisfaction and well-being. In addition, incorporating children’s own perceptions of their 
well-being (and also that provided by proxy informants) can deepen researchers’ 
understanding of treatment effects, and facilitate identification of treatment targets that 
are ecologically valid and personally desired.  
Measuring QoL 
Since comprehensive reviews of QoL measures are available elsewhere (Bullinger 
& Ravens-Sieberer, 1995; Eiser & Morse, 2001b; Harding, 2001; Ravens-Sieberer et al., 
2006), the following will highlight several commonly used measures that focus 
specifically on assessment of children and adolescents, are generic measures that are not 
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restricted for use in specific health populations, and have demonstrated sound 
psychometric properties. 
Child Health Questionnaire (CHQ) 
The self-report form of the CHQ (Landgraf, Abetz, & Ware, 1996) consists of 87 
items to assess 14 physical (e.g., physical function, pain, health perception) and 
psychosocial (e.g., self-esteem, mental health, behavior) concepts in children and 
adolescents between 10 to 18 years of age. In addition, an assessment of interference with 
family activities and social roles is provided. Parent-report (28 or 50 items) versions of 
the CHQ are also available. Psychometric properties of the CHQ have been 
demonstrated, with internal consistency ranging from .43 to .97 (Landgraf et al., 1998). 
The CHQ has also been successful in discriminating among general middle school 
children, those with ADHD, and children with end-stage renal disease.  
Child Health and Illness Profile (CHIP) 
The CHIP (Riley, Forrest, Starfield, Green, & Robertson, 2004; Riley, Forrest, 
Starfield, Robertson, & Green, 2004; Starfield et al., 1993; Starfield et al., 1995) consists 
of an adolescent version (ages 12 to 17) and a child version (ages 6 to 11). Six domains 
of well-being and functioning are assessed: Satisfaction, discomfort, risk avoidance, 
resilience, achievement (adolescent version only), and health conditions (adolescent 
version only). The adolescent version consists of 188 items categorized into 20 
subdomains (e.g., self-esteem, physical comfort, home safety, peer influences).  The child 
version comprises 45 items, and children provide responses based on illustrations 
representing extreme responses. Internal consistency for the domains on the parent form 
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has been reported to range from .68 to .88, and test-retest reliability over a 2-week period 
ranged from .63 to .85 (Riley, Forrest, Starfield, Robertson, et al., 2004). Internal 
consistency for the domains on the child form has been reported to range from .70 to .82 
(Riley, Forrest, Starfield, Green, et al., 2004), and test-retest reliability over a 2-week 
period range ranged from .63 to .76. Although the CHIP can be used in the general 
population, the standardization sample comprised individuals from specific health 
populations (e.g., those with cystic fibrosis, minor infectious illnesses, and juvenile 
rheumatoid arthritis).  
KIDSCREEN Quality of Life Questionnaire 
The KIDSCREEN (Ravens-Sieberer et al., 2005)  is a 52-item instrument 
assessing 10 QoL domains in 8- to 18-year-old children and adolescents: physical well-
being, psychological well-being, moods and emotions, self-perception, autonomy, 
relationships with parents and home functioning, social and peer support, school 
environment, social acceptance and bullying, and financial resources. Two abbreviated 
versions (27 items and 10 items) are also available. The psychometric properties of the 
KIDSCREEN have been demonstrated to be strong, with internal consistency ranging 
from .77 to .89, and it was developed and examined in several European countries, 
suggesting that items are relevant in different cultural groups. Generation of items via 
focus groups also enhance the validity and relevance of items. Further, norms were 
established based on approximately 22,296 individuals, suggesting representativeness of 
the standardization sample.  
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Revididerter KINDer Lebensqualiatsfragebogen (KINDL-R) 
The KINDL-R (Ravens-Sieberer & Bullinger, 1998a; Ravens-Sieberer & 
Bullinger, 1998b) is currently the most widely used QoL measure in Germany (Ravens-
Sieberer et al., 2006), and has also been translated into different languages. Age-
appropriate versions are available (12 items for 4- to 7-year-olds, 24 items for 8- to 12-
year-olds, 24 items for 13- to 16-year-olds). Each version also has a parallel parent-report 
version. In addition to providing a total QoL score, the KINDL-R assesses functioning in 
the following domains: physical, psychological, family, social, school, and self-esteem. 
Disease-specific modules for various health conditions are also available (e.g., asthma, 
diabetes, epilepsy). Items on the KINDL-R were derived from interviews with children, 
and the KINDL has been examined in both health and chronically ill children and their 
parents. Three-year test-retest reliability has been reported to be .80, and internal 
consistency has been described to range from .74 to .95. 
Pediatric Quality of Life Inventory (PedsQL 4.0) 
The PedsQL 4.0 (Varni, Seid, & Rode, 1999) is a 23-item measure assessing QoL 
in 2- to 18-year-old children and adolescents. Parallel parent reports are available. The 
PedsQL 4.0 assesses four core domain of functioning: Physical, emotional, social, and 
school. Summary scores are provided in terms of a total score, a physical health summary 
score, and a psychosocial health summary score. This measure was originally developed 
for chronically ill children and adolescents, though has been administered in otherwise 
physically health youth as well (Bastiaansen, Koot, & Ferdinand, 2005a; Bastiaansen, 
Koot, Bongers, Varni, & Verhulst, 2004; Bastiaansen et al., 2005b; Bastiaansen, Koot, 
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Ferdinand, et al., 2004). Internal consistency has been reported to range from .86 to .90 
for the parent form, and from .80 to .88 for the child form (Varni, Seid, & Kurtin, 2001).  
As can be seen, a range of measures are available to assess QoL in children and 
adolescents. The measures described above vary in length, breadth of domains assessed, 
availability of parent proxy versions and age-specific versions, and options for including 
disease-specific modules.  
Functional Impairment or QoL in Resilience Research 
It has likely been made apparent that the relationship between functional 
impairment and QoL is complex. Argued to be unique and separate constructs, they are 
nonetheless linked. It is not difficult to imagine that when a child’s functioning is 
significantly impaired given his/her psychopathology (e.g., a child with severe social 
phobia who is unable to attend school or participate in other extra-curricular activities), 
s/he would exhibit lower QoL as well, particularly in domains most affected by 
symptoms (e.g., for this child, one might expect for him/her to perceive lower satisfaction 
with his/her social interactions). However, it is also conceivable that even without 
significant impairment from psychopathology (e.g., perhaps due to low levels of 
symptoms), one might still experience low QoL. For example, factors other than 
psychopathology may influence QoL, such that a lack of access to resources or 
opportunities to develop adaptive skills may hinder a child from experiencing high QoL 
(e.g., experiencing low QoL in the social domain because a child lives in a neighborhood 
with no other children close to his/her age or where playing outside is dangerous due to 
the presence of drug dealers and violence). In addition, although measurement of 
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functional impairment is in essence “anchored” by the experience of psychopathology, 
assessment of QoL allows one to examine individuals’ global well-being without 
psychopathology as well as despite experiencing psychopathology. All this suggests that 
functional impairment and QoL at once share similar characteristics and are related to 
one another, and each plays a distinctive role in explaining the life experience of children 
with psychopathology.  
In sum, functional impairment is conceptualized as a more objective measurement 
of the negative impact psychological symptoms and disorders on one’s functioning. 
Whether tied explicitly to specific symptom constellations (e.g., GAF, CGAS) or not 
(e.g., WHODAS), measures of functional impairment when discussed in the context of 
psychopathology are at least conceptually related to symptoms one is experiencing or 
exhibiting. QoL is conceptualized as a subjective measure of one’s well-being and 
satisfaction with life. Although it has been more sparsely studied in the context of 
psychopathology, this has begun to be done in recent years. Given its conceptual 
separation from symptoms and psychopathology, QoL is a more suitable measure of 
positive adaptation when examining resilience in children with psychopathology. This is 
not to say that QoL is “more important” than functional impairment, for both have their 
unique value in contributing to our understanding of the well-being of children with 
psychopathology and warrant continued study. However, when exploring the construct of 
resilience, QoL seems to be the more appropriate choice. Specifically, one can ask the 
questions: Do some children experiencing psychopathology, with or without significant 
functional impairment from their symptoms, who nevertheless experience high QoL? 
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What predicts these resilient outcomes, and do these children demonstrate different 
trajectories of their psychopathology over time compared to those who do not 
demonstrate resilience? 
 To my knowledge, no studies have examined the construct of resilience in the 
context of psychopathology using measures of QoL as an indicator of positive adaptation 
or competence. What follows is a brief review of the literature examining indices of QoL 
among children with diagnoses of psychological disorders or symptoms of 
psychopathology. As mentioned, there is currently scant research exploring QoL across 
psychological disorders in children, though more work has been conducted in some 
diagnostic groups than others. Following this review, aims and hypotheses of the current 
study will be presented.  
Studies Focused on Attention-Deficit/Hyperactivity Disorder (ADHD) 
This diagnostic group is perhaps the one in which the most QoL research in 
children with mental disorders has been conducted. Danckaerts and colleagues (2010) 
conducted a thorough, systematic review of the current available literature examining 
QoL in children with ADHD. Several notable findings are described in this review. 
Overall, the authors note that QoL research in this population of children has somewhat 
neglected to incorporate self-reported QoL from children themselves, with the majority of 
studies relying solely on proxy report provided by parents. Based on parent reports, 
children with ADHD display reduced QoL in various domains, such as psychosocial, 
achievement, and self-esteem, compared to children without ADHD. With regard to 
physical functioning, no robust effects are found. For the few studies identified that did 
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incorporate children’s perspectives, negative effects of ADHD on QoL appear to be less 
than when ratings are provided by parents. In addition, QoL of children with ADHD 
seems to be comparable to those with other health conditions, such as cancer, cerebral 
palsy, and other mobility impairment. Just as increased ADHD symptoms and 
impairment generally predict lower QoL, comorbid disorders such as oppositional defiant 
disorder, conduct disorder, depression, and anxiety disorders also reduce QoL. Other 
psychosocial stressors such as parental mental illness and tobacco use by mothers during 
pregnancy are associated with poorer QoL in children with ADHD. Further, Danckaerts 
and colleagues describe promising evidence suggesting the role that pharmacological 
treatments play in improving QoL, though much more work has examined the effects of 
atomoxetine than other medications such as methylphenidate and amphetamines. 
Findings from specific studies discussing QoL in children with ADHD are highlighted 
below.   
In an open-label study evaluating the effects of a modified-release 
methylphenidate in 6- to 17-year-old children and adolescents diagnosed with ADHD 
(Becker, Roessner, Breuer, Dopfner, & Rothenberger, 2011), baseline analyses revealed 
that although core symptoms of ADHD as measured by the Strength and Difficulties 
Questionnaire (Goodman, 1997) did not predict QoL assessed by the KINDL (Ravens-
Sieberer & Bullinger, 1998a), having an additional diagnosed conduct disorder in 
adolescents was associated with lower overall self-reported QoL and in the specific 
domains of physical well-being, emotional well-being, self-esteem, family functioning, 
and friendships. Further, 12 to 17-year-old adolescents who received medication 
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treatment at baseline showed higher self-reported QoL in the domain of school 
functioning compared those who did not. Similar trends were found in the self-esteem 
and family functioning domains. Riley and colleagues (2006) also examined baseline 
characteristics related to QoL among 1,478 children diagnosed with ADHD at entry to 
the ADHD Observational Research in Europe (ADORE) study. Based on parent-reported 
QoL on the CHIP, children with ADHD had lower QoL in the risk avoidance and 
achievement domains compared to general community norms. Several factors were 
associated with lower QoL, including: levels of ADHD symptoms, conduct problems, 
peer difficulties, presence of asthma, physical symptoms, parental mental health 
problems, not living in two-parent households, and maternal smoking in pregnancy. In 
addition, having multiple comorbid psychiatric problems was also associated with lower 
QoL across domains (Steinhausen et al., 2006). 
Klassen (2005) reviewed 10 studies examining QoL in children with ADHD and 
found that overall, children with ADHD experienced poorer QoL in the domains of 
psychosocial functioning and family activities compared to normative data from the 
general population of children. Focusing specifically on studies using the CHQ as a QoL 
measure, pooled effect sizes for comparisons between children with ADHD and those in 
the general population ranged from -0.55 to -1.67 in various domains (effect size smallest 
for the mental health domain, and largest for the family activities domain), indicating that 
children with ADHD do in fact experience lower QoL than children in the general 
population. In an analysis of a database consisting of PedsQL 4.0 responses from 5- to 
16-year-old children and their parents, Varni and Burwinkle (2006) found that the 
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PedsQL was successful in distinguishing healthy children from those with ADHD, such 
that QoL in children with ADHD was consistently lower than healthy children. Self-
reported QoL by children with ADHD appeared comparable to that reported by newly 
diagnosed children with cancer and children with cerebral palsy. In addition, Hakkaart-
van Roijen et al. (2007) revealed that comparing 70 children diagnosed with and being 
treated for ADHD with a community sample of children with high levels of behavioral 
problems and another with low levels of behavioral problems, children with ADHD 
displayed lower levels of psychosocial QoL on the CHQ than children in the comparison 
samples. However, no differences among the groups were found for physical QoL.  
Escobar and colleagues (2005) examined QoL among 6- to 12-year-old children 
newly diagnosed with untreated ADHD and two age- and gender-matched control groups, 
including children with asthma and healthy children. Results from the CHQ revealed that 
children with ADHD showed lower QoL on most domains measured by the CHQ 
compared to both children with asthma and healthy children. In particular, the domains of 
behavior, limitations on social functioning due to physical problems, emotional impact on 
parents, and family activities were most affected. In a recent study comparing QoL in 120 
7- to 12-year-old children diagnosed with ADHD and 99 health children, Zambrano-
Sánchez, Martínez-Cortés, Del Rio Carlos, Dehesa-Moreno, and Poblano (2012) also 
found that children with ADHD exhibited significantly lower levels of QoL in domains 
such as family and peer relationships.  
There is also evidence that with effective pharmacological treatment (e.g., 
atomoxetine), significant improvements in QoL are found (Wehmeier, Schacht, & 
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Barkley, 2010). In a 24-month open-label trial of atomoxetine among 6- to 17-year-old 
children and adolescents (Perwien et al., 2006), significant improvements on 
psychosocial domains of parent-reported QoL as measured by the CHQ were observed in 
the short term (10-week acute phase) and maintained in the long term (24 months). No 
significant improvements on physical QoL were found in either the acute phase or long-
term follow-up. Comparing results from three randomized-controlled trials (RCTs), 
Perwien and colleagues (2004) found that children and adolescents who received 7- to 8-
week treatment of atomoxetine exhibited higher levels of psychosocial QoL than those 
who received a placebo pill. As with Perwien and colleagues’ findings in 2006, no 
differences in physical QoL were found. Factors that predicted improvement in these 
QoL domains include lower initial QoL scores, no history of stimulant treatment, and the 
absence of oppositional defiant disorder (ODD). Interestingly, Wehmeier et al. (2011) 
found that in their 9-week RCT examining the effect of atomoxetine among 180 6- to 17-
year-old children and adolescents who had ADHD with comorbid ODD or conduct 
disorder (CD) diagnosis, parent-reported QoL as measured by the KINDL-R improved 
significantly more among those treated with atomoxetine than among those who received 
a placebo pill.  
In a 12-week randomized controlled trial (RCT) of atomoxetine among 151 newly 
diagnosed children and adolescents with ADHD, Escobar and colleagues (2009) revealed 
that at baseline, parents reported low QoL in the areas of risk avoidance and achievement 
on the CHIP, whereas children and adolescents reported somewhat higher though still 
compromised QoL (according to the CHIP’s scoring procedures), especially in the 
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achievement domain. Following this 12-week atomoxetine treatment, parent reported 
significant improvements in both the risk avoidance and achievement domains, and 
according to children, significant improvements in the risk avoidance domain were 
reported. Examining relationships between clinical symptoms of ADHD and QoL among 
297 children and adolescents enrolled in an 8-week RCT of atomoxetine, Matza and 
colleagues (2004) reported significant negative correlations between ADHD symptoms 
and domains of QoL (other than physical health) as measured by the CHQ. Further, 
improvement in symptoms after atomoxetine treatment was associated positively with 
improvements in QoL.  
Although the above pharmacological treatment studies seem to suggest QoL 
improvements with atomoxetine treatment, Brown and colleagues’ (2006) RCT of 
atomoxetine among 153 8- to 12-year-old children with ADHD revealed only a trend in 
parent-reported psychosocial QoL improvement among treated children versus those who 
received a placebo pill. In a study conducted in Taiwan examining QoL in 119 6- to 15-
year-old children diagnosed with ADHD who were treated with methylphenidate (Yang, 
Hsu, Chiou, & Chao, 2007), children with ADHD had lower parent-reported 
psychosocial QoL compared to a community sample of 129 healthy children. However, 
improvements in core ADHD symptoms after treatment with methylphenidate predicted 
higher psychosocial QoL. This study provides a cross-cultural indication that children 
with ADHD experience poorer QoL compared to healthy children, and effective 
pharmacological treatment can serve to improve psychosocial QoL.  
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Several studies have also examined the relationship between parents’ ratings of 
children’s QoL and children’s own ratings. In a questionnaire survey study of 10- to 17-
year-old children diagnosed with ADHD and their parents, Klassen, Miller, and Fine 
(2006) found that children rated their QoL significantly higher than their parents 
regarding their behavior, self-esteem, mental health, and family cohesion, but rated their 
physical functioning as poorer than that reported by their parents. Consistent with 
previous findings suggesting greater parent-child concordance on more observable than 
covert domains, children and parents in this study showed greater agreement in domains 
such as physical functioning and bodily pain, and lower agreement on mental health and 
self-esteem domains. Sciberras, Efron, and Iser (2011) found that parents’ reports of the 
QoL in their 8- to 18-year-old children and adolescents with ADHD were significantly 
lower across psychosocial, but not physical, domains, compared to youth’s self-reports. 
In contrast, Varni and Burwinkle (2006) found similar QoL ratings across psychosocial 
and physical domains between 5- to 16-year-old children and adolescents with ADHD 
and their parents.  
Summary of QoL Research in ADHD 
Overall, research on QoL in children with ADHD suggests that these children 
experience lower QoL compared to healthy children. More ADHD symptoms, and the 
presence of comorbid conditions such as disruptive behavior disorders, are associated 
with lower QoL. In addition, effective pharmacological treatments, primarily 
atomoxetine, increase QoL. Further examinations of parent-child agreement in QoL 
ratings is necessary, but current available findings suggest that children and parents may 
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show more comparable ratings in observable, physical domains, yet lower agreement is 
generally found in more covert domains. Further, there is some evidence that children 
may rate their QoL as higher than ratings by their parents, particularly regarding their 
psychosocial QoL.  
Studies Focused on Disruptive Behavior and Substance Use Disorders 
Few studies have examined QoL specifically in youth with conduct disorder and 
substance abuse. Nevertheless, it appears that both medication treatment and 
psychosocial intervention may improve QoL among adolescents with conduct and 
substance use disorders. Azrin et al. (2001) examined the QoL of 12- to 17-year-old 
adolescents with both conduct and a substance use disorder who were randomly assigned 
to participate in individual cognitive therapy or family behavioral therapy (each were 15 
sessions). Results suggest that not only did both of these treatments reduce illicit drug use 
from pre- to post-treatment with gains maintained at 6-month follow-up, youths’ 
satisfaction with their parents (measured by the Youth Happiness with Parent Scale; 
DeCato, Donohue, Azrin, & Teichner, 2001), parents’ satisfaction with their youth 
(measured by the Parent Happiness with Youth Scale; Donohue, DeCato, Azrin, & 
Teichner, 2001), and youths’ satisfaction with work and school as well as overall life 
satisfaction (measured by the Life Satisfaction Scale for Adolescents; Teichner, Azrin, 
Donohue, Howell, Rindsberg, Decato, & Ward, 1998) were significant improved at post-
treatment and 6-month follow-up.  
In a 7-week RCT examining the effect of quetiapine on symptoms and QoL of 12- 
to 17-year-old youth with a CD diagnosis and moderate-to-severe aggression (Connor, 
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McLaughlin, & Jeffers-Terry, 2008), those who received quetiapine showed significantly 
greater improvement in parent-reported QoL, measured by the Quality of Life Enjoyment 
and Satisfaction Questionnaire (Endicott, Nee, Harrison, & Blumenthal, 1993) compared 
to those who received a placebo. Those in the active treatment group also demonstrated 
improvements in clinical severity compared to those in the placebo group. However, no 
significant between-group differences on parent-rated aggression were noted.  
Finally, among 106 13- to 21-year-old youth with a substance use disorder who 
participated in the 5-session Effective Adolescent Treatment project (Becker, Curry, & 
Yang, 2009), which combined motivational enhancement and cognitive-behavioral 
therapy, reduced substance use was associated with improvement in self-reported QoL, as 
measured by the Quality of Life Profile – Adolescent Version (Raphael, Rukholm, 
Brown, Hillbailey, & Donato, 1996). Interestingly, frequency of substance use predicted 
QoL, whereas the reverse relationship was not supported. Further, greater peer 
involvement with substance use and adolescent depression severity predicted lower 
baseline QoL. Unexpectedly, higher baseline depression was associated with greater QoL 
improvements over a 12-month follow-up period (Becker et al., 2011).   
Summary of QoL Research in Disruptive Behavior and Substance Use Disorders 
Although QoL research focused specifically on these disorders is sparse, available 
findings suggest that both pharmacological and psychological treatments contribute to 
improved QoL among adolescents. When examining QoL in these populations, it may be 
important to consider levels of peer substance use and adolescents’ own depressive 
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symptoms, and their effects on QoL as well as trajectories of improvement from 
treatment.  
Studies Focused on Anxiety, Obsessive-Compulsive, and Tic Disorders 
Obsessive-Compulsive Disorder (OCD) 
Anecdotal clinical experiences suggest that children with OCD experience 
increased somatic and depressive symptoms, show reduced engagement in peer activities, 
and are frequently implicated in family conflicts (Lack et al., 2009). In a study examining 
QoL in children and adolescents, 62 8- to 17-year-olds with a diagnosis of OCD and one 
of their parents or caregivers completed the PedsQL 4.0 (Lack et al., 2009). Data from 
the Child Behavior Checklist (CBCL; Achenbah, 1991a)  and the Children’s Yale-Brown 
Obsessive Compulsive Scale (CY-BOCS; Scahill et al., 1997) were also available. Lack 
and colleagues (2009) reported that QoL in youth with OCD was significantly lower than 
that of healthy controls but comparable to those in a general psychiatric sample on most 
QoL domains. In this study, there were strong positive parent-child correlations on the 
total, psychosocial health, and emotional functioning scores among 6- to 11-year-old 
children. Among 12- to 17-year-old adolescents, concordance with parents was observed 
in all domains except for physical health. Parents generally perceived lower QoL than 
children and adolescents themselves. In addition, internalizing symptoms, but not OCD 
severity rated by clinicians, significantly predicted QoL as reported by children. On the 
other hand, neither externalizing symptoms nor OCD severity independently predicted 
child-reported QoL, though together they predicted QoL. Regarding parent-reported QoL, 
both internalizing symptoms and OCD severity were significant predictors, and in a 
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model containing externalizing symptoms and OCD severity, only externalizing 
symptoms significantly predicted parent-reported QoL. Thus, it seems that levels of 
comorbid internalizing and externalizing symptoms are informative in predicting QoL in 
children with OCD, more so than OCD severity, highlighting that severity and QoL are 
two related though distinct constructs that each warrants careful study.  
In an initial randomized controlled waitlist trial of a QoL intervention aimed at 
increasing QoL of children with OCD and their mothers (Abedi & Vostanis, 2010), 
mothers of 49 6- to 18-year-old children and adolescents were randomized to a waitlist or 
to participate in an 8-session intervention, QoL therapy (QoLT), aimed at fostering skills 
in managing life situations. Strategies taught in this intervention include: achieving a 
balanced lifestyle, showing increased affection to their child, spending greater quality 
time with their child, and focusing on positive aspects of one’s life. Results suggest that 
based on children’s report on the Brief Multidimensional Students’ Life Satisfaction 
Scale (BMSLSS; Seligson, Huebner, & Valois, 2003), significant improvements in 
children’s overall QoL, family life, satisfaction with themselves, and satisfaction with 
their living arrangements were observed among children in the treatment group. Children 
in the QoLT condition also reported lower anxiety and OCD symptom, and mothers who 
participated in QoLT reported improvements in their own QoL.  
Separation Anxiety Disorder (SAD) 
Schneider et al. (2011) conducted a randomized waitlist controlled trial of a 16-
session treatment program 5- to 7-year-old children with SAD and their parents, which 
incorporates cognitive-behavioral therapy (CBT) and parent training components. Based 
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on child- and parent-reported QoL on the 9-item Inventory for the Assessment of Quality 
of Life in Children and Adolescents (Mattejat et al., 1998; Mattejat et al., 2005), mothers 
and fathers reported the QoL of children in the treatment condition to be higher than 
those in the waitlist group. At 4-week follow-up, fathers in the combined sample reported 
significantly improved QoL compared to scores at post-treatment. These findings provide 
preliminary support that psychosocial treatment programs for children with SAD and 
their families may be successful at improving children’s QoL.  
Post-Traumatic Stress 
Landolt, Vollrath, Gnehm, and Sennhauser (2009) recruited 6- to 14-year-old 
children and adolescents who had experienced a recent traffic accident in which 
hospitalization for at least 24 hours was required. Compared to a community Dutch 
sample, children in this study self-reported lower motor functioning, autonomy, and 
positive emotions, but surprisingly, reported higher physical functioning than the 
reference sample on the Toegepast Natuurwetenschappelijk Onderzoek-Academisch 
Ziekenhuis Leiden (TNO-AZL) Children’s Quality of Life (TACQOL) questionnaire 
(Vogels et al., 2000). However, at one-year follow-up, the target children’s QoL domain 
scores were in the normal range or above; they even reported lower physical problems 
and greater social functioning than children in the reference sample. Importantly, 
children’s post-traumatic stress reactions (e.g., symptoms of post-traumatic stress 
disorder) significantly predicted QoL (inverse relationship) at the one-year follow-up. In 
a study exploring the relationships among trauma exposure, posttraumatic stress 
reactions, and QoL, Alisic, van der Schoot, van Ginkel, and Kleber (2008) found that 
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among children from 36 randomly selected primary schools in the Netherlands, those 
who experienced trauma reported lower QoL on the KIDSCREEN-27 compared to those 
not exposed to trauma. Also, higher levels of posttraumatic stress reactions showed a 
significant inverse relationship with QoL, further supporting the negative effect of 
exposure to trauma and posttraumatic stress reactions on children’s QoL.  
Tic Disorders 
 Storch et al. (2007) examined the QoL of 59 8- to 17-year-old children and 
adolescents with diagnosed Tourette’s syndrome or a chronic tic disorder. Comparing the 
QoL of these children and adolescents with that of youth in psychiatric (Bastiaansen, 
Koot, Bongers, et al., 2004) and healthy control (Varni, Burwinkle, Seid, & Skarr, 2003) 
samples, Storch and colleagues (2007) found that the parent-reported QoL of children 
with tic disorders were generally higher than that of children in a psychiatric sample (e.g., 
higher psychosocial health, emotional functioning, social functioning), whereas both 
child- and parent-reported QoL of children with tic disorders were lower than healthy 
children on most domains (e.g., psychosocial health, emotional functioning, social 
functioning, school functioning). The physical health domain of both child- and parent-
reported QoL did not differ across the three samples. Clinician-rated tic severity was 
more negatively associated with child-reported than parent-reported QoL, and parent-
reported internalizing and externalizing symptoms were also negatively associated with 
both child- and parent-reported QoL. An interaction effect suggested that increased tic 
severity predicted worse parent-reported QoL only among children with low levels of 
externalizing symptoms, and severity was unrelated to QoL among those with high levels 
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of externalizing symptoms. Storch and colleagues postulated that since parents rated their 
children’s QoL as generally lower among those with high externalizing symptoms, 
disruptive behavior symptoms among these children may be more concerning for parents 
than their tic symptoms.  
In a study examining the effect of comorbid OCD and ADHD on the QoL 
(measured by the Young Quality of Life Instrument – Research Version; Edwards, 2002; 
Patrick, 2002) of 11- to 17-year-old adolescents’ diagnosed with Tourette Syndrome, 
Eddy et al. (2012) found that those who had both OCD and ADHD showed lower overall 
QoL and relational functioning compared to those with only Tourette Syndrome. In the 
whole sample, high levels of ADHD symptoms were associated with lower QoL in the 
domains of self-perception and relational functioning. On the other hand, high levels of 
OCD symptoms were associated with lower QoL across all domains (i.e., self-perception, 
relational functioning, environment, and general).  
Summary of QoL Research in Anxiety, Obsessive-Compulsive, and Tic Disorders 
QoL research in these disorders is fairly recent, yet existing findings seem to 
converge on the observation that children experiencing symptoms and diagnoses of an 
anxiety disorder, OCD, and tic disorders exhibit lower QoL compared to children who do 
not. The presence of comorbid symptoms and diagnoses may also negatively impact QoL 
in various domains. In addition, symptom severity appears to be distinct from QoL, 
suggesting there is value in treating these two constructs as unique in psychopathology 
research. Further, there is some evidence that treatments targeted at improving QoL and 
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those that aim to address specific disorders (e.g., SAD) can contribute to improved QoL 
post-intervention.    
Studies Focused on Depressive Disorders 
The Treatment for Adolescents with Depression Study (TADS) was a 12-week 
multisite, randomized clinical trial in which 439 outpatient adolescents with moderate to 
severe MDD received one of the following: fluoxetine alone, CBT alone, CBT with 
fluoxetine, or pill placebo with clinical management (TADS, 2003). Short-term symptom 
outcomes suggest that those who received fluoxetine alone and CBT in combination with 
fluoxetine demonstrated greater improvement than those who received CBT alone or pill 
placebo (March et al., 2004). With regard to long-term outcomes, fluoxetine alone and 
combination treatment demonstrated more rapid symptom improvement, though by 24 
weeks, treatment effects converged and there were no significant differences among the 
three treatment groups in symptom scores (March et al., 2007). Focusing on functioning 
and QoL outcomes in the TADS sample at post-treatment, Vitiello et al. (2006) found 
that adolescents who received combination treatment reported higher total QoL based on 
their responses on the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire 
(Endicott, Nee, Yang, & Wohlberg, 2006) compared to those in the placebo condition. 
Adolescents in the combination condition also reported greater QoL improvement than 
those in either the fluoxetine or CBT alone conditions; no significant differences in QoL 
were found between the latter two conditions. Thus, among adolescent with moderate to 
severe depression, receiving both pharmacological treatment and CBT improved their 
QoL in addition to reducing their depressive symptoms.  
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In a general population of 237 8- to 18-year-old children and adolescents, 
Stevanovic (2013) found that levels of depressive symptoms reported by youth on the 
Short Mood and Feeling Questionnaire (Angold et al., 1995) negatively predicted self-
reported QoL on the PedsQL 4.0. Further, in a study comparing QoL between 679 parent-
child dyads in Japan (Kobayashi & Kamibeppu, 2011), children with depressive 
symptoms consistently rated their QoL on the PedsQL as lower than their peers without 
depressive symptoms. However, no significant differences in parents’ proxy-report were 
found between these two groups. On the other hand, parents with and without depressive 
symptoms rated the QoL of their children differently, such that parents with depressive 
symptoms consistently rated their children lower on QoL compared to parents without 
depressive symptoms, regardless of children’s actual level of depressive symptoms. 
Overall, parents tended to underestimate (compared to children’s self-reports) children’s 
school and social functioning, but significantly overestimate children’s emotional 
functioning. Based on these findings, Kobayashi and Kamibeppu emphasized the 
importance of exploring both parents’ and children’s reports of QoL and to consider the 
impact of parents’ own mental health in their proxy-reports of children’s QoL.  
Summary of QoL Research in Depression 
Few studies have examined the QoL construct as described above specifically in 
children with depressive disorders. While not explicitly measuring QoL per se, research 
among children with depressive disorders or symptoms suggest that these youth sustain 
poorer interpersonal relationships with family members and friends, show more 
problematic academic functioning, have lower self-esteem, and also show reduced 
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activity level (Birmaher, Arbelaez, & Brent, 2002; Birmaher et al., 2007; Birmaher et al., 
2004; Goodyer, Herbert, Tamplin, Secher, & Pearson, 1997; Hammen, Shih, Altman, & 
Brennan, 2003; Lewinsohn, Gotlib, & Seeley, 1997). A review of studies examining QoL 
in general and psychiatric samples (i.e., not specific to depression) will be presented later 
in this document, which further elucidates QoL indices in children experiencing 
depression and depressive symptoms, along with other disorders and symptoms. For now, 
it appears that the presence of depressive symptoms can negatively affect children’s QoL. 
It is informative to incorporate both parents’ and children’s reports of QoL, and to also 
recognize the impact that parental mental health may have on the reporting of children’s 
QoL.  
Studies Focused on Suicidality 
In a national survey (the “BELLA” study) conducted in Germany (Ravens-
Sieberer & Kurth, 2008) with 2,863 7- to 17-year-old children and adolescents and one of 
their parents, youth presenting with suicidal thoughts, attempt, or self-injurious behavior 
exhibited lower QoL compared to those without these symptoms, according to both self- 
and parent-reports on the KIDSCREEN. In a study of 5,557 11- to 18-year-old youth in 
Hong Kong, QoL-related correlates were examined to predict suicidal ideation in this 
sample (Kwok & Shek, 2010). Results suggest that hopelessness in adolescents mediated 
the effect of emotional competence, social problem-solving, parent-child communication, 
and family functioning on suicidal ideation. Further, in an investigation of 114 completed 
suicides among 15- to 24-year-old youth in China (Li, Nussbaum, & Richards, 2007), in 
addition to recent severe life events, presence of depressive symptoms, and acute stress at 
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the time of death, QoL indicators such as physical health, psychological well-being, 
familial relationships, and other interpersonal relationships in the month prior to death, 
were significantly more impaired in suicide completers than those who died by injury. To 
be described in the next section, suicide ideation and attempts were associated with lower 
levels of parent-reported total QoL and family functioning among 5- to 18-year-old 
children and adolescents with a bipolar disorder diagnosis (Algorta et al., 2011). In sum, 
it appears that suicidality is negatively related to QoL and QoL-related constructs. 
Findings from those who completed suicide highlight the importance of assessing QoL 
among those presenting with suicide ideation and intent to protect these youth from 
ending their lives.  
Studies Focused on Bipolar Spectrum Disorders (BPSD) 
 Freeman et al. (2009) examined QoL among treatment-seeking 8- to 18-year-old 
youth. Based on parent-reported QoL on the KINDL-R, those with a bipolar spectrum 
disorder (BPSD) diagnosis showed significantly lower QoL in various domains compared 
to youth with depression, behavior disorders, other non-mood and non-behavioral 
diagnoses, and youth with various physical conditions (e.g., asthma, obesity arthritis). In 
addition, depressive, hypomanic, manic, and mixed mood symptoms were negatively 
related to QoL, after controlling for the effects of age, sex, comorbidities, ethnicity, and 
site. Overall, girls had greater mood symptoms and lower QoL, and those presenting at 
community mental health centers had higher QoL than those presenting at an academic 
medical center. Further, depressive symptoms had the strongest negative association with 
QoL, compared to hypomanic or mixed mood states.  
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In a study examining QoL using the KINDL-R among 54 7- to 13-year-old youth 
with a diagnosed BPSD, Van Meter, Henry, and West (2013) found that child depressive 
symptoms as rated by parents on the Child Bipolar Depression Rating Scale (CBDRS; 
Pavuluri, unpublished) negatively predicted child-reported overall QoL and physical 
well-being, as well as parent-reported overall QoL, physical and emotional well-being, 
self-esteem, and family functioning. Parent-reported mania symptoms on the Child Mania 
Rating Scale (CMRS; Pavuluri, Henry, Devineni, Carbray, & Birmaher, 2006) were 
associated positively with child-reported self-esteem and parent-reoprted physical well-
being. An interaction effect revealed that for children with both severe manic and 
depressive symptoms, better family functioning was observed compared to those with 
only severe depressive symptoms. Considering clinician-rated depressive and manic 
symptoms on the Children’s Depression Rating Scale-Revised (CDRS-R; Poznanski, 
Freeman, & Mokros, 1985; Poznanski, 1984) and Young Mania Rating Scale (YMRS; 
Young, Biggs, Ziegler, & Meyer, 1978), respectively, depressive symptoms were 
associated negatively with child-reported overall QoL, physical and emotional well-
being, self-esteem, friendship quality, and school functioning, as well as parent-rated 
overall QoL. Clinician-rated manic symptoms were related positively to child-rated 
physical functioning but not with parent-reported QoL. Interaction effects detected in this 
sample also suggested that although clinician-rated depressive symptoms predicted lower 
child-reported emotional functioning, comorbid manic symtoms may have a protective 
effect. Similar effects were found in parent-reported school functioning. These results 
suggest that although mania can certainly negatively impact functioning, bipolar 
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depression may have a stronger negative effect on youth’s QoL and warrants careful 
treatment, particularly since youth may spend greater periods of time in depressive rather 
than manic states (Birmaher, Axelson, Goldstein, et al., 2009; Birmaher, Axelson, 
Strober, et al., 2009).  
The QoL of children and adolescents with a BPSD and those with psychosis have 
also been examined in those participating in pharmacological trials. Stewart, DelBello, 
Versavel, and Keller (2009) explored baseline parent-reported QoL, measured by the 
CHQ, of 10- to 17-year-olds in an open-label trial of ziprasidone. Across diagnoses of 
BP-I, schizophrenia, and schizoaffective disorder, youth’s psychosocial QoL was below 
that based on CHQ norms, particularly in the domains of family activities, impact on 
parents’ time and emotions, mental health, self-esteem, and behavior. Consistent across 
diagnostic groups, psychosocial QoL was more greatly impaired than physical well-
being. Rademacher, DelBello, Adler, Stanford, and Strakowski (2007) compared parent-
reported QoL of adolescents (average age, 15 years old) with a bipolar disorder I (BP-I) 
diagnosis who were currently in a manic or mixed episode, and who were assigned to 
receive either divalproex treatment or quetiapine treatment for 28 days. At baseline, the 
reported QoL of these youth (based on parent ratings on the CHQ) was significantly 
lower than national norms for the CHQ, except for domains involving physical 
functioning, for which there were no significant differences from CHQ norms. At 28 
days, parents of adolescents who received divalproex continued to report significantly 
lower QoL compared to CHQ norms in these domains (other than those related to 
physical functioning). On the other hand, adolescents who received quetiapine showed no 
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differences in behavior, bodily pain, or self-esteem, compared to CHQ norms. In 
addition, although QoL scores for those in the medication trial generally remained lower 
than CHQ norms, significant improvements in QoL were observed from baseline to post-
treatment for both treatment groups.  
Olsen et al. (2012) conducted a trial of olanzapine among 160 13- to 17-year-old 
adolescents currently experiencing a manic or mixed episode. Parent-reported QoL on the 
CHQ revealed that both adolescents in the olanzapine and placebo groups had lower 
psychosocial (not physical) QoL than those in the CHQ normative sample. Although all 
adolescents continued to show lower QoL compared to CHQ norms on various 
psychosocial QoL domains at 3 weeks of treatment, those in the olanzapine group 
exhibited greater improvements in psychosocial QoL, particularly in the behavior, family 
activities, and mental health domains, compared to those in the placebo group. In 
addition, improvements in manic symptoms were related to improvements in QoL scores. 
These results suggest that while olanzapine may contribute to improvements in some 
psychosocial domains in the QoL of adolescents with a BPSD and that improvement in 
mood symptoms is associated with QoL improvement, further treatment appears to be 
required to raise QoL to normal levels.  
Twenty-eight 12- to 25-year-old individuals diagnosed with BP-I participated in a 
24-week observational trial of aripiprazole in Taiwan (Tang et al., 2010). Self-reported 
QoL on the WHOQOL questionnaire (The WHOQOL Group) suggested significant 
improvement in physical well-being and social relationships from pre- to post-treatment, 
though no significant improvement was observed in patients’ psychological health or 
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environment scores. In addition, participants with current depressive, manic, or mixed 
episodes did not show significantly different QoL changes. As mentioned above, Algorta 
et al. (2011) examined the relationship between QoL and suicidality among 5- to 18-year-
old children and adolescents with a BPSD. Results revealed that suicide ideation and 
attempts were related negatively to parent-reported QoL (particularly in the family 
domain and overall QoL) and family functioning (Algorta et al., 2011).   
Although not exploring QoL per se, Keenan-Miller, Peris, Axelson, Kowatch, and 
Miklowitz (2012) found that among 12- to 18-year-old adolescents with BP-I or BP-II, 
higher levels of depressive symptoms were associated with poor family functioning as 
rated by children. In contrast, moderate levels of mania were associated with reduced 
family conflict, increased adaptability, and greater family cohesion. Aggression was 
related to lower levels of family functioning, as reported by adolescents, parents, and 
clinicians, controlling for effects of mood and other symptoms. Further, high levels of 
expressed emotion in parents are implicated in both BPSD symptoms and relapse 
following recovery from mania (Geller et al., 2002; Geller, Tillman, Craney, & 
Bolhofner, 2004; Miklowitz, 2004; Miklowitz, Biuckians, & Richards, 2006). This 
provides a convincing rationale for treatments to target family functioning not only to 
improve overall QoL, but also to improve BPSD symptoms. 
Summary of QoL Research in BPSD 
Overall, these findings suggest that QoL of children with BPSD is generally lower 
than those in the general population, particularly in psychosocial domains. There is also 
evidence that depressive symptoms among youth with BPSD affect QoL more negatively 
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than do manic, hypomanic, or mixed symptoms. Further, medication treatments seem to 
show some positive effects in improving QoL, although results suggest that additional 
treatment is necessary to produce broader and greater improvements in QoL. Finally, 
characteristics of the family environment, such as expressed emotion, serve as critical 
factors in the treatment of BPSD in youth. Improving family dynamics and interactions 
may improve overall QoL in children with a BPSD in addition to reducing their BPSD 
symptoms.  
Studies of General and Psychiatric Samples 
Bastiaansen and colleagues (2004) examined QoL of 310 6- to 18-year-old 
children and adolescents who were referred to outpatient child psychiatric clinics in the 
Netherlands for psychiatric problems. Comparing children’s and parents’ ratings on the 
PedsQL 4.0 and clinicians’ ratings on the Child and Adolescent Functional Assessment 
Scale (Hodges, 1997). There were no significant differences in overall QoL across 
diagnostic categories between children and parents, although clinicians rated children 
with a pervasive developmental disorder (PDD) as having lower QoL compared to those 
in other diagnostic groups. Focusing on specific domains and based on parents’ report, 
however, children with ADHD and/or a disruptive behavior disorder (DBD) showed 
lower emotional functioning compared to those with other disorders (e.g., learning 
disorders, somatoform disorders), and had lower school functioning than those with other 
disorders or no diagnoses. Interestingly, the presence of conditions comorbid to ADHD 
and DBD did not influence QoL in these children. Based on clinicians’ ratings, children 
with ADHD and/or DBD had greater problematic behaviors towards others than those 
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with anxiety or mood disorders. For children with anxiety disorders, both parents and 
clinicians reported their emotional functioning to be lower than those with other 
diagnoses. Emotional functioning was also found to be compromised in children with 
mood disorders. According to children’s report, there were no differences in QoL across 
diagnostic categories. With regard to agreement among informants, parents showed 
moderate concordance with both children and clinicians, whereas concordance between 
children and clinicians was small. Overall, results from this study suggests that specific 
domains of QoL are compromised in different diagnoses, and given small to moderate 
concordance among raters in QoL ratings, obtaining both self and proxy reports is useful 
and informative.  
Focusing on a subsample of children and adolescents in the previous study, 
Bastiaansen, Koot, and Ferdinand (2005b) sought to determine factors that are associated 
with QoL in children with psychiatric disorders. Psychological symptoms as measured by 
Total Problems scores on the Child Behavior Checklist (CBCL) and Teacher’s Report 
Form (TRF) (Achenbach, 1991a, 1991b) were negatively associated with QoL as 
reported by children, parents, and clinicians. The influence of psychopathology on QoL 
was also greater for girls than boys. Above and beyond the impact of psychopathology, 
levels of social skills and self-esteem predicted QoL, as did the presence of a chronic 
physical illness (negative prediction) and age. Interaction effects revealed that boys with 
a chronic physical illness and younger children had lower QoL than girls with a chronic 
physical illness and older children, respectively. Boys with mothers experiencing high 
parenting stress had lower QoL, and family functioning, stressful life events, and 
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receiving social support from classmates (particularly for boys) were also predictive of 
QoL. It appears that in addition to psychopathology, other factors related to the child, the 
family, and broader contextual factors play unique roles in predicting QoL outcomes in 
children and adolescents affected by psychopathology. 
A national survey conducted in 3,597 6- to 17-year-old children and adolescents 
and their parents in Australia examined QoL in three diagnostic groups: ADHD, Major 
Depressive Disorder (MDD), and Conduct Disorder (CD) (Sawyer et al., 2002). With 
children who had comorbid diagnoses excluded from the analyses, parent-reported QoL 
on the CHQ revealed that children with one of these three disorders experienced lower 
QoL across domains than those with no disorder. Further, children with a mental disorder 
showed lower QoL in almost all areas compared to those with a physical disorder; 
children with both a physical illness and a mental disorder tended to show worse QoL 
than those with either type of disorders alone. In addition, children with MDD were 
reported to experience greater levels of pain, discomfort, and emotional problems 
compared to those with ADHD or CD, while children with ADHD and CD had higher 
levels of behavior problems. In the German BELLA study (Ravens-Sieberer, Erhart, 
Wille, & Bullinger, 2008), 7- to 17-year-old children and adolescents with mental health 
problems as reported by parents on the Strength and Difficulties Questionnaire had 
significantly lower QoL compared to children with other chronic health conditions (e.g., 
asthma, chronic pain).  
Comparing the QoL of 8- to 15-year-old children and adolescents with ADHD-
related problems, anxiety and depression problems, and an age- and sex-matched sample 
  
55 
 
of healthy children in Norway, Thaulow and Jozefiak (2012) found that children in the 
ADHD group self-reported higher QoL on the Inventory of Life Quality in Children and 
Adolescents (Mattejat et al., 1998) than those in the anxious/depressed group, while both 
groups reported lower QoL than youth in the healthy group. While parent-proxy reports 
also revealed lower QoL in the two clinical groups than the healthy group, no significant 
differences between the ADHD and anxious/depressed groups were observed. Further, 
children in the ADHD group reported significantly higher QoL than that reported by their 
parents, while this difference was not found in the anxious/depressed group. The authors 
offer several possible explanations for these discrepancies (e.g., children with ADHD 
may tend to view their lives in a more optimistic manner than those who are anxious or 
depressed), and emphasized the importance of obtaining multiple reports when 
examining QoL in children with clinical profiles.  
Bartels, Cacioppo, van Beijsterveldt, and Boomsma (2013) examined the 
relationship between subjective well-being (SWB) and psychopathology in 9,136 twins 
and 1,474 non-twin siblings in the Netherlands. SWB in this study was assessed by 
participants’ life satisfaction, subjective happiness, and a general rating of where their 
lives fall between the “worst possible life” to the “best possible life”. Overall, SWB was 
associated negatively with psychopathology, as measured by the Youth Self-Report 
(Achenbach & Rescorla, 2001), and these associations were largely explained by genetic 
correlations. The overlap between SWB and psychopathology was higher in females, and 
for both males and females, relationships between SWB and psychopathology showed 
higher genetic overlap than nonshared environment overlap, suggesting that this 
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relationship is complex and that SWB and psychopathology are not merely opposite ends 
of the mental health spectrum (Bartels et al., 2013). 
Greenspoon and Saklofske (2001) compared SWB and psychopathology in 407 
children in grades 3 to 6, and identified four groups of children: those with low SWB (as 
measured by the Multidimensional Students' Life Satisfaction Scale, Huebner, 1994) and 
low psychopathology (as measured by the Behavior Assessment System for Children, 
Reynolds & Kamphaus, 1992), those with high SWB and low psychopathology, those 
with low SWB and high psychopathology, and those with high SWB and high 
psychopathology. Results suggest that children with low SWB were less confident about 
their academic competence and perceived lower satisfaction with their interpersonal 
relationships than children who had high SWB and low psychopathology. However, 
among children with high psychopathology, those who also had high SWB were 
identified as more sociable and sustained good interpersonal relationships compared to 
children with low SWB. Suldo and Shaffer (2008) also examined SWB in a sample of 
349 students in middle school. Four groups of children were again identified: complete 
mental health (average to high SWB and low psychopathology), vulnerable (low SWB 
and low psychopathology), symptomatic but content (average to high SWB and high 
psychopathology), and troubled (low SWB and high psychopathology). Children with 
complete mental health demonstrated higher SWB than their vulnerable peers regarding 
their perceptions of academic performance, social support, perceived physical health, and 
social problems. On the other hand, symptomatic but content children exhibited better 
perceived social and physical functioning than their troubled peers. These studies 
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highlight the importance of examining both psychopathology and overall well-being in 
youth, reiterating the postulation that these two constructs are not simply opposite poles 
of a mental health continuum, but children with high levels of psychopathology can 
exhibit high levels of well-being, and those with low levels of psychopathology can also 
exhibit low levels of well-being.  
In a one-year follow-up study of Bastiaansen and colleagues’ sample (2004) 
conducted to examine trajectories of psychopathological symptoms and course of QoL 
over time (Bastiaansen et al., 2005a), four trajectories for psychopathology and QoL were 
identified: recovered (improved symptoms and scores moved from clinical to normal 
range), improved (improved symptoms but scores remained in the clinical range), 
unchanged (no significant change in symptoms and scores remained in the clinical 
range), and deteriorated within the clinical range (worsened symptoms in the clinical 
range). Based on these trajectories, four groups of children were identified: no reduction 
in symptoms and no improvement in QoL (38.1%), improvement in symptoms and 
reduction in QoL (33.3%), either reduction in symptoms or improvement in QoL 
(28.6%), and no reduction in symptoms but improvement in QoL (11.1%). Of note, age, 
gender, and diagnosis did not predict these trajectories over time.  
In sum, studies examining QoL and SWB in children with various forms of 
psychopathology reveal that specific domains of QoL are uniquely impacted by specific 
diagnoses, and children with mental disorders seem to experience lower QoL than 
children with physical illnesses. This point is critical considering that historically, QoL 
has focused on physical health populations and its research in mental health populations 
  
58 
 
has been less attended to. Predictors of QoL have also been identified (e.g., levels of 
social skills, parenting stress), and concordance rates in reports of children’s QoL are 
small and moderate at best. Studies have also identified subgroups of children who 
although experience high levels of psychopathology, still show high QoL and well-being. 
It is this latter point that is particularly pertinent to the current research on resilience in 
children with psychopathology. One of the primary questions to be addressed in the 
current work is this: which factors predict increased QoL in children experiencing 
psychopathology? In other words, what predicts resilience – positive adaptation despite 
adversity – in children with psychopathology? While positive social functioning (e.g., 
sociability and good social relationships) and perceived physical health have been 
identified as factors that may predict greater SWB among children with high levels of 
psychopathology, other factors such as age, gender, and diagnoses have not been shown 
to predict QoL in children with psychopathology (Bastiaansen et al., 2005a). Given the 
paucity of research addressing these questions, there is need for a comprehensive study of 
resilience in these children and adolescents. Further, while Bastiaansen and colleagues 
(2005a) provide a one-year study of trajectories in QoL and psychopathology, additional 
longitudinal studies can further illuminate predictors of resilience processes over time.  
Summary of Literature Review 
 Resilience research has its roots in observations that a subset of children who, 
despite experiencing adverse life circumstances such as severe maternal 
psychopathology, poverty, familial discord, and disadvantaged rearing conditions, 
nevertheless exhibits adaptive outcomes, measured by the absence of psychopathology 
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and demonstration of competence in various domains of life, including academic 
achievement, social competence, and conduct. The construct of resilience describes a 
dynamic process in which interactions among multiple levels of analyses, from the 
genetic and biological to the broader societal levels, produce better-than-expected 
outcomes despite experiences of adversity. Factors that have been implicated in such 
adaptive functioning despite adversity include characteristics of the individual (e.g., 
positive and flexible temperament, high intelligence, being female, adaptive coping, high 
self-esteem), the family (e.g., parental warmth, close parent-child relationships, 
competent parenting), and the environment (e.g., presence of supportive, caring adults, 
SES). Genetic and biological factors including specific gene polymorphisms and 
hormonal processes have also been demonstrated as protective in the context of adversity. 
While an examination of these multiple levels of influences is necessary to obtain a 
comprehensive depiction of resilience processes in children, the focus of the current 
study is on psychosocial correlates of resilience.   
 Resilience processes have been investigated among populations of children in 
various adverse life circumstances, but there is a paucity of research examining resilience 
among children with psychopathology, which is arguably considered as a vulnerability 
that increases the likelihood for negative outcomes. Identifying factors that predict 
adaptive outcomes among those experiencing psychopathology is critical, particularly 
when implications for intervention and preventative measures are considered. In addition 
to reducing symptom severity and functional impairment caused by psychopathological 
symptoms, which areas and characteristics can treatments target to foster overall well-
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being even in children who may be experiencing severe psychopathology? In a similar 
vein, among children with significant psychopathology, for example, are there specific 
areas at which treatments can intervene to steer children in the direction of positive well-
being rather than the expected path of compromised life satisfaction? It may very well be 
the case that factors that predict the presence of psychopathological symptoms are the 
same or similar to those that predict positive well-being despite psychopathology. 
However, without careful research exploring these resilience correlates, the field may be 
neglecting to attend to important factors that foster overall life satisfaction among 
children with psychopathology and their families.  
Given the complexity in the definition of mental disorders and the intrinsic 
relationship between symptoms and functional impairment, an appropriate indicator of 
adaptive outcomes in the face of psychopathology is QoL, which is defined as a 
multidimensional construct involving individuals’ subjective perception of their 
functioning in various aspects of their lives, including physical, psychological, social, and 
sometimes cognitive domains. When assessing QoL in children, seeking additional proxy 
reports, typically provided by parents or caregivers, may be necessary to obtain a more 
comprehension representation of children’s QoL, due to developmental and other 
considerations that may limit children’s ability to accurately and reliably report on their 
QoL. However, parents’ proxy-reports are not without limitations, and less-than-perfect 
concordance rates between children and parents suggest that both informants can provide 
unique information regarding children’s QoL.  
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QoL research, as with resilience research, historically has been conducted 
infrequently in populations of children with psychopathology, but understanding 
relationships between QoL and psychopathology is critical. Especially in the context of 
resilience research, conceptualizing better-than-expected QoL as an indicator of adaptive 
functioning can elucidate factors that when incorporated into treatment research, reveal 
intervention targets that foster overall increased life satisfaction rather than exclusively 
focusing on symptom reduction. Further, while domains of functioning that are most 
related to presenting symptoms are more likely than other areas to be identified as 
treatment targets, assessing QoL across domains can inform strategies that may improve 
children’s well-being in broader and more comprehensive ways. On the other hand, as 
with the selection of appropriate indicators of adaptive outcomes in historical resilience 
research, it may also be informative to assess resilience outcomes in QoL domains most 
conceptually related with the pattern of psychopathological symptoms experienced (e.g., 
those with internalizing disorders who nevertheless demonstrate high QoL in the 
emotional domain).  
 QoL research has been conducted among youth with various psychiatric 
diagnoses, with more work performed for some diagnostic subtypes than others (e.g., 
more work has been done in children with ADHD and less in some specific anxiety 
disorder diagnoses). Results from studies examining QoL across diagnostic categories 
have generally been consistent. Children and adolescents experiencing various forms of 
psychopathology appear to experience lower QoL in most psychosocial domains 
compared to healthy children and those with physical conditions. Physical well-being, 
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however, does not seem to be lowered in children with psychological disorders compared 
to healthy children. Both psychosocial and pharmacological treatments also appear to 
have some positive effects in improving the QoL of children with psychopathology. 
Severity of symptoms and the presence of comorbid diagnoses tend to show negative 
relations with QoL, while psychosocial factors such as social skills, self-esteem, and 
social support tend to predict increased QoL.  
In studies where both self- and parent proxy-reports of children’s QoL were 
obtained, greater agreement between the two informants is observed in physical domains 
than in emotional or social ones. There is also some evidence that parents may rate their 
children’s QoL as lower than children’s own self ratings. Parental psychopathology may 
additionally influence parents’ ratings of their children’s QoL. For example, mothers with 
depressive symptoms rate their children’s QoL as lower than non-depressed parents. 
Specifically for youth with a BPSD, the presence of depressive symptoms seems to be 
more strongly associated with worse QoL than manic, hypomanic, and mixed 
presentations. Results from studies comparing QoL of children with various diagnoses 
suggest that specific domains may be more or less affected given children’s diagnoses 
(e.g., children with mood and anxiety disorders show more compromised emotional 
functioning compared to children with other disorders, such as behavioral disorders), 
while no consistent differences in overall QoL among diagnostic group have emerged. 
Most pertinent to the current research, several studies have examined factors that predict 
high levels of QoL in children experiencing high levels of psychopathology. Factors such 
as high sociability, positive interpersonal relationships, and greater physical functioning 
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appear to be implicated in resilient outcomes. In contrast, age, gender, and specific 
diagnoses were not associated with high QoL among those with high levels of 
psychopathology.  
Aims and Hypotheses of Current Study 
 The current study built upon existing QoL research in children with various forms 
of psychopathology to begin examining resilience processes in this population of youth. 
Although available research suggests that psychiatric disorders and levels of 
psychopathological symptoms predict worse QoL, there is evidence that even among 
those with high levels of psychopathology, some demonstrate high QoL. What remains to 
be understood, however, are the specific demographic, parental/familial, and individual 
protective factors that are associated with high QoL despite experiences of 
psychopathology in children. Do protective and resiliency factors that predict resilient 
outcomes in previous resilience research among children in adverse life circumstances 
serve to protect children with psychopathology from experiencing low QoL? Do these 
protective and resiliency factors differ across different patterns of symptoms and 
diagnoses? Do child- and parent-reports of QoL lead to similar or different outcomes?  
 Using baseline to 2-year data (three assessment time points) from the 
Longitudinal Assessment of Manic Symptoms (LAMS) Study of outpatient children and 
adolescents, the aims and hypotheses of the current study were as follows: 
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Primary Aim 1: Elucidate the relationship between symptom severity and overall 
QoL.  
Hypothesis 1: In a multilevel model in which only symptom severity and age (as a 
time variable) is used to predict QoL, a negative relationship between symptom severity 
and in QoL will be found (i.e., increasing symptom severity will be associated decreasing 
QoL).   
 Primary Aim 2: Identify demographic, parental/familial, and youth variables that 
are associated with resilient outcomes across the 2 years of assessments.   
Hypothesis 2: Demographic, parental/familial, and youth variables will moderate 
the time-linked correspondence between symptom severity and overall QoL. In other 
words, a set of these variables will be associated with resilience outcomes over time, 
defined as: (1) smaller negative relationship between symptom severity and QoL over 
time; (2) nonsignificant relationship between symptom severity and QoL over time, or (3) 
positive relationship between symptom severity and QoL over time. Table 1 lists the 
hypothesized time-varying and time-invariant covariates that were expected to moderate 
the relationship between symptom severity and QoL. Time-varying covariates are those 
that were measured at each annual assessment; Time-invariant covariates are those that 
were measured only at baseline.  
Exploratory Hypothesis 2: Determine whether the time-varying and time-invariant 
covariates listed in Table 2 would moderate the time-linked correspondence between 
symptom severity and QoL.  
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Secondary Aim: Replicate findings from previous research regarding 
concordance between self- and proxy-reports of children’s QoL. 
 Secondary Hypothesis 1: Self-reported QoL will be higher than parent-reported 
QoL across overall, physical, emotional, self-esteem family, friends, and school domains. 
 Secondary Hypothesis 2: Concordance rates between self- and parent-reported 
QoL will be higher in the physical domain than other domains.   
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Chapter 2: Method 
 
 In the current study, I analyzed a subset of two-year data from the Longitudinal 
Assessment of Manic Symptoms (LAMS) study. This ongoing multicenter study is being 
conducted at four sites: Case Western Reserve University (Coordinating Principal 
Investigator [PI]: Robert Findling, M.D.); Cincinnati Children’s Medical Center (PI: 
Robert Kowatch, M.D.); The Ohio State University (PI: Mary Fristad, Ph.D); and the 
University of Pittsburgh Medical Center/Western Psychiatric Institute and Clinic (PI: 
Boris Birmaher, M.D.). Procedures in the LAMS study protocol were reviewed and 
approved by the Institutional Review Boards affiliated with each site. The LAMS study is 
a prospective, longitudinal study of outpatient youth with elevated symptoms of mania 
(ESM+) and a comparison sample of youth without elevated symptoms of mania (ESM-), 
matched on age, sex, race/ethnicity, and insurance status. Primary aims of the LAMS 
study include: (1) estimate the rate of ESM+ among 6- to 12-year-old children presenting 
at outpatient mental health clinics, (2) document the course of symptoms and natural 
course of diagnoses in children with ESM+ over time, and (3) identify factors that predict 
poor longitudinal functional outcomes among children with ESM+ at baseline (Horwitz 
et al., 2010). Details of the study design (Horwitz et al., 2010) and characteristics at 
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baseline (Findling et al., 2010) have been reported elsewhere, and are described briefly 
below. 
Screening and Enrollment 
 A total of 2,622 English-speaking parents or guardians presenting with children 
between the ages of 6 years, 0 months, to 12 years, 11 months, at outpatient clinics 
completed the Parent General Behavior Inventory – 10-Item Mania Scale (PGBI-10M) 
(Youngstrom et al., 2005; Youngstrom, Frazier, Demeter, Calabrese, & Findling, 2008) 
regarding their child. A brief demographic questionnaire asking children’s age, sex, 
race/ethnicity, and insurance status was also completed by parents or guardians. Children 
who received mental health treatment at the clinic in the past 12 months, those with a 
sibling who participated in the study, and those who had already been invited to 
participate, were excluded from screening procedures. The PGBI-10M assesses 
hypomanic, manic, and biphasic mood symptoms, and was used to screen for ESM in the 
previous six months. A cut-off score of 12 was used to classify children as ESM+, and 
children with scores of 11 and lower were classified as ESM-. The PGBI-10M was 
selected as the screening instrument for the LAMS study given that it contains items that 
are accurate in discriminating children with bipolar disorder from those without (please 
see Horwitz et al., 2010 for additional detail regarding rationale for selecting this measure 
for us in the LAMS study), and served the study’s goal of obtaining a sample enriched for 
bipolar disorder, while not including all BPSD symptoms. All ESM+ children (N = 
1,124) and one of their parents were invited to participate in the LAMS study. At each 
clinic, one ESM- child was selected for every 10 ESM+ children to be recruited for the 
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comparison group. For clinics with lower ESM+ enrollment, one ESM- child was 
selected for every five ESM+ children enrolled. The chosen ESM- control child was 
matched by age (+ 2 years), sex, race/ethnicity, and insurance status with the “modal” 
ESM+ child given the enrollment time period. The PGBI-10 was also administered at 
subsequent assessments. 
Baseline Assessment and Longitudinal Follow-Up Assessments 
 Children and parents who were enrolled in the study completed an initial baseline 
assessment approximately 3 to 6 weeks post-screening. At this assessment, children’s 
current and past psychiatric diagnoses, current mood symptom severity, family 
psychiatric history, medication history, psychosocial functioning, global functional 
assessment, quality of life, stressful life events, parenting stress, treatment utilization, and 
demographic information were assessed. Semi-structured interviews were conducted 
separately with parents and children; parent- and self-report questionnaires, and 
psychological testing were used as assessment procedures. Following the baseline 
assessment, children and parents were invited to the longitudinal portion of the study, 
which consisted of follow-up assessments every six months, unless they met exclusion 
criteria of: (1) manic symptoms due to a general medical condition, (2) a pervasive 
developmental disorder (PDD) diagnosis other than Asperger’s syndrome or pervasive 
developmental disorder not otherwise specified (PDD-NOS), or (3) an IQ of less than 70 
and exhibiting deficient adaptive functioning. These exclusion criteria were chosen to 
avoid confounding factors that may negatively affect the interpretability of results 
obtained from the LAMS study. Each follow-up assessment took approximately 2 to 4 
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hours. At annual follow-up assessments, symptoms and diagnoses were assessed and 
reviewed. At six-month assessments, only symptoms of mood disorders (i.e., depressive 
disorders, BPSD) were assessed and reviewed. For purposes of this study, only data from 
the baseline and two annual follow-up assessments were analyzed. 
Participants 
 Across the four study sites, 707 children between ages 6 and 12 years were 
enrolled in the longitudinal study, with 621 in the ESM+ group and 86 in the ESM- 
control group. One parent or guardian of each child served as the primary informant 
through the duration of the study.  Upon subsequent examination of enrolled participants’ 
eligibility post-baseline, 22 participants were deemed ineligible given IQ less than 70 (n 
= 8), having an autism or other pervasive developmental disorder diagnosis (n = 8), 
guardianship changes (n = 3), relocation of the family (n = 2), and having mood 
symptoms that were better attributed to a general medical condition (n = 1). Therefore, 
the final sample used in the current study comprised 685 children/adolescents and one of 
their caregivers.  
 There were 525 families who attended the 12-month assessment (n = 125 missed 
their visit; 21 withdrew from the study), and 467 families attended the 24-month 
assessment (n = 173 missed their visit; 45 withdrew from the study).  
Instruments Administered Only at Baseline 
Wechsler Abbreviated Scales of Intelligence  
The Wechsler Abbreviated Scales of Intelligence (WASI; The Psychological 
Corporation, 1999) is a brief, standardized intelligence measure that provides an estimate 
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of the verbal, nonverbal, and general cognitive ability for individuals between ages 6 and 
89. The two-subtest form, which includes vocabulary and matrix reasoning subtests, was 
administered to identify children with a Full Scale IQ lower than 70. Although the WASI 
was not designed to replace more comprehensive measures of intelligence, such as the 
Wechsler Intelligence Scales for Children, Fourth Edition (WISC-IV), it was appropriate 
for use in the current study given its brevity.  
Weissman Family History Screen  
The Family History Screen (FHS; Weissman et al., 2000) was used in the LAMS 
study to obtain information on 15 psychiatric disorders and suicidal behavior in the 
primary informant (i.e., parent or guardian) and child participants’ first- and second-
degree relatives. A wide range of sensitivity and specificity values has been observed for 
specific disorders (Weissman et al., 2000). Based on participants’ reports on their 
relatives, the lowest sensitivity was observed for simple phobia (2.4%), and highest 
sensitivity was observed for alcohol dependence (46.4%); specificity values were more 
consistent, with values ranging from 81.2% for MDD and 98.9% for simple phobia and 
drug dependence. Based on relatives’ self-reports, the lowest sensitivity was again 
observed for simple phobia (9.8%), and highest sensitivity was observed for suicide 
attempts (87.0%); specificity was again more consistent, with values ranging from 75.7% 
for MDD to 99.3% for drug dependence. Overall, sensitivity of participants’ reports on 
their relatives (median sensitivity = 37.5%) was lower than sensitivity of relatives’ own 
self-reports (median sensitivity = 71.1%). Over 15 months, test-retest reliability was 
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found to be low to acceptable for most disorders, with Cohen’s kappas ranging from .30 
to .74.   
 For the current analyses, first- and second-degree biological relatives’ psychiatric 
histories were analyzed.  
Demographics Questionnaire 
In this interview-based demographics questionnaire developed by investigators on 
the LAMS study, information regarding children’s primary, secondary, and out-of-home 
caretakers was obtained. Basic information such as caregivers’ age, sex, race/ethnicity, 
marital status, education level, employment information, and annual income were asked, 
along with child-related information such as primary source of healthcare coverage, 
number of moves and school changes, any psychiatric or out-of-home placements, and 
academic services received. An update on participating families’ demographic 
information was completed at each follow-up assessment in an abbreviated demographics 
questionnaire.   
Instruments Administered at Baseline and Annual Follow-Up Assessments 
Revididerter KINDer Lebensqualiatsfragebogen  
As described above, the Revididerter KINDer Lebensqualiatsfragebogen 
(KINDL-R; Ravens-Sieberer & Bullinger, 1998a, b) is a QoL measure with versions for 
both self and proxy reports. Age-specific versions provide a developmentally-sensitive 
assessment of QoL that accounts for developmental changes in key QoL domains to be 
measured. Three child-report versions are available: the KIDDY-KINDL-C (12 items; 
ages 4 to 7), the KID-KINDL-C (24 items; ages 8 to 12), and the KIDDO-KINDL-C (24 
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items; ages 13 to 16). In the current study, appropriate versions were administered given 
children’s ages, and questionnaire items were read to children who required assistance. 
Two 24-item parent-report versions are available: KIDDY-KINDL-P (parents of children 
from ages 4 to 7 years), and KINDL-P (parents of children and adolescents from ages 8 
to 16 years).  
 With the exception of the KIDDY-KINDL-C, which provides only an overall 
QoL score, the KINDL-R provides an overall QoL score, as well as subscale scores in the 
domains of physical well-being, emotional well-being, self-esteem, family interactions, 
peer relationships, and school functioning. Additional questions on the KIDDY-KINDL-
P regarding children’s behavior supplement the shortened analogous self-report version 
(KIDDY-KINDL) due to developmental considerations. The KINDL-R, when 
administered in an observational study of 345 healthy children demonstrated sufficient 
reliability (Cronbach’s alpha greater than 0.70) and validity (r = 0.70 with other 
instruments assessing similar concepts). Psychometric properties of the KINDL-R have 
been demonstrated in German samples of school children (Ravens-Sieberer, Gortler, & 
Bullinger, 2000) and those with bronchial asthma, atopic dermatitis, and obesity (Ravens-
Sieberer, Redegeld, & Bullinger, 2000). For child-report versions, internal consistency 
Cronbach’s α ranged from 0.63 to 0.76 for the different subscales, and a Cronbach’s α of 
0.84 was observed for the total score. For the parent-reported versions, internal 
consistency ranged from 0.62 to 0.81 for the different subscales, and an overall α of 0.89 
was observed for the total score. Convergent validity with other measures of QoL (such 
as the CHQ) has also been observed, with Pearson’s correlations (r) ranging from 0.15 to 
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0.59 for specific subscales, and rs between 0.39 and 0.72 were observed for total QoL. 
Discriminant validity of the KINDL-R has also been demonstrated. As mentioned earlier, 
children with BPSD exhibited lower scores on the KINDL-R than those with other health 
conditions, as well as other psychiatric disorders.  
 For the current analyses, both total scores and individual domain scores were 
analyzed. Self-reports and parent proxy reports were analyzed separately. Total scores 
were used in the primary analyses using multilevel models; domain scores were used to 
examine parent-child concordance rates. Since no domain scores are provided in the 
KIDDY-KINDL-C version, scores from this measure were not included in the 
examination of parent-child concordance rates. For the KIDDY-KINDL-C version, total 
scores were multiplied by four to facilitate ease of comparison among all KINDL-C 
versions
1
.  
Clinical Global Impression Scale - Severity  
The Clinical Global Impression Scale - Severity (CGI; NIMH, 1985) assesses 
both symptoms severity and symptom improvement over time. In the LAMS study, only 
CGI Severity ratings were completed. CGI ratings were made by interviewers and 
confirmed by a doctoral level, licensed clinician during the diagnostic consensus meeting. 
At the baseline and 6-month interim assessments, CGI scores were collected for 
children’s mania, depression, and overall illness. Ranging from 0 (“Not assessed”) to 7 
(“Among the most extremely ill patients”), the severity of children’s psychopathology 
                                                 
1
 Significant findings from multilevel models (described later in the document) were examined with 
combined original standardized KINDL-C scores for participants with available scores. Significant results 
remained unchanged.  
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both currently and in any worst past period was rated. At the annual assessments in which 
comprehensive evaluations of psychiatric disorders (in addition to mood disorders) were 
made, severity ratings of children’s overall illness took into consideration any other 
psychopathological symptoms children may have exhibited. CGI overall current scores 
were used in the current analyses. A constant value of 1 was subtracted from each CGI 
score to improve interpretation in statistical analyses (e.g., a centered score of 0 would 
correspond to “Normal, not at all ill”; see Appendix B). 
Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children 
– Present and Lifetime Version with additional items from the WASH-U-K-SADS 
(K-SADS-PL-W) 
The K-SADS is considered the gold standard for assessing psychiatric disorders 
in youth. Adaptations of the K-SADS have been made for use in various studies, and the 
K-SADS – Present and Lifetime Version used in this study shows concurrent validity 
with other child psychopathology measures, and good to excellent test-retest reliability (κ 
= 0.77 to 1.00 for MDD, BPSD, generalized anxiety disorder, conduct disorder, and 
ODD; κ = 0.63 to 0.67 for posttraumatic stress disorder and ADHD) and inter-rater 
reliability (96% to 100% agreement; Kaufman et al., 1997). Additional items provided a 
more extensive assessment of mania from the Washington University K-SADS (WASH-
U-K-SADS; Geller, Warner, Williams, & Zimmerman, 1998; Geller et al., 2001) were 
added to the K-SADS-PL.  
 Children and one of their parents were interviewed separately using the KSADS-
PL-W. The KSADS-PL-W includes screening items and supplemental questions to 
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comprehensively and thoroughly assess DSM-IV psychiatric disorders both currently and 
in children’s lifetime (or since the previous assessment). In addition to independent 
ratings based on children’s and parents’ responses for each symptom, interviewers 
provided a summary rating that most accurately reflected a child’s presentation. In 
consensus meetings held jointly with interviewers and a doctoral level, licensed clinician, 
current and most severe lifetime (or since the previous assessment) diagnoses for each 
DSM-IV disorder were determined.  
 For the current analyses, consensus diagnoses were used. Thirteen descending 
hierarchical diagnostic groups were formed based on current diagnoses at each 
assessment, and are listed in Table 3. This method of forming diagnostic groups ensures a 
comprehensive representation of all major diagnoses and comorbid conditions present in 
the LAMS study sample without overlap in category membership (i.e., any given child 
can only be assigned to one diagnostic group). The hierarchy of diagnostic groups begins 
with psychotic disorders alone and psychotic disorders with maximally inclusive 
comorbidities. The next diagnostic grouping is the BPSD only category, followed by the 
BPSD with non-psychotic, no-mood comorbidity. The remaining diagnostic groups are as 
follows: depressive spectrum disorder (DSD) alone; DSD with non-psychotic, non-mood 
disorder comorbidity; anxiety disorders alone; anxiety disorder with non-psychotic, non-
psychotic, non-mood disorder comorbidity; disruptive behavior disorder (DBD) alone; 
DBD with non-psychotic, non-mood, non-anxiety comorbidity; ADHD alone; ADHD 
with non-psychotic, non-mood, non-anxiety, and non-DBD comorbidity; and other 
disorders, with non-psychotic, non-mood, non-anxiety, non-DBD, and non-ADHD 
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comorbidity. To ensure that a limited number of statistical models was tested, these 
diagnostic groups were then further combined to form eight final diagnostic groups: (1) 
psychotic disorder, (2) BPSD, (3) DSD, (4) anxiety disorder, (5) DBD, (6) ADHD, (7) 
other, and (8) no diagnosis.  
Stressful Life Events Schedule  
The Stressful Life Events Schedule (SLES; Williamson et al., 2003), originally 
developed to assess life stressors in children and adolescents in an interview format, has 
been adapted for use as a questionnaire. Child- (SLES-C), adolescent- (SLES-A), and 
parent-report (SLES-P) formats were administered in the LAMS study. The SLES aimed 
to address limitations in previous measures of life stressors (e.g., the Life Events and 
Difficulties Schedule; Brown, Sklair, Harris, & Birley, 1973), such as considerations of 
time and costs. Consisting of possible negative life events that may have occurred in the 
past six months, informants are asked to indicate which events happened, and for those 
events, to rate on a 4-point Likert scale (ranging from “not at all” to “a lot”) the degree to 
which each event affected the child. Informants were also provided with an opportunity 
to indicate any additional stressful life events and their effect at the end of the 
questionnaire. Domains of events assessed include school (e.g., “I had trouble with 
grades or schoolwork”, “I did badly on a big test”), work (e.g., “I applied for a job and 
did not get hired” [SLES-A], “I had problems at my job” [SLES-A]), living environment 
(e.g., “My neighborhood was not safe”, “Problems with my house”), deaths (e.g., “A 
close relative died”, “My parent or brother/sister died”), family relationships (e.g., I was 
fighting more with my parents”, “My parents fought with each other”), other 
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interpersonal relationships (e.g., “I started dating someone”, “I broke up with my 
boyfriend/girlfriend”, “I had problems being liked by my school friends”, “I stopped 
talking to a good friend”), and other stressful life events (e.g., “I had a bad accident or 
health problems”, “I moved”).  
Substantial inter-rater reliability has been observed (κ = 0.67 to 0.84), and 
substantial test-retest reliability has been found for comparisons of specific events (κ = 
0.68). Concurrent validity for overall stressful life events has been observed with the Life 
Events Checklist (LEC; Johnson & McCutcheon, 1980; ICC = 0.83) and Life Events and 
Difficulties Schedule (LEDS; κ = 0.77). However, lower agreement was observed when 
examining specific events between the SLES and the LEC (κ = 0.26).  
 For the current analyses, number of stressful life events and total impact of 
stressful life events scores were used. As child and adolescent participants may have 
completed different SLES versions (i.e., SLES-C at baseline and SLES-A at 12-month 
assessment), scores from the SLES-C and SLES-A were standardized and combined into 
one variable at each time point. 
Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up 
Evaluation  
The Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up 
Evaluation (ALIFE; Keller, 1993), adapted from the Longitudinal Interval Follow-Up 
Evaluation (LIFE) for adults (Keller et al., 1987), is a semi-structured interview used to 
assess psychiatric symptoms and course of psychosocial functioning in 6- to 18-year-old 
children and youth. Psychometric properties of the LIFE have been demonstrated, with 
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internal consistency values ranging from Cronbach’s α of 0.78 to 0.84, and inter-rater 
reliability values (ICC) ranging from 0.94 to 0.99 (Leon et al., 2000). For the purposes of 
the LAMS study, the Psychosocial Schedule of the ALIFE was administered. Seven areas 
of psychosocial functioning are assessed, including relationships with primary and 
secondary caregiver, siblings, peers, and significant adult, school and academic 
functioning, and recreational activities. A rating of children’s global functioning is also 
provided by the interviewer. In the LAMS study, children and parents were interviewed 
separately and independent scores for each domain were therefore obtained. Furthermore, 
scores for children’s current functioning and their functioning in the past six months were 
provided. Based on both children’s and parents’ ratings, interviewers provided summary 
scores for each domain and time period. Functioning was rated on a five-point Likert 
scale, with low scores indicating better functioning. For purposes of the current study, 
ALIFE scores were multiplied by -1 prior to completing statistical analyses to facilitate 
ease of interpretation of results (i.e., higher scores indicate better functioning post-
transformation).  
 In the current analyses, only clinician-rated current domain scores of youth’s 
relationships with their primary caregiver, secondary caregiver, and peers were analyzed. 
Children’s Global Assessment Scale  
The Children’s Global Assessment Scale (CGAS; Shaffer et al., 1983) is a single-
item instrument completed by clinicians to provide an assessment of children’s severity 
of functional impairment. Scores range from 1 to 100, with 1 being the most severely 
impaired and 100 being the healthiest. Scores higher than 70 are considered to indicate 
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normal functioning. Behavioral descriptions are provided for every 10-point increment, 
and considerations of children’s functioning in the home, at school, and with peers are 
made. Excellent inter-rater reliability has been observed (ICC = 0.84), and test-retest 
reliability has been observed to range from 0.69 to 0.95. Discriminant validity has also 
been demonstrated, such that children in an inpatient facility had significantly lower 
CGAS scores than those in outpatient psychiatric clinics. A moderate correlation (r = -
0.25) between the CGAS and an abbreviated parent-reported behavior rating scale 
provides some evidence of the concurrent validity of the CGAS (Shaffer et al, 1983). 
 The CGAS was completed at each assessment time point in the LAMS study. A 
CGAS score was provided for children’s current functioning at each assessment as well 
as for any worst period of psychiatric presentation since the previous assessment. Only 
the CGAS score for children’s current functioning was used.  
Parent Stress Survey  
The Parent Stress Survey (PSS; Sisson & Fristad, 2001) is a 25-item parent self-
report measure that assesses stressors encountered by parents with a psychiatrically-ill 
child. Examples of stressors examined include those related to parental health (e.g., 
“Dealing with your own multiple bouts of physical illness”), stigma (e.g., “Feeling 
embarrassed by your child’s public rages”), time conflicts (e.g., “Having less time for 
taking care of yourself”), blame (e.g., “Accusations or implications from your family that 
you are a bad parent or that you are at fault”), family tension (e.g., “Having less time to 
devote to your marriage or significant relationships”), insurance problems (e.g., “Dealing 
with your insurance company or having no insurance coverage”), and work absences 
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(e.g., “Dealing with lost wages in your family due to taking off work or quitting job”). 
Parents are asked to indicate whether they have experienced each stressor in the past six 
months, and if so, the extent to which the experience is currently stressful for them on a 
5-point Likert scale, ranging from “Not at all” to “Very”. Six factors (i.e., 
physical/emotional stress, stigma, time conflicts, outside accusations, family tension, and 
insurance/financial issues) of the PSS have been identified when administered to 732 
caregivers of children with a BPSD via an online survey (Sisson, 2001), and when the 
factor structure of the PSS was examined in the LAMS study sample, a 7-factor solution 
(i.e., time constraints, parental health, family tension, insurance issues, work absence, 
child effectiveness, and stigma) was found (Rycyna, 2012). However, due to the few 
number of items in some of the factors, results of second-order factoring suggest that a 
single factor of parental stress was a best fit.  
 For the current analyses, the number of stressors and total PSS scores were used. 
Service Assessment for Children and Adolescents  
The Service Assessment for Children and Adolescents (SACA; Hoagwood et al., 
2000) assesses youth’s use of inpatient, outpatient, and school mental health services. In 
the LAMS study, parents were interviewed to assess the types of services that children 
may have received in the past six months. When categories of services were endorsed, 
additional questions about the specific interventions received and treatment satisfaction 
were asked. Excellent test-retest reliability on the parent-reported SACA has been found 
regarding children’s lifetime mental health service use (κ = 0.82 to 0.94) and service use 
in the past year (κ = 0.75 to 0.86) (Horwitz et al., 2001). Substantial concordance 
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between parents’ reports and medical records have also been found (κ = 0.76), with 
concordance regarding inpatient hospitalization services being higher (κ = 1.00) 
compared to specific inpatient services (κ = 0.50 to 0.66) and outpatient services (κ = 
0.66 to 0.67) (Hoagwood et al., 2000). Comparing parents’ and children’s reports on the 
SACA, Stiffman and colleagues (2000) found fair to excellent concordance regarding 
youth’s lifetime mental health service use (κ = 0.43 to 0.86), and good to excellent 
concordance regarding service use in the past year (κ = 0.45 to 0.77).  
 For the current study, parent-reported mental health service use (any and number 
of inpatient hospitalizations, any outpatient services, number of outpatient professionals 
seen, and any school services) was analyzed.  
General Behavior Inventory  
The General Behavior Inventory (GBI; Depue et al., 1981) is a 73-item self-report 
measure completed by parents to assess their own symptoms of mania, hypomania, and 
depression. Providing scores on two subscales, hypomanic/biphasic and depressive, the 
GBI consists of items that asseses mood symptoms experienced in the past six months 
that are rated on a 4-point Likert scale (from “Never or hardly ever” to “Very often or 
almost constantly”). High internal consistency has been observed (Cronbach’s α = 0.94), 
along with good 15-week test-retest reliability (r = 0.73). The GBI has also been 
successful in distinguishing adults with BPSD from nondepressed individuals, those with 
mild depression, and those with personality or other psychiatric disturbances. For the 
current analyses, total scores on the GBI were analyzed as a measure of current parental 
psychopathology specifically in the mood symptoms domain.  
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Rater and Reliability Training 
 At the initial study start-up, all investigators and each site’s project coordinators 
participated in a two-day didactic training on the LAMS protocol. All initial and 
subsequent interviewers received formal, comprehensive training from the site’s study 
coordinator. Didactic training included review of interviewing techniques, discussion of 
the development, purposes, and structure of the K-SADS-PL-W, detailed review of 
instruments used in the study, and viewing of sample interviews completed by 
experienced interviewers. Subsequent to the didactic training, the interviewers completed 
live observations of at least three annual follow-up assessments and completed ratings 
along with the experienced interviewer. New interviewers were required to match 
experienced interviewers’ diagnoses on seven of eight diagnostic categories (BPSD, 
depressive spectrum, ADHD spectrum, disruptive behavior disorders spectrum, psychotic 
disorders spectrum, anxiety disorders spectrum, substance abuse disorders spectrum, and 
adjustment disorders) on the K-SADS-PL-W. In addition, weighted kappas of 0.40 or 
greater in item-level analyses of ratings on the K-SADS-PL-W, CDRS-R (not included in 
the current analyses), and YMRS (not included in the current analyses) were required. 
New interviewers were then observed by experienced interviewers on three additional 
baseline or annual follow-up assessments, and the reliability criteria just described must 
be fulfilled for new interviewers to be considered fully-trained.  
 Across sites, inter-rater reliability was calculated twice a year for the K-SADS-
PL-W, CDRS-R, and YMRS. All interviewers watched the same taped interview and 
provided ratings along with the taped experienced interviewer. Intra-class correlations > 
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0.70 and item-level weighted kappas were required to be > 0.40, and agreement on 7 of 
the 8 diagnostic categories on the K-SADS-PL-W were necessary. Interviewers who 
failed to meet these reliability criteria were provided additional training as necessary.  
Data Analysis 
Statistical Software Used 
Statistical analyses were performed using the statistical software packages SPSS 
Statistics for Windows, Version 20.0 (International Business Machines Corporation, 
2011) and HLM 6.08 (Raudenbush, Bryant, Cheong, & Cogdon, 2004).  
Missing Data and Multiple Imputation Procedures 
As is common and expected in longitudinal designs for missing data to be present, 
chi-square and t-test analyses to compare individuals with and without missing data on 
key variables used in statistical models were performed. Potential differences in sex, race, 
ethnicity, study site, baseline family income, insurance status, age, IQ, CGAS total score, 
and number of diagnoses were examined for the variables of KINDL total scores and CGI 
(symptom severity). Results from these analyses are found in Table 4. Although the 
randomness of missing data cannot be definitely determined (Graham, 2009; Schafer & 
Graham, 2002), it seems reasonable to assume that although the missing data may not be 
completely at random (i.e., not related to observed or missing data), it may be at random 
(i.e., can be related to observed data but not on missing data). Thus, to preserve the 
maximum number of participants analyzed in multilevel models run in the current study, 
multiple imputation was performed on the dataset comprising predictors to be included in 
the multilevel models.  
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Using SPSS Statistics for Windows, Version 20.0, the multiple imputation tool 
was used. The dataset (with time-varying variables in its “wide” form [i.e., repeated 
measures as separate variables]) was subjected to 10 imputations. The fully conditional 
specification was used, as a monotone pattern of missingness was not observed. 
Dichotomous variables were constrained to take on the values of 0 or 1 and were rounded 
to the nearest integer. Since the Level-2 (time-invariant) variables had a maximum 
missing data rate of < 3%, missing values were not imputed for missing level-2 variables 
to allow for one Level-2 dataset to be used in the HLM 6.08 program. All Level-1 
variables were initially specified as both predictors and dependent variables in the 
imputation model. If the model was unable to find an imputed value for a variable, the 
role of the variable was constrained to only serve as a dependent variable in the 
imputation model. In the final imputation model, all variables served as predictors and 
dependent variables except for 12-month mood stabilizer, 12-month antidepressant, 12-
month antipsychotic, 12-month stimulant, 12-month outpatient treatment, and baseline 
and 12-month number of outpatient professionals, which were constrained to the role of 
dependent variables.  
Primary Aims 1 and 2: Elucidate the Relationship between Symptom Severity and 
Overall QoL; Identify Demographics, Parental/Familial, and Child Variables that 
are Associated with Resilient Outcomes across the 2 Years of Assessments 
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Multilevel modeling (MLM) was used to examine the relationship between 
symptom severity and overall QoL
2
, and to identify demographic, parental/familial, and 
child variables associated with resilience outcomes. By building concurrent Level-1 and 
Level-2 models, MLM provides estimates of both within-individual change and between-
individual differences in trajectories of change over time (Singer & Willett, 2003). 
Multilevel modeling is well-suited for analyses of repeated measures in a longitudinal 
dataset, as it accounts for dependency in hierarchically-structured data (e.g., repeated 
measures of an outcome nested within individuals), explicitly models within- and 
between-individual variance components, and is capable of estimating models even with 
unbalanced data among participants. For the current analyses, overall QoL served as the 
dependent variable in each multilevel model. Separate models with child-reported QoL 
and parent-reported QoL were fitted. Full information maximum likelihood estimation 
was used to estimate all population parameters that most likely gave rise to the observed 
sample data.  
 Analyzing multiply imputed data in HLM 6.08. The 10 multiply imputed Level 
1 datasets described above were imported into the HLM 6.08 program; the same non-
imputed Level 2 dataset was used. HLM 6.08 performs analyses separately on each 
imputed dataset; in the current analyses, each model was run 10 times on the separate 
Level 1 datasets  Parameter estimates then were averaged across the 10 analyses. 
Variances of parameter estimates were first averaged across the imputed datasets, then 
                                                 
2
 Given the lack of a clear theoretical rationale to expect differential effects of covariates on the relationship 
between symptom severity and specific QoL domains, total QoL scores initially served as the dependent 
variable.  
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the variance of each parameter estimate (from each imputed dataset) from the averaged 
estimate were calculated. These two variances were combined to produce the variance of 
the average parameter estimate; the square root of this variance yields the standard error 
of the estimate.  
Unconditional models. First, an unconditional means model was fitted, and an 
intraclass correlation coefficient (ICC) was calculated (between the within- and between-
person variances) to determine whether significant within-person and between-person 
variance in QoL exists to be explained by additional predictors. Next, an unconditional 
growth model with grand mean-centered age at assessment entered as a time variable was 
entered at Level 1 to determine whether there were significant changes in QoL across 
age. Symptom severity was then entered as a time-varying covariate in Level 1. 
Examination of random effects of intercept, age, and symptom severity was completed to 
determine whether these effects should be retained in subsequent models. The random 
effect of intercept at Level 2 was removed to allow for estimation of random effects that 
were most pertinent to the current hypotheses, including the random effects of rate of 
change in QoL and slope of symptom severity.  
Predictor-added models. Given that resilience was defined statistically as less 
negative, none, or positive time-linked correspondence between symptom severity and 
QoL, the model with age at assessment and symptom severity entered at Level 1 served 
as the base model to which hypothesized time-varying (entered at Level 1) and time-
invariant predictors (entered at Level 2) were added, in order to examine their potential 
moderating effects on the severity-QoL relationship. Table 1 lists the hypothesized 
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covariates that were examined. Each of these covariates was entered separately into the 
base model. Predictors’ effects on model intercepts, effects on rate of change, and effects 
on symptom severity were explored.  
 Variables determined to be significant contributors to resilience outcomes were 
those found to moderate the time-linked relationship between symptom severity and QoL, 
producing a model where symptom severity demonstrated differential effects on QoL 
depending on the level of the tested covariate. In other words, including these covariates 
in the multilevel model reduced the effect of symptom severity on QoL, resulting in no 
significant effect of symptom severity on QoL across time, a significant positive effect of 
symptom severity on QoL, or a less negative effect of symptom severity on QoL
3
.  
 Level-1 predictors. Level-1 time-varying predictors (TVPs) are variables that 
were measured at every assessment time point. In order to examine effects of TVPs on 
effect of symptom severity, estimated slopes across time for Level-1 predictors were first 
extracted for each participant in each multiply imputed dataset. Slopes for continuous 
Level-1 predictors were extracted using the following multilevel model: 
Level 1: TVPij = π0i + π1i(ageij) +  εij 
Level 2: π0i = γ00 
  π1i = γ10 + ζ1i 
Slopes for dichotomous Level-1 predictors were extracted using the following Bernoulli 
multilevel model:  
                                                 
3
 Although multiple models were run and hence multiple statistical tests were performed, corrections to 
critical p-values were not made due the exploratory nature of the study and the costs of Type-II errors (i.e., 
not identifying potentially significant effects) given current study goals. 
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Level 1: Prob(TVPj =1) = φ 
Log[(
φ
1 − φ
)] =  η 
   η = π0+ π1(Ageij) 
Level 2: π0i = γ00 
  π1i = γ10 + ζ1i 
Please see equations in Appendix A (“Model to extract individual slopes for time-varying 
predictor”) for a further description of each component in these models. Extracted slopes 
for each individual were then averaged across the 10 multiply imputed datasets. The 
average slopes for each predictor were next added as Level-2 covariates to the base 
model (Appendix A: “Level-1 time-varying predictor (TVP) slope added to base model”), 
producing the following mixed model:  
QoLij = γ00 + γ01(extracted TVP slopei) + γ10(ageij) + γ11(extracted TVP slopei x ageij) + 
γ20(severityij) + γ21(extracted TVP slopei x severityij) +  ζ1i(ageij)
4
 + ζ2i(severityij)
5
 
+ εij. 
Significant interaction effects (i.e., γ21) were probed using a web utility developed by 
Preacher, Curran, and Bauer (2006), by examining simple slopes and graphical displays.  
 Level-2 predictors. Level-2 time-invariant predictors (TIPs), or those measured 
only at baseline, were directly added as Level-2 covariates to the base model (Appendix 
                                                 
4
 This effect was removed from the parent-reported QoL models due to its non-significant effect. 
5
 This effect was removed from both the parent- and youth-reported QoL models due to its non-significant 
effect.  
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A: “Level-2 time-invariant predictor added to base model”), which produced the 
following mixed model: 
QoLij = γ00 + γ01(TIP) + γ10(ageij) + γ11(TIPi x ageij) + γ20(severityij) + γ21(TIPi x severityij)  
+ ζ1i(ageij)
6
 + ζ1i(severityij)
7
 + εij. 
As with multilevel models examining TVPs, significant interaction effects  (i.e., γ21) were 
probed using Preacher, Curran, and Bauer’s (2006) web utility. Simple slopes and 
graphical displays were examined.  
 The above analyses were performed on the hypothesized and exploratory Level-1 
and Level-2 covariates listed in Table 2.   
Secondary Aim: Replicate Findings from Previous Research Regarding 
Concordance between Self- and Proxy-Reports of Youth’s QoL 
Using the original (not imputed) dataset
8
, dependent-samples t-tests were 
performed to compare mean youth- and parent-reported total QoL and QoL domain 
scores. To examine concordance rates between youth- and parent-reported QoL, mean 
differences, mean biases, Pearson’s correlation coefficients (rs), and ICCs9 between 
youth and parent reports were computed for each QoL total and domain score at each 
assessment time point. Comparisons of parent-youth agreement between QoL domains 
                                                 
6
 This effect was removed from the parent-reported QoL models due to its non-significant effect. 
7
 This effect was removed from both the parent- and youth-reported QoL models due to its non-significant 
effect. 
8
 The original dataset, rather than the imputed datasets, were used in these analyses, since domain QoL 
were scores were not included in the multilevel models and were therefore not included in the multiple 
imputation process.  
9
 Pearson’s correlation coefficients are calculated based on each variable’s mean and standard deviation, 
while ICCs are calculated based on the pooled mean and standard deviation of the two variables being 
compared.  
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were tested using the modified Pearson-Filon (ZPF) test (Raghunathan, Rosenthal, & 
Rubin, 1996), which allows for comparisons between non-overlapping dependent 
correlations: 
 
 
 
 
The correlation r12 is that between parent- and youth-report on one domain of the KINDL, 
and r34 is the correlation between parent- and youth-report on the second domain of 
KINDL that is being compared. These ZPF tests were performed using SPSS 20.0.  
  
  
91 
 
 
 
 
Chapter 3. Results 
 
Descriptive Statistics 
Tables 5 to 11 display descriptive statistics of the following: demographic 
characteristics and time-invariant covariates (Table 5); time-varying covariates of age, 
insurance status, physical health problems, medication treatment, and psychosocial 
treatment (Table 6); parent- and self-reported QoL (Table 7); clinician-rated measures of 
ALIFE, CGAS, and CGI (Table 8); detailed ratings of symptom severity (Table 9); self-
report measures of parenting stress, stressful life events, parental bipolar disorder 
symptoms, parent-rated youth bipolar disorder symptoms (Table 10); and youth 
psychiatric diagnoses, suicidality, and psychosis (Table 11). Table 12 displays Pearson’s 
correlations among Level-1 predictors; Table 13 displays Pearson’s correlations between 
Level-1 and Level-2 predictors, and among Level-2 predictors.  
 
General Observations on Pearson’s Correlations 
Attention is specifically drawn to correlations between QoL and ALIFE scores 
(Table 12). Despite some conceptual overlap between the two constructs (e.g., quality of 
interpersonal relationships are an aspect of QoL), time-concordant rs between these two 
scores ranged from 0.09 to 0.41. These positive correlations suggest there is value in 
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examining these variables as related but potentially unique constructs. Next, the 
distinction between functional impairment and QoL discussed thus far appears supported, 
again by positive though non-perfect rs ranging from 0.18 to 0.39.   
For parent-reported QoL alone (Table 13), parental psychiatric history of 
psychosis, suicidality, anxiety, substance use, and disruptive behavior was generally 
positively associated with Medicaid status across time points (rs range from -0.38 to -
1.0), while baseline intact family structure was negatively associated with Medicaid 
status (rs range from 0.40 to 0.42). Although not consistent across categories of 
psychiatric history, there were significant positive associations between parental and 
familial psychiatric histories and both parent- and youth-reported life stress.  
 
Multilevel Models Examining Resilience with Parent-Reported QoL as Outcome 
 Table 14 displays parameter estimates for both hypothesized and exploratory 
Level-1 covariates; Table 15 displays parameter estimates for hypothesized and 
exploratory Level-2 covariates. The unconditional means model yielded a significant 
effect of intercept (P-KINDL score at mean age of 10.39), and both within- and between-
person variance components. The ICC calculated was significant at p < .001, indicating 
that significant between-person variance is present and adding additional level-2 
predictors to the model is warranted: 
ICC = 68.61 / (68.61 + 76.39) = 0.47 
Figure 1 is a scatterplot displaying the non-significant relationship between age and 
parent-reported QoL. Symptom severity was next added to the model. Figure 2 is a 
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scatterplot displaying the negative association between symptom severity and QoL. 
Figure 3 displays the relationship between age and symptom severity; no clear 
relationship between these two variables correlation is observed, consistent with the non-
significant correlations between age and symptom severity at each assessment time point 
(see Table 12). The final base model to which hypothesized and exploratory covariates 
was added was as follows: 
Level 1: QoLij = π0i + π1i(Ageij) + π2i(Severityij) + εij 
         Level 2: π0i = γ00  
           π1i = γ10 + ζ1i 
           π2i = γ20 + ζ2i 
   Mixed Model: QoLij = γ00 + γ10(Ageij) + γ20(Severityij) + ζ1i(Ageij)  + 
ζ2i(Severityij)  + εij (Base Model) 
The following will focus primarily on the interaction effects between 
hypothesized or exploratory covariates on symptom severity, with covariates’ effects on 
intercept and rate of change highlighted where applicable.  
 
Level-1 Hypothesized Covariates  
 As described above, slopes of Level-1 covariates across time were first extracted, 
and these slopes were added as Level-2 effects to the base model to examine their 
interaction effects with symptom severity: 
Level 1: QoLij = π0i + π1i(Ageij) + π2i(Severityij) + εij 
         Level 2: π0i = γ00 + γ01(Extracted TVP Slopei)  
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           π1i = γ10 + γ11(Extracted TVP Slopei) + ζ1i 
           π2i = γ20 + γ21(Extracted TVP Slopei) + ζ2i 
Mixed Model: QoLij = γ00 + γ01(Extracted TVP Slopei) + γ10(Ageij) + γ11(Extracted TVP 
Slopei x  Ageij) + γ20(Severityij) + γ21(Extracted TVP Slopei x Severityij) + ζ1i(Ageij)  + 
ζ2i(Severityij) + εij. 
(Level-1 Predictor-Added Model) 
 
 Social support (ALIFE) – Primary caregiver, secondary caregiver, and peers. 
Clinician-rated social relationships with children’s primary and secondary caregivers and 
their peers were hypothesized to moderate the time-linked relationship between symptom 
severity and QoL. While none of these interaction effects with symptom severity were 
significant (p > .05), each of these three variables significantly predicted change in QoL 
over time, such that improving relationships with their primary caregiver, secondary 
caregiver, and peers were associated with increasing QoL over time (γ11(ALIFE-Primary) = 
4.08, 95% CI [3.04, 5.12]; γ11(ALIFE-Secondary) = 3.34, 95% CI [2.26, 4.42]; and γ11(ALIFE-Peer) 
= 3.31, 95% CI [2.25, 4.37]; all ps < .001).  
 Number of diagnoses. The number of diagnoses children had at each assessment 
time point was hypothesized to moderate the time-linked relationship between symptom 
severity and QoL. Although this interaction effect was not significant (p > .05), number 
of diagnoses significantly predicted change in QoL across time, such that an increasing 
number of diagnoses was associated with decreasing QoL (γ11(Number of Diagnoses) = -1.44, 
95% CI [-2.22, -0.66,], p < .01).  
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 Psychiatric medication. Psychiatric medication children received was 
hypothesized to moderate the time-linked relationship between symptom severity and 
QoL. Dichotomous variables (received or not received) for different classes of 
medication were created: No medication, antipsychotic medication, antidepressant 
medication, anxiolytic medication, stimulant medication, mood stabilizer medication, 
other medication. It is of note that the model fitted to extract individual slopes of 
anxiolytic medication did not converge on a solution
10
; hence the effect of receiving 
anxiolytic medication on the time-linked relationship between symptom severity and QoL 
could not be assessed. This is not surprising given how infrequently anxiolytic 
medications were prescribed (less than 3% at any time period). Entering anxiolytic 
medication as a time-varying covariate (along with age and symptom severity) to predict 
parent-reported QoL revealed no unique main effect (γ30(Anxiolytic) = -2.06, SE = 2.66, p > 
.05). None of the interaction effects of each medication class and symptom severity was 
statistically significant, nor were the effects on change in QoL over time (p > .05). 
 Psychosocial treatment. School services, inpatient psychiatric hospitalization, 
and outpatient treatment were hypothesized to moderate the time-linked relationship 
between symptom severity and QoL. School services included attending a special school, 
being placed in a special classroom, receiving special help in the classroom, and/or 
receiving school counseling. The interaction effects of school services, whether or not 
children were inpatient hospitalized, whether children received outpatient services, and 
                                                 
10
 Lack of convergence may have been due to the lack of variability in this variable across time for each 
participant or the model run was not accurately specified given the patterns of the data. 
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the number of outpatient professionals children saw, were not significant (ps > .05). 
Receiving outpatient services across time was associated with worse QoL at mean age 
(γ01(Outpatient Services) = -9.01, 95% CI [-17.83, -0.19], p < .05). The number of outpatient 
professionals children saw was related significantly to changes in QoL over time, such 
that decreasing number of outpatient professionals seen was associated with increasing 
QoL (γ11(Number of Outpatient Professionals) = -0.80, 95% CI [-1.36, -0.24], p < .01). Although the 
effect of the number of inpatient hospitalization on changes in QoL was not significant, 
its effect on QoL at mean age was significant (γ01(Number of Inpatient Hospitalizations) = -6.43, 95% 
CI [-12.19, -0.67], p < .05), and its interaction effect with symptom severity was 
significant (γ21(Number of Inpatient Hospitalizations) = 1.82, 95% CI [0.56, 3.08], p < .01). This 
significant interaction effect was probed, and results are presented below. 
 Moderating effect of slope of number of inpatient hospitalizations on the timed-
linked relationship between symptom severity and QoL. Using Preacher. Curran, and 
Bauer’s (2006) software, simples slopes of the relationship between symptom severity 
and QoL were obtained at three levels of the slopes of the number of inpatient 
hospitalizations: (1) 1 SD below the mean of the extracted slopes (mean 0.02, SD = 0.38), 
(2) mean slope, and (3) 1 SD above the mean slope. The simple slopes of symptom 
severity on QoL were as follows: 
1) 1 SD below the mean slope of number of inpatient hospitalizations: -3.17 
(0.35), p < .001; 
2) At mean slope of number of inpatient hospitalizations: -2.48 (0.28), p < .001; 
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3) 1 SD above the mean slope of number of inpatient hospitalizations: -1.79 
(0.41), p < .001. 
While simple slopes of symptom severity were significant at each level of the number of 
inpatient hospitalizations slopes, the slope of the number of hospitalizations increased, 
the negative relationship between symptom severity and QoL becomes less negative. This 
effect is consistent with the hypothesized moderating effect of number of hospitalizations 
to buffer the negative effect of symptom severity on QoL. Figure 4 displays this 
interaction effect graphically. 
 Global functioning. Greater total current score on the CGAS, suggestive of better 
functioning, was hypothesized to moderate the time-linked relationship between 
symptom severity and QoL. Although this interaction effect was not significant (p > .05), 
increasing functioning over time was expectedly associated with increasing QoL 
(γ11(CGAS) = 0.18, 95% CI [0.08, 0.28], p < .01). 
 Parenting stress. The number of parenting stressors reported on the PSS and total 
stress scores were hypothesized to moderate the time-linked relationship between 
symptom severity and QoL. Although neither of the two variables demonstrated a 
statistically significant interaction effect with symptom severity, both were associated 
with QoL over time, such that increasing number of stressors and increasing total stress 
predicted decreasing QoL (γ11(Number of PSS Stressors) = -0.88, 95% CI [-1.08, -0.68], p < .001; 
γ11(Total PSS Stress) = -0.26, 95% CI [-0.32, -0.02], p < .001).  
 Stressful life events. Increasing numbers of stressful life events in children’s life 
and the total effect of these stressors, as reported by parents and youth on the SLES, were 
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hypothesized to moderate the time-linked relationship between symptom severity and 
QoL. Although youth-reported number of stressors and total stress did not interact with 
symptom severity and did not uniquely predict change in QoL over time (ps > .05), 
parent-reported number of stressors and total stress significantly predicted change in 
QoL, such that increasing number of stressors and total stress were associated with 
decreasing QoL over time (γ11(Number of P-SLES stressors) = -0.41, 95% CI [ 
-0.59, -0.23], p < .001; γ11(Total P-SLES stress) = -0.18, 95% CI [-0.24, -0.12], p < .001). 
Furthermore, the interaction effect of the slope of parent-reported total stress with 
symptom severity was significant (γ21(Total P-SLES stress) = 0.08, 95% CI [0, 0.16], p < .05), 
while the interaction effect of parent-reported number of stressors with symptom severity 
approached significance (γ21(Number of P-SLES stressors) = 0.20, 95% CI [-0.02, 0.42], p < .10). 
The significant effect was probed, and results are presented below.  
 Moderating effect of slope of total parent-reported impact of stressful life events 
on the time-linked relationship between symptom severity and QoL. Simple slopes of the 
relationship between symptom severity and QoL were obtained at 3 levels of the slopes 
of the total impact of parent-reported stressful life events: (1) 1 SD below the mean of the 
extracted slopes (mean = 0.41, SD = 6.40), (2) mean slope, and (3) 1 SD above the mean 
slope. The simple slopes of symptom severity on QoL were as follows: 
1)  1 SD below the mean slope of parent-reported total impact of stressful life 
events: -2.87 (0.33), p < .001; 
2) At mean slope of parent-reported total impact of stressful life events: -2.34 
(0.28), p < .001; 
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3) 1 SD above the mean slope of parent-reported total impact of stressful life 
events: -1.81 (0.39), p < .001). 
Although simple slopes of symptom severity were significant at each level of the parent-
reported total effect of stressful life events slopes, as the total effect of stressful life 
events increased, the relationship between symptom severity and QoL becomes less 
negative. It was hypothesized that decreasing total effect of stressful life events (i.e., 
negative slope) would buffer the negative relationship between symptom severity and 
QoL; in contrast, these results suggest that increasing total effect of stressful life events 
buffer the time-linked symptom severity-QoL relationship.  
Figure 5 displays this interaction effect graphically. 
Insurance status. It was hypothesized that non-Medicaid status would moderate 
the time-linked relationship between symptom severity and QoL. However, this 
interaction was not significant (p > .05). The effect of losing Medicaid on changes in 
QoL over time was significant, such that losing Medicaid status was associated with 
decreasing QoL (γ11(Non-Medicaid) = -1.99, 95% CI [-3.89, -0.09], p < .05).  
 
Level-1 Exploratory Covariates 
 Significant physical health problems. The model first fitted to extract slopes of 
youth’s physical health problems across time did not converge on a solution. Therefore, 
the effect of this TVP on the relationship between symptom severity and QoL was not 
examined. Entering significant physical health problems as a time-varying covariate 
(along with age and symptom severity) to predict parent-reported QoL revealed no 
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unique main effect (γ30(Physical Health Problems) = -1.38, SE = 0.80, 95% CI [-2.95, 0.19], p > 
.05). 
 Diagnostic group. As explained above, condensed hierarchically-formed 
diagnostic groups were entered into separate multilevel models to explore their effects on 
the time-linked relationship between symptom severity and QoL. It is of note that models 
fitted to extract the slopes of Other Diagnosis and No Diagnosis were unable to converge 
on a solution; therefore, the interaction effects of these variables with symptom severity 
were unable to be examined. Entering Other Diagnosis as a time-varying covariate (along 
with age and symptom severity) to predict parent-reported QoL revealed no unique main 
effect (γ30(Other Diagnosis) = -0.62, SE = 2.10, p > .05). However, entering No Diagnosis as a 
time-varying covariate (along with age and symptom severity) to predict parent-reported 
QoL revealed a significant unique main effect (γ30(No Diagnosis) = 2.74, SE = 1.14, 95% CI 
[0.51, 4.97], p < .05), suggesting that having no diagnosis was associated with better 
QoL at mean age. No significant interaction effects were found across diagnostic 
categories (ps < .05). However, group membership in the ADHD Diagnosis category 
(combined Groups 11 and 12 in Table 3) significantly predicted QoL across time, such 
that entering into this diagnosis group across time was associated with increasing QoL 
(γ11(ADHD Diagnosis) = 7.49, 95% CI [4.69, 10.29], p < .001). Group membership in the 
Depressive Spectrum Disorder Diagnosis category (combined groups 5 and 6) 
significantly predicted worsening QoL across time (γ11(Depressive Disorder Diagnosis) = -5.91, 
95% CI [-9.11, -2.71], p < .001). 
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 Parent-reported mania symptoms in youth. The effects of parent-reported total 
scores on the PGBI-10M and elevated symptoms of mania positive (ESM+) status on the 
time-linked relationship between symptom severity and QoL were examined. Although 
no interaction effects were significant, PGBI-10M total scores and ESM+ status 
significantly predicted QoL over time, such that increasing PGBI-10M total scores and 
gaining ESM+ status was associated with decreasing QoL (γ11(PGBI-10M) = -0.41, 95% CI [ 
-0.55, -0.27], p < .001; γ11(ESM+) = -4.96, 95% CI [-7.10, -2.82], p < .001).  
 Parent self-reported bipolar disorder symptoms. The effect of parent self-
reported bipolar disorder symptoms on the GBI-P on the time-linked relationship 
between symptom severity and QoL were examined. The interaction effect between GBI-
P and symptom severity was not significant (p > .05), though GBI-P total scores 
significantly predicted QoL (γ11(GBI-P) = -0.06, 95% CI [-0.08, -0.04], p < .001); 
increasing GBI-P symptoms was associated with decreasing QoL over time.  
 School challenges. The effect of school challenges, which included repeating a 
grade, having an academic tutor, and/or receiving special education services, on the time-
linked relationship between symptom severity and QoL was explored. Having increasing 
school challenges predicted worsening QoL (γ11(School Challenges) = -1.97, 95% CI [-3.97,  
0.03], p < .05). 
 Suicidality. The effect of suicidality, which included suicidal ideation, gesture, 
and/or attempt, on the time-linked relationship between symptom severity and QoL was 
explored. Although the interaction effect was not significant (p > .05), increasing 
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suicidality across time was associated with decreasing QoL (γ11(Suicidality) = -3.92, 95% CI 
[-7.52, -0.32], p < .05).  
 Psychosis. The effect of psychosis on the time-linked relationship between 
symptom severity and QoL was explored; there were no significant relationships found 
(ps > .05).  
 
Level-2 Hypothesized Covariates 
 As described above, level-2 time-invariant predictors were entered to the base 
model depicted above:  
Level 1: QoLij = π0i + π1i(Ageij) + π2i(Severityij) +  εij 
         Level 2: π0i = γ00 + γ01(TIPi)  
                                               π1i = γ10 + γ11(TIPi) + ζ1i 
           π2i = γ20 + γ21(TIPi) + ζ2i 
Mixed Model: QoLij = γ00 + γ01(TIP) + γ10(Ageij) + γ11(TIPi x Ageij) + γ20(Severityij) + 
γ21(TIPi x Severityij) + ζ1i(Ageij) + ζ2i(Severityij) + εij. 
(Level-2 Predictor-Added Model) 
IQ. Full-scale IQ scores obtained from the WASI administered at baseline were 
hypothesized to moderate the time-linked relationship between symptom severity and 
QoL. However, no significant effects of IQ were found (ps > .05).  
Family structured at baseline. The effect of youth living in two-parent families 
at baseline was hypothesized to moderate the time-linked relationship between symptom 
severity and QoL. However, no significant effects were found (ps > .05). 
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Family income at baseline. Higher baseline family income was hypothesized to 
moderate the time-linked relationship between symptom severity and QoL. Four 
dichotomous variables of family income were formed: (1) < $19,999, (2) $20,000-
$39,999, (3) $40,000-$49,999, and (4) $50,000-More than $200,000. There were no 
significant effects (ps > .05).  
 
Level-2 Exploratory Covariates 
Site. Even though study site was not a hypothesized contributor to resilience 
outcomes, its effect on symptom severity and QoL was examined to explore the potential 
impact of site on QoL outcomes. The interaction of site with symptom severity was not 
significant. However, site was a significant predictor of QoL at mean age (γ01(Site ) = 1.44, 
95% CI [0.26, 2.62], p < .05). A one-way ANOVA subsequently performed on the 
original dataset revealed significant site differences in baseline (F(3, 384) = 3.51, p < .05) 
and 12-month (F(3, 452) = 7.22, p < .001) parent-reported QoL. No significant differences 
in parent-reported QoL were found at the 24-month assessment (p > .05). For the 
baseline and 12-month parent-reported QoL scores, Tukey’s honest significant difference 
(HSD) tests were performed to compute all pairwise comparisons among study sites. At 
baseline, parent-reported QoL was lower at Case Western Reserve University compared 
to Pittsburgh (mean difference = 3.82, SE = 1.41, 95% CI [1.06, 6.58], p < .05), and 
Cincinnati had a lower score than to Pittsburgh (mean difference = 4.06, SE = 1.40, 95% 
CI [1.32, 6.80], p < .05). At the 12-month assessment, Case Western had lower scores 
compared to both Ohio State (mean difference = 3.98, SE = 1.49, 95% CI [1.06, 6.90], p 
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< .05) and Pittsburgh (mean difference = 5.67, SE = 1.54, 95% CI [2.65, 8.69], p < .01), 
and Cincinnati was lower than Ohio State (mean difference = 3.83 SE = 1.40, 95% CI 
[1.09, 6.57], p < .05) and Pittsburgh (mean difference = 5.52, SE = 1.46, 95% CI [2.66, 
8.38], p < .01). Table 16 displays additional examinations of site differences on key 
demographic variables and ratings of symptom severity and QoL. 
 Demographic variables. The effects of the demographic variables of sex (male = 
0, female = 1), race (non-Caucasian = 0, Caucasian = 1), and ethnicity (non-Hispanic = 0, 
Hispanic = 1) on the time-linked relationship between symptom severity and QoL were 
examined. No significant interaction effects were found (ps > .05). However, an 
approaching significance finding was found, such that females had lower QoL at mean 
age (γ01(Female) = -2.53, 95% CI [-5.43, 0.37], p < .10). 
 Parental psychiatric history. Ten separate variables of parental psychiatric 
history were formed (No Diagnosis, Symptoms of ADHD, Mania, Depression, Anxiety, 
Disruptive Behavior, Substance Use, Suicidality, and Psychosis, and Total Number of 
Diagnoses), and the individual effects on the time-linked relationship between symptom 
severity and QoL were explored. No significant interaction effects were found (ps > .05). 
With the exception of the effect of Parental Depression on change in QoL over time 
(γ11(Parental Depression) = 0.85, 95% CI [0.11, 1.59], p < .05; having a parental history of 
depression was associated with increasing QoL over time), no other significant results 
were found. 
 Family psychiatric history. Nine separate variables of family (non-parent) 
psychiatric history were formed (No Diagnosis, Symptoms of ADHD, Mania, 
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Depression, Anxiety, Conduct, Substance Use, Suicidality, and Psychosis), and the 
individual effects on the time-linked relationship between symptom severity and QoL 
were explored. No significant interaction effects were found (ps > .05). With the 
exception of the significant effect of familial conduct symptoms on QoL at mean age 
(γ01(Familial Conduct) = 3.85, 95% CI [0.37, 7.33], p < .05; having a family history of conduct 
symptoms was associated with greater QoL at mean age), no other significant effects 
were found (ps > .05).  
 
Multilevel Models Examining Resilience with Youth-Reported QoL as Outcome 
 Table 17 displays parameter estimates for both hypothesized and exploratory 
Level-1 covariates; Table 18 displays parameter estimates for hypothesized and 
exploratory Level-2 covariates. The unconditional means model yielded a significant 
effect of intercept (C-KINDL score at grand mean-centered age of 10.39), and both 
within- and between-person variance components. The ICC calculated was significant at 
p < .001, indicating that significant between-person variance is present and adding 
additional Level-2 predictors to the model is warranted:  
ICC = 43.79 / (43.79 + 131.50) = 0.25. 
Both age and symptom severity were added as Level-1 predictors (unconditional growth 
model). The final base model to which hypothesized and exploratory covariates was 
added was as follows: 
Level 1: QoLij = π0i + π1i(Ageij)* + π2i(Severityij)** + εij 
         Level 2: π0i = γ00  
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           π1i = γ10 + ζ1i 
           π2i = γ20 + ζ2i 
   Mixed Model: QoLij = γ00 + γ10(Ageij) + γ20(Severityij) + ζ1i(Ageij) + 
ζ2i(Severityij) + εij. 
(Base Model) 
The following will focus primarily on the interaction effects between 
hypothesized or exploratory covariates on symptom severity, with covariates’ effects on 
intercept and rate of change highlighted where applicable.  
 
Level-1 Hypothesized Covariates 
 Procedures to extract slopes and examine the effects of Level-1 covariates on 
youth-reported QoL were identical as those used with parent-reported QoL as the 
outcome. The following models were fitted: 
Level 1: QoLij = π0i + π1i(Ageij) + π2i(Severityij) + εij 
         Level 2: π0i = γ00 + γ01(Extracted TVP Slopei)  
           π1i = γ10 +  γ11(Extracted TVP Slopei) + ζ1i 
           π2i = γ20 + γ21(Extracted TVP Slopei) + ζ2i  
Mixed Model: QoLij = γ00 + γ01(Extracted TVP Slopei) + γ10(Ageij) + γ11(Extracted TVP 
Slopei x  Ageij) + γ20(Severityij) + γ21(Extracted TVP Slopei x Severityij) +  ζ1i(Ageij) + 
ζ2i(Severityij)  +  εij.  
(Level-1 Predictor-Added Model) 
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 Social support (ALIFE) – Primary caregiver, secondary caregiver, and 
peers.
11
 Although no significant interaction effects with symptom severity were found, 
each of these variables predicted change in QoL across time, such that improving 
relationships with their primary caregiver, secondary caregiver, and peers were associated 
with increasing QoL (γ11(ALIFE-Primary) = 1.89, 95% CI [0.55, 3.23], p < .01; γ11(ALIFE-
Secondary) = 2.30, 95% CI [1.06, 3.54], p < .001; and γ11(ALIFE-Peer) = 2.44, 95% CI [1.24, 
3.64], p < .001). 
 Number of diagnoses. Although this interaction effect was not significant (p > 
.05), number of diagnoses predicted change in QoL across time, such that an increasing 
number of diagnoses was associated with decreasing QoL (γ11(Number of Diagnoses) = -1.28, 
95% CI [-2.22, -0.34], p < .05).  
 Psychiatric medication. The model fitted to extract individual slopes of axiolytic 
medication did not converge on a solution; hence the effect of receiving anxiolytic 
medication on the time-linked relationship between symptom severity and QoL could not 
be assessed. It is again of note that less than 3% of the sample at any assessment time 
point was prescribed anxiolytic medication. Entering anxiolytic medication as a time-
varying covariate (along with age and symptom severity) to predict youth-reported QoL 
revealed no unique main effect (γ30(Anxiolytic) = 1.04, SE = 2.52, p > .05). None of the 
interaction effects of each medication class and symptom severity were statistically 
significant, nor were the effects on change in QoL over time (p > .05). 
                                                 
11
 Given that identical predictor variables were examined in child-reported QoL models as parent-reported 
QoL, descriptions of the variables are not repeated here, and the focus herein will be on statistical findings.  
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 Psychosocial treatment. Although none of the interaction effects of school 
services, whether or not children were inpatient hospitalized, the number of inpatient 
hospitalizations, whether children received outpatient services, and the number of 
outpatient professionals children saw, were significant (ps > .05), the effect of whether 
children received inpatient hospitalization on change in QoL over time was significant 
(γ11(Inpatient Hospitalization) = -6.08, 95% CI [-11.84, -0.32], p < .05), such that being inpatient 
hospitalized was associated with decreasing QoL over time.  
 Global functioning. The interaction effect between CGAS and symptom severity 
was not significant (p > .05); however, increasing functioning over time was expectedly 
associated with increasing QoL (γ11(CGAS) = 0.26, 95% CI [0.14, 0.38], p < .001). 
Parenting stress. Neither the number of parenting stressors reported on the PSS 
nor the total stress scores demonstrated significant interaction effects with symptom 
severity. However, both were associated with QoL over time, such that increasing 
number of stressors and increasing total stress predicted decreasing QoL (γ11(Number of PSS 
Stressors) = -0.38, 95% CI [-0.64, -0.12], p < .01; γ11(Total PSS Stress) = -0.10, 95% CI [-0.18, -
0.02], p < .05).  
 Stressful life events. Parent-reported number of stressors and total stress on the 
SLES did not significantly interact with symptom severity, but uniquely predicted change 
in QoL over time, such that increasing number of stressors and total stress were 
associated with decreasing QoL over time (γ11(Number of P-SLES stressors) = -0.27, 95% CI [ 
-0.49, -0.05], < .05; γ11(Total P-SLES stress) = -0.12, 95% CI [-0.20, -0.04], p < .01). Both 
youth-reported number of standardized stressors and standardized total stress 
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significantly predicted change in QoL, such that increasing number of stressors and total 
stress were associated with decreasing QoL over time (γ11(Number of K-SLES stressors) = -2.16, 
95% CI [-3.70, -0.62], p < .01; γ11(Total K-SLES stress) = -2.43, 95% CI [-3.87, -0.99], p < .01). 
Further, the interaction effects of youth-reported number of stressors and total stress with 
symptom severity were significant (γ21(Number of K-SLES stressors) = 1.75, 95% CI [0.51, 2.99], 
p < .01; γ21(Total K-SLES stress) = 1.83, 95% CI [0.43, 3.23], p < .05). These interaction effects 
were probed, and results are presented below. 
Moderating effect of slope of number of youth-reported stressful life events on the 
time-linked relationship between symptom severity and QoL. Simple slopes of the 
relationship between symptom severity and QoL were obtained at three levels of the 
slopes of the youth-reported number of stressful life events: (1) 1 SD below the mean of 
the extracted slopes (mean = 0.04, SD = 0.37), (2) mean slope, and (3) 1 SD above the 
mean slope. The simple slopes of symptom severity on QoL were as follows: 
1) 1 SD below the mean slope of number of youth-reported stressful life events: -
2.17 (0.37), p < .001; 
2) At mean slope of number of youth-reported stressful life events:  
-1.52 (0.29), p < .001; 
3) 1 SD above the mean slope of number of youth-reported stressful life events: -
0.88 (0.36), p < .001. 
Although simple slopes of symptom severity were significant at each level of the number 
of youth-reported stressful life events slopes, it can be seen that as the slope of the 
number of stressful life events increased, the relationship between symptom severity and 
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QoL becomes less negative. It was hypothesized that decreasing numbers of stressful life 
events (i.e., negative slope) would buffer the negative symptom severity and QoL; in 
contrast, these results suggest that increasing numbers of stressful life events buffer the 
time-linked symptom severity-QoL relationship.  
Figure 6 displays this interaction effect graphically. 
 Moderating effect of total youth-reported impact of stressful life events on the 
time-linked relationship between symptom severity and QoL. Simple slopes of the 
relationship between symptom severity and QoL were obtained at three levels of the 
slopes of the total effect of youth-reported stressful life events: (1) 1 SD below the mean 
of the extracted slopes (mean = 0.03, SD = 0.37), (2) mean slope, and (3) 1 SD above the 
mean slope. The simple slopes of symptom severity on QoL were as follows: 
1)  1 SD below the mean slope of parent-reported total effect of stressful life 
events: -2.18 (0.40), p < .001; 
2) At mean slope of parent-reported total effect of stressful life events: -1.51 
(0.29), p < .001; 
3) 1 SD above the mean slope of parent-reported total effect of stressful life 
events: -0.83 (0.38), p < .05). 
Although simple slopes of symptom severity were significant at each level of the youth-
reported total effect of stressful life events slopes, as the slope of the total effect of 
stressful life events increased, the relationship between symptom severity and QoL 
becomes less negative. It was hypothesized that decreasing total effect of stressful life 
events (i.e., negative slope) would buffered the negative relationship between symptom 
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severity and QoL; in contrast, these results suggest that increasing total effect of stressful 
life events buffered the time-linked symptom severity-QoL relationship.  
Figure 7 displays this interaction effect graphically. 
 Insurance status. No significant effects of insurance status were found (ps > 
.05). 
 
Level-1 Exploratory Covariates 
 Significant physical health problems. The model first fitted to extract the slopes 
of youth’s physical health problems across time did not converge on a solution. 
Therefore, the effect of this TVP on the relationship between symptom severity and QoL 
was not examined. However, entering significant physical health problems as a time-
varying covariate (along with age and symptom severity) to predict youth-reported QoL 
revealed a significant unique main effect (γ30(Physical Health Problems) = -2.77, SE = 0.83, 95% 
CI [-4.40, -1.14], p < .01), suggesting that youth with significant physical health 
problems experienced worse QoL at mean age.  
 Diagnostic group. Models fitted to extract the slopes of other diagnosis and no 
diagnosis were did not converge on a solution; therefore, the interaction effects of these 
variables with symptom severity could not be examined. No significant interaction effects 
were found across diagnostic categories (ps < .05). Entering other diagnosis as a time-
varying covariate (along with age and symptom severity) to predict youth-reported QoL 
revealed no unique main effect (γ30(Other Diagnosis) = 2.65, SE = 2.26, p > .05). In contrast to 
parent-reported QoL, entering No Diagosis as a time-varying covariate (along with age 
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and symptom severity) to predict youth-reported QoL revealed no unique main effect 
(γ30(No Diagnosis) = 0.002, SE = 1.39, p > .05). Entering into membership in the depressive 
spectrum disorder diagnosis category (combined Groups 5 and 6 in Table 3) was 
associated with decreasing QoL over time (γ11(Depressive Disorder Diagnosis) = -4.62, 95% CI [-
8.48, -0.76], p < .05), and as with parent-reported QoL, membership in the ADHD 
diagnosis category (combined Groups 11 and 12 in Table 3) significantly predicted QoL 
across time, such that entering into this diagnosis group across time was associated with 
increasing QoL (γ11(ADHD Diagnosis) = 3.86, 95% CI [0.84, 6.88], p < .05).  
 Parent-reported mania symptoms in youth. There was no significant effect of 
ESM+ status (ps > .05).  However, PGBI-10M total scores approached significance in 
predicting worsening QoL (γ11(P-GBI10) = -0.15, 95% CI [-0.33, 0.03], p < .10).  
 Parent self-reported bipolar disorder symptoms. No significant effects of GBI-
P total scores were found (ps > .05).  
 School challenges. No significant effects of school challenges were found (ps > 
.05).  
 Suicidality. Although the interaction effect was not significant (p > .05), 
increasing suicidality across time was associated with decreasing QoL (γ11(Suicidality) =  
-6.63, 95% CI [-11.07, -2.19], p < .01). 
 Psychosis. The model fitted to extract individual slopes of psychotic symptoms 
did not converge; therefore, the effect of this variable on the time-linked relationship 
between symptom severity and QoL not examined. Entering psychosis as a time-varying 
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covariate (along with age and symptom severity) to predict youth-reported QoL revealed 
no unique main effect (γ30(Psychosis) = -2.76, SE = 1.93, p > .05). 
 
Level-2 Hypothesized Covariates 
 As described above, Level-2 time-invariant predictors were entered to the base 
model depicted above:  
 
Level 1: QoLij = π0i + π1i(Ageij) + π2i(Severityij) +  εij 
         Level 2: π0i = γ00 + γ01(TIPi)  
                                               π1i = γ10 + γ11(TIPi) + ζ1i 
           π2i = γ20 + γ21(TIPi) + ζ2i 
Mixed Model: QoLij = γ00 + γ01(TIP) + γ10(Ageij) + γ11(TIPi x Ageij) + 
γ20(Severityij) + γ21(TIPi x Severityij) + ζ1i(Ageij) + ζ2i(Severityij) 
+ εij, 
(Level-2 Predictor-Added Model) 
IQ. No significant effects of full-scale IQ scores were found (ps > .05). 
Family structured at baseline. No significant effects of living in two-parent 
families at baseline were found (ps > .05). 
 Family income at baseline. No significant effects of each of the four family 
income categories were found (ps > .05). 
Level-2 Exploratory Covariates 
Site. No significant effects of site were found (ps > .05). 
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Demographic variables. No significant effects of sex, race, or ethnicity were 
found (ps > .05). 
Parental psychiatric history.  No significant effects of each of the parental 
psychiatric history variables were found (ps > .05). 
Family psychiatric history. With the exception of the approaching significance 
effect of Familial Conduct Symptoms on QoL at grand mean-centered age (γ01(Familial 
Conduct) = 3.23, 95% CI [-0.37, 6.83], p < .10; having a familial history of conduct 
symptoms was associated with greater QoL at mean age).  
Exploratory Analyses of Significant Interaction Effects in Specific QoL Domains 
 In order to further explore the observed significant interaction effects described 
above, multilevel models using the original dataset with specific QoL domains as 
outcomes were fitted to examine whether significant interaction effects of predictors held 
when specific QoL domains were considered. Table 19 displays the significance levels of 
predictors across QoL domains. Significant interactions were in the same direction as 
findings when total QoL scores were used as outcomes.  
 
 Number of inpatient hospitalizations (P-KINDL as outcome). The interaction 
effect of the number of inpatient hospitalizations and symptom severity was significant 
when total QoL was used. When examining specific QoL domains, this significant 
interaction held for Emotional, Esteem, and Family QoL (ps < .05), but was not 
significant for Physical, Friends, and School domains.  
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 Total effect of parent-reported stressful life events (P-KINDL as outcome). 
The interaction effect of the total impact of parent-reported stressful life events and 
symptom severity was significant when total QoL was used. When examining specific 
QoL domains, the interaction effect was significant for the Physical and Family domains 
(ps < 0.05), approached significance for the Esteem and School domains (p < .10), but 
was not significant for all other domains. 
 Number of youth-reported stressful life events (C-KINDL as outcome). The 
interaction effect of the number of youth-reported stressful life events and symptom 
severity was significant when total QoL was used. When examining specific QoL 
domains, the interaction held for Esteem, Family, Friends, and School domains (ps < 
.05). The interaction was not significant for the Physical and Emotional domains. 
 Total effect of youth-reported stressful life events (C-KINDL as outcome). 
The interaction effect of the total impact of youth-reported stressful life events and 
symptom severity was significant when total QoL was used. The pattern of significant 
results when specific QoL domains were examined was largely the same as that for the 
number of stressful life events, with the exception that the effect for the Family domain 
approached significance (p < .10).  
 
Concordance between Proxy- and Self-Reports of Youth’s QoL 
 Table 7 displays the descriptive statistics of parent- and self-reported QoL on the 
KINDL at each assessment time point.  
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Correlations, Mean Differences, and Mean Biases between Proxy- and Self-Reports 
in KINDL Domains 
 Table 20 displays the ICCs between parent- and youth-reported KINDL domain 
scores at each assessment time point; Table 21 displays correlations, mean differences, 
and mean biases between parent- and youth-reports in KINDL domains across time 
points. All correlations were statistically significant, with the majority at p < .001. Paired-
samples t-tests on mean differences between parent- and self-reported domain scores 
were performed. It was hypothesized that self-reported QoL would be higher than parent-
reported QoL across all domains. At baseline, this hypothesis was supported for the 
domains of Esteem, Family, Friends, and Total scores (t-values range from -9.24 to -.041, 
ps < .01). However, parent-reported Physical and School domain scores were higher than 
child-reported ones (t-values range from 1.99 to 4.46, ps < .05). There was no significant 
difference between parent- and self-reported Emotional domain scores.  
At 12-month assessment, this hypothesis was also supported for the domains of 
Esteem, Family, Friends, and Total scores (t-values range from -9.56 to -0.82, ps < .05). 
However parent-reported Emotional and School domain scores were significantly higher 
than self-reported ones (t-values range from 2.14 to 3.13, ps < .05). There was no 
significant difference in Physical domain scores.  
At 24-month assessment, this hypothesis was once again supported for Family 
and Friends domain scores (t-values range from -8.99 to -2.34 (ps < .05). The expected 
difference in Esteem domain scores approached significance (t-value of -1.82, p < .10). 
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However, parent-reported Emotional and School domain scores were significantly greater 
than that reported by youth (t-values range from 2.07 to 3.07, ps < .05). There was again 
no significant difference in Physical domain scores.  
Parent-Youth Agreement among QoL Domains on the KINDL 
 Table 22 displays results from modified Pearson-Filon tests of dependent 
correlations (e.g., between parent- and youth-reported scores in various QoL domains). It 
was hypothesized that parent-youth agreement would be higher in the Physical domain 
than other domains. This hypothesis was partially supported. At baseline, parent-youth 
agreement was greater in the Physical domain compared to the Emotional, Esteem, 
Family, and School domains (ps range from < .05 to < .001). Agreement was also greater 
in the Emotional domain compared to the Esteem domain (p < .05). Agreement was 
greater in the Friends domain compared to Esteem and Family (ps range from < .05 to < 
.001). Agreement in Total scores was greater than agreement in Esteem and Family (ps 
range from < .05 to < .001).  
 At 12-month assessment, agreement in the Physical domain was greater than 
agreement in the Esteem domain (p < .01). Agreement in Esteem was lower than 
agreement in Family and Friends domains (ps range from < .05 to < .001). Agreement in 
Friends was greater than agreement in School (p < 0.05). Agreement in Total scores was 
greater than agreement in Emotional and Esteem domains (ps range from < .05 to .01).  
 At 24-month assessment, agreement in the Physical domain was greater than 
agreement in the School domain (p < .05). Agreement in the Friends domain was greater 
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than agreement in the School domain (p < .05). Finally, agreement in Total scores was 
greater than agreement in the School domain (p < .001).  
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Chapter 4: Discussion 
  
 This study is one of the first to examine resilience processes in a sample of youth 
with psychopathology, an area in clinical child and adolescent psychology that has been 
scarcely explored yet potentially offers promise to improve the well-being of these youth. 
Throughout this document, resilience was defined as adaptive functioning exceeding that 
which is expected given one’s vulnerability and exposure to adversity. Protective factors 
are external or contextual variables that foster resilience outcomes, whereas resiliency 
factors are internal, personal variables that contribute to resilience. I conceptualized 
youth’s symptom severity as vulnerability that increases likelihood of negative outcomes, 
measured by parent- and self-reported QoL. Using 2 years of data across three annual 
assessment points from the LAMS study, I aimed to identify demographic, personal, 
familial, and clinical variables that might buffer the negative effects of symptom severity 
on self- and parent-reported QoL. By building separate multilevel models with parent- 
and youth-reported QoL as outcomes, both covariates that were hypothesized to moderate 
time-linked relations between symptom severity and QoL, and covariates for which no 
clear hypotheses were formed a priori, were examined for interaction effects with 
symptom severity. Tables 23 and 24 provide a summary of the Level-1 and Level-2 
covariates examined. In addition to exploring these interaction effects, which comprised 
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my aims, covariates’ unique effects on change in QoL over time were examined. Second, 
concordance rates between parent- and youth-reported QoL were tested, to determine 
whether findings from previous literature regarding differential concordance across QoL 
domains would replicate in our sample, or whether parent-youth agreement patterns in 
this study would differ from those generally reported in the literature.  
Symptom Severity as Vulnerability Predicting Worse QoL 
 Consistent with my hypothesis, increasing symptom severity predicted worsening 
parent- and youth-reported QoL across time. This was in accordance with findings 
reported in the literature for various psychiatric diagnoses, including ADHD (e.g., 
Steinhausen et al., 2006), substance use disorders (e.g., Becker, Curry, & Yang, 2009), 
OCD (e.g., Lack et al., 2009), post-traumatic stress (e.g., Vogels et al., 2000), tic 
disorders (e.g., Storch et al., 2007), depressive disorders (e.g., Kobayashi & Kamibeppu, 
2011; Stevanovic, 2013), bipolar disorders (e.g., Olsen et al., 2012; Van Meter, Henry, & 
West, 2013), and general psychopathological symptoms (e.g., Bartels et al., 2013). Given 
this relationship across models even with the addition of various time-invariant and time-
varying predictors, this finding reinforces the importance of assessing and incorporating 
specific treatment components targeted at improving QoL in interventions for youth with 
psychopathology. Although intervention approaches and packages must certainly focus 
on improving symptoms, it may be worthwhile and necessary to assess youth’s and 
caregivers’ satisfaction with their functioning and well-being throughout treatment. 
Incorporating such considerations into treatment planning and subsequent treatment 
strategies might not only increase families’ engagement with treatment, but may 
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additionally facilitate symptom improvement and reduce the possibility that potential 
intervention opportunities in significant aspects of youth’s lives are overlooked. As just 
one example, an eight-session intervention aimed at increasing QoL in children with 
OCD and their mothers by focusing on improving stress-management, general life skills, 
and the mother-child relationship, demonstrated significant effects in increasing life-
satisfaction and overall QoL (Abedi & Vostanis, 2010).  
Search for Protective and Resiliency Factors 
Findings with Parent-Reported QoL 
 Since I used existing data, the nature of covariates allowed for exploration of 
potential protective factors, whereas several potential resiliency factors were investigated. 
The following discussion organizes findings by covariates’ time-varying (Level 1) or 
time-invariant (Level 2) nature, and by their external (protective factor) or internal 
(resiliency factor) attributes.  
 Time-varying covariates examined as protective factors. Two covariates 
emerged as protective or potentially protective, revealed by their significant interaction 
effects, respectively, with symptom severity in predicting parent-reported QoL across 
time: (1) the number of inpatient hospitalizations, (2) the total parent-reported effect of 
stressful life events experienced by youth.   
 Number of inpatient hospitalizations. The slope of number of inpatient 
hospitalizations youth received interacted with symptom severity to predict parent-
reported QoL over time, such that with increasing numbers of inpatient hospitalizations, 
the negative impact of symptom severity on QoL was lessened (i.e., lower negative 
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slope). The number of inpatient hospitalizations alone, however, did not predict QoL. 
Several hypotheses may explain this interaction effect. First, it may be that youth whose 
symptoms required and who received inpatient hospitalization (i.e., increasing 
hospitalizations across time) were better able to maintain their QoL compared to those 
who would have benefited from but did not receive adequate inpatient care (i.e., 
decreasing hospitalizations across time). As shown in Figure 4, at the highest level of 
symptom severity (“Severely Ill”), increasing hospitalizations were associated with 
higher QoL compared to decreasing hospitalizations. At symptom severity between 
“Moderately Ill” and “Markedly Ill” (CGI ratings between 3 and 4), there were no 
differences in QoL between those who had increasing hospitalizations and those who had 
decreasing hospitalizations. It may be that for youth with greater than “Moderately Ill” 
symptom severity, consideration and seeking of inpatient care may prove beneficial in 
maintaining QoL.  
Receiving this higher level of care for youth whose symptoms warrant this form 
of intensive treatment may be helpful in protecting them from the detrimental effects of 
their symptoms on their QoL. These findings are consistent with previous work 
indicating that psychiatric hospitalization exerts beneficial effects on youth’s functioning. 
For example, Mayes, Calhoun, Krecko, Vesell, and Hu (2001) examined psychological 
functioning of children admitted to a teaching hospital’s psychiatric unit for an average of 
14 days at admission, discharge, and one- and six-month follow-up. Results from the 
parent-report version of the Columbia Impairment Scale (Bird, Shaffer, Fisher, & Gould, 
1993) revealed significant improvements from admission to discharge, and though 
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functional impairment was greater at 1- and 6-month follow-ups than at discharge, 
children were significantly less impaired at follow-up than admission, indicating some 
maintenance of gains. Interestingly, other than behavior disorders predicting worse 
outcomes, various demographic (e.g., age, race, sex), family (e.g., family functioning, 
parental SES, family psychiatric history, parental involvement in treatment), psychiatric 
(e.g., specific diagnoses) and other (IQ, length of admission, negative life events) 
variables did not associate with outcome.  
Additional factors associated with receiving increasing inpatient hospitalizations 
may jointly or uniquely explain this moderating effect. For example, families of youth 
who receive increasing hospitalizations may themselves be receiving the types and levels 
of support and assistance they need to help manage their youth’s symptoms at home, and 
this improved family support may contribute to observed resilience. Additionally, in 
separate studies, behavioral disorders including ADHD and DBD were associated with 
lower levels of improvement throughout admission (Kolko, 1992), and predicted 
psychiatric hospitalization among a national cohort of European adolescents (Nordstrom, 
Hurtig, Moilanen, Taanila, & Ebeling, 2013). Examining whether these clinical 
characteristics play a role in resilience would be informative in future studies.  
Furthermore, families may experience a sense of relief as they become 
increasingly aware of resources and options of care that are available and accessible for 
their youth, and this may contribute to resilience outcomes suggested by their perceived 
QoL of their youth. If so, disseminating information regarding care options and 
availability to parents with youth with moderately severe or greater psychopathological 
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symptoms may be beneficial. Incorporating psychoeducation on access to appropriate 
psychosocial care in treatment approaches for youth with psychopathology would also be 
beneficial. For example, one of the targeted treatment areas in Multi-Family 
Psychoeducational Psychotherapy (MF-PEP), developed as an adjunctive intervention for 
youth with bipolar and unipolar mood disorders (Fristad, Goldberg-Arnold, & Leffler, 
2011), focuses on providing families psychoeducation on empirically-supported 
treatments and assisting families in forming supportive treatment teams. In a randomized 
controlled trial comparing youth diagnosed with a mood disorder who participated in 
MF-PEP versus those who received treatment-as-usual, participation in MF-PEP was 
associated with improved quality of services received as mediated by parents’ treatment 
beliefs, and improved mood symptoms was mediated by improved quality of services 
received (Mendenhall, Fristad, & Early, 2009). Thus, increasing families’ knowledge of 
appropriate treatment options and facilitating access to such services may contribute to 
improved psychiatric outcomes, which is reasonably expected to enhance QoL. In 
addition to providing such knowledge in structured intervention formats, presenting 
treatment information in publications available to lay audiences such as in the form of a 
general interest or self-help book may further increase accessibility of such information 
(e.g., Fristad & Goldberg-Arnold, 2004).  
Although not explored in the current study, it also seems reasonable to propose 
potential curvilinear effects in number of hospitalizations’ moderating effects on the 
time-linked symptom severity-QoL relationship. Perhaps the effects of hospitalization are 
seen most clearly at higher levels of symptom severity, for which inpatient care may be 
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most suited and indicated. Future work further explicating and testing these effects in 
other samples is desired. Interestingly, the interaction effects held for Emotional and 
Esteem domains when specific QoL domains were examined, though no effects for 
Physical, Friends, and School domains were found, suggesting that the former QoL 
domains may be more affected by inpatient hospitalization compared to the latter 
domains.  
 Total impact of parent-reported stressful life events. The slope of the total effect 
of parent-reported stressful life events experienced by youth interacted with symptom 
severity to predict parent-reported QoL over time, such that with increasing total stress 
experienced, the negative effect of symptom severity on QoL was lessened (i.e., lower 
negative slope). Although this pattern were in contrast to the hypothesized direction of 
relationship (i.e., that decreasing stressors and total stress would contribute to resilience 
outcomes) and its implications not intuitive, I propose several possible explanations that 
may help explicate these results and spur future work to elucidate the effect of stressful 
life events on the time-linked relationship between symptom severity and QoL.  
 First, increasing total stress predicted worsening QoL over time. Thus, the 
interaction effects in no way suggest that greater stress is predictive of better QoL! The 
interaction effect explains the effect of increasing stress on the relationship between 
symptom severity and QoL. As seen in Figure 5, those with increasing stress had lower 
QoL at 0 symptom severity (“Normal”) compared to those with decreasing stress over 
time. No difference in QoL is observed when symptom severity is between “Mildly Ill” 
and “Moderately Ill” (CGI ratings of 2 and 3). At the “Severely Ill” symptom severity 
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level, those with increasing stress across time was associated with higher QoL compared 
to those with decreasing stress. One potential explanation for these findings may be that 
when youth’s lives are relatively low in observable stressors and stress, the effect of 
youth’s symptoms on their QoL are more apparent and noticed by parents. When 
stressors and stress increase in youth’s lives, it is possible that the effect of these stressors 
may overshadow the effect of youth’s symptoms on QoL, particularly when family-
related stressors abound. If this is the case and is replicated in future studies, then 
increasing stress would certainly not be a protective factor, but may in fact prevent 
parents from accurately perceiving the adverse effects of youth’s symptoms on their QoL. 
This would invite treatment-development researchers to consider incorporating into 
treatment approaches not only stress management strategies for parents, but ways to 
ensure that youth’s symptoms and their widespread effects are not neglected when 
increased life stress occurs in youth’s and families’ lives. Targeting families with 
identifiable increases in life stress would be beneficial. Additionally, parents’ attributions 
of the nature of youth’s symptoms may also help explain these effects. For example, 
parents may view high levels of youth’s symptoms in the context of high stress as more 
transient and perhaps expected, whereas high levels of symptoms in the context of 
relatively low stress may be viewed as more long-lasting and intrinsic to their youth. 
These differential attributions may help explain the effects of life stressors across time in 
predicting the symptom severity-QoL relationship.  
 If we were to view increasing stressors and stress as somehow serving a 
protective effect on youth’s functioning, it is necessary to consider potential correlates of 
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increased stress that may have protective effects on youth’s QoL across levels of 
symptoms severity. When faced with increased life stress, youth and families with 
available social supports may receive additional resources and assistance to manage those 
events. For families who do have such resources, these additional supports may serve to 
buffer the negative effect of youth’s symptoms on QoL when greater life stress is present. 
As discussed below, better relationships with youth’s primary and secondary caregivers 
and their peers predict improved QoL over time, which is consistent with previous 
research implicating the role of social support in predicting QoL (e.g., Bastiaansen et al., 
2005b). Incorporating variables such as these into multilevel models examining 
interaction effects of stress with symptom severity would provide further clarity into 
these effects.  
 Next, future studies would do well to explore the effects of specific types of 
stressors and stress experienced on time-linked relations between symptom severity and 
QoL. Although the majority of stressors assessed on the SLES can be considered 
“negative” (e.g., “Our family had money problems”, “My child’s close friends or family 
members had trouble with the police”, “My child’s close friends or family tried to hurt 
themselves”), some can be considered positive (e.g., “Someone is my child’s home is 
having a baby”, “My child started dating someone”, “My child’s mom or dad 
remarried”). Furthermore, some of the stressors assessed are other-related (e.g., “My 
child’s close friend or family member was robbed”), whereas some are self-related (e.g., 
“My child tried out for a sports team or club and did not make it”). I focused on total 
number of stressors and the total effect of these stressors on youth, but I did not examine 
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specific types of stressors experienced. Future work conducting more fine-grained 
analyses on observed interaction effects would shed light onto whether differential effects 
are found when different types and natures of stress are experienced. Examining youth’s 
and parents’ perceptions of the nature of stressors experienced may also be enlightening. 
 Finally, exploration of this interaction effect revealed that for total effect of 
parent-reported stressful life events, the interaction effect remained significant for the 
physical and family domains, and approached significance for the esteem and school 
domains, but was not significant in other domains. It appears that the effect of symptom 
severity on physical- and family-related QoL is more modifiable by life stress while for 
other QoL domains, including emotional, esteem, friends, and school, the negative effect 
of symptom severity and QoL may be similar regardless of levels of life stress. Again, 
examining whether different types of stressors influence this severity-QoL relationship in 
different ways would be informative in future work. Particularly for parent-reported QoL, 
it may be that effects of life stress on physical and family-related QoL are more apparent 
and noticeable to parents, whereas effects on other domains may be more difficult to 
observe and detect. Furthermore, if the attributional biases discussed above are supported 
in future work, parents may be able to more readily compare their youth’s functioning 
with their peers in the physical and family domains than other domains, contributing to 
the selective interaction effects observed here.  
 Non-significant findings for time-varying covariates examined as protective 
factors. Social support, psychiatric mediation, outpatient psychosocial treatment and 
school services, functional impairment, insurance status, parent bipolar disorder 
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symptoms, parenting stress, and school challenges did not interact with symptom severity 
to predict parent-reported QoL. Despite non-significant moderating effects, better social 
relationships with youth’s primary and secondary caregivers and peers predicted 
increasing QoL across time, and increasing parent self-reported bipolar disorder 
symptoms was associated with decreasing QoL across time. No significant findings for 
various classes of psychiatric medication  on changes in QoL across time were found.  
 Although not found to moderate the time-linked relationship between symptom 
severity and QoL, the positive association between caregiver- and peer-relationships and 
QoL highlights the importance of addressing conflictual close relationships and striving 
to enhance satisfaction with these relationships in youth with psychopathology. Although 
the non-significant interaction effects are unexpected, it is possible that close 
relationships may also interact with other variables to produce resilience outcomes. Since 
models run in the current study comprised individual covariates due to the lack of a clear 
a priori theoretical framework with multiple covariates, more complex models were not 
explored. It may be that as discussed above, increasing life stress, for example, affect 
relationship satisfaction in youth, which in turn moderate time-linked relations between 
symptom severity and QoL. Follow-up studies exploring such possible mediation 
relationships would be informative. Additionally, since slopes of social support were 
entered into multilevel models, their changes across time were examined. It may be that 
even though changes in social relationships across time do not exert moderating effects 
on the symptom severity-QoL relationship, absolute levels of social support may interact 
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with symptom severity. In future studies, examining mean levels of social support would 
provide additional insights.  
 No significant effects were found for medication treatment. This is in contrast to 
previous findings in youth with ADHD (e.g., Escobar et al., 2009; Perwien et al., 2006; 
Wehmeier et al., 2011), conduct disorder (e.g., Connor et al., 2008), depressive disorders 
(e.g., March et al., 2004), and bipolar disorder (e.g., Olsen et al., 2012; Rademacher et al., 
2007; Tang et al., 2010), for which significant improvements in QoL were associated 
with medication treatment. Although I examined individual medication types separately, 
effects were all examined in the sample as a whole. Significant findings in previous 
literature focused on specific diagnostic categories, and it may be that future resilience 
work examining the role of medication treatment in moderating effect of symptom 
severity on QoL in specific diagnostic groups may yield significant results. As with other 
covariates described in this discussion, it is possible that potential protective factors may 
interact with one another to produce resilience outcomes. Thus, models in which singular 
interaction effects with symptom severity are not significant should not be unequivocally 
interpreted as not playing an important role in resilience processes. 
With regards to outpatient services, increasing number of different outpatient 
professionals seen was associated with worsening QoL across time. It may be that 
increasing number of outpatient providers seen is associated with less satisfaction with 
services received (e.g., leading to frequent changes in providers), or that greater number 
of professionals seen is associated with less well-managed overall symptoms, which may 
better explain this result. The number of outpatient professionals seen was also a crude 
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proxy for the intensity of services received. Examining specific characteristics of the 
types of treatments received (e.g., talk therapy, medication management, cognitive-
behavioral therapy, behavioral therapy) may provide insights into whether specific types 
of treatment exert protective effects on youth’s QoL across levels of symptom severity. 
More detailed information regarding the satisfaction with, nature, type, duration of 
services received would also be informative, and may yield different results.  
 No significant interaction effect of functional impairment, measured by the 
CGAS, with symptom severity was detected, though better functioning across time was 
associated with increasing QoL. Similarities and differences between functional 
impairment and QoL were described elsewhere in the document, with functional 
impairment being considered as a more objective indicator of the effect that symptoms 
have on overall functioning, and QoL as a subjective measure of overall satisfaction with 
life without explicit consideration of levels of symptoms. As expected, lower levels of 
functional impairment were associated with greater QoL over time.  
 No significant interaction effect of insurance status with symptom severity was 
detected, though there was a significant finding of losing Medicaid status on decreasing 
QoL across time. Specific details regarding reasons families lost Medicaid status were 
unavailable. It may be that families gained sufficient financial independence and did not 
require government support, or families were no longer eligible for government support 
yet would have benefited from having Medicaid. Given the negative effect of losing 
Medicaid on QoL over time, it seems that the latter explanation may be more plausible. It 
is not difficult to imagine that those with no healthcare coverage are less likely to seek 
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and access appropriate and necessary physical and mental health care. The effects of not 
receiving proper preventive and intervention services, such as the presence of untreated 
medical problems and psychopathology and associated impairment, are expected to 
contribute to the observed reduction QoL over time. With the implementation of the 
Affordable Care Act, which aims to increase Medicaid eligibility for uninsured 
Americans and to reduce insurance costs for individuals and families within certain 
income brackets (HealthCare.gov, 2014), families who otherwise were left with no 
healthcare coverage may now be eligible for and be able to access such support. 
Providing lower-income families with appropriate education on healthcare coverage 
options, and offering assistance in overcoming other barriers to accessing care (e.g., 
providing transportation support or home-based services) would be important targets for 
intervention with these families.   
Next, parents’ self-reported bipolar disorder symptoms were found to negatively 
predict QoL across time, despite their non-significant interaction effects with symptom 
severity. Previous work suggests that parents experiencing higher levels of depressive 
symptoms are more likely to rate their children as having lower QoL compared to 
children without depressive symptoms (e.g., Kobayashi & Kamibeppu, 2011). The 
combined mania and depression total scores from the GBI were examined in the current 
study, hence I cannot conclude whether increasing total scores were driven largely by 
depression symptoms, mania symptoms, or both. Regardless, the possibility that parental 
psychopathology biased parents’ reports of their youth’s symptoms cannot be discounted. 
Even accounting for such possible biases, parental psychopathology may additionally 
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affect other factors that may contribute to worsening QoL for youth. For example, 
parental psychopathology may compromise parents’ parenting competency (Burbach, 
1986; Calam, Jones, Sanders, Dempsey, & Sadhnani, 2012; Childs, Fite, Moore, 
Lochman, & Pardini, 2014; Cummings, 1994; Kaslow, Deering, & Racusin, 1994; 
Watson et al., 2014), and given that parenting quality has been associated with QoL in 
previous research (e.g., Masten et al., 1999), it is possible that parental bipolar disorder 
symptoms may negatively predict QoL through compromised parenting quality. 
Examining such a mediation model in future work would provide greater clarity into the 
relationship between parental psychopathology and QoL. 
Although measures of parenting quality were not available in the current study, 
parenting stress was examined and found to negatively predict QoL over time. This is 
consistent with previous work that demonstrated a negative relationship between 
parenting stress and QoL (e.g., Bastiaansen et al., 2005b), and reinforces the utility of 
identifying parents experiencing high stress related to parenting their youth with 
psychopathology and providing sufficient supports to assist them with managing their 
stress. Despite the non-significant interaction effect with symptom severity found in the 
current study, it is again possible that including other covariates in the model, such as 
parenting competency and parent-child relationship quality, may yield informative results 
regarding resilience processes. 
Finally, having increasing school-related challenges was associated with 
worsening QoL. This is not surprising, and emphasizes the importance of school 
professionals to attempt to foster competency in school-related domains that are both 
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releated and unrelated to academic performance, in order to improve their overall 
functioning at school despite academic struggles.  
 Time-varying covariates examined as resiliency factors. None of the time-
varying covariates, which included number of diagnoses, absence of significant physical 
health problems, psychiatric characteristics (diagnostic group), parent-reported mania 
symptoms, and suicidality, emerged as significant resiliency factors in the current study.  
While not significantly moderating the time-linked relationship between symptom 
severity and QoL, increasing number of diagnoses and suicidality expectedly predicted 
worsening QoL across time. Intuitively, a greater number of psychiatric diagnoses is 
likely associated with a greater number of areas of functioning affected, and clearly, 
prioritizing safety concerns and reduction of comorbid symptoms is paramount. It is also 
imperative to consider the impact of youth’s suicide-related concerns and comorbid 
pschopathology on families’ functioning and QoL, and how that in turn affects youth’s 
own experience of QoL. Particularly for youth with suicide-related problems, in addition 
to ensuring that proper measures are in place to protect youth’s immediate safety, 
equipping parents and families with increased understanding of suicidal ideation and 
behavior and appropriate skills to manage crisis situations can improve parents’ 
competency, sense of control, and relieve guilt and self-blame potentially associated with 
their youth’s symptoms. To the extent that these changes affect parents’ interactions with 
their youth and their home environment, improvements in youth’s QoL across time may 
be observed. Teaching and empowering youth with skills to manage their symptoms and 
promote adaptive coping can also increase youth’s sense of internal locus of control, 
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foster optimism and hope, and perhaps thereby improve their QoL over time. Ensuring 
that attention to QoL domains in youth with suicide-related concerns and multiple 
comorbid diagnoses is also given and that appropriate intervention and supports are 
provided to help increase subjective well-being are therefore recommended. Since a bi-
directional relationship between suicidality and QoL is likely to exist, efforts to improve 
QoL in these youth may additionally exert a preventative effect of reducing suicidal 
ideation and behavior in the future. 
Unfortunately, the effect of change in significant physical health concerns on the 
effect of symptom severity on QoL was unable to be examined, due to the statistical 
model’s inability to converge on a solution to estimate individual slopes of changes in 
physical health problems over time. However, combining the finding that having physical 
health concerns was associated with worse youth-reported QoL at mean age, and 
extracting from previous literature that physical health problems are consistently 
predictive of worse QoL, it remains hypothesized that increasing physical health concerns 
would predict worse QoL over time and may influence resilience processes. This 
hypothesis awaits statistical exploration in future work. 
 With regards to effects of diagnostic grouping, being in the depressive spectrum 
disorder category across time was associated with worsening QoL. Interestingly, results 
revealed that membership in the ADHD Diagnosis category significantly predicted better 
QoL across time. At first blush, this finding may seem to contradict previous research 
suggesting that youth with ADHD experience worse QoL compared to those who do not 
(e.g., Danckaerts et al., 2010; Klassen, 2005; Roijen et al., 2007; Steinhausen et al., 2006; 
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Varni & Burwinkle, 2006). However it is important to remember this study comprised a 
clinical sample with the majority of youth having at least one psychiatric diagnosis. The 
hierarchical method in forming the diagnostic groups entered into multilevel models also 
produced a unique group of youth in the ADHD Diagnosis category; specifically, those 
with either no comorbid diagnoses, or had non-psychotic disorder, non-mood disorder, 
non-anxiety disorder, and non-DBD comorbid diagnoses. As such, the significant 
positive relationship between ADHD Diagnosis category and QoL can better be 
interpreted as the following: having fewer comorbid psychiatric conditions across time is 
associated with better QoL, akin to the negative relationship found between number of 
diagnoses and QoL described above. This is also consistent with previous findings 
suggesting that having an additional conduct disorder diagnosis among those with ADHD 
was associated with worse QoL compared to those without (e.g., Becker et al., 2011). 
Unfortunately, I was unable to examine the effects of change in having no diagnosis, due 
to the lack of model convergence when slopes of No Diagnosis were attempted to be 
extracted. However, in a model where membership in the No Diagnosis category was 
entered as a time-varying covariate (i.e., not its slope), a significant positive association 
between membership in the No Diagnosis category and better parent-reported QoL was 
found. Previous literature suggests that while children with ADHD tended to experience 
higher QoL compared to those with anxiety and depressive disorders, they experience 
lower QoL compared to healthy children (e.g., Thaulow & Jozefiak, 2012). The current 
finding that having no diagnoses predicts improved QoL provides some support of these 
results. Future studies examining these effects would be greatly informative. For now, it 
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seems reasonable to suggest that compared to having a greater number of diagnoses 
and/or having other diagnoses in the hierarchically-formed diagnostic groups listed in 
Table 3, youth with “pure” ADHD diagnoses and few comorbidities experience greater 
QoL across time. 
 Time-invariant covariates examined as protective factors.  
There were no significant findings from time-invariant covariates examined as 
protective factors. No significant moderating effects on the time-linked relationship 
between symptom severity and QoL were found for family structure, parental psychiatric 
history, and family psychiatric history. 
No significant effects of youth’s family structure at baseline were found. Such a 
non-significant finding was also previously reported in the literature (e.g., Bastiaansen et 
al., 2005b). It was hypothesized that living in intact two-parent families would buffer the 
negative impact of symptom severity on QoL, but this was not found. Given that family 
structure is expected to change and fluctuate across time (e.g., due to changes in parents’ 
marital status, deaths in the family), examining family structure as a time-varying 
variable in future studies would be informative. It is also conceivable that rather than the 
actual structure of youth’s families being the key variable in predicting resilience 
outcomes per se, the specific relationships children share with individuals living in their 
household may be more influential in predicting QoL and the interaction effect with 
symptom severity across time. As such, incorporating additional relationship variables 
into models in future work would be greatly informative. 
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No significant moderating effects were found for parental psychiatric history. 
However, having a parental history of depression predicted increasing QoL over time, 
which is in contrast to previous literature suggesting reporting biases in parents with 
psychopathology (e.g., that parents with psychopathology tend to report lower QoL in 
their youth compared to youth’s own self reports). Additionally, parenting competency 
and the parent-child relationship has been demonstrated to be negatively affected by 
parental depression (Burbach, 1986; Hammen, Burge, & Stansbury, 1990; Kaslow et al., 
1994; Watson et al., 2014), and it was therefore hypothesized that these intervening 
variables may contribute to a negative relationship between parental history of depression 
and QoL. Obtaining additional information regarding parents’ current symptoms and any 
psychiatric treatment currently received would be informative, given that parental 
psychiatric history was obtained at baseline and fluctuations in their symptom 
presentation are likely and expected, which in turn may influence their associations with 
their perceptions of youth’s QoL.  Future work examining such more comprehensive 
models would be enlightening. At present, it seems appropriate to suggest that when a 
significant parental psychiatric history is identified, incorporating into interventions ways 
to support parents’ functioning and strategies to enhance youths’ QoL would be 
beneficial.  
With regards to family psychiatric history, no significant interaction effects were 
found. However, having a family history of conduct symptoms was unexpectedly 
associated with higher QoL at mean age. Although these results were not found for 
parental history of conduct symptoms in the current study, they are in contrast to previous 
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work examining the effcts of parental history of conduct symptoms on youth’s QoL. For 
example, in a comparative study between children with mothers with only depression and 
those with mothers with depression and antisocial personality disorder symptoms, 
children whose mothers had both depression and conduct symptoms were at higher risk 
for being maltreated physically, experiencing maternal hostility, and being exposed to 
domestic violence (Kim-Cohen, Caspi, Rutter, Tomás, & Moffitt, 2006). Having a family 
history of conduct disorder was also associated with childhood-onset (versus adolescent-
onset) bipolar disorder (Rende et al., 2007). The age of onset of reported conduct 
symptoms may also influence their effects on youth outcomes. For example, maternal 
antisocial personality disorder symptoms prior to age 15 was associated with worsening 
conduct symptoms in boys (as did poorer parenting practices and greater mother-son 
conflict); maternal antisocial personality disorder symptoms after age 15 were not 
predictive of boys’ symptoms (Ehrensaft et al., 2003). It is unclear as to whether the 
timing of conduct symptoms in first- and second-degree relatives, other than parents, may 
also impact youth’s functioning in similar ways.  
It is additionally possible that witnessing impairment caused by conduct 
symptoms of first- and second-degree relatives may bias parents’ and youth’s subjective 
evaluations of youth’s well-being. For example, in comparison to their relatives’ 
experiences of possible legal and other consequences of their conduct symptoms, youth’s 
own QoL may be viewed in a particularly positive and favorable fashion, thereby 
contributing to the observed increased QoL in the current study. If future studies replicate 
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the current observed effects, examining the potential impact of response biases and 
objective incidators of functioning would be informative.  
Subsequent exploratory analyses
12
 examining potential differences between youth 
with a family history of conduct symptoms versus those who do not revealed that those 
with such a family history were more likely to have Medicaid status at each assessment 
time point (χ2 values range from 21.03 to 27.45, ps < .001), were more likely to be male 
(χ2 = 6.76, df = 1, p < .01), were less likely to have family income greater or equal to 
$50,000 (χ2 = 4.22, df = 1, p < .05), were more likely to belong in the Psychotic Disorder 
Diagnosis grouping at baseline (χ2 = 5.88, df = 1, p < .05), had higher self-reported 12-
month QoL (t(440) = -2.70, p < .01) and 24-month QoL (t(411) = -2.98, p < .01), had greater 
symptom severity at each assessment time point (t-values range from -5.88 to -2.97, ps < 
.001), had lower global functioning scores at each time point (t-values range from 4.35 to 
4.80, ps < .001), had worse baseline and 24-month peer relationships (t-values range 
from 2.49 to 2.69, ps < .05), and had lower IQ (t(678) = 2.37, p < .05). It seems plausible 
that these factors may help explain the unexpected positive relationship between family 
history of conduct problems and higher QoL at mean age. These patterns of differences 
may also support the possible role of response biases discussed above. Despite more 
objective indicators of lower family income, worse global functioning, and more severe 
symptoms, these youth are generally reporting higher QoL. Perhaps the contextual factors 
described above, such as viewing the negative consequences suffered by relatives due to 
their conduct symptoms, allow these youth’s QoL to be compared to that of their relatives 
                                                 
12
 These analyses were performed on the original dataset. 
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and afford a more positive evaluation of their well-being. Incorporating indicators of 
response patterns along with some of these variables in a more comprehensive theory-
driven model in future studies (e.g., including Medicaid status, family income, IQ, sex, 
and peer relationship quality as additional predictors) would help clarify the role of a 
family history of conduct problems on QoL in youth.   
 Time-invariant covariates examined as resiliency factors. None of the time-
invariant covariates examined as resiliency factors yielded significant interaction effects. 
In previous literature, the effect of IQ on resilience outcomes has been equivocal, with 
some studies finding a significant effect (e.g., Garmezy et al., 1984; Masten et al., 1999), 
while others demonstrate no significant effects (e.g., Luthar, 2006). This study revealed 
no significant effect of IQ on QoL or the effect of symptom severity on QoL. Of note, 
there was a lower limit of FSIQ = 70 to participate in this study. Thus, no comment can 
be made about the impact of intellectual disabilities on QoL. Additionally, no significant 
effects of race or ethnicity were found. As reiterated throughout this discussion, 
incorporating these variables in more comprehensive models might yield a more 
complete depiction of the effects of these variables, if any, in resilience processes. The 
non-significant findings described here, if replicated in future work, may be encouraging 
in that they would suggest resilience processes do not “discriminate” against youth of 
varying IQ levels and racial and ethnic backgrounds. Interventions aimed at fostering 
resilience processes in youth with psychopathology, while they must be developmentally 
and culturally sensitive, may therefore be applicable and potentially effective for youth 
regardless of specific demographic characteristics. Finally, females were found to have 
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lower QoL at mean age. This sex difference suggests that gender-specific interventions 
aimed to improve QoL in youth with psychopathology may be beneficial. Further, given 
that the mean age in the study was approximately 10 years old, pubertal events taking 
place that may exert a unique toll on girls’ QoL may help explain the observed results.   
 Findings with Youth-Reported QoL
13
 
Time-varying covariates examined as protective factors. Two covariates 
emerged as protective factors in the current study, revealed by their significant interaction 
effects with symptom severity in predicting youth-reported QoL across time: (1) the 
number of youth-reported stressful life events, and (2) the total youth-reported impact of 
stressful life events.  
Number and total impact of youth-reported stressful life events. As with the 
approaching significant effect of parent-reported stressful life events experienced by 
youth and symptom severity, with increasing number of youth-reported stressors and total 
stress experienced, the negative impact of symptom severity on QoL was lessened (i.e., 
lower negative slope). As discussed with parent-reported QoL, these effects were in 
contrast to the hypothesized direction of relationship, but several possible explanations 
may clarify these results. When stress is decreasing in youth’s lives across time, the 
impact of their symptoms on their satisfaction with life as symptom severity increases 
may be more apparent and greater frustration with perceived difficulties maintaining high 
                                                 
13
 In order to preserve the conciseness of this document, implications of youth-reported QoL findings that 
share remarkable similarity with those for parent-reported QoL findings will only be briefly mentioned in 
the following sections. Readers are encouraged to refer to the relevant parent-reported QoL sections for a 
more thorough discussion. 
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overall functioning may be felt, whereas for youth with increasing life stress across time, 
they may view their suboptimal functioning as expected given the life stressors they face, 
and therefore may rate their QoL as higher compared to youth with lowering stress. 
Future work examining youth’s level of insight regarding the impact their symptoms have 
on their functioning may be helpful to elucidate whether such insights may also play a 
role in moderating the effect of symptom severity on QoL. For example, youth who 
demonstrate a greater awareness of the nature of their psychopathological symptoms and 
the impairment they can cause may be less likely to attribute blame to themselves when 
their overall functioning is compromised despite experiencing relatively few objective 
stressors in their lives. This perception of their well-being may increase self-ratings of 
QoL. Similarly, even for youth with increasing stressors in their lives, fostering accurate 
perceptions of the nature of their symptoms to reduce self-blame may further enhance the 
protective moderating effects observed in the current findings, and emphasizes the 
importance of psychoeducation as a key treatment goal.  
As with parent-reported stressors and QoL, it would be informative to examine 
potential correlates of increased stress that may have protective effects on youth’s self-
reported QoL across levels of symptom severity. Might it be that youth receive greater 
levels of social and other types of supports when stressors and stress increase in their 
lives, and that it is these additional sources of supports that help buffer the negative 
effects of symptoms on QoL? Might it also be that different types of stressors 
encountered in youth’s lives moderate the severity-QoL relationship in different ways? 
Future work considering the interaction effects of specific life stressors (e.g., positive or 
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negative, self-related or others-related) with QoL would be important. For both number 
of stressors and total impact of youth-reported stress, the interaction effects observed 
when total QoL was used as the outcome were also maintained when Esteem, Friends, 
and School domains were examined. The interaction effect approached significance for 
the Family domain with regards to total impact of stress (significant for number of 
stressors), and were not significant in the Physical and Emotional domains. These 
domain-specific effects provide some support for the hypothesis that increasing levels of 
stress have implications on interpersonal well-being and satisfaction.  
Non-significant findings for time-varying covariates examined as protective 
factors. Social support, psychiatric mediation, psychosocial treatment and school 
services, insurance status, functional impairment, parent bipolar disorder symptoms, 
parenting stress, and school challenges were not found to interact with symptom severity 
to predict youth-reported QoL. 
Consistent with findings for parent-reported QoL, although not found to moderate 
the time-linked relationship between symptom severity and QoL, improving caregiver- 
and peer-relationships was expectedly associated with better QoL across time. These 
similar findings with parent-reported QoL further reinforce the importance of fostering 
strong social relationships in youth with psychopathology and focusing on addressing 
problematic caregiver- and peer relationships. As with findings from parent-reported 
QoL, examining more comprehensive models with additional hypothesized covariates in 
future work may provide insight into potential pathways involving social relationships by 
which resilience outcomes may be produced.  
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Again, no significant effects were detected for medication treatments. Examining 
the role of individual medication categories on QoL may have yielded non-significant 
results due to possible interactive pathways through which medication impacts symptom 
severity and QoL in youth with psychopathology; testing medication effects in isolation 
of other variables may therefore have been inadequate. Including additional covariates in 
future models and examining effects in specific diagnostic groups will further illuminate 
the role, if any, of medication QoL and resilience outcomes. 
No effects of receiving school services or outpatient services were detected. 
However, inpatient hospitalization was uniquely associated with change in QoL over 
time, such that individuals who were hospitalized across time had worsening QoL 
compared to those who were not. In other words, controlling for symptom severity, 
accessing inpatient hospitalization has negative implications on QoL. Combining the 
interaction effect of number of hospitalizations and symptom severity for parent-reported 
QoL and this current finding, it is reasonable to propose that appropriate, well-timed 
seeking and receiving of inpatient care for youth whose severity of psychopathological 
symptoms warrants this level of treatment is recommended. Providing psychoeducation 
to parents to equip them with knowledge of appropriate treatment-seeking is therefore 
paramount. At the broader systemic level, issues such as the availability of inpatient beds 
and other resources required to maintain appropriate care for hospitalized youth, certainly 
impact whether and when youth for whom inpatient hospitalization is necessary and 
beneficial actually receive this higher level of care. Further exploring reasons for why 
youth who would benefit from inpatient hospitalization do not receive such care, 
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identifying and raising awareness of systemic barriers preventing timely access of 
inpatient care, and considering directing increased funding and resources to inpatient 
psychiatric services appear to be warranted.   
No significant interaction effects of functional impairment, measured by the 
CGAS, with symptom severity were detected, and as with parent-reported QoL, better 
functioning across time was expectedly associated with increasing QoL. There were also 
no significant effects detected for change in Medicaid status across time. The 
approaching significant finding of losing Medicaid status on decreasing QoL for parent-
reported QoL was not found with youth-reported QoL, suggesting that the effect of 
change in Medicaid status seem to have affected parents’ perceptions of youth’s QoL to a 
greater extent compared to youth’s own report of their QoL. Consistent with parent-
reported QoL, suicidality was associated with worsening youth-reported QoL across time. 
As discussed above, timely and appropriate intervention to address suicidal concerns in 
youth is paramount, both clearly for safety reasons as well as for overall improved 
perceived well-being.  
There were no significant effects detected for parents’ self-reported bipolar 
disorder symptoms, in contrast to the negative relationship with QoL found for parent-
reported QoL. A possible explanation for the parent-reported QoL finding was that 
parents’ psychopathological symptoms may have biased their reports of their youth’s 
QoL. This hypothesis seems supported particularly since the negative relationship 
between parents’ bipolar disorder symptoms and QoL was not found when youth-
reported QoL was used as an outcome. If this is indeed the case, focusing on careful 
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assessment of parental psychopathology and being mindful of such biases in parents’ 
reports of their youth’s functioning would facilitate appropriate and effective treatment 
planning and delivery when intervening with families and youth with psychopathology.  
As with parent-reported QoL, increasing parenting stress was found to predict 
worsening youth-reported QoL over time. These consistent findings emphasize the 
widespread effects of parenting stress on QoL, both from youth’s and parents’ own 
perspectives. The task of identifying parents experiencing high parenting stress and 
offering appropriate and timely supports is therefore essential. Engaging parents in 
discussions of how their own levels of stress may contribute to compromised parenting 
and decreased life satisfaction in their youth would also inform strategies to promote 
effective management of parenting-associated stress in caregivers. 
School challenges were not associated with symptom severity or QoL. 
Replication of this non-significant effect and examination of potential additional 
covariates is warranted before conclusive interpretations can be made.  
 Time-varying covariates examined as resiliency factors. Consistent with 
results from parent-reported QoL, none of the time-varying covariates, number of 
diagnoses, absence of significant physical health problems, psychiatric characteristics 
(diagnostic group), parent-reported mania symptoms, and suicidality, emerged as 
significant resiliency factors when youth-reported QoL was used as an outcome.  
 While not significantly moderating the time-linked relationship between symptom 
severity and QoL, increasing number of diagnoses expectedly predicted worsening youth-
reported QoL over time. The impact of physical health problems on resilience outcomes 
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was again not able to be examined, due to the lack of model convergence when individual 
slopes were attempted to be estimated.  
 The significant finding of membership in the ADHD Diagnosis category 
predicting parent-reported QoL was replicated with youth-reported QoL, such that 
membership in this diagnostic grouping was associated with improving QoL over time. 
As discussed above, due to the hierarchically-formed nature of diagnostic grouping used 
in the current study and the clinical nature of the study’s sample, this finding can be 
interpreted as the positive impact of few psychiatric comorbidities on QoL over time. 
Interestingly, the positive relationship between no diagnoses and better parent-reported 
QoL at mean age was not replicated for youth-reported QoL. Future work comparing 
these relationships with psychiatrically healthy youth would yield greater insight into 
potentially differing effects of psychopathology on resilience processes in clinical 
samples of youth.  
 Time-invariant covariates examined as protective factors.  
 There were again no significant findings from time-invariant covariates examined 
as protective factors. No significant moderating effects on the time-linked relationship 
between symptom severity and QoL were found for family structure, parental psychiatric 
history, and family income.  
 As with parent-reported QoL, no significant effects of youth’s family structure at 
baseline were found. Examining the effects of family structure across time, and focusing 
on specific familial relationships in future models may offer potentially differing findings 
in future studies examining more comprehensive models. There were also no significant 
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effects found for parental psychiatric history on symptom severity on QoL. The 
significant effect of parental history of depression found for parent-reported QoL was not 
replicated when youth-reported QoL was used as an outcome. Future work further 
examining the effects of parents’ current psychopathological symptoms on reported QoL 
in their youth and comparisons in parents’ and youth’s ratings would be informative. 
 One additional approaching significant finding with family psychiatric history 
was found. Having a family history of conduct symptoms was associated with higher 
QoL at mean age. This finding, consistent with that detected with parent-reported QoL, 
was unexpected. As discussed above, significant differences in some demographic and 
clinical variables were found between youth with and without a family history of conduct 
problems. Future work would certainly need to replicate this observed result before 
conclusive interpretations can be made. Nevertheless, including some of these additional 
predictors in fuller models would provide further insight into the unique role, if any, of 
such a family history on youth’s QoL.  
 Time-invariant covariates examined as resiliency factors. As with parent-
reported QoL, none of the time-invariant covariates examined as resiliency factors 
yielded significant findings. Incorporating these variables along with other covariates 
identified as potential moderators of the time-linked relationship between symptom 
severity and QoL would be greatly informative to potentially obtain a clearer depiction of 
resilience processes. Nevertheless, as mentioned above, replication of these non-
significant findings in future may also be optimistic, suggesting that resilience processes 
do not depend on specific demographic variables that are not modifiable, and that for 
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youth across these demographic variables, having psychopathological symptoms need not 
“doom” these children and adolescents to having co-occurring compromised QoL.  
Site Differences 
 No specific hypotheses regarding potential site differences in outcomes were 
formed a priori. In the parent-reported QoL multilevel models, site was a significant 
predictor of total QoL at mean age, while site was not a significant predictor in the youth-
reported QoL multilevel models. Parent-reported QoL site differences were reported in 
the Results section, and youth-reported QoL site differences were as follows. Based on 
Tukey’s HSD tests, baseline youth-reported QoL was higher at Case Western Reserve 
University compared to Cincinnati (mean difference = 4.79, SE = 1.59, p < .05) and OSU 
(mean difference = 4.35, SE = 1.62, p < .05). At 12 months, youth-reported QoL was 
higher at OSU compared Cincinnati (mean difference = 4.47, SE = 1.51, p < .05), and 
youth-reported QoL was higher Pittsburgh compared to Cincinnati (mean difference = 
5.29, SE = 1.61, p < .01). At 24 months, Case Western was again higher than Cincinnati 
(mean difference = 4.93, SE = 1.74, p < .05). Figures 8, 9, and 10 display site differences 
in symptom severity, parent-reported QoL, and youth-reported QoL.  
 With regards to additional site differences listed in Table 16, general observations 
suggest that families participated in the Cincinnati site appears to be less likely to have 
Medicaid status and are more likely to be Caucasian. Given that neither Medicaid status 
nor race emerged with significant interaction effects on resilience outcomes, there does 
not appear to be clear reason to suspect that resilience findings differed among sites. With 
regards to ratings of symptom severity and QoL, it appears that OSU consistently rated 
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youth as having higher symptom severity (mean differences ranged from 0.51 to 1.15), 
and youth in Cincinnati tended to self-report lower QoL (mean differences ranged from 
0.43 to 5.29). Since there are no clear systematic co-occurring site differences in ratings 
of symptom severity and QoL, there again does not appear to be clear reason to suspect 
that resilience findings differed among sites. Subsequent exploratory analyses including 
site as a covariate support this postulation. The significant interaction effects found for 
slope of number of inpatient hospitalization (with parent-reported QoL as outcome) and 
slope of youth-reported number and total impact of stressful life events (with youth-
reported QoL as outcome) remained significant and with identical patterns of effects 
when site was entered as a covariate. The significant effect for slope of parent-reported 
total impact of stressful life events (with parent-reported QoL as outcome) was 
approaching significance when site was added as a covariate
14
. Given the benefits of 
preserving sample size and power by performing analyses using the longitudinal sample 
as a whole, site-specific analyses were not performed, though future work examining 
potential site, and therefore regional differences in resilience outcomes may be 
informative.  
Parent-Youth Concordance in Ratings of Youth QoL 
                                                 
14
 Additional exploratory analyses revealed that parents at the Cincinnati site tended to report lower number 
and total impact of stressful life events in their youth. Figures 11 and 12 display site differences in mean 
number and total impact of stressful life events. How these differences in conjunction with site differences 
in symptom severity and parent-reported QoL affect the approaching significant interaction effects are 
unclear. It is of note that of the four study sites, inpatient hospitalization is most easily accessed in 
Cincinnati due to the number of available beds per capita, and these differences may be associated with the 
lower levels of life stress reported by parents at the Cincinnati site. The relationships among parent-
reported stressful life events, availability and accessibility of inaptient care, and the severity-QoL 
relationship were not examined by site in the current study, and future work exploring whether and how 
differences in these variables may contribute to resilience outcomes would be greatly informative. 
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 Based on ICCs and Pearson’s correlation coefficients, there were significant 
though far from perfect associations between parent- and youth-reported QoL. Based on 
previous literature (e.g., Eiser & Morse, 2001a; Theunissen et al., 1998; Verrips et al., 
2000; Vogels et al., 1998), it was hypothesized that self-reported QoL would be higher 
than parent-reported QoL across domains, and agreement in more overt domains, such as 
physical functioning, would be higher than agreement in more covert domains, such as 
emotional and esteem QoL. These hypotheses were only partially supported. Youth-
reported QoL was consistently greater than parent-reported QoL in the domains of 
Family and Friends domain scores. However, parent-reported Emotional QoL was either 
not significantly different from or greater than youth-reported Emotional QoL scores, and 
parent-reported School QoL was consistently greater than youth-reported QoL. Further, it 
is interesting to observe that differences in parent- and self-reported Emotional QoL 
seemed to increase across time, while differences in Esteem QoL seemed to decrease 
across time. These parent- and self-report differences suggest there to be unique value in 
incorporating both self and proxy reports in studies of QoL in youth with 
psychopathology, and exploration of reasons for discrepant perceptions of youth’s QoL 
and potential implications of these differences across time is warranted.  
With regards to levels of parent-youth agreement, the number of significant 
differences in agreement across domains decreased across the longitudinal course of the 
study. It may be that as youth grow older, communication between youth and parents 
about youth’s functioning may increase across domains and parents may become more 
knowledgeable about youth’s functioning and perceptions of their life satisfaction. 
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Although not consistent across time points, agreement in the presumably more overt 
Physical domain was higher than more covert domains such as Esteem QoL, as predicted. 
Additionally, agreement in the Esteem domain tended to be lower than domains such as 
Friends, Emotional, and Family, though this was also not consistent across time points.  
Other than the above patterns, few general trends were able to be extracted from 
these findings. Previous literature examining parent-child agreement in QoL has seldom 
compared these concordance rates in samples of youth with psychopathology. The partial 
replication of previous findings observed here may reflect potential differences in 
concordance rates in youth with physical illnesses (commonly examined in the existing 
literature) compared to youth with mental health concerns. Overall, it appears that despite 
the lack of perfect agreement in parent-youth agreement in QoL reports, the observed 
associations of rs between 0.14 to 0.39 are consistent with levels of parent-child 
agreement in reports of emotional and behavioral problems (e.g., Achenbach et al., 1987), 
though may be lower compared to parent-child agreement in reports of QoL among 
pediatric health populations (e.g., Eiser & Morse, 2001; Theunissen et al., 1998).  
Contrary to hypotheses, youth-reported QoL was not higher than parent-reported 
QoL across domains, with the exception of Family and Friends QoL. It may be that 
compared to medical populations, the impact of psychiatric symptoms on youth with 
psychopathology, particularly in Emotional and School domains, may be more covert and 
less readily observable by parents, contributing to the tendency for parents to provide 
higher ratings in these domains compared to youth. In contrast, parents’ perceptions or 
expectations of the impact that psychopathological symptoms on domains such as Family 
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and Friends may be higher than that of youth’s, contributing to the comparatively higher 
ratings provided by youth than parents in these domains. Interventions targeted at 
improving communication between youth and parents regarding youth’s satisfaction with 
multiple aspects of their lives appear warranted. While high agreement in reports of QoL 
may not be an absolute necessity in fostering positive outcomes, misperceptions 
regarding youth’s well-being may hinder potentially beneficial interventions from being 
sought and implemented. Since parents are typically gatekeepers to services available to 
youth, accurate perceptions of youth’s functioning would facilitate appropriate and timely 
treatment seeking, thereby increasing the likelihood of positive outcomes. Further, it can 
be beneficial for parents to know that their youth’s satisfaction with aspects of life such 
as Family and Friends domains may be greater than they expect; such knowledge may 
help relieve parenting-related stress and guilt, thereby facilitating effective parenting and 
potentially initiating positive trickling effects on both youth’s and parents’ overall QoL.  
Limitations/Future Directions 
 The current study offers unique and novel insights into resilience processes in 
youth with psychopathology. However, while this study examined a seldom-examined 
topic in child and adolescent psychology and utilized powerful statistical techniques in 
exploring longitudinal outcomes using multilevel modeling, several limitations were 
present and should be addressed in future work. 
 First, given the nature of the available data, the current study focused largely on 
identifying protective factors, or those considered more external to an individual child, 
rather than resiliency factors, or those considered more internal to a child. In addition to 
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examining the role of mostly demographic variables on resilience processes, as done in 
the current study, exploring the impact of other factors identified as contributing to 
resilience outcomes in the literature, such as coping styles, problem-solving skills, 
cognitive styles, spirituality, locus of control, and genetic or biological factors in future 
work would be greatly informative. Considering the unique effects of these factors, as 
well as their joint or interactive effects on resiliency processes is warranted. In light of 
findings from the current study, might specific coping styles or competency in problem-
solving potentially mediate the protective effects of inpatient hospitalizations on QoL as 
symptom severity increases, for example? Might there be resiliency factors that facilitate 
optimal functioning in the face of significant life stress despite worsening symptoms over 
time? Intentionally examining these resiliency factors in future studies would likely yield 
a fuller depiction of resilience processes in youth with psychopathology.  
 Building upon the above point, another limitation of the current work is that 
potential protective and resiliency factors were examined singularly in separate models. 
Due to the exploratory nature of the study and the lack of clear a priori theoretical 
framework for the development of more comprehensive models, the initial decision to 
examine simple models seems appropriate. Nevertheless, as reiterated at various points in 
the above discussion, offering adequate and definitive explanations of the current 
findings is yet not possible, for it is likely that multiple influences are at work in such a 
dynamic and interactive process as resilience. Investigating additional moderators (e.g., 
parenting competency, resiliency factors mentioned above) and mediating pathways to 
further elucidate possible intricate influences on the time-linked relationship between 
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symptom severity and QoL would be enlightening. Returning to Rutter’s (1987) 
postulations of possible pathways by which resilience processes unfold (e.g., altering 
experiences of or exposure to risk, reducing processes that perpetuate effects of risk, 
increasing self-esteem, opening up new opportunities and experiences in one’s life), it 
would be important to examine whether and how identified resiliency and protective 
factors buffer the negative impact of symptom severity on QoL through one or several of 
these pathways. When applied to results from the current work revealing the moderating 
effects of stressful life events on the severity-QoL relationship, it may be that 
experiencing increased life stress modifies individuals’ experiences of their symptoms, 
and that these changes lessen the negative impact of symptom severity on QoL. It may 
also be that individuals’ successes in coping with significant life stressors increase their 
confidence in their ability to manage adversity, and that these increases in self-esteem 
may be driving the moderation of the severity-QoL relationship. The idea of novel 
opportunities and turning points as serving protective effects is additional interesting. 
Relating to the current findings, it may be that receiving adequate treatment (e.g., 
inpatient care) for significant psychopathological symptoms or experiencing increased 
life stressors are related to the opening up of experiences or opportunities that were 
previously unavailable, and that this latter point may be contributing to observed 
resilience outcomes. Future work further exploring these relationships is warranted. 
 Next, the current study examined only two years of data from the LAMS study, 
and participants were generally in the late childhood to early adolescence age range at the 
two-year follow-up assessment. It seems plausible that resilience processes and factors 
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influencing these processes would change across development, and particularly as youth 
transition across the adolescent years, factors that enhance youth’s QoL with increasing 
symptom severity may differ from those for younger children. As such, conducting 
further analyses on additional waves of data from the LAMS study would be informative, 
and the added variability with a greater number of assessment time points may allow for 
examination of variables for which models did not converge in the current study.  
 Given the current goals to examine resilience processes in youth with 
psychopathology and the lack of significant interaction effects for the hierarchically-
formed diagnostic categories, it would be further informative to examine other 
diagnostically-related characteristics and their possible roles in resilience processes in 
future work. For example, exploring symptom counts in specific categories (e.g., manic 
symptoms, depressive symptoms, anxiety symptoms, etc.) rather than broad diagnostic 
groupings would perhaps provide more fine-grained information regarding the potential 
moderating role of specific psychopathological symptoms on the severity-QoL 
relationship. While the current work investigated moderators of the relationship between 
overall symptom severity and QoL, identifying resiliency and protective factors that 
moderate the relationship between severity of specific symptom caterogies and QoL 
would be helpful in future studies, so that more targeted treatment implications for youth 
with various fors of psychopathology can be inferred and extracted.  
 The current study utilized a variable-based approach to examine resilience 
processes, by considering the effects of variables on resilience processes across time. 
Person-based approaches have also been utilized in the literature to examine resilience. 
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For example, groups of youth who display or experience various levels of adversity and 
various levels of adaptive functioning are formed, and those who experience high 
adversity yet also exhibit high adaptive functioning are thought to demonstrate resilience 
outcomes. Protective and resiliency factors associated with membership in such a 
“resilient” group have then been identified. It may be of interest in future work to 
combine both variable- and person-based approaches. For example, initial efforts may 
focus on identifying possible protective and resiliency factors using variable-based 
techniques such as those performed in the current study. Then, identifying individuals 
who have high levels of these factors and possibly examining their functioning across 
time may help confirm the protective effects of these variables and potentially more 
acutely explore the mechanisms of their effects throughout individuals’ life. 
 With regards to concordance rates between parent- and youth-reported QoL, 
examining additional factors that predict concordance, as well as examining functioning 
outcomes predicted by concordance would be informative. Examining the potential 
impact of parental psychopathology on concordance rates, for example, and investigating 
whether improved parent-youth concordance exerts beneficial outcome on youth’s 
functioning may offer helpful insights into interventions involving the family that may 
maximize improvements on youth’s symptoms and QoL. Further, the current work 
utilized the KINDL as the sole measure of QoL in youth. It would be informative in 
future work to examine resilience processes in youth with psychopathology using 
different measures of QoL, such as the the Child Health Questionnaire (Landgraf et al., 
1996), the Child Health and Illness Profile (Riley, Forrest, Starfield, Green, et al., 2004; 
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Riley, Forrest, Starfield, Robertson, et al., 2004; Starfield et al., 1993; Starfield et al., 
1995), the KIDSCREEN (Ravens-Sieberer et al., 2005), and the Pediatric Quality of Life 
Inventory (Varni, Seid, & Rode, 1999), to ascertain the replicability of the current 
findings using different assessments of QoL in youth.  
 Finally, as mentioned previously, corrections for multiple comparisons were not 
made in the current analyses, due to the exploratory nature of the present work and 
concerns about the impact of Type-II errors (e.g., failing to detect existing effects). 
Nevertheless, given that a number of models were fitted and multiple tests were 
performed, it is imperative to be mindful of the presence of Type-I errors (e.g., 
erroneously rejecting null hypotheses) and to avoid drawing concrete conclusions based 
solely on the current results. Particularly for findings where no a priori hypotheses and 
post-hoc speculations are theoretically-based, and those that were inconsistent across 
parent- and youth-reported QoL, interpretations must be made with caution. Despite these 
limitations, the current work provides thought-provoking findings that will hopefully spur 
additional future work in exploring resilience processes in youth with psychopathology.  
Conclusions 
 Resilience, the dynamic process giving rise to better-than-expected outcomes 
despite individuals’ vulnerability and experiences of adversity, is a critical area in child 
and adolescent psychology that has not been well-examined in populations of youth with 
psychopathology. The current study offers an exploratory analysis of possible protective 
and resiliency factors that may contribute to favorable QoL despite experiencing 
symptoms of severity. Findings suggest that adequate and appropriate level of psychiatric 
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care and experiences of life stress play moderating roles in influencing the relationship 
between symptom severity and QoL across time. Additional findings suggest that factors 
such as social support, physical health problems, parental psychopathology, suicidality, 
and parental psychiatric history may exert unique effects on youth’s QoL over time. 
Agreement between parents’ and youth’s perceptions of youth’s QoL also appears to 
differ among domains and over the course of the current longitudinal study. The current 
study invites future work further explicating the likely complex processes contributing to 
resilience as well as potential implications of concordance and discordance in parent- and 
youth-reported outcomes, providing insights that may drive hypotheses for the 
development of more complex theoretical models in future studies.  
 To conclude, the current work provides some optimism that youth with 
psychopathology who experience increasing symptoms over time are not necessarily 
“doomed” to synchronously worsening QoL. Current results have suggested several 
protective factors that may buffer the negative impact of symptom severity on QoL and 
contribute to resilience outcomes. Returning to Masten’s (2001) description of resilience 
as “ordinary magic”, future research and clinical endeavors to identify and promote 
protective and resiliency factors in youth with psychopathology and their families would 
do well to focus on the process by which resilience processes unfold. Going beyond 
identifying factors associated with resilience outcomes, examining how these factors 
interact with internal and external characteristics across time and in varying contexts 
promises to propel resilience research in youth with psychopathology, yielding invaluable 
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insight on ways to foster fulfilling and satisfying lives in children and adolescents with 
psychopathological symptoms.   
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Appendix A: Equations for Multilevel Models 
  
  
187 
 
Unconditional Means Model 
Level 1: QoLij = π0i + εij 
Level 2: π0i = γ00 + ζ0i 
where 
QoLij is the score for the ith child at assessment j; 
π0i is the mean QoL for the ith child; 
εij is the random measurement error for the ith child at assessment j; 
γ00 is the mean population QoL; and 
ζ0i is the deviation from the mean population QoL for the ith child. 
 
 
*Age was centered at the grand mean.  
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Unconditional Growth Model 
Level 1: QoLij = π0i + π1i(ageij) +  εij 
Level 2: π0i = γ00 + ζ0i 
   π1i = γ10 + ζ1i, 
where 
QoLij is the score for the ith child at assessment j; 
Ageij is the age of the ith child at assessment j;  
π0i is the predicted QoL score at mean age for the ith child; 
π1i is the linear rate of change in QoL for the ith child;  
εij is the random measurement error for the ith child at assessment j; 
γ00 is the average population QoL at mean age; 
ζ0i is the random effect of the ith child on QoL at mean age; 
γ10 is the average population rate of change in QoL; and 
ζ1i is the random effect of the ith child on the average population rate of change in QoL 
over time. 
 
 
* Age was centered at the grand mean. 
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Model to Extract Individual Slopes for Time-Varying Predictor (TVP) 
Continuous TVP: 
Level 1: TVPij = π0i + π1i(ageij)* +  εij 
Level 2: π0i = γ00  
              π1i = γ10 + ζ1i  
where 
TVPij is the TVP score for the ith child at assessment j; 
Ageij is the age of the ith child at assessment j;  
π0i is the predicted TVP score at mean age for the ith child; 
π1i is the linear rate of change in TVP for the ith child; 
εij is the random measurement error for the ith child at assessment j; 
γ00 is the average population TVP at mean age; 
γ10 is the average population rate of change in TVP; and 
ζ1i is the random effect of the ith child on the average population rate of change in TVP 
over time.  
Dichotomous TVP: 
Level 1: Prob(TVPi =1) = φ 
  Log[(
φ
1 − φ
)] =  η 
   η = π0+ π1(Ageij) 
Level 2: π0i = γ00 
  π1i = γ10 + ζ1i 
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where 
φ is the probability of belonging to TIPi =1; 
η is the log-odds of TIPi =1; 
TIPi is the TIP score for the ith child; 
Ageij is the age of the ith child at assessment j;  
π0i is the predicted TIP score at mean age for the ith child; 
π1i is the linear rate of change in TIP for the ith child; 
γ00 is the average population TIP at mean age; 
γ10 is the average population rate of change in TIP; and 
ζ1i is the random effect of the ith child on the average population rate of change in TIP 
over time. 
 
*Age was centered at the grand mean. 
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Level-1 Time-Varying Predictor (TVP) Slope Added to Base Model 
Level 1: QoLij = π0i + π1i(ageij)* + π2i(severityij)** + εij 
Level 2: π0i = γ00 + γ01(extracted TVP slopei) 
   π1i = γ10 +  γ11(extracted TVP slopei) + ζ1i 
   π2i = γ20 + γ21(extracted TVP slopei) + ζ2i 
Mixed Model: QoLij = γ00 + γ01(extracted TVP slopei) + γ10(Ageij) + γ11(extracted TVP 
slopei x ageij) + γ20(severityij) + γ21(extracted TVP slopei x severityij) + ζ1i(ageij) + 
ζ1i(severityij) + εij, 
where 
QoLij is the QoL for the ith child at assessment j; 
Ageij is the age of the ith child at assessment j;  
Severityij is the symptom severity of the ith child at assessment j;  
Extracted TVP Slopei is the extracted slope of TVP for the ith child; 
π0i is the predicted QoL score at mean age and Severity = 0, for the ith child; 
π1i is the linear rate of change in QoL, at Severity = 0, for the ith child;  
π2i is the slope of Severity on QoL, at mean age, for the ith child; 
εij is the random measurement error for the ith child at assessment j; 
γ00 is the average population QoL at mean age, Severity = 0, and Extracted TVP Slope = 
0; 
γ01 is the effect of Extracted TVP Slope on average population QoL at mean age and 
Severity = 0;  
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γ10 is the average population linear rate of change in QoL, at Severity = 0 and Extracted 
TVP Slope = 0; 
γ11 is the effect Extracted TVP Slope on the population linear rate of change in QoL;  
ζ1i is the random effect the ith child on the average population linear rate of change in 
QoL; 
γ20 is the effect of Severity on QoL, at mean age and Extracted TVP Slope = 0;  
γ21 is the effect of Extracted TVP Slope on the slope of Severity on QoL; and 
ζ2i is the random effect the ith child on the slope of Severity on QoL. 
 
*Age was centered at the grand mean. 
 
** Severity was centered at the lowest possible rating (“Normal”). 
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Level-2 Time-Invariant Predictor (TIP) Added to Base Model 
Level 1: QoLij = π0i + π1i(ageij) + π2i(severityij)** +  εij 
Level 2: π0i = γ00 + γ01(TIPi)  
   π1i = γ10 + γ11(TIPi) + ζ1i 
   π2i = γ20 + γ21(TIPi) + ζ2i 
Mixed Model: QoLij = γ00 + γ01(TIP) + γ10(ageij) + γ11(TIPi x ageij) + γ20(severityij) + 
γ21(TIPi x Severityij) +  ζ0i  + ζ1i(ageij) + ζ1i(severityij) + εij, 
where 
QoLij is the QoL for the ith child at assessment j; 
Ageij is the age of the ith child at assessment j;  
Severityij is the symptom severity of the ith child at assessment j;  
TIPi is the TIP score for the ith child; 
π0i is the predicted QoL score at mean age, Severity = 0, and TIP = 0, for the ith child; 
π1i is the linear rate of change in QoL, with Severity = 0 and TIP = 0, for the ith child;  
π2i is the effect of Severity on QoL at mean age and TIP = 0, for the ith child; 
εij is the random measurement error for the ith child at age j; 
γ00 is the average population QoL at mean age, Severity = 0, and TIP = 0; 
γ01 is the effect of TIP on the average population QoL at mean age and Severity = 0; 
γ10 is the average population rate of change in QoL, with Severity = 0 and TIP = 0; 
γ11 is the effect of TIP on the average population linear rate of change in QoL;  
ζ1i is the random effect the ith child on the linear rate of change in QoL; 
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γ20 is the effect of Severity on the average population linear rate of change in QoL, with 
TIP = 0;  
γ21 is the effect of TIP on the slope of Severity on QoL; and 
ζ2i is the random effect the ith child on the slope of Severity on QoL. 
 
 
* Age was centered at the grand mean. 
** Severity was centered at the lowest possible rating (“Normal”). 
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Appendix B: Clinical Global Impression – Severity Ratings 
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Appendix C: KINDL-R – Youth Self-Report 
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Appendix D: KINDL-R – Parent Proxy-Report 
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Table 1 
Table of covariates hypothesized to moderate the time-linked correspondence between 
symptom severity and QoL 
Variable Time Point Assessed Instrument Variable Type 
Level 1 Hypothesized Covariates 
Social support 
(with primary 
caregiver) – 
Clinician rating 
BL and FU A-LIFE
1
 Continuous 
Social support 
(with secondary 
caregiver) – 
Clinician rating 
BL and FU A-LIFE
2
 Continuous 
Social support 
(with peers) – 
Clinician rating 
BL and FU A-LIFE
3
 Continuous 
Number of 
diagnoses  
BL and FU K-SADS Continuous 
Psychiatric 
medication  
BL and FU SACA 
Categorical  
 No Medication 
Antipsychotic 
Antidepressant 
Anxiolytic 
Stimulant 
Mood Stabilizer 
Other Medication  
Psychosocial 
treatment  
BL and FU SACA 
Categorical  
School Services  
Any Inpatient Hospitalization 
Any Outpatient Services 
Continuous 
Number of Inpatient 
Hospitalizations 
Number of Outpatient Professionals 
Continued 
 
 
                                                 
1
 Sign of variable reversed, such that higher (less negative) scores indicate better functioning.  
2
 Sign of variable reversed, such that higher (less negative) scores indicate better functioning. 
3
 Sign of variable reversed, such that higher (less negative) scores indicate better functioning. 
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Table 1 continued 
 
Variable Time Point Assessed Instrument Variable Type 
Level 1 Hypothesized Covariates 
Global functioning BL and FU CGAS Continuous 
Parenting stress 
(Number of stressors 
and total stress) 
BL and FU PSS Continuous 
Stressful life events – 
Parent report 
(Number of stressors 
and total stress) 
BL and FU SLES-P Continuous 
Stressful life events – 
Child self-report 
(Number of stressors 
and total stress l) 
BL and FU SLES-C or SLES-A Continuous 
Insurance status  BL and FU Demographic Form 
Categorical 
Non-Medicaid (Yes/No) 
Level 2 Hypothesized Covariates 
Intelligence (FSIQ) BL WASI Continuous 
Annual Income BL Demographics 
Categorical 
< $19,999 
$20,000-$39,999 
$40,000-$49,999 
$50,000-More than $200,000 
Family Structure BL Demographics 
Categorical 
Both parents (Yes/No) 
 
Note. QoL = Quality of life; BL = Baseline; FU = Each of two annual follow-up assessments; ALIFE = 
Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up Evaluation; K-SADS = Kiddie 
Schedule for Affective Disorders and Schizophrenia for School-Age Children – Present and Lifetime 
Version with additional items from the WASH-U-K-SADS; SACA = Service Assessment for Children and 
Adolescents; SLES-P = Stressful Life Events Schedule – Parent Version; SLES-C = Stressful Life Events 
Schedule – Child Version; SLES-A = Stressful Life Events Schedule – Adolescent Version; FSIQ = Full 
Scale Intelligence Quotient; WASI = Wechsler Abbreviated Scales of Intelligence. 
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Table 2 
Table of covariates for which potential moderating effects on the time-linked 
correspondence between symptom severity and QoL were explored 
Variable Time Point Assessed Instrument Variable Type 
Level 1 Exploratory Covariates 
Child significant 
physical health 
problems 
BL and FU Parent report Categorical (Yes/No) 
Diagnosis type
1
  BL and FU K-SADS 
Categorical 
Psychotic Disorder  
Bipolar Spectrum Disorder 
Depressive Spectrum Disorder 
Anxiety Disorder 
Disruptive Behavior Disorder 
Attention-Deficit/Hyperactivity 
Disorder 
Other Diagnosis 
No Diagnosis 
Elevated 
symptoms of 
mania (ESM) – 
Parent report 
BL and FU PGBI-10M 
Continuous 
PGBI-10M Total  
Categorical  
ESM+ (>12; Yes/No) 
Parental current 
mood symptoms 
(Total) 
BL and FU GBI Continuous 
School-related 
challenges 
BL and FU 
Demographic 
Form 
Categorical 
Repeated grade (Yes/No) 
Academic Tutor (Yes/No) 
Special education class placement 
(Yes/No)  
Suicidality BL and FU K-SADS 
Categorical 
Ideation AND/OR 
Gesture AND/OR 
Attempt  
Psychosis BL and FU K-SADS 
Categorical 
Hallucinations and/or Delusions – 
mild or higher AND/OR Mood 
disorder diagnosis with psychotic 
features (Yes/No) 
Continued 
                                                 
1
 Based on hierarchically-formed diagnostic groups listed in Table 3.  
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Table 2 continued 
 
Note. QoL = Quality of life; BL = Baseline; FU = Each of two annual follow-up assessments; PGBI-10M = 
Parent General Behavior Inventory – 10-Item Mania Scale; GBI = General Behavior Inventory; ADHD = 
Attention-Deficit/Hyperactivity Disorder. 
 
  
Level 2 Exploratory Covariates 
Sex of child BL 
Demographic 
Form 
Categorical 
Male 
Female 
Race of child BL 
Demographic 
Form 
Categorical 
Caucasian (Yes/No) 
Ethnicity of child BL 
Demographic 
Form 
Categorical 
Hispanic/Latino (Yes/No) 
Parental/familial 
psychiatric history 
– Diagnoses 
BL Weissman 
Continuous (Parent only) 
Total Number of Diagnoses 
Categorical 
No Diagnosis 
ADHD 
Mania 
Depression  
Anxiety  
Disruptive Behavior/Conduct 
Substance Use Suicidality  
Psychosis  
(Yes/No) 
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Table 3 
 
Hierarchically-formed diagnostic groups  
 
 
Note. Diagnostic groups were hierarchically-formed to ensure comprehensive representation of diagnoses 
and comorbidities in exclusive categories.  
 
 
Diagnostic Groups 
1. Any psychotic disorder alone 
2 Psychotic disorder with comorbidity 
3. Any bipolar spectrum disorder (BPSD) alone  
4. BPSD with non-psychotic, non-mood disorder comorbidity 
5. Any depressive spectrum disorder (DSD) alone 
6. DSD with  non-psychotic, non-mood disorder comorbidity 
7. Anxiety disorders alone 
8. Anxiety disorders with  non-psychotic, non-mood disorder comorbidity 
9. Disruptive behavior disorders (DBD) alone 
10. DBD with  non-psychotic, non-mood, non-anxiety comorbidity 
11. Attention-deficit hyperactivity disorder (ADHD) alone 
12. ADHD with  non-psychotic, non-mood, non-anxiety, non-DBD comorbidity 
13. Other disorders 
  
 
 
 
Table 4 
Significant differences between participants with and without missing values on key variables 
  Significant differences between missing and non-missing 
Key 
Variable 
Rate of 
Missingness 
N (%)  
Sex Race Age Ethnicity Study Site 
Baseline 
Family 
Income 
Medicaid 
Status 
IQ 
CGAS 
Total 
Score 
Number of 
Diagnoses 
BL CGI 1 (0.1) ns ns ns ns ns ns ns ns ns ns 
BL C-
KINDL 
Total 
96 (14) ns ns ns ns 
χ2(3) = 
13.70**
1
 
ns 
χ2(1) = 
3.90*
2
 
ns 
t(678) = 
2.36*
3
 
ns 
BL P-
KINDL 
Total 
97 (14.2) ns ns ns ns 
χ2(3) = 
23.45***
4
 
ns 
χ2(1) = 
4.30*
5
 
ns ns ns 
M-12 CGI 160 (23.4) ns ns ns ns 
χ2(3) = 
13.69**
6
 
ns ns 
t(678) = 
2.78**
7
 
  
Continued 
                                                 
1
 OSU ~ Pittsburgh ~ Cincinnati; Pittsburgh ~ Cincinnati ~ Case Western; OSU > Case Western 
2
 Medicaid > Other Insurance 
3
 Missing related to higher CGAS 
4
 Pittsburgh ~ OSU; OSU ~ Case Western ~ Cincinnati; Pittsburgh > Case Western ~ Cincinnati 
5
 Medicaid > Other Insurance 
6
 Case Western ~ Pittsburgh ~ OSU > Cincinnati 
7
 Missing related to lower IQ 
2
2
2
 
  
 
 
 
 
Table 4 continued 
Continued 
                                                 
8
 Missing related to higher age 
9
 Not Hispanic > Hispanic 
10
 Pittsburgh ~ OSU; OSU ~ Case Western ~ Cincinnati; Pittsburgh > Case Western ~ Cincinnati 
11
 Not Hispanic > Hispanic 
12
 Pittsburgh ~ Case Western ~ OSU; Pittsburgh ~ Case Western > Cincinnati 
13
 Case Western ~ OSU; OSU ~ Pittsburgh ~ Cincinnati; Case Western > Pittsburgh ~ Cincinnati 
14
 Missing related to lower IQ 
15
 Case Western ~ Pittsburgh ~ OSU; OSU ~ Cincinnati; Case Western ~ Pittsburgh > Cininnati 
16
 Not Hispanic > Hispanic 
17
 Case Western > Pittsburgh ~ OSU ~ Cincinnati 
18
 Missing related to lower IQ 
  Significant differences between missing and non-missing 
Key 
Variable 
Rate of 
Missingness 
N (%)  
Sex Race Age Ethnicity Study Site 
Baseline 
Family 
Income 
Medicaid 
Status 
IQ 
CGAS 
Total 
Score 
Number of 
Diagnoses 
M-12 C-
KINDL 
Total 
243 (35.5) ns ns 
t(523) = 
2.62**
8
 
χ
2
(1) = 
6.72*
9
 
χ
2
(3) = 
21.68***
10
 
ns ns ns ns ns 
M-12 P-
KINDL 
Total 
229 (33.4) ns ns ns 
χ
2
(1) = 
3.96*
11
 
χ
2
(3) = 
13.83**
12
 
ns ns ns ns ns 
M-24 CGI 221 (32.3) ns ns ns ns 
χ
2
(3) = 
23.47***
13
 
ns ns 
t(678) = 
2.31*
14
 
ns ns 
M-24 C-
KINDL 
Total 
272 (39.7) ns ns ns ns 
χ
2
(3) = 
16.42**
15
 
ns ns ns ns ns 
M-24 P-
KINDL 
Total 
256 (37.4) ns ns ns 
χ
2
(1) = 
4.05*
16
 
χ
2
(3) = 
24.5***
17
 
ns ns 
t(678) = 
2.60*
18
 
ns ns 
IQ 5 (0.7) ns ns ns ns ns ns ns ns ns ns 
2
2
3
 
  
 
 
 
Table 4 continued 
Note. BL = Baseline assessment; M-12 = 12-Month assessment; M-24 = 24-Month assessment; CGI = Clinical Global Impression Scale – Severity; KINDL = Revididerter 
KINDer Lebensqualiatsfragebogen; C-KINDL = Child-Report of KINDL (QoL measure); P-KINDL = Parent-Report of KINDL (QoL measure); IQ = Intelligence Quotient; 
CGAS = Children’s Global Assessment Scale; *p < .05; **p < .01; ***p < .001; ns = non-significant. 
2
2
4
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Table 5 
Descriptive statistics of demographic characteristics and time-invariant covariates 
 
 N (%) 
Sex (Male) 459 (67) 
Race    
 White 443 (64.7) 
 African American 179 (26.1) 
 Biracial 59 (8.6) 
 Asian 2 (0.3) 
 American Indian 2 (0.3) 
Ethnicity (Not Hispanic) 655 (95.6) 
Family Structure at Baseline  
 Both parents 243 (35.5) 
 One parent 221 (32.3) 
 Blended 143 (20.9) 
 Other 63 (9.2) 
Family Income at Baseline  
 $0-$19,999 335 (54.3) 
 $20,000-$39,999 183 (29.7) 
 $40,000-$49,999 39 (6.3) 
 $50,000-More than $200,000 60 (9.7) 
Site   
 Case Western Reserve University 165 (24.1) 
 Cincinnati Children’s Medical Center 169 (24.7) 
 The Ohio State University 176 (25.7) 
 University of Pittsburgh Medical 
Center/Western Psychiatric Institute and Clinic 
175 (25.5) 
Parental Psychiatric History
1
  
 Depression 432 (64.2) 
 Disruptive Behavior Disorder 422 (62.7) 
 Anxiety 358 (53.8) 
 Substance Use Disorder 307 (45.5) 
 ADHD 184 (27.4) 
 Suicidality 159 (23.3) 
 Mania 131 (21.0) 
 Psychosis 78 (11.6) 
Continued 
                                                 
1
 Based on screening questions of key symptoms, not full diagnostic evaluations. 
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Table 5 continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. ADHD = Attention-Deficit/Hyperactivity Disorder; FSIQ = Full Scale Intelligence 
Quotient.  
                                                 
2
 First- and second-degree relatives, excluding parents. Based on screening questions of key symptoms, not 
full diagnostic evaluations.  
 N (%) 
Family Psychiatric History
2
  
 Substance Use Disorder 419 (61.2) 
 Anxiety 355 (51.8) 
 Depression 350 (51.1) 
 ADHD 204 (29.8) 
 Conduct Disorder 179 (26.1) 
 Suicidality 176 (25.7) 
 Psychosis 118 (17.2) 
 Mania 109 (15.9) 
 Mean (SD) 
Intelligence (FSIQ) 98.4 (15.8) 
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Table 6 
Descriptive statistics for time-varying covariates of age insurance status, significant 
physical health problems, medication treatment, and psychosocial treatment 
 Baseline 
M (SD) 
12-Month 
M (SD) 
24-Month 
M (SD) 
Age 9.39 (1.93) 10.38 (1.92) 11.39 (1.91) 
 N (%) N (%) N (%) 
Insurance Status (Non-
Medicaid) 
328 (47.9) 257 (49.0) 227 (48.7) 
Significant Health Problems
1
 409
2
 (59.7) 88 (12.8) 61 (8.9) 
School-Related Challenges
3
 365 (53.5) 182 (34.7) 144 (31.0) 
Medication    
 None 257 (37.5) 143 (27.2) 130 (27.8) 
 Antipsychotic 150 (21.9) 165 (31.4) 138 (29.6) 
 Antidepressant 82 (12.0) 89 (17.0) 94 (20.1) 
 Anxiolytic 10 (1.5) 14 (2.7) 10 (2.1) 
 Mood Stabilizer 48 (7.0) 50 (9.5) 50 (10.7) 
 Stimulant 253 (36.9) 244 (46.5) 226 (48.4) 
 Other Medication 141 (20.6) 84 (16.0) 83 (17.8) 
School Services
4
 346 (50.7) 275 (53.5) 234 (51.1) 
Psychiatric Treatment    
 Any Outpatient 
Services 
569 (83.1) 557 (95.9) 464 (91.5) 
 Any Inpatient 
Hospitalization 
32 (4.7) 35 (7.4) 27 (6.3) 
  M (SD) M (SD) M (SD) 
 Number of Outpatient 
Professionals Seen 
2.59 (2.54)
5
 
Range: 0 to 53 
3.22 (1.71) 
Range: 0 to 10 
2.97 (1.90) 
Range: 0 to 10 
 Number of 
Hospitalizations 
0.18 (0.93)
6
 
Range: 0 to 14 
0.097 (0.38) 
Range: 0 to 3 
0.097 (0.58) 
Range: 0 to 9 
 Total N: 685 Total N: 525 Total N: 467 
  
                                                 
1
 Includes hospitalizations, head injuries and/or loss of consciousness, and surgeries.  
2
 Lifetime significant health problems. 
3
 Includes having an academic tutor, repeating a grade, and/or receiving special education services.  
4
 Includes attending a special school, being placed in a special classroom, receiving special help in the 
regular classroom, and/or receiving counseling services at school.  
5
 Lifetime number of professionals seen. 
6
 Lifetime number of inpatient hospitalizations. 
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Table 7 
Descriptive statistics for parent- and youth-reported QoL on the KINDL-R 
 
Note. Possible range of total scores = 0 to 96; possible range of subscale scores = 0 to 16; 
Higher scores indicate better QoL; QoL = Quality of life; KINDL = Revididerter KINDer 
Lebensqualiatsfragebogen. 
  
 Baseline 
M (SD) 
12-Month 
M (SD) 
24-Month 
M (SD) 
Parent KINDL    
 Total 57.16 (11.93) 60.06 (11.29) 60.67 (11.55) 
 Physical 11.10 (3.11) 11.25 (2.90) 11.36 (2.79) 
 Emotional 11.65 (2.80) 12.07 (2.52) 12.24 (2.59) 
 Esteem 7.41 (3.36) 7.69 (3.11) 7.69 (3.36) 
 Family 8.41 (3.09) 9.21 (2.94) 9.27 (3.23) 
 Friends 9.63 (3.06) 10.09 (2.98) 10.38 (3.05) 
 School 9.09 (3.06) 9.76 (2.81) 9.69 (2.63) 
Child KINDL    
 Total 59.51 (13.93) 62.69 (11.75) 62.08 (12.38) 
 Physical 10.44 (3.14) 11.32 (2.66) 11.37 (2.67) 
 Emotional 11.29 (2.94) 11.73 (2.54) 11.78 (2.63) 
 Esteem 8.29 (4.22) 8.31 (4.19) 8.09 (4.39) 
 Family 9.82 (3.00) 10.67 (2.79) 10.83 (2.86) 
 Friends 10.28 (3.64) 10.91 (3.12) 10.90 (3.31) 
 School 8.38 (3.35) 9.30 (3.45) 9.04 (3.53) 
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Table 8 
Descriptive statistics for clinician-rated measures of ALIFE, CGAS, and CGI 
 
 
 
 
  
                                                 
1
 Clinician-rated current functioning; lower ratings indicate better functioning (range of possible scores: 1 
to 5). Scores multiplied by -1 are used in primary analyses.  
2
 Clinician-rated current overall functioning; higher scores indicate better functioning (range of possible 
scores: 1-100).  
3
 Clinician-rated current overall symptom severity; higher ratings indicate greater symptom severity (range 
of possible score when symptom severity was assessed: 0 to 6) 
 Baseline 
M (SD) 
12-Month 
M (SD) 
24-Month 
M (SD) 
Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up Evaluation 
(A-LIFE)
1
 
 With Primary Caregiver 2.37 (0.95) 2.23 (0.88) 2.27 (0.91) 
 With Secondary 
Caregiver 
2.54 (0.97) 2.44 (0.95) 2.40 (0.89) 
 With Peers 2.61 (1.02) 2.33 (0.98) 2.25 (0.99) 
Children’s Global Assessment Scale (CGAS)2 
 CGAS – Current 54.90 (10.09) 59.87 (10.49) 60.67 (11.03) 
Clinical Global Impression Scale – Overall Current Severity (CGI)3 
 CGI – Current  2.41 (1.17) 2.15 (1.18) 2.09 (1.16) 
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Table 9 
Descriptive statistics for specific ratings of symptom severity on the CGI 
Note. CGI = Clinical Global Impression Scale – Overall current severity. 
  
CGI Categories 
 Baseline 
N (%) 
12-Month 
N (%) 
24-Month 
N (%) 
 Normal  61 (8.9) 79 (15.0) 62 (13.4) 
 Borderline Mentally Ill 64 (9.4) 40 (7.6) 52 (11.2) 
 Mildly Ill 212 (31.0) 178 (33.9) 175 (37.7) 
 Moderately Ill 246 (36.0) 189 (36.0) 139 (30.0) 
 Markedly Ill 84 (12.3) 31 (5.9) 28 (6.0) 
 Severely Ill 17 (2.5) 8 (1.5) 8 (1.7) 
 Among Most Extremely Ill 0 (0) 0 (0) 0 (0) 
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Table 10 
Descriptive statistics for self-reported measures of parenting stress, stressful life events, 
parental bipolar disorder symptoms, and parent-rated youth bipolar disorder symptoms 
Note. Possible ranges: PSS Number of Stressors = 0 to 25 (higher scores indicate more stressors); PSS Total Stress = 0 to 100 
(higher scores indicate greater stress); P-SLES and A-SLES Number of Stressors = 0 to 79 (higher scores indicate more 
stressors); P-SLES and A-SLES Total Stress = 0 to 316 (higher scores indicate greater stress); C-SLES Number of Stressors = 
0 to 61 (higher scores indicate more stressors); C-SLES Total Stress = 0 to 244 (higher scores indicate greater stress); GBI-P = 
0 to 219 (higher scores indicate more mood symptoms); PGBI-10M = 0 to 30 (higher scores indicate more mood symptoms).  
                                                 
1
 PGBI-10M score of 12 or greater. 
 Baseline 
M (SD) 
12-Month 
M (SD) 
24-Month 
M (SD) 
Parent Stress Survey (PSS) 
 Number of Stressors 8.83 (4.27) 7.47 (4.15) 6.88 (4.33) 
 Total Stress Intensity 21.02 (13.91) 24.53 (16.10) 23.51 (17.53) 
 Average Stress Intensity 2.24 (0.76) 3.10 (0.74) 3.09 (0.78) 
Stressful Life Events Schedule (SLES) – Parent (P-SLES), Child (C-SLES), and Adolescent 
(A-SLES) Reports 
 P-SLES Number of Stressors 9.26 (5.70) 7.10 (4.87) 7.20 (5.11) 
 P-SLES Total Stress 
Intensity 
25.22 (17.54) 18.58 (14.47) 18.73 (15.07) 
 P-SLES Average Stress 
Intensity 
2.66 (0.61) 2.53 (0.65) 2.50 (0.67) 
 C-SLES Number of Stressors 10.26 (8.40) 7.89 (6.27) 7.88 (6.66) 
 C-SLES Total Stress 
Intensity 
27.01 (23.77) 20.03 (17.62) 19.34 (17.57) 
 C-SLES Average Stress 
Intensity 
2.54 (0.71) 2.50 (0.66) 2.43 (0.69) 
 A-SLES Number of Stressors -- 8.11 (7.24) 6.51 (5.66) 
 A-SLES Total Stress 
Intensity 
-- 20.57 (20.73) 15.56 (17.28) 
 A-SLES Average Stress -- 2.35 (0.72) 2.26 (0.82) 
General Behavior Inventory – Parent Symptoms (GBI-P) 
 Total 46.50 (41.48) 33.75 (36.31) 33.98 (35.91) 
Parent General Behavior Inventory – 10-Item Mania Scale (PGBI-10M) 
 Total 12.79 (7.16) 8.55 (6.54) 8.18 (6.60) 
 N (%) N (%) N (%) 
 Elevated Symptoms of Mania 
– Positive (ESM-Positive)1 
376 (56.5) 160 (31.3) 121 (26.5) 
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Table 11 
Descriptive statistics for youth psychiatric diagnoses, suicidality, and psychosis 
 Baseline 
N (%) 
12-Month 
N (%) 
24-Month 
N (%) 
Diagnostic Group    
 No diagnosis 15 (2.2%) 30 (5.7%) 46 (9.9%) 
 
Any psychotic disorder 
alone 
1 (0.1%) 0 (0%) 0 (0%) 
 
Psychotic disorder with 
comorbidity 
14 (2%) 12 (2.3%) 9 (1.9%) 
 
Any bipolar spectrum 
disorder (BPSD) alone 
19 (2.8%) 20 (3.8%) 20 (4.3%) 
 
BPSD with non-
psychotic, non-mood 
disorder comorbidity 
144 (21%) 116 (22.1%) 116 (24.8%) 
 
Any depressive spectrum 
disorder (DSD) alone 
6 (0.9%) 8 (1.5%) 1 (0.2%) 
 
DSD with  non-
psychotic, non-mood 
disorder comorbidity 
114 (16.6%) 48 (9.2%) 42 (9%) 
 Anxiety disorders alone 10 (1.5%) 9 (1.7%) 10 (2.1%) 
 
Anxiety disorders with  
non-psychotic, non-mood 
disorder comorbidity 
88 (12.8%) 56 (10.7%) 45 (9.6) 
 
Disruptive behavior 
disorders (DBD) alone 
19 (2.8%) 12 (2.3%) 8 (1.7%) 
 
DBD with  non-
psychotic, non-mood, 
non-anxiety comorbidity 
139 (20.3%) 97 (18.5%) 78 (16.7%) 
 
Attention-deficit 
hyperactivity disorder 
(ADHD) alone 
74 (10.8%) 76 (14.5%) 67 (14.3%) 
 
ADHD with  non-
psychotic, non-mood, 
non-anxiety, non-DBD 
comorbidity 
24 (3.5%) 27 (5.2%) 
18 (3.9%) 
 
 Other disorders only 18 (2.6%) 12 (2.3%) 7 (1.5%) 
Suicidality 106 (15.5) 39 (7.4) 34 (7.3) 
Psychosis 34 (5.0) 18 (3.4) 14 (3.0) 
 M (SD) M (SD) M (SD) 
Number of diagnoses 2.49 (1.26) 
Range: 0 to 6 
2.11 (1.33) 
Range: 0 to 6 
2.00 (1.36) 
Range: 0 to 7 
  
 
Table 12 
Pearson’s correlations among level-1 predictors 
  BL_CKINDL m12_CKINDL m24_CKINDL BL_PKINDL m12_PKINDL m24_PKINDL BL CGI m12 CGI m24 CGI 
BL_CKINDL_Tot 1 
 
       
m12_CKINDL_Tot .315** 1        
m24_CKINDL_Tot .266** .387** 1       
BL_PKINDL_Tot .345** .137** .212** 1      
m12_PKINDL_Tot .211** .325** .229** .535** 1     
m24_PKINDL_Tot .197** .226** .383** .560** .522** 1    
BL CGI -.211** .007 -.021 -.276** -.071 -.143** 1   
m12 CGI -.163** -.146** -.116* -.224** -.335** -.167** .315** 1  
m24 CGI -.083 -.073 -.229** -.248** -.125* -.336** .395** .510** 1 
BL Age -.129** -.065 -.039 -.213** -.103* -.138** .038 -.023 -.077 
m12 Age -.106* -.067 -.060 -.178** -.098* -.130** .035 -.024 -.070 
m24 Age -.127* -.086 -.042 -.166** -.105* -.139** .041 -.013 -.081 
BL Non-Medicaid -.006 -.036 -.024 -.086* -.115* -.044 -.110** -.088* -.091* 
m12 Non-Medicaid -.026 -.057 .030 -.075 -.122** -.005 -.119** -.132** -.127** 
m24 Non-Medicaid .014 -.070 -.009 -.057 -.168** -.001 -.107* -.079 -.091* 
BL NoMeds .004 .008 -.034 .010 .013 .022 -.106** -.031 -.015 
BL AnyMed -.004 -.008 .034 -.010 -.013 -.022 .106** .031 .015 
BL Antipsychotic .030 -.059 .000 -.046 -.098* -.095* .096* .060 .106* 
BL Antidep .045 -.045 -.025 -.066 -.007 -.077 .037 -.024 .016 
BL Anxiolytic -.054 -.060 .064 -.044 -.113* .028 .104** .089* .040 
BL OthMeds -.061 -.037 -.091 -.075 -.025 -.067 .157** .114** .106* 
BL MoodStab .019 -.084 -.108* -.078 -.072 -.134** .154** .069 .128** 
BL Stim -.035 .092 -.001 .054 .074 .044 .032 .026 -.013 
m12 NoMeds .027 -.008 .037 .112* .042 .107* -.109* -.094* -.172** 
m12 AnyMed -.027 .008 -.037 -.112* -.042 -.107* .109* .094* .172** 
m12 MoodStab -.017 -.067 -.162** -.121* -.106* -.203** .155** .075 .158** 
m12 Antidep -.060 -.073 -.072 -.142** -.116* -.160** .026 .051 .077 
m12 Antidep .027 -.068 -.050 -.173** -.165** -.128* .126** .090* .131** 
m12 Anxio -.106* -.048 .078 -.051 -.105* -.057 .037 .030 .045 
m12 OthMeds -.071 -.023 -.041 .006 .044 .027 .093* .100* .100* 
m12 Stim -.029 .051 .012 .036 .117* .030 .035 .046 .079 
m24 NoMeds -.011 .080 .047 .086 .099 .086 -.082 -.087 -.146** 
m24 AnyMeds .011 -.080 -.047 -.086 -.099 -.086 .082 .087 .146** 
m24 MoodStab -.119* -.095 -.194** -.174** -.100 -.179** .148** .069 .130** 
m24 Antidep -.014 -.120* -.080 -.089 -.153** -.129** -.015 .071 .133** 
m24 Anxio -.033 -.014 .051 -.027 -.099 -.043 .014 .090 .039 
m24 OthMeds .034 -.064 -.010 .015 .053 .039 .080 .048 .110* 
m24 Antipsychotic -.013 -.103* -.126* -.189** -.180** -.156** .106* .106* .137** 
m24 Stim -.009 .073 .115* .046 .106* .095* .016 .023 -.007 
BL PSS_NumStress -.097* -.080 -.116* -.350** -.304** -.321** .195** .112* .140** 
BL PSS_Tot Stress -.116** -.046 -.148** -.387** -.301** -.333** .232** .126** .143** 
m12 PSS_Num Stress -.121* -.037 -.092 -.304** -.360** -.314** .144** .190** .177** 
m12 PSS_Tot Stress -.118* -.070 -.138** -.303** -.329** -.354** .159** .235** .233** 
m24 PSS_Num Stress -.066 -.053 -.158** -.209** -.261** -.352** .134** .206** .295** 
Continued 
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Table 12 continued 
Continued 
 
 
 
  BL_CKINDL m12_CKINDL m24_CKINDL BL_PKINDL m12_PKINDL m24_PKINDL BL CGI m12 CGI m24 CGI 
m24 PSS_Tot Stress -.080 -.081 -.181** -.254** -.249** -.427** .163** .241** .332** 
BL PSLES_Num 
Stress 
-.109** -.025 -.085 -.303** -.199** -.208** .157** .190** .106* 
BL PSLES_Tot Stress -.150** -.041 -.120* -.359** -.226** -.267** .183** .197** .140** 
m12 PSLES_Num 
Stress 
-.105* -.125** -.137** -.254** -.249** -.258** .132** .216** .157** 
m12 PSLES_Tot Stress -.132** -.146** -.163** -.284** -.297** -.311** .141** .237** .178** 
m24 PSLES_Num 
Stress 
-.110* -.142** -.119* -.240** -.156** -.288** .154** .225** .193** 
m24 PSLES_To Stress -.133** -.160** -.168** -.246** -.186** -.356** .167** .234** .240** 
BL CSLES_Num 
Stress 
-.149** -.069 -.038 -.167** -.119* -.155** .150** .129** .038 
BL CSLES_Tot Stress -.198** -.065 -.035 -.177** -.105* -.143** .157** .169** .076 
m12 CSLES_Num 
Stress 
-.107* -.113* -.199** -.059 -.094* -.108* .047 .167** .154** 
m12 CSLES_Tot 
Stress 
-.097* -.135** -.214** -.059 -.096* -.125* .042 .169** .178** 
m24 CSLES_Num 
Stress 
-.009 -.007 -.196** .014 -.050 -.091 -.034 .058 .037 
m24 CSLES_Tot 
Stress 
.009 -.002 -.203** -.014 -.065 -.126* -.007 .060 .053 
BL Num Dx -.174** -.030 -.117* -.352** -.175** -.246** .396** .283** .404** 
m12 Num Dx -.171** -.146** -.114* -.272** -.323** -.237** .297** .549** .508** 
m24 Num Dx -.097 -.109* -.194** -.227** -.178** -.328** .259** .415** .660** 
BL PGBI10 Tot -.040 -.012 .062 -.269** -.187** -.155** .248** .144** .112* 
BL ESM+ -.030 -.088 .041 -.231** -.159** -.124* .229** .103* .108* 
m12 PGBI10 Tot -.092 -.065 -.086 -.284** -.330** -.274** .168** .321** .205** 
m12 ESM+ -.086 -.097* -.072 -.220** -.256** -.225** .130** .294** .183** 
m24 PGBI10 Tot -.032 -.016 -.061 -.219** -.174** -.277** .155** .230** .298** 
m24 ESM+ -.004 -.012 -.022 -.120* -.092 -.197** .164** .188** .218** 
BL GBI-P Tot -.053 -.022 -.105* -.224** -.221** -.237** .159** .198** .124* 
m24 GBI-P Tot -.056 -.048 -.117* -.133** -.218** -.271** .126** .189** .162** 
m24 GBI-P Tot -.051 .009 -.089 -.144** -.127* -.229** .156** .213** .171** 
BL CGAS .291** .041 .066 .350** .155** .198** -.665** -.377** -.450** 
m12 CGAS .206** .183** .117* .283** .348** .261** -.433** -.716** -.539** 
m24 CGAS .126* .090 .246** .257** .202** .387** -.417** -.475** -.737** 
BLalifeprimary (rev) .107** .053 .149** .315** .181** .255** -.111** -.135** -.242** 
BLalifesecondary (rev) .142** .158** .082 .283** .200** .212** -.133** -.155** -.121* 
BLalifepeer (rev) .211** .084 .121* .300** .201** .262** -.304** -.236** -.263** 
m12alifeprimary (rev) .059 .085 .167** .206** .323** .225** -.072 -.277** -.152** 
m12alifesecondary 
(rev) 
.123* .167** .165** .172** .231** .237** -.033 -.238** -.182** 
m12alifepeer (rev) .171** .110* .119* .248** .320** .196** -.184** -.334** -.300** 
m24alifeprimary (rev) .084 .091 .229** .246** .241** .412** -.135** -.160** -.329** 
m24alifesecondary 
(rev) 
.172** .177** .257** .158** .213** .365** -.130* -.097 -.233** 
m24alifepeer (rev) .131** .105* .234** .267** .273** .395** -.254** -.251** -.430** 
BL Sig Health Prob -.073 -.059 -.019 -.092* -.109* .006 .005 .120** .101* 
m12 Sig Health Prob .042 -.069 -.003 -.074 -.003 -.046 .045 .095* .074 
m24 Sig Health Pob -.024 -.088 -.106* -.053 -.057 -.044 -.016 .041 .022 
BL Psychotic Dx -.024 .045 .009 -.088* -.023 -.088 .127** .054 .129** 
BL BP Dx -.041 -.089 -.041 -.190** -.196** -.172** .225** .087* .131** 
BL Dep Dx -.109** -.044 -.029 -.239** -.109* -.141** .188** .074 .091* 
BL Anx Dx .041 -.027 -.052 -.015 -.021 -.031 -.093* .074 .068 
BL DBD Dx .006 .079 -.004 .118** .076 .090 -.147** -.052 -.106* 
BL ADHD Dx .102* .072 .104* .316** .232** .276** -.157** -.134** -.156** 
BL Oth Dx .027 .009 .020 .066 .085 .049 -.073 -.071 -.065 
BL No Dx .034 -.016 .039 .115** .040 .013 -.172** -.103* -.131** 
m12 Psychotic Dx -.047 -.071 -.118* -.093* -.126** -.130** .158** .165** .230** 
m12 BP Dx -.068 -.091 -.021 -.208** -.155** -.128* .218** .122** .142** 
m12 Dep Dx -.064 -.113* -.074 -.225** -.211** -.212** .118** .191** .132** 
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Table 12 continued 
Continued 
 
 
 
 
 
 
 
  BL_CKINDL m12_CKINDL m24_CKINDL BL_PKINDL m12_PKINDL m24_PKINDL BL CGI m12 CGI m24 CGI 
m12 Anx Dx .000 -.019 .010 .047 .025 .010 -.043 .029 .048 
m12 DBD Dx -.055 .056 .002 .039 .032 .036 -.143** .032 -.019 
m12 ADHD Dx .132** .112* .049 .255** .243** .236** -.101* -.164** -.148** 
m12 Oth Dx .079 .098* .037 .010 .003 -.020 -.008 -.086 -.053 
m12 No Dx .065 .036 .089 .157** .158** .105* -.169** -.348** -.324** 
m24 Psychotic Dx -.038 -.039 -.053 -.050 -.025 -.021 .089 .134** .192** 
m24 BP Dx -.005 -.062 -.058 -.222** -.145** -.151** .214** .146** .190** 
m24 Dep Dx -.053 -.133* -.182** -.170** -.125* -.260** .026 .048 .183** 
m24 Anx Dx -.025 -.046 .006 -.016 -.055 -.017 .019 .130** .155** 
m24 DBD Dx -.043 .060 -.001 .101* -.001 .005 -.101* .007 -.024 
m24 ADHD Dx .045 .073 .098* .244** .232** .245** -.150** -.152** -.173** 
m24 Oth Dx .002 .079 .046 -.043 -.020 -.033 .019 -.014 -.010 
m24 No Dx .096 .086 .139** .119* .122* .197** -.096* -.273** -.464** 
BL School Chall -.054 .072 -.046 -.112** -.023 -.060 .158** .100* .092* 
m12 School Chall .012 .056 .067 -.093* .059 -.013 .256** .235** .184** 
m24 School Chall .034 .090 -.006 -.050 .052 -.034 .241** .209** .281** 
BL School Services -.043 -.026 -.027 -.105* -.033 -.097* .216** .138** .114* 
m12 School Services -.135** -.078 -.060 -.171** -.057 -.073 .142** .276** .204** 
m24 School Services -.001 -.051 -.074 -.106* -.013 -.047 .185** .200** .276** 
BL Inpatient -.081 -.150** -.111* -.092* -.030 -.029 .113** .018 .054 
m12 Inpatient -.066 -.152** -.062 -.099* -.116* -.116* .071 .125** .110* 
m24 Inpatient -.068 -.061 -.126* -.178** -.109* -.140** .070 .075 .140** 
BL Outpatient -.016 .013 .046 .015 .012 .013 .087* .108* .086 
m12 Outpatient .035 -.049 -.038 -.044 -.015 .016 .047 .005 .072 
m24 Outpatient -.045 -.073 -.057 -.151** -.149** -.135** .172** .175** .204** 
BL Inpatient Number -.021 -.158** -.109* -.111** -.100* -.131** .151** .104* .143** 
m12 Inpatient Number -.081 -.147** -.094 -.129** -.147** -.122* .114* .186** .160** 
m24 Inpatient Number -.033 -.103 -.108* -.173** -.120* -.110* .050 .052 .146** 
BL Outpt Professionals -.058 -.108* -.113* -.150** -.174** -.201** .183** .131** .145** 
m12 Outpt Profs -.055 -.068 -.100 -.173** -.079 -.177** .216** .180** .214** 
m24 Outpt Profs -.031 -.107* -.093 -.179** -.140** -.228** .198** .216** .285** 
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Table 12 continued 
  
BL Age m12 Age m24 Age 
BL Non-
Medicaid  
m12 Non-
Medicaid 
m24 Non-
Medicaid 
BL NoMeds BL AnyMed 
BL 
Antipsychotic 
BL Antidep 
BL Age 1          
m12 Age .997** 1         
m24 Age .996** .996** 1        
BL Medicaid (Ins) .050 .079 .061 1       
m12 Medicaid (Ins) .090* .097* .075 .807** 1      
m24 Medicaid (Ins) .000 .015 .013 .777** .824** 1     
BL NoMeds -.004 -.002 .009 -.145** -.160** -.132** 1    
BL AnyMed .004 .002 -.009 .145** .160** .132** -1.000** 1   
BL Antipsychotic .005 -.007 -.031 .143** .155** .157** -.410** .410** 1 
 
BL Antidep .148** .163** .125** .187** .228** .147** -.286** .286** .109** 1 
BL Anxiolytic .060 .066 .026 .005 .031 .041 -.094* .094* .083* -.007 
BL OthMeds .007 -.018 -.055 .040 .034 .029 -.395** .395** .150** .079* 
BL MoodStab .057 .039 .034 .023 .028 .024 -.213** .213** .242** .040 
BL Stim -.033 -.027 -.025 -.001 -.007 -.002 -.593** .593** .019 .016 
m12 NoMeds .067 .068 .087 -.180** -.146** -.143** .477** -.477** -.300** -.137** 
m12 AnyMed -.067 -.068 -.087 .180** .146** .143** -.477** .477** .300** .137** 
m12 MoodStab .006 .000 .002 .084 .072 .076 -.186** .186** .247** -.011 
m12 Antidep .123** .122** .102* .168** .197** .149** -.165** .165** .107* .515** 
m12 Antidep -.004 -.006 -.047 .179** .166** .169** -.236** .236** .648** .052 
m12 Anxio .080 .067 .078 .020 .027 .048 -.073 .073 .103* -.029 
m12 OthMeds -.037 -.032 -.065 .001 -.012 .016 -.215** .215** .063 .076 
m12 Stim -.097* -.096* -.072 .034 .004 .003 -.379** .379** .129** .056 
m24 NoMeds .094* .082 .089 -.106* -.110* -.089 .420** -.420** -.273** -.129** 
m24 AnyMeds -.094* -.082 -.089 .106* .110* .089 -.420** .420** .273** .129** 
m24 MoodStab .069 .074 .065 .027 .008 .023 -.191** .191** .188** -.002 
m24 Antidep .104* .138** .110* .138** .124** .099* -.138** .138** .079 .368** 
m24 Anxio .056 .043 .053 .029 .028 .004 -.051 .051 .094* -.055 
m24 OthMeds -.149** -.135** -.143** -.040 -.003 .018 -.225** .225** .077 .066 
m24 Antipsychotic -.023 -.035 -.020 .139** .144** .134** -.239** .239** .524** .131** 
m24 Stim -.079 -.085 -.080 -.011 -.009 -.001 -.345** .345** .150** .071 
BL PSS_NumStress .052 .047 -.002 .083* .089* .036 -.076 .076 .159** .055 
BL PSS_Tot Stress .079* .050 .021 .010 .014 -.037 -.057 .057 .114** .039 
m12 PSS_Num Stress .044 .044 .067 .066 .060 .062 -.077 .077 .110* .023 
m12 PSS_Tot Stress .042 .041 .070 .050 .027 .011 -.059 .059 .081 .017 
m24 PSS_Num Stress -.021 .009 -.019 .084 .044 .038 -.079 .079 .142** .121* 
m24 PSS_Tot Stress -.006 .029 -.003 .046 -.008 -.024 -.073 .073 .081 .110* 
BL PSLES_Num 
Stress 
.165** .143** .134** -.210** -.213** -.241** .109** -.109** -.065 -.007 
BL PSLES_Tot Stress .190** .158** .158** -.166** -.163** -.193** .110** -.110** -.047 .016 
m12 PSLES_Num 
Stress 
.123** .120** .158** -.149** -.186** -.160** .070 -.070 -.006 -.049 
m12 PSLES_Tot Stress .102* .100* .145** -.113** -.154** -.124* .085 -.085 -.010 -.047 
m24 PSLES_Num 
Stress 
.081 .089 .078 -.169** -.219** -.218** .025 -.025 -.059 .007 
m24 PSLES_To Stress .071 .088 .070 -.134** -.174** -.179** .055 -.055 -.065 .024 
BL CSLES_Num 
Stress 
.165** .157** .168** -.188** -.203** -.191** .045 -.045 -.044 .097* 
BL CSLES_Tot Stress .127** .122** .137** -.166** -.190** -.188** .058 -.058 -.058 .072 
m12 CSLES_Num 
Stress 
.048 .042 .055 -.095* -.165** -.139** .059 -.059 -.066 -.031 
m12 CSLES_Tot 
Stress 
.025 .019 .040 -.094* -.170** -.150** .083 -.083 -.059 -.050 
m24 CSLES_Num 
Stress 
.009 .007 .012 -.142** -.177** -.149** .073 -.073 -.092* -.047 
m24 CSLES_Tot 
Stress 
-.004 .002 -.001 -.169** -.199** -.169** .069 -.069 -.061 -.067 
BL Num Dx -.071 -.085 -.066 -.009 -.053 -.016 -.037 .037 .064 -.007 
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Table 12 continued 
  
BL Age m12 Age m24 Age 
BL Non-
Medicaid 
m12 Non-
Medicaid 
m24 Non-
Medicaid 
BL NoMeds BL AnyMed 
BL 
Antipsychotic 
BL Antidep 
m12 Num Dx -.149** -.152** -.129** -.035 -.054 -.038 -.043 .043 .093* -.064 
m24 Num Dx -.113* -.111* -.118* -.132** -.132** -.126** -.058 .058 .073 .042 
BL PGBI10 Tot -.003 -.050 -.037 -.062 -.007 -.033 -.104** .104** .174** -.027 
BL ESM+ -.023 -.077 -.059 -.049 -.019 -.045 -.122** .122** .126** -.031 
m12 PGBI10 Tot -.102* -.106* -.058 -.105* -.110* -.038 -.002 .002 .102* -.070 
m12 ESM+ -.079 -.083 -.032 -.149** -.136** -.104* .056 -.056 .048 -.066 
m24 PGBI10 Tot -.107* -.125** -.099* -.092 -.071 -.086 -.046 .046 .170** -.010 
m24 ESM+ -.096* -.110* -.089 -.071 -.069 -.079 -.108* .108* .113* -.001 
BL GBI-P Tot -.016 -.034 -.040 -.217** -.214** -.243** .082* -.082* -.063 -.055 
m24 GBI-P Tot .016 .016 .029 -.198** -.181** -.180** .058 -.058 -.059 -.012 
m24 GBI-P Tot -.041 -.021 -.047 -.202** -.208** -.208** .053 -.053 -.091 .042 
BL CGAS .062 .080 .089 .104** .141** .109* .055 -.055 -.110** .011 
m12 CGAS .036 .042 .032 .116** .160** .153** .010 -.010 -.140** .050 
m24 CGAS .093* .102* .099* .198** .207** .207** -.018 .018 -.077 .039 
BLalifeprimary -.056 -.017 -.017 -.002 .020 .074 -.033 .033 -.069 .020 
BLalifesecondary -.120** -.065 -.119* -.028 -.007 -.043 -.017 .017 -.067 -.013 
BLalifepeer .053 .059 .013 .000 -.015 -.007 .087* -.087* -.093* .019 
m12alifeprimary .007 .004 .004 .044 .107* .098* -.030 .030 -.112* .000 
m12alifesecondary -.105* -.109* -.150** -.038 -.025 -.059 .002 -.002 -.065 .018 
m12alifepeer .064 .066 .046 .001 .046 -.007 .080 -.080 -.126** .034 
m24alifeprimary -.070 -.067 -.070 .085 .060 .102* -.007 .007 -.102* -.030 
m24alifesecondary -.096 -.091 -.094 -.048 -.059 -.017 -.001 .001 -.070 -.010 
m24alifepeer .090 .077 .092* .029 .068 .032 .095* -.095* -.138** -.049 
BL Sig Health Prob .017 .027 -.004 .081* .104* .074 -.095* .095* .087* .086* 
m12 Sig Health Prob -.020 -.017 -.021 -.125** -.109* -.145** .041 -.041 .047 -.042 
m24 Sig Health Pob .001 -.007 .007 .029 .012 .001 -.001 .001 -.018 .010 
BL Psychotic Dx -.025 -.003 -.007 -.044 -.053 -.055 -.013 .013 .065 -.024 
BL BP Dx .095* .088* .071 .075* .096* .100* -.121** .121** .251** .047 
BL Dep Dx .154** .107* .111* .020 -.043 -.035 .055 -.055 -.086* .090* 
BL Anx Dx -.090* -.071 -.066 .076* .079 .084 .062 -.062 -.055 .042 
BL DBD Dx -.116** -.129** -.139** -.081* -.084 -.038 .077* -.077* -.106** -.117** 
BL ADHD Dx -.062 -.038 -.012 -.083* -.049 -.103* -.110** .110** -.065 -.048 
BL Oth Dx -.025 -.002 -.021 .098* .074 .113* .024 -.024 .023 -.004 
BL No Dx .072 .103* .118* -.084* -.033 -.077 .090* -.090* -.007 .006 
m12 Psychotic Dx -.034 -.036 -.032 -.055 -.073 -.075 .021 -.021 .065 -.060 
m12 BP Dx .087* .086* .091 .081 .091* .084 -.117** .117** .284** .039 
m12 Dep Dx .046 .042 .017 .029 -.030 -.057 .069 -.069 -.048 .048 
m12 Anx Dx -.040 -.038 -.037 .066 .083 .066 .014 -.014 -.019 .024 
m12 DBD Dx -.051 -.049 -.037 -.107* -.102* -.068 .042 -.042 -.089* -.090* 
m12 ADHD Dx -.056 -.055 -.049 -.036 -.004 .023 -.053 .053 -.174** .006 
m12 Oth Dx -.010 -.010 -.039 .047 .054 .060 -.033 .033 .095* .053 
m12 No Dx .056 .055 .067 -.023 -.044 -.072 .128** -.128** -.099* -.023 
m24 Psychotic Dx -.065 -.049 -.066 -.047 -.105* -.074 -.042 .042 .034 -.005 
m24 BP Dx .065 .071 .071 .065 .105* .050 -.115* .115* .286** .035 
m24 Dep Dx -.017 -.023 -.019 -.023 -.086 -.118* .173** -.173** -.104* -.028 
m24 Anx Dx -.009 -.015 -.012 .072 .085 .096* -.002 .002 -.059 .067 
m24 DBD Dx -.066 -.072 -.064 -.134** -.124** -.087 .029 -.029 -.051 -.059 
m24 ADHD Dx -.015 -.016 -.017 -.029 -.015 .040 -.105* .105* -.114* -.023 
m24 Oth Dx -.025 -.028 -.027 .053 .053 .056 .016 -.016 .058 .062 
Continued 
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Table 12 continued 
 
  
BL Age m12 Age m24 Age 
BL Non-
Medicaid 
m12 Non-
Medicaid 
m24 Non-
Medicaid 
BL NoMeds BL AnyMed 
BL 
Antipsychotic 
BL Antidep 
m24 No Dx .073 .078 .070 .057 .032 .009 .122** -.122** -.096* -.013 
BL School Chall .072 .060 .030 -.111** -.148** -.145** -.061 .061 .069 .002 
m12 School Chall -.055 -.055 -.061 -.127** -.113** -.083 -.071 .071 .047 -.046 
m24 School Chall -.094* -.091 -.097* -.196** -.173** -.178** -.043 .043 .005 .019 
BL School Services .030 .014 .020 -.038 .012 -.042 -.114** .114** .091* .013 
m12 School Services -.047 -.043 -.056 -.077 -.082 -.084 -.067 .067 .102* -.022 
m24 School Services -.145** -.140** -.137** -.158** -.160** -.143** -.053 .053 .126** -.008 
BL Inpatient .091* .044 -.022 .009 -.022 -.075 -.114** .114** .184** .110** 
m12 Inpatient .061 .060 .026 -.043 -.068 -.132** -.066 .066 .175** .001 
m24 Inpatient .099* .065 .107* -.035 -.082 -.057 .066 -.066 -.009 -.037 
BL Outpatient .002 .017 -.007 -.081* -.040 -.034 -.149** .149** .060 .083* 
m12 Outpatient .009 .009 -.002 -.018 .015 .019 -.221** .221** .113** .052 
m24 Outpatient -.073 -.073 -.076 .023 .049 .042 -.206** .206** .148** .094* 
BL Inpatient Number .077* .034 .029 -.058 -.075 -.103* -.105** .105** .235** .035 
m12 Inpatient Number .053 .052 .034 -.049 -.098* -.150** -.054 .054 .150** -.006 
m24 Inpatient Number .115* .104* .117* -.024 -.035 -.093 .012 -.012 .002 .063 
BL Outpt Professionals .094* .096* .081 .082* .074 .083 -.137** .137** .171** .074 
m12 Outpt Profs .017 .020 .007 .036 .017 -.004 -.342** .342** .269** .199** 
m24 Outpt Profs -.085 -.085 -.088 .033 -.036 -.001 -.216** .216** .278** .140** 
Continued 
 
 
 
 
 
 
 
 
 
2
3
8
 
  
 
 
 
Table 12 continued 
  BL Anxiolytic BL OthMeds BL MoodStab BL Stim m12 NoMeds m12 AnyMed m12 MoodStab m12 Antidep m12 Antidep m12 Anxio 
BL Anxiolytic 1          
BL OthMeds .028 1         
BL MoodStab .110** .454** 1        
BL Stim -.093* .104** .015 1       
m12 NoMeds -.023 -.256** -.173** -.269** 1      
m12 AnyMed .023 .256** .173** .269** -1.000** 1     
m12 MoodStab .050 .303** .551** .013 -.199** .199** 1    
m12 Antidep .011 .036 .027 -.020 -.276** .276** .009 1   
m12 Antidep .086* .157** .262** .010 -.414** .414** .256** .088* 1 
 
m12 Anxio .496** -.025 .043 -.032 -.075 .075 .027 -.012 .092* 1 
m12 OthMeds .091* .450** -.005 .118** -.267** .267** .071 .038 .051 .057 
m12 Stim -.102* .116** -.016 .496** -.570** .570** .036 .027 .085 -.059 
m24 NoMeds -.028 -.177** -.119* -.224** .688** -.688** -.146** -.209** -.346** -.088 
m24 AnyMeds .028 .177** .119* .224** -.688** .688** .146** .209** .346** .088 
m24 MoodStab -.040 .249** .436** .055 -.170** .170** .754** -.006 .187** .000 
m24 Antidep -.010 .098* .044 -.055 -.216** .216** .054 .604** .040 -.031 
m24 Anxio .377** -.039 .015 -.025 -.061 .061 .002 .092 .127** .732** 
m24 OthMeds -.003 .383** -.022 .094* -.248** .248** .011 .027 .087 -.025 
m24 Antipsychotic -.032 .131** .198** .040 -.342** .342** .192** .124** .763** .080 
m24 Stim .004 .064 -.007 .418** -.412** .412** .039 .078 .120* .020 
BL PSS_NumStress .031 .107** .145** .009 -.121** .121** .159** .127** .183** .113* 
BL PSS_Tot Stress .016 .085* .090* .010 -.075 .075 .125** .072 .145** .097* 
m12 PSS_Num Stress .084 .067 .136** .013 -.095* .095* .164** .095* .114* .071 
m12 PSS_Tot Stress .065 .056 .103* .014 -.054 .054 .144** .087 .076 .030 
m24 PSS_Num Stress .126** .021 .076 -.034 -.103* .103* .099* .077 .139** .092 
m24 PSS_Tot Stress .108* .028 .074 -.014 -.050 .050 .079 .049 .090 .088 
BL PSLES_Num 
Stress 
.020 -.011 .017 -.053 .070 -.070 .034 .020 -.049 .062 
BL PSLES_Tot Stress .030 .007 .028 -.075 .050 -.050 .059 .040 -.030 .080 
m12 PSLES_Num 
Stress 
-.032 -.039 -.033 .025 .002 -.002 -.004 .007 -.024 .016 
m12 PSLES_Tot Stress -.015 -.034 -.025 .004 .013 -.013 -.013 .020 -.024 .051 
m24 PSLES_Num 
Stress 
.040 .054 .077 -.005 -.003 .003 .046 -.016 -.058 .065 
m24 PSLES_To Stress .032 .037 .054 -.028 .015 -.015 .031 -.019 -.051 .077 
BL CSLES_Num 
Stress 
-.026 .014 -.008 -.011 .063 -.063 -.048 .020 -.047 .024 
BL CSLES_Tot Stress -.021 .025 -.001 -.011 .045 -.045 -.051 .040 -.041 .035 
m12 CSLES_Num 
Stress 
-.043 .046 .014 .045 .015 -.015 -.041 -.028 -.148** -.070 
m12 CSLES_Tot 
Stress 
-.035 .041 .019 .039 .017 -.017 -.035 -.043 -.121** -.065 
m24 CSLES_Num 
Stress 
-.029 -.010 -.022 .038 .065 -.065 .013 -.038 -.100* -.024 
m24 CSLES_Tot 
Stress 
-.078 .023 .009 .035 .054 -.054 .030 -.048 -.068 -.061 
BL Num Dx .011 .126** .062 .002 -.118** .118** .104* .080 .120** .078 
m12 Num Dx .061 .112* .074 .114** -.154** .154** .015 .033 .117** .083 
m24 Num Dx .084 .130** .108* .049 -.176** .176** .067 .122* .157** .109* 
BL PGBI10 Tot .087* .099* .103** .030 -.148** .148** .122** -.033 .223** .020 
BL ESM+ .050 .085* .104** .054 -.110* .110* .141** -.028 .155** -.003 
m12 PGBI10 Tot .122** .010 .039 -.001 -.065 .065 .089* -.038 .140** .081 
m12 ESM+ .118** -.009 .028 -.030 .002 -.002 .062 -.015 .075 .042 
m24 PGBI10 Tot .073 .049 .114* -.017 -.183** .183** .142** .020 .289** .078 
m24 ESM+ .061 .056 .101* .022 -.122* .122* .093 -.019 .161** .025 
BL GBI-P Tot -.033 .013 -.016 -.055 .102* -.102* .025 -.001 -.099* -.005 
m24 GBI-P Tot .039 -.014 -.050 -.009 .074 -.074 -.031 .034 -.116* -.005 
m24 GBI-P Tot .050 .031 .031 -.007 .063 -.063 .008 .060 -.053 .048 
BL CGAS -.066 -.162** -.143** .012 .114** -.114** -.130** -.059 -.132** -.044 
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Table 12 continued 
 
  BL Anxiolytic BL OthMeds BL MoodStab BL Stim m12 NoMeds m12 AnyMed m12 MoodStab m12 Antidep m12 Antidep m12 Anxio 
m12 CGAS -.113** -.105* -.171** -.006 .114** -.114** -.135** -.015 -.168** -.060 
m24 CGAS -.055 -.151** -.164** .030 .160** -.160** -.163** -.063 -.184** -.054 
BLalifeprimary .022 -.036 -.049 .035 .056 -.056 -.079 .015 -.141** .013 
BLalifesecondary .020 -.006 -.029 .016 .059 -.059 .032 -.049 -.127** -.014 
BLalifepeer -.010 -.140** -.082* -.014 .157** -.157** -.178** -.080 -.116** -.050 
m12alifeprimary .084 .021 .001 .068 .030 -.030 -.039 -.002 -.068 .070 
m12alifesecondary .023 .027 .019 -.009 -.008 .008 .034 .010 -.038 .039 
m12alifepeer -.024 -.027 -.068 -.046 .096* -.096* -.129** -.070 -.103* -.053 
m24alifeprimary .033 -.053 -.090 .037 .068 -.068 -.073 -.049 -.158** .022 
m24alifesecondary .052 -.040 -.084 -.038 .044 -.044 -.041 -.009 -.145** .086 
m24alifepeer -.086 -.100* -.076 -.016 .132** -.132** -.096* -.088 -.173** -.065 
BL Sig Health Prob .074 .060 .093* .057 -.137** .137** .056 .085 .130** .082 
m12 Sig Health Prob .049 .012 .046 -.057 -.025 .025 .043 .030 .076 -.012 
m24 Sig Health Pob .068 .051 .062 -.046 -.030 .030 .002 -.009 -.004 .081 
BL Psychotic Dx -.018 .047 -.002 -.053 .040 -.040 .050 .011 -.004 -.023 
BL BP Dx .075 .106** .209** -.023 -.121** .121** .282** .002 .319** .043 
BL Dep Dx -.056 .022 -.006 -.058 .001 -.001 -.053 .135** -.060 -.040 
BL Anx Dx -.015 -.043 -.079* -.054 -.005 .005 -.132** .135** -.042 .034 
BL DBD Dx -.038 -.056 -.069 .026 .057 -.057 -.052 -.123** -.082 -.033 
BL ADHD Dx .020 -.022 -.079* .188** -.024 .024 -.085 -.109* -.141** .027 
BL Oth Dx .056 -.038 -.009 -.031 .085 -.085 -.013 -.043 -.036 -.027 
BL No Dx -.018 -.052 -.002 -.094* .123** -.123** -.052 -.007 -.055 -.026 
m12 Psychotic Dx -.021 .049 .054 -.015 .021 -.021 .124** -.035 .061 -.025 
m12 BP Dx .140** .121** .263** -.027 -.127** .127** .267** .022 .357** .064 
m12 Dep Dx -.048 -.053 -.028 -.094* -.003 .003 -.049 .139** -.062 .058 
m12 Anx Dx -.010 -.033 -.085 .037 -.074 .074 -.103* .107* -.044 .081 
m12 DBD Dx -.072 -.041 -.075 .057 .065 -.065 -.072 -.096* -.138** -.086 
m12 ADHD Dx -.034 .023 -.104* .065 -.010 .010 -.096* -.071 -.171** -.052 
m12 Oth Dx .072 -.046 .005 -.015 .050 -.050 -.050 -.001 .088* -.025 
m12 No Dx -.034 -.084 -.070 -.059 .201** -.201** -.052 -.068 -.079 -.041 
m24 Psychotic Dx -.016 .120** .021 -.014 -.047 .047 .071 .028 .054 -.020 
m24 BP Dx .052 .113* .238** -.001 -.157** .157** .256** .032 .389** .050 
m24 Dep Dx -.036 -.108* -.089 -.114* .104* -.104* -.050 .002 -.079 -.046 
m24 Anx Dx .017 -.007 -.051 .013 -.044 .044 -.098* .127** -.102* .094 
m24 DBD Dx -.054 -.039 -.069 .023 .028 -.028 -.047 -.096* -.074 -.067 
m24 ADHD Dx .045 .018 -.047 .142** -.002 .002 -.100* -.052 -.192** .011 
m24 Oth Dx -.014 -.020 .033 -.061 .002 -.002 -.042 -.010 .070 -.019 
m24 No Dx -.038 -.081 -.093* -.083 .172** -.172** -.056 -.009 -.109* -.048 
BL School Chall .089* .121** .096* .043 -.070 .070 .044 .012 .105* .013 
m12 School Chall .103* .118** .099* .071 -.077 .077 .105* -.009 .076 .078 
m24 School Chall .047 .125** .026 .026 -.064 .064 .078 -.027 .039 .061 
BL School Services .071 .109** .065 .080* -.087* .087* .073 -.032 .056 .045 
m12 School Services .075 .080 .085 .041 -.072 .072 .058 .061 .141** .069 
m24 School Services .051 .027 .019 .023 -.131** .131** .082 .026 .165** .095* 
BL Inpatient .088* .110** .183** .031 -.097* .097* .171** .066 .176** .074 
m12 Inpatient .020 .113* .159** -.010 -.117* .117* .297** .061 .169** .006 
m24 Inpatient .051 .036 .004 -.088 -.058 .058 .068 -.030 .153** .180** 
BL Outpatient .055 .085* .093* .031 -.085 .085 .079 .030 .014 .075 
m12 Outpatient -.039 .085* .059 .159** -.340** .340** .071 .100* .149** .036 
m24 Outpatient .036 .140** .085 .082 -.460** .460** .105* .143** .215** .049 
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Table 12 continued 
 
  BL Anxiolytic BL OthMeds BL MoodStab BL Stim m12 NoMeds m12 AnyMed m12 MoodStab m12 Antidep m12 Antidep m12 Anxio 
BL Inpatient Number .029 .126** .174** -.035 -.101* .101* .247** -.007 .192** .029 
m12 Inpatient Number .086 .127** .214** -.011 -.117* .117* .348** .059 .193** .064 
m24 Inpatient Number .014 -.014 .033 -.083 .038 -.038 .036 -.043 .061 .037 
BL Outpt Professionals .049 .085* .126** .014 -.174** .174** .148** .038 .218** .065 
m12 Outpt Profs .037 .190** .147** .134** -.462** .462** .224** .223** .282** .105* 
m24 Outpt Profs 
 
.034 .163** .184** .022 -.393** .393** .216** .193** .319** .086 
 
m12 OthMeds m12 Stim m24 NoMeds m24 AnyMeds 
m24 
MoodStab 
m24 Antidep m24 Anxio m24 OthMeds 
m24 
Antipsychotic 
m24 Stim 
m12 OthMeds 1          
m12 Stim .125** 1         
m24 NoMeds -.207** -.447** 1        
m24 AnyMeds .207** .447** -1.000** 1       
m24 MoodStab .068 .051 -.215** .215** 1      
m24 Antidep .103* .035 -.312** .312** .085 1     
m24 Anxio .017 -.052 -.092* .092* -.003 -.037 1    
m24 OthMeds .705** .143** -.289** .289** .020 .046 -.030 1   
m24 Antipsychotic .098* .085 -.402** .402** .246** .131** .099* .055 1 
 
m24 Stim .079 .714** -.601** .601** .039 .027 -.025 .121** .115* 1 
BL PSS_NumStress .044 -.023 -.077 .077 .115* .066 .082 .060 .210** -.055 
BL PSS_Tot Stress .022 -.056 -.060 .060 .124** .057 .082 .036 .195** -.074 
m12 PSS_Num Stress .027 -.031 -.048 .048 .153** .111* .063 .018 .148** -.013 
m12 PSS_Tot Stress .029 -.030 -.059 .059 .155** .129** .054 -.012 .151** -.052 
m24 PSS_Num Stress .034 .013 -.098* .098* .098* .091 .089 .024 .166** -.030 
m24 PSS_Tot Stress .007 -.026 -.067 .067 .083 .090 .091 -.001 .162** -.066 
BL PSLES_Num 
Stress 
.023 -.068 .106* -.106* .085 -.002 .064 -.056 .000 -.097* 
BL PSLES_Tot Stress .027 -.080 .090 -.090 .106* .034 .088 -.061 .021 -.106* 
m12 PSLES_Num 
Stress 
-.032 .015 -.019 .019 .078 .040 .044 -.046 .046 .027 
m12 PSLES_Tot 
Stress 
-.033 -.012 -.018 .018 .069 .053 .101* -.064 .063 .008 
m24 PSLES_Num 
Stress 
.050 -.022 .024 -.024 .074 .072 .073 -.023 .005 -.085 
m24 PSLES_To Stress .051 -.060 .011 -.011 .063 .093* .078 -.031 .026 -.111* 
BL CSLES_Num 
Stress 
.045 .023 .051 -.051 .001 -.002 .041 -.012 .032 -.036 
BL CSLES_Tot Stress .054 .034 .057 -.057 -.002 .006 .067 .008 .027 -.025 
m12 CSLES_Num 
Stress 
.036 .056 -.007 .007 -.030 -.015 -.100* .022 -.063 -.012 
m12 CSLES_Tot 
Stress 
.010 .043 -.016 .016 -.022 .007 -.095 .010 -.042 -.026 
m24 CSLES_Num 
Stress 
.074 -.002 .061 -.061 -.005 -.003 -.006 -.005 -.026 -.034 
m24 CSLES_Tot 
Stress 
.071 -.006 .042 -.042 -.007 -.010 -.040 .011 -.011 -.035 
BL Num Dx .112* .084 -.117* .117* .106* .053 .096* .079 .147** .052 
m12 Num Dx .118** .157** -.143** .143** .071 .014 .130** .110* .181** .076 
m24 Num Dx .121* .115* -.146** .146** .085 .049 .119** .130** .160** .060 
BL PGBI10 Tot .094* .046 -.133** .133** .092 -.002 .004 .073 .218** .089 
BL ESM+ .077 .045 -.150** .150** .130** -.010 .005 .087 .152** .069 
m12 PGBI10 Tot -.020 .030 -.108* .108* .027 -.033 .068 -.012 .149** .099* 
m12 ESM+ -.054 .009 -.028 .028 -.001 -.027 .029 -.012 .064 .060 
m24 PGBI10 Tot -.011 .094 -.161** .161** .039 .108* .053 .007 .213** .078 
m24 ESM+ .018 .104* -.112* .112* .032 .073 .012 .026 .141** .086 
BL GBI-P Tot -.032 -.041 .076 -.076 .043 .012 -.011 -.014 -.067 -.028 
m24 GBI-P Tot -.042 -.049 .043 -.043 -.019 .009 -.024 .002 -.053 -.035 
m24 GBI-P Tot -.018 -.094 .080 -.080 -.038 .049 .038 -.010 -.077 -.092 
BL CGAS -.084 -.080 .108* -.108* -.133** -.041 -.055 -.065 -.153** -.046 
m12 CGAS -.087* -.068 .098* -.098* -.153** -.012 -.112* -.014 -.201** -.033 
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Table 12 continued 
 
  
m12 OthMeds m12 Stim m24 NoMeds m24 AnyMeds 
m24 
MoodStab 
m24 Antidep m24 Anxio m24 OthMeds 
m24 
Antipsychotic 
m24 Stim 
m24 CGAS -.096* -.055 .099* -.099* -.126** -.043 -.086 -.110* -.175** .021 
BLalifeprimary -.040 -.001 .083 -.083 -.060 -.039 .073 -.023 -.194** -.018 
BLalifesecondary .020 .027 .101 -.101 -.024 .030 .037 -.048 -.119* -.054 
BLalifepeer -.038 -.141** .090 -.090 -.168** -.091 -.122** -.044 -.064 -.076 
m12alifeprimary -.020 .028 .047 -.047 -.035 -.045 .056 .002 -.156** .059 
m12alifesecondary -.035 .000 -.017 .017 .004 -.027 .060 -.010 -.060 -.024 
m12alifepeer .020 -.006 .086 -.086 -.107* -.031 -.129** .003 -.147** -.041 
m24alifeprimary .001 -.006 .077 -.077 -.061 -.108* .059 .025 -.158** .015 
m24alifesecondary -.069 -.039 -.018 .018 -.039 .007 .108* .005 -.145** -.020 
m24alifepeer -.037 -.019 .107* -.107* -.065 -.069 -.082 -.088 -.133** -.013 
BL Sig Health Prob .074 .035 -.113* .113* .029 .058 .092* .080 .126** .023 
m12 Sig Health Prob -.002 -.057 .050 -.050 -.021 -.001 .055 -.015 .055 -.075 
m24 Sig Health Pob .024 .018 .017 -.017 .050 .076 .074 .001 .056 -.060 
BL Psychotic Dx .015 -.018 .073 -.073 .044 -.037 -.022 .009 .001 -.025 
BL BP Dx -.020 -.053 -.142** .142** .167** .011 .022 -.034 .315** .018 
BL Dep Dx .050 .000 .037 -.037 -.003 .097* .015 .023 -.082 -.102* 
BL Anx Dx .000 .034 .001 -.001 -.084 .141** .107* .015 -.015 -.047 
BL DBD Dx -.025 -.048 .058 -.058 -.052 -.128** -.079 -.007 -.076 .058 
BL ADHD Dx .029 .162** -.060 .060 -.062 -.039 -.027 .047 -.152** .129** 
BL Oth Dx -.040 -.036 .052 -.052 .002 -.070 -.021 -.024 -.057 -.011 
BL No Dx -.036 -.124** .171** -.171** -.012 -.048 -.024 -.076 -.016 -.130** 
m12 Psychotic Dx -.032 .011 .067 -.067 .083 -.043 -.025 .002 .021 -.040 
m12 BP Dx .026 -.037 -.189** .189** .216** .018 .051 .047 .343** .048 
m12 Dep Dx -.067 -.075 .031 -.031 .000 .079 .048 -.060 -.044 -.150** 
m12 Anx Dx .104* .091* -.104* .104* -.089 .147** .128** .080 -.006 .025 
m12 DBD Dx -.009 -.010 .137** -.137** -.060 -.061 -.081 -.038 -.100* -.014 
m12 ADHD Dx .045 .107* -.013 .013 -.101* -.084 -.076 .059 -.200** .113* 
m12 Oth Dx -.067 -.015 .045 -.045 -.005 -.037 -.024 -.072 .032 .004 
m12 No Dx -.086 -.131** .161** -.161** -.056 -.048 -.038 -.090 -.077 -.082 
m24 Psychotic Dx .081 .008 -.018 .018 .052 .007 -.021 .057 .080 -.011 
m24 BP Dx .002 .043 -.135** .135** .190** .054 .035 .010 .360** .049 
m24 Dep Dx -.117* -.077 .083 -.083 -.014 .006 -.047 -.051 -.093* -.131** 
m24 Anx Dx .069 .029 -.064 .064 -.041 .098* .130** .056 -.091* -.008 
m24 DBD Dx .035 -.028 .038 -.038 -.039 -.115* .006 .025 -.066 -.029 
m24 ADHD Dx .013 .117* -.021 .021 -.074 -.029 -.070 .027 -.172** .132** 
m24 Oth Dx -.056 -.011 .002 -.002 -.043 -.018 -.018 -.057 -.003 .022 
m24 No Dx -.039 -.142** .179** -.179** -.091* -.005 -.049 -.097* -.088 -.076 
BL School Chall .050 .070 -.073 .073 .027 -.020 .053 .054 .058 .149** 
m12 School Chall .086* .092* -.007 .007 .074 -.083 .052 .037 .038 .129** 
m24 School Chall .062 .078 -.052 .052 .037 -.014 .075 .015 .018 .030 
BL School Services .025 .128** -.012 .012 .038 -.079 .052 -.017 .001 .120** 
m12 School Services .032 .100* -.060 .060 .046 .045 .087 .007 .102* .090 
m24 School Services .039 .187** -.101* .101* .018 .038 .117* .062 .125** .130** 
BL Inpatient -.024 .043 -.044 .044 .118* .016 -.029 -.060 .125** .018 
m12 Inpatient .075 -.027 -.086 .086 .216** .124* .097* -.048 .193** -.018 
m24 Inpatient -.023 .002 -.067 .067 .164** .185** .099* -.042 .239** -.014 
BL Outpatient .047 .039 -.078 .078 .032 .063 -.048 .082 .040 .053 
m12 Outpatient .071 .205** -.251** .251** .074 .081 .032 .071 .117* .208** 
m24 Outpatient .138** .272** -.500** .500** .113* .164** .048 .151** .210** .286** 
BL Inpatient Number .081 .015 -.080 .080 .202** .054 .001 .031 .211** .006 
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Table 12 continued 
 
  
m12 OthMeds m12 Stim m24 NoMeds m24 AnyMeds 
m24 
MoodStab 
m24 Antidep m24 Anxio m24 OthMeds 
m24 
Antipsychotic 
m24 Stim 
m12 Inpatient Number .054 -.021 -.094 .094 .244** .130** .068 -.059 .216** .017 
m24 Inpatient Number -.028 -.013 -.083 .083 .232** .165** .032 -.056 .210** -.033 
BL Outpt Professionals .043 .070 -.165** .165** .128** .028 .059 .026 .224** .041 
m12 Outpt Profs .197** .233** -.401** .401** .211** .228** .148** .155** .312** .213** 
m24 Outpt Profs .108* .240** -.470** .470** .220** .251** .158** .112* .329** .241** 
  BL 
PSS_NumStres
s 
BL PSS_Tot 
Stress 
m12 
PSS_Num 
Stress 
m12 PSS_Tot 
Stress 
m24 
PSS_Num 
Stress 
m24 PSS_Tot 
Stress 
BL 
PSLES_Num 
Stress 
BL 
PSLES_Tot 
Stress 
m12 
PSLES_Num 
Stress 
m12 
PSLES_Tot 
Stress 
BL PSS_NumStress 1          
BL PSS_Tot Stress .874** 1         
m12 PSS_Num Stress .553** .523** 1        
m12 PSS_Tot Stress .513** .559** .928** 1       
m24 PSS_Num Stress .552** .548** .574** .559** 1      
m24 PSS_Tot Stress .529** .583** .519** .584** .943** 1     
BL PSLES_Num 
Stress 
.349** .386** .300** .291** .296** .291** 1    
BL PSLES_Tot Stress .365** .426** .317** .320** .314** .330** .942** 1   
m12 PSLES_Num 
Stress 
.284** .321** .454** .457** .362** .366** .489** .484** 1 
 
m12 PSLES_Tot Stress .289** .345** .473** .508** .352** .389** .438** .470** .949** 1 
m24 PSLES_Num 
Stress 
.326** .343** .374** .372** .449** .478** .489** .477** .591** .560** 
m24 PSLES_To Stress .326** .364** .384** .400** .471** .520** .426** .452** .568** .586** 
BL CSLES_Num 
Stress 
.120** .134** .099* .146** .100* .154** .314** .321** .215** .204** 
BL CSLES_Tot Stress .108** .133** .120** .162** .113* .141** .298** .318** .221** .220** 
m12 CSLES_Num 
Stress 
.047 .086 .081 .133** .142** .162** .179** .156** .327** .317** 
m12 CSLES_Tot 
Stress 
.026 .063 .083 .130** .117* .136** .121** .110* .320** .328** 
m24 CSLES_Num 
Stress 
.053 .082 -.002 .045 .065 .122* .201** .169** .240** .228** 
m24 CSLES_Tot 
Stress 
.067 .100* .019 .047 .090 .138** .183** .167** .243** .232** 
BL Num Dx .237** .269** .194** .239** .129** .186** .117** .163** .109* .138** 
m12 Num Dx .194** .176** .237** .249** .223** .251** .094* .101* .141** .176** 
m24 Num Dx .126** .109* .144** .155** .230** .275** .086 .106* .103* .123* 
BL PGBI10 Tot .272** .328** .250** .270** .140** .169** .238** .284** .181** .196** 
BL ESM+ .242** .287** .206** .232** .131** .152** .208** .240** .177** .184** 
m12 PGBI10 Tot .206** .256** .349** .395** .268** .322** .168** .204** .321** .376** 
m12 ESM+ .151** .189** .244** .282** .213** .261** .138** .160** .306** .342** 
m24 PGBI10 Tot .241** .255** .225** .241** .342** .352** .234** .275** .222** .229** 
m24 ESM+ .193** .203** .151** .189** .301** .318** .183** .218** .128** .137** 
BL GBI-P Tot .343** .466** .288** .357** .297** .365** .318** .353** .305** .341** 
m24 GBI-P Tot .250** .324** .397** .482** .360** .400** .263** .255** .379** .413** 
m24 GBI-P Tot .272** .387** .277** .343** .456** .524** .314** .332** .302** .332** 
BL CGAS -.240** -.253** -.174** -.177** -.167** -.199** -.193** -.209** -.180** -.188** 
m12 CGAS -.179** -.196** -.261** -.287** -.272** -.275** -.219** -.212** -.240** -.253** 
m24 CGAS -.201** -.202** -.251** -.280** -.346** -.364** -.195** -.211** -.243** -.251** 
BLalifeprimary -.274** -.275** -.169** -.199** -.233** -.258** -.167** -.166** -.164** -.185** 
BLalifesecondary -.201** -.209** -.186** -.197** -.101 -.124* -.111** -.152** -.121* -.157** 
BLalifepeer -.131** -.123** -.136** -.127** -.044 -.075 -.106** -.122** -.103* -.110* 
m12alifeprimary -.100* -.145** -.217** -.233** -.152** -.171** -.123** -.130** -.216** -.240** 
m12alifesecondary -.064 -.092 -.206** -.178** -.103 -.097 -.135** -.127* -.127* -.153** 
m12alifepeer -.146** -.129** -.208** -.189** -.086 -.091 -.103* -.108* -.122** -.141** 
m24alifeprimary -.142** -.175** -.179** -.246** -.240** -.307** -.131** -.141** -.221** -.215** 
m24alifesecondary -.117* -.143** -.168** -.191** -.194** -.205** -.158** -.157** -.088 -.080 
m24alifepeer -.153** -.143** -.209** -.222** -.269** -.265** -.133** -.136** -.175** -.184** 
BL Sig Health Prob .111** .117** .130** .104* .122* .089 .066 .058 .073 .065 
m12 Sig Health Prob .132** .093* .102* .091* .017 .045 .149** .145** .185** .171** 
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Table 12 continued 
 
  BL 
PSS_NumStres
s 
BL PSS_Tot 
Stress 
m12 
PSS_Num 
Stress 
m12 PSS_Tot 
Stress 
m24 
PSS_Num 
Stress 
m24 PSS_Tot 
Stress 
BL 
PSLES_Num 
Stress 
BL 
PSLES_Tot 
Stress 
m12 
PSLES_Num 
Stress 
m12 
PSLES_Tot 
Stress 
m24 Sig Health Pob .068 .032 .042 .034 .081 .085 .022 .019 .070 .104* 
BL Psychotic Dx .063 .070 .011 .023 -.017 .017 .021 .027 -.026 -.009 
BL BP Dx .199** .215** .168** .183** .177** .181** .066 .091* .065 .084 
BL Dep Dx .108** .131** .056 .060 .032 .041 .128** .147** .079 .099* 
BL Anx Dx -.041 -.065 .002 -.006 -.044 -.056 -.034 .005 .007 .019 
BL DBD Dx -.059 -.092* -.035 -.059 -.028 -.033 .002 -.040 .012 -.026 
BL ADHD Dx -.189** -.171** -.143** -.137** -.075 -.092 -.148** -.184** -.118** -.118** 
BL Oth Dx -.114** -.125** -.121** -.110* -.063 -.074 -.080* -.086* -.047 -.067 
BL No Dx -.080* -.074 -.055 -.070 -.133** -.109* -.021 -.032 -.067 -.085 
m12 Psychotic Dx .107* .120** .049 .067 .088 .131** .096* .103* .061 .079 
m12 BP Dx .233** .216** .159** .151** .183** .147** .070 .085 .073 .089* 
m12 Dep Dx .101* .148** .079 .108* .051 .094 .069 .089* .054 .082 
m12 Anx Dx .013 -.030 .057 .060 -.020 -.024 -.005 .028 -.005 .012 
m12 DBD Dx -.057 -.091* -.015 -.043 .006 .001 -.006 -.033 .032 -.001 
m12 ADHD Dx -.212** -.180** -.175** -.164** -.164** -.162** -.125** -.153** -.095* -.106* 
m12 Oth Dx -.071 -.061 -.062 -.056 -.008 -.012 -.066 -.074 -.024 -.047 
m12 No Dx -.154** -.130** -.146** -.158** -.167** -.157** -.013 -.014 -.102* -.113* 
m24 Psychotic Dx .107* .129** .057 .086 .052 .051 .059 .054 .031 .033 
m24 BP Dx .247** .234** .143** .145** .220** .206** .087 .103* .095* .103* 
m24 Dep Dx .044 .062 .039 .099* .054 .104* .120* .140** .084 .115* 
m24 Anx Dx -.035 -.038 .038 .011 -.013 -.019 -.050 -.026 -.013 .000 
m24 DBD Dx -.076 -.090 .023 -.010 .012 .009 -.004 -.026 -.032 -.068 
m24 ADHD Dx -.168** -.164** -.172** -.160** -.169** -.163** -.139** -.165** -.073 -.060 
m24 Oth Dx .004 .029 -.026 -.004 -.022 -.024 .015 .010 .018 .003 
m24 No Dx -.124** -.131** -.114* -.146** -.190** -.210** -.042 -.045 -.096* -.117* 
BL School Chall .111** .130** .066 .036 .094* .085 .153** .159** .083 .070 
m12 School Chall .086 .083 .101* .077 .048 .042 .067 .095* .008 -.001 
m24 School Chall -.010 .035 .055 .082 .126** .129** .034 .045 .040 .055 
BL School Services .064 .042 .070 .038 .000 .007 .105** .107** .021 .034 
m12 School Services .052 .062 .055 .059 .056 .042 .108* .097* .046 .041 
m24 School Services .092 .099* .050 .050 .182** .159** .108* .126** .035 .045 
BL Inpatient .141** .130** .033 .040 .039 .066 .094* .104** .012 .003 
m12 Inpatient .104* .063 .044 .050 -.058 -.012 .090 .069 .070 .053 
m24 Inpatient .111* .105* .050 .099 .170** .209** .149** .148** .138** .132** 
BL Outpatient .026 .017 .063 .039 .060 .056 .074 .080* .009 .006 
m12 Outpatient .006 -.040 .033 -.001 .006 -.017 -.018 -.014 -.017 -.042 
m24 Outpatient .187** .165** .137** .129** .209** .134** .056 .073 .143** .155** 
BL Inpatient Number .126** .122** -.011 .007 -.005 .063 .057 .065 -.017 -.015 
m12 Inpatient Number .098* .059 .036 .053 -.056 .009 .101* .070 .057 .047 
m24 Inpatient Number .061 .074 .052 .086 .149** .195** .127** .139** .146** .129** 
BL Outpt Professionals .116** .145** .069 .044 .078 .085 .031 .072 .007 .026 
m12 Outpt Profs .152** .112* .224** .186** .212** .175** .074 .100* .102* .091* 
m24 Outpt Profs .210** .178** .225** .233** .291** .265** .050 .075 .132** .160** 
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Table 12 continued 
  m24 
PSLES_Num 
Stress 
m24 
PSLES_To 
Stress 
BL 
KSLES_Nu
m Stress 
BL 
KSLES_Tot 
Stress 
m12 
KSLES_Nu
m Stress 
m12 
CSLES_Tot 
Stress 
m24 
CSLES_Num 
Stress 
m24 
CSLES_Tot 
Stress 
BL Num Dx m12 Num Dx m24 Num Dx 
m24 PSLES_Num 
Stress 
1           
m24 PSLES_To Stress .947** 1          
BL CSLES_Num 
Stress 
.241** .220** 1         
BL CSLES_Tot Stress .254** .244** .929** 1        
m12 CSLES_Num 
Stress 
.246** .248** .287** .301** 1       
m12 CSLES_Tot 
Stress 
.212** .230** .305** .334** .949** 1      
m24 CSLES_Num 
Stress 
.273** .264** .203** .240** .440** .441** 1     
m24 CSLES_Tot 
Stress 
.300** .313** .248** .285** .429** .465** .934** 1    
BL Num Dx .133** .161** .083* .131** .072 .089* -.047 -.028 1   
m12 Num Dx .171** .184** .046 .097* .113* .131** -.004 -.012 .587** 1 
 
m24 Num Dx .210** .224** .093* .139** .117* .131** .079 .070 .522** .689** 1 
BL PGBI10 Tot .162** .178** .079* .089* .038 .041 .005 .036 .222** .166** .097* 
BL ESM+ .139** .148** .061 .073 .017 .013 .031 .048 .180** .130** .097* 
m12 PGBI10 Tot .270** .292** .149** .151** .124** .129** .072 .084 .195** .291** .226** 
m12 ESM+ .251** .259** .162** .164** .140** .151** .096 .112* .129** .230** .174** 
m24 PGBI10 Tot .311** .316** .103* .114* .084 .066 .088 .082 .186** .266** .344** 
m24 ESM+ .238** .227** .135** .127** .075 .044 .058 .050 .145** .234** .287** 
BL GBI-P Tot .328** .334** .159** .176** .094* .079 .138** .152** .177** .176** .146** 
m24 GBI-P Tot .337** .352** .179** .195** .180** .200** .104* .144** .145** .186** .150** 
m24 GBI-P Tot .408** .411** .116* .147** .164** .128* .128** .143** .158** .204** .208** 
BL CGAS -.201** -.200** -.140** -.184** -.109* -.113* -.004 -.013 -.521** -.441** -.401** 
m12 CGAS -.264** -.267** -.171** -.212** -.178** -.208** -.115* -.120* -.375** -.639** -.513** 
m24 CGAS -.314** -.340** -.111* -.155** -.172** -.191** -.112* -.140** -.415** -.514** -.664** 
BLalifeprimary -.142** -.150** -.060 -.057 -.112* -.131** -.085 -.081 -.166** -.168** -.161** 
BLalifesecondary -.112* -.146** -.079 -.073 -.089 -.090 -.033 -.051 -.159** -.133** -.140** 
BLalifepeer -.108* -.105* -.012 -.055 .018 -.003 -.078 -.086 -.285** -.271** -.257** 
m12alifeprimary -.177** -.187** -.130** -.114** -.160** -.176** -.140** -.184** -.080 -.225** -.170** 
m12alifesecondary -.096 -.116* -.047 -.062 -.168** -.169** -.146** -.158** -.054 -.172** -.122* 
m12alifepeer -.029 -.039 -.075 -.089* -.101* -.088 .006 -.023 -.151** -.298** -.254** 
m24alifeprimary -.222** -.252** -.156** -.145** -.207** -.215** -.139** -.156** -.178** -.245** -.249** 
m24alifesecondary -.164** -.204** -.124* -.141** -.124* -.082 -.108* -.119* -.097 -.153** -.182** 
m24alifepeer -.211** -.255** -.057 -.075 -.167** -.177** -.043 -.068 -.274** -.338** -.397** 
BL Sig Health Prob .122** .116* -.018 -.004 -.034 -.044 -.003 -.010 .074 .088* .081 
m12 Sig Health Prob .143** .137** -.036 -.006 .029 .012 .024 .043 .019 .078 .096* 
m24 Sig Health Pob .160** .180** .074 .084 .110* .101* .179** .160** .008 .032 .045 
BL Psychotic Dx -.032 -.008 .002 .026 .043 .061 .017 .019 .116** .082 .065 
BL BP Dx .118* .130** -.028 -.035 -.017 -.013 -.021 .009 .167** .090* .061 
BL Dep Dx .085 .091* .095* .109** .013 .018 -.028 -.022 .296** .099* .088 
BL Anx Dx -.022 -.008 -.019 .008 -.037 -.015 -.057 -.033 .172** .144** .119** 
BL DBD Dx -.053 -.062 .006 .007 .079 .055 .077 .034 -.140** -.071 -.047 
BL ADHD Dx -.085 -.108* -.069 -.082* -.044 -.047 .004 -.006 -.382** -.173** -.145** 
BL Oth Dx -.024 -.041 -.029 -.045 -.024 -.025 .015 .025 -.157** -.139** -.069 
BL No Dx -.073 -.078 .059 .001 -.024 -.035 .009 -.013 -.295** -.143** -.170** 
m12 Psychotic Dx .108* .137** -.067 -.054 .153** .132** .136** .096 .113** .217** .164** 
m12 BP Dx .047 .050 .026 .033 -.017 -.001 -.068 -.066 .146** .125** .044 
m12 Dep Dx .077 .087 .096* .119** .010 .031 -.072 -.060 .177** .225** .159** 
m12 Anx Dx .006 .017 -.027 -.014 -.070 -.044 -.083 -.043 .124** .198** .142** 
m12 DBD Dx .009 .000 -.006 -.027 .059 .043 .129** .109* -.062 .018 .025 
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Table 12 continued 
 
  m24 
PSLES_Num 
Stress 
m24 
PSLES_To 
Stress 
BL 
KSLES_Nu
m Stress 
BL 
KSLES_Tot 
Stress 
m12 
KSLES_Nu
m Stress 
m12 
CSLES_Tot 
Stress 
m24 
CSLES_Num 
Stress 
m24 
CSLES_Tot 
Stress 
BL Num Dx m12 Num Dx m24 Num Dx 
m12 ADHD Dx -.112* -.129** -.102* -.103* -.010 -.025 .011 -.001 -.232** -.300** -.206** 
m12 Oth Dx -.005 -.014 .064 .025 -.045 -.041 -.001 .045 -.067 -.128** -.033 
m12 No Dx -.090 -.092 .046 .037 -.026 -.053 .017 -.002 -.207** -.392** -.268** 
m24 Psychotic Dx .013 .026 .033 .055 .195** .202** .060 .093 .083 .122* .171** 
m24 BP Dx .147** .150** .051 .079 -.020 -.007 -.032 -.044 .181** .154** .150** 
m24 Dep Dx .088 .111* .107* .122** .021 .049 .029 .045 .121** .112* .271** 
m24 Anx Dx -.018 -.003 -.072 -.043 -.035 .014 -.034 -.016 .152** .233** .204** 
m24 DBD Dx .012 -.002 .065 .038 .067 .000 .133** .100* -.089 -.004 .051 
m24 ADHD Dx -.137** -.150** -.145** -.166** -.047 -.049 -.092* -.097* -.209** -.228** -.267** 
m24 Oth Dx .002 -.006 .048 .002 -.065 -.061 -.017 .023 -.018 -.079 -.065 
m24 No Dx -.133** -.145** -.037 -.054 -.029 -.039 -.018 -.017 -.201** -.313** -.487** 
BL School Chall .109* .076 .122** .129** .060 .080 .019 .027 .145** .114** .145** 
m12 School Chall .047 .004 .044 .080 -.037 -.040 -.028 -.050 .183** .205** .212** 
m24 School Chall .115* .102* .108* .106* .075 .096 .027 .025 .234** .208** .245** 
BL School Services .031 .011 .024 .029 -.025 .005 -.065 -.053 .153** .143** .168** 
m12 School Services .084 .056 .035 .071 .010 .004 .024 .001 .154** .216** .204** 
m24 School Services .099* .093 -.039 -.010 -.023 -.027 .052 .062 .111* .196** .224** 
BL Inpatient .035 .038 .031 .028 .029 -.012 .001 -.014 .046 .014 .041 
m12 Inpatient .029 .004 .094* .070 -.003 .001 -.015 -.014 .033 .046 .057 
m24 Inpatient .197** .198** .108* .133** .095 .105* .148** .103* .064 .031 .086 
BL Outpatient -.014 .002 .023 .008 .003 -.041 -.034 -.062 .026 .051 .055 
m12 Outpatient -.025 -.035 -.050 -.080 -.018 -.041 -.021 -.045 .041 .013 .077 
m24 Outpatient .171** .175** .079 .087 .103* .121* .040 .108* .139** .191** .212** 
BL Inpatient Number .056 .055 .013 -.003 -.025 -.032 .007 .013 .090* .083 .127** 
m12 Inpatient Number .052 .038 .077 .072 .019 .022 .029 .029 .078 .097* .124* 
m24 Inpatient Number .191** .214** .084 .098* .031 .043 .098* .068 .011 .005 .104* 
BL Outpt Professionals .054 .080 .110** .104** -.065 -.047 .009 .011 .152** .125** .113* 
m12 Outpt Profs .079 .088 .036 .021 -.063 -.075 -.076 -.076 .178** .138** .220** 
m24 Outpt Profs .110* .136** .109* .097* .017 .051 -.016 .024 .160** .174** .247** 
  BL PGBI10 Tot BL ESM+ m12 PGBI10 
Tot 
m12 ESM+ m24 PGBI10 
Tot 
m24 ESM+ BL GBI-P Tot m24 GBI-P Tot m24 GBI-P Tot 
BL PGBI10 Tot 1         
BL ESM+ .828** 1        
m12 PGBI10 Tot .461** .393** 1       
m12 ESM+ .358** .316** .825** 1      
m24 PGBI10 Tot .428** .376** .630** .484** 1     
m24 ESM+ .320** .321** .474** .404** .817** 1    
BL GBI-P Tot .308** .265** .374** .288** .343** .269** 1   
m24 GBI-P Tot .204** .196** .389** .293** .258** .202** .689** 1 
 
m24 GBI-P Tot .220** .196** .329** .300** .364** .282** .715** .705** 1 
BL CGAS -.251** -.236** -.171** -.148** -.205** -.172** -.202** -.144** -.191** 
m12 CGAS -.240** -.220** -.357** -.309** -.299** -.241** -.204** -.212** -.256** 
m24 CGAS -.192** -.191** -.286** -.268** -.377** -.294** -.212** -.241** -.282** 
BLalifeprimary -.208** -.147** -.230** -.173** -.218** -.145** -.178** -.098* -.157** 
BLalifesecondary -.194** -.185** -.141** -.149** -.104* -.076 -.085 -.058 -.040 
BLalifepeer -.153** -.109** -.138** -.113* -.137** -.093* -.147** -.100* -.120* 
m12alifeprimary -.133** -.076 -.295** -.237** -.179** -.120* -.139** -.133** -.105* 
m12alifesecondary -.088 -.037 -.219** -.204** -.080 -.084 -.030 -.048 .056 
m12alifepeer -.136** -.126** -.250** -.195** -.126** -.055 -.116* -.104* -.084 
Continued 
 
 
 
2
4
6
 
  
 
 
Table 12 continued 
 
  
BL PGBI10 Tot BL ESM+ 
m12 PGBI10 
Tot 
m12 ESM+ 
m24 PGBI10 
Tot 
m24 ESM+ BL GBI-P Tot m24 GBI-P Tot m24 GBI-P Tot 
m24alifeprimary -.104* -.102* -.235** -.203** -.263** -.188** -.185** -.250** -.177** 
m24alifesecondary -.062 -.035 -.090 -.112* -.132* -.134* -.106* -.133* -.104 
m24alifepeer -.112* -.109* -.260** -.219** -.261** -.211** -.153** -.156** -.206** 
BL Sig Health Prob .070 .094* .048 .058 .099* .076 -.058 -.032 .014 
m12 Sig Health Prob .127** .131** .116** .099* .153** .087 .073 .065 .034 
m24 Sig Health Pob -.028 -.061 .075 .002 .121** .077 .004 -.004 -.037 
BL Psychotic Dx .030 .031 .027 .026 .016 -.056 .146** .069 .107* 
BL BP Dx .322** .281** .273** .207** .303** .246** .091* .117* .096* 
BL Dep Dx -.004 .059 -.060 -.032 -.037 -.032 .049 .057 .058 
BL Anx Dx -.097* -.132** -.056 -.053 -.053 -.066 .012 -.057 -.051 
BL DBD Dx -.023 -.033 -.005 -.040 -.041 -.057 -.046 -.017 -.071 
BL ADHD Dx -.209** -.176** -.145** -.087* -.141** -.055 -.115** -.096* -.030 
BL Oth Dx -.100** -.115** -.113* -.087* -.075 -.049 -.085* -.094* -.056 
BL No Dx -.062 -.051 -.048 -.002 -.119* -.068 -.074 -.033 -.071 
m12 Psychotic Dx .085 .063 .137** .118** .181** .141** .129** .102* .227** 
m12 BP Dx .333** .287** .254** .214** .288** .210** .072 .090* .051 
m12 Dep Dx -.021 .037 .050 .037 .019 .011 .131** .108* .104* 
m12 Anx Dx -.050 -.101* -.089* -.107* -.043 -.077 -.019 -.025 -.039 
m12 DBD Dx -.107* -.087* .016 .031 -.091 -.060 -.072 -.054 -.058 
m12 ADHD Dx -.178** -.151** -.213** -.199** -.216** -.131** -.100* -.088 -.090 
m12 Oth Dx .001 -.028 -.041 -.022 .001 .015 -.074 -.043 -.034 
m12 No Dx -.084 -.057 -.143** -.080 -.088 -.056 -.026 -.072 -.054 
m24 Psychotic Dx .077 .037 -.018 .018 .011 .022 .044 .036 .071 
m24 BP Dx .323** .283** .295** .228** .379** .289** .120* .061 .126** 
m24 Dep Dx .016 .024 .036 .031 .052 .015 .128** .102* .046 
m24 Anx Dx -.142** -.116* -.097* -.110* -.062 -.066 -.068 .006 -.043 
m24 DBD Dx -.079 -.075 .038 .023 -.035 -.029 -.068 .009 -.002 
m24 ADHD Dx -.172** -.126** -.171** -.126** -.211** -.167** -.101* -.084 -.105* 
m24 Oth Dx .032 .009 .005 .032 -.020 .006 .062 -.006 .024 
m24 No Dx -.080 -.092 -.193** -.140** -.244** -.145** -.067 -.114* -.097* 
BL School Chall .155** .115** .085 .067 .131** .122** .080* .043 .117* 
m12 School Chall .144** .113* .074 .020 .137** .104* .125** .035 .141** 
m24 School Chall .086 .020 .075 .049 .137** .120* .120* .080 .157** 
BL School Services .137** .114** .087* .055 .069 .062 .020 .048 .036 
m12 School Services .176** .066 .107* .111* .180** .131** .079 .021 .155** 
m24 School Services .072 .051 .063 .043 .197** .142** .081 .070 .124* 
BL Inpatient .113** .098* .010 .030 .107* .048 .046 -.016 .063 
m12 Inpatient .154** .160** .076 .062 .106* .033 -.039 -.050 -.048 
m24 Inpatient -.023 -.042 .077 .044 .155** .083 .083 .036 .037 
BL Outpatient .051 -.014 .028 .003 -.001 -.001 -.013 -.059 -.033 
m12 Outpatient .078 .055 .012 -.010 .097* .051 -.093* -.077 -.061 
m24 Outpatient .115* .094* .147** .100* .210** .156** .072 .082 .078 
BL Inpatient Number .095* .059 .050 .057 .158** .166** .035 -.028 .069 
m12 Inpatient Number .122** .153** .072 .073 .126* .069 -.035 -.053 -.023 
m24 Inpatient Number -.005 -.004 .025 .018 .117* .076 .100* .031 .015 
BL Outpt Professionals .136** .098* .015 -.014 .064 .070 .035 -.020 .024 
m12 Outpt Profs .137** .106* .090 .012 .231** .162** -.067 -.019 .011 
m24 Outpt Profs .125* .098* .167** .109* .247** .190** .008 .038 .021 
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Table 12 continued 
  BL CGAS m12 CGAS m24 CGAS BLalifeprim
ary 
BLalifeseco
ndary 
BLalifepeer m12alifepri
mary 
m12alifesec
ondary 
m12alifepe
er 
m24alifepri
mary 
m24alifesec
ondary 
m24alifepee
r BL CGAS 1            
m12 CGAS .546** 1           
m24 CGAS .535** .684** 1          
BLalifeprimary .190** .155** .263** 1         
BLalifesecondary .179** .178** .145** .439** 1        
BLalifepeer .427** .266** .289** .205** .186** 1       
m12alifeprimary .124** .292** .225** .283** .158** .058 1      
m12alifesecondary .082 .266** .147** .188** .387** .039 .415** 1     
m12alifepeer .300** .403** .294** .113** .156** .338** .221** .195** 1    
m24alifeprimary .159** .240** .386** .396** .153** .096* .359** .198** .122* 1   
m24alifesecondary .131* .158** .283** .240** .284** .218** .170** .370** .056 .452** 1 
 
m24alifepeer .350** .427** .537** .228** .106* .371** .151** .141** .414** .329** .318** 1 
BL Sig Health Prob .008 -.092* -.069 -.041 .026 -.076* -.033 .098* -.037 .017 -.008 -.032 
m12 Sig Health Prob -.057 -.084 -.073 -.067 -.055 -.074 -.011 -.034 -.020 -.044 -.021 -.001 
m24 Sig Health Pob -.015 -.013 -.038 -.049 .056 -.008 -.047 -.005 .005 .000 .036 .047 
BL Psychotic Dx -.125** -.083 -.087 -.046 .000 -.067 -.011 .009 -.095* -.087 -.028 -.112* 
BL BP Dx -.193** -.190** -.113* -.137** -.137** -.073 -.090* -.119* -.124** -.093* -.053 -.095* 
BL Dep Dx -.177** -.075 -.118* -.015 -.026 -.095* -.020 .018 -.022 -.075 -.078 -.047 
BL Anx Dx .034 .005 -.005 .085* .022 .026 -.046 .010 .088* .106* .062 .056 
BL DBD Dx .032 .006 -.034 -.052 -.020 .026 -.018 .006 -.015 -.092* -.023 -.020 
BL ADHD Dx .303** .227** .224** .164** .166** .124** .184** .085 .096* .175** .110* .124** 
BL Oth Dx .019 .120** .126** -.032 .014 -.008 .003 .049 .068 .058 .067 .020 
BL No Dx .227** .097* .121** .069 .071 .100** .028 .021 .029 .047 -.049 .083 
m12 Psychotic Dx -.139** -.216** -.220** -.121** -.068 -.171** -.032 -.089 -.196** -.166** -.190** -.215** 
m12 BP Dx -.184** -.233** -.152** -.187** -.152** -.065 -.090* -.159** -.071 -.057 -.058 -.078 
m12 Dep Dx -.158** -.227** -.199** -.027 -.037 -.073 -.111* -.061 -.059 -.115* -.068 -.136** 
m12 Anx Dx .031 -.001 .022 .133** -.002 .031 .027 .057 .027 .096* .063 .073 
m12 DBD Dx -.010 -.043 -.065 -.070 .014 -.008 -.125** -.051 -.030 -.094 -.117* -.021 
m12 ADHD Dx .244** .324** .305** .155** .164** .094* .207** .175** .129** .135** .204** .173** 
m12 Oth Dx -.018 .046 .030 .042 .008 -.004 .069 .065 .013 .025 .092 -.058 
m12 No Dx .206** .369** .225** .087* .080 .138** .112* .138** .134** .133** .014 .127** 
m24 Psychotic Dx -.114* -.196** -.184** -.076 -.096 -.106* .015 -.045 -.154** .007 .009 -.137** 
m24 BP Dx -.204** -.254** -.202** -.223** -.154** -.065 -.143** -.102 -.035 -.113* -.072 -.115* 
m24 Dep Dx -.024 -.069 -.223** -.069 -.041 -.054 -.063 -.070 -.003 -.147** -.156** -.093* 
m24 Anx Dx -.054 -.083 -.055 .177** .065 -.009 .031 .040 -.019 .070 .025 -.027 
m24 DBD Dx .001 -.040 -.077 -.022 -.038 -.036 -.140** -.070 -.088 -.128** -.077 -.019 
m24 ADHD Dx .198** .304** .290** .091* .117* .083 .208** .105 .092 .156** .193** .158** 
m24 Oth Dx -.046 -.040 -.028 -.035 -.055 .036 .012 -.082 -.037 .017 .009 -.004 
m24 No Dx .206** .298** .403** .174** .170** .137** .135** .186** .148** .191** .068 .180** 
BL School Chall -.171** -.184** -.124** -.040 .001 -.118** -.013 .012 -.104* -.002 .007 -.157** 
m12 School Chall -.234** -.256** -.205** -.031 .029 -.057 .015 .000 -.139** .036 .040 -.102* 
m24 School Chall -.228** -.267** -.306** -.081 -.017 -.112* -.046 .037 -.017 -.057 .034 -.169** 
BL School Services -.172** -.164** -.152** -.013 .013 -.180** .019 .011 -.130** .039 .008 -.119* 
m12 School Services -.241** -.279** -.208** -.102* -.067 -.235** -.001 .004 -.198** -.046 .023 -.175** 
m24 School Services -.228** -.228** -.255** -.122** -.027 -.227** -.014 -.022 -.176** -.101* -.118* -.222** 
BL Inpatient -.064 -.072 -.047 -.066 -.089* .004 -.002 .016 -.052 -.119* -.055 .015 
m12 Inpatient -.102* -.189** -.131** -.159** -.066 -.095* -.141** -.096 -.219** -.089 -.041 -.074 
m24 Inpatient -.124* -.136** -.170** -.144** -.020 -.117* -.035 -.005 -.063 -.163** .009 -.031 
BL Outpatient -.053 -.061 -.084 .050 .055 .010 .012 -.028 -.061 .001 -.066 -.089 
m12 Outpatient -.078 -.033 -.091 .068 .016 -.011 .056 .040 -.028 .071 -.019 -.020 
m24 Outpatient -.192** -.152** -.195** -.092* -.090 -.128** -.104* .016 -.118* -.119* -.022 -.126** 
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Table 12 continued 
 
  
BL CGAS m12 CGAS m24 CGAS 
BLalifeprim
ary 
BLalifeseco
ndary 
BLalifepeer 
m12alifepri
mary 
m12alifesec
ondary 
m12alifepe
er 
m24alifepri
mary 
m24alifesec
ondary 
m24alifepee
r 
BL Inpatient Number -.158** -.119** -.125** -.144** -.102* -.083* -.053 -.036 -.143** -.107* -.096 -.082 
m12 Inpatient Number -.155** -.246** -.168** -.150** -.072 -.121** -.118* -.076 -.227** -.105* -.042 -.098 
m24 Inpatient Number -.091 -.083 -.170** -.126** -.030 -.064 -.059 -.016 -.060 -.149** .036 -.020 
BL Outpt Professionals -.164** -.179** -.193** -.062 -.057 -.132** -.043 .013 -.024 -.152** -.176** -.128** 
m12 Outpt Profs -.221** -.218** -.265** -.075 -.045 -.114* -.023 .002 -.126** -.131** -.015 -.183** 
m24 Outpt Profs -.237** -.227** -.290** -.134** -.117* -.203** -.091 -.008 -.148** -.117* -.051 -.254** 
  BL Sig 
Health Prob 
m12 Sig 
Health Prob 
m24 Sig 
Health Pob 
BL Psychotic 
Dx 
BL BP Dx BL Dep Dx BL Anx Dx BL DBD Dx BL ADHD 
Dx 
BL Oth Dx BL No Dx 
BL Sig Health Prob 1           
m12 Sig Health Prob .075 1          
m24 Sig Health Pob .041 .089 1         
BL Psychotic Dx -.043 .049 -.058 1        
BL BP Dx .107** .084 .053 -.084* 1       
BL Dep Dx .003 -.011 .025 -.069 -.258** 1      
BL Anx Dx .019 .023 .019 -.061 -.228** -.188** 1     
BL DBD Dx -.074 -.048 -.026 -.082* -.306** -.252** -.224** 1    
BL ADHD Dx -.072 -.037 -.056 -.061 -.228** -.188** -.167** -.224** 1   
BL Oth Dx .058 -.012 .038 -.025 -.092* -.076* -.067 -.090* -.067 1 
 
BL No Dx -.002 -.073 -.023 -.022 -.084* -.069 -.061 -.082* -.061 -.025 1 
m12 Psychotic Dx -.011 .101* .061 .352** .031 -.032 -.026 -.022 -.065 -.025 -.024 
m12 BP Dx .080 .044 .068 -.019 .793** -.212** -.193** -.247** -.203** -.098* -.011 
m12 Dep Dx .012 -.001 -.008 .042 -.184** .472** -.036 -.083 -.130** -.057 .024 
m12 Anx Dx -.003 .029 -.033 -.010 -.202** -.039 .524** -.120** -.047 -.027 -.060 
m12 DBD Dx -.008 -.027 -.034 -.072 -.219** -.060 -.010 .417** -.089* -.057 -.022 
m12 ADHD Dx -.045 -.044 -.017 -.034 -.250** -.033 -.107* -.014 .484** .007 -.048 
m12 Oth Dx .033 -.070 -.018 -.021 -.028 -.032 -.026 -.022 -.030 .370** -.024 
m12 No Dx -.078 -.025 -.015 -.034 -.141** .026 -.101* .064 .009 .163** .225** 
m24 Psychotic Dx .052 .123* .038 .194** -.004 -.020 -.014 .000 -.021 -.020 -.023 
m24 BP Dx .034 .042 .074 .035 .699** -.155** -.144** -.230** -.224** -.090 -.015 
m24 Dep Dx -.009 .032 -.034 -.047 -.159** .261** .016 -.010 -.043 .009 -.052 
m24 Anx Dx .055 .006 -.024 .038 -.203** .055 .433** -.132** -.110* .045 -.017 
m24 DBD Dx .010 -.023 -.005 -.032 -.173** -.075 -.055 .343** -.005 -.067 -.042 
m24 ADHD Dx -.091 .002 -.019 -.031 -.249** -.043 -.085 .054 .399** -.026 -.077 
m24 Oth Dx -.007 -.008 -.048 -.018 .056 .041 -.051 -.066 -.055 .239** -.020 
m24 No Dx -.021 -.127** -.020 -.049 -.167** .068 -.055 .013 .025 .110* .264** 
BL School Chall .043 .013 -.023 .019 .050 .033 -.021 -.053 .021 -.021 -.081* 
m12 School Chall -.055 .036 -.023 .103* .012 -.001 .034 -.022 -.001 -.071 -.065 
m24 School Chall -.021 -.033 -.004 .061 -.042 .034 .082 .008 -.052 -.027 -.080 
BL School Services .053 .097* -.018 .068 .033 .055 -.010 -.074 .019 -.057 -.052 
m12 School Services .006 .090* .000 .075 .014 .032 -.001 -.042 -.013 .023 -.060 
m24 School Services .088 .032 .020 .076 -.002 .034 .004 .020 -.022 -.004 -.140** 
BL Inpatient .165** .066 -.008 .014 .217** -.011 -.071 -.088* -.051 -.036 -.033 
m12 Inpatient .054 .269** .071 .079 .136** -.054 .000 -.035 -.099* -.047 .051 
m24 Inpatient -.029 .096 .295** .029 .038 .133** -.080 .001 -.071 -.038 -.044 
BL Outpatient -.046 .025 -.006 .068 -.031 -.027 .040 -.058 .051 .001 .041 
m12 Outpatient -.046 .002 .022 .029 -.001 -.001 .034 .008 .041 -.130** -.080 
m24 Outpatient .119** -.020 .015 -.008 .083 .042 .086 -.060 -.072 .047 -.232** 
BL Inpatient Number .143** .059 .078 .003 .238** -.040 -.062 -.084* -.066 -.032 -.008 
m12 Inpatient Number .084 .279** .080 .086 .149** -.048 -.025 -.030 -.094* -.043 .025 
m24 Inpatient Number .022 .100* .272** .004 .041 .034 .034 -.020 -.067 -.025 -.029 
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Table 12 continued 
 
  BL Sig 
Health Prob 
m12 Sig 
Health Prob 
m24 Sig 
Health Pob 
BL Psychotic 
Dx 
BL BP Dx BL Dep Dx BL Anx Dx BL DBD Dx 
BL ADHD 
Dx 
BL Oth Dx BL No Dx 
BL Outpt Professionals .033 -.019 -.007 -.011 .078* .119** -.026 -.095* -.053 -.020 -.039 
m12 Outpt Profs .087 .101* -.004 .055 .068 .014 .015 -.008 -.047 -.097* -.066 
m24 Outpt Profs .122* .021 .022 -.032 .130** .035 .042 -.057 -.073 -.041 -.124* 
  m12 Psychotic 
Dx 
m12 BP Dx m12 Dep Dx m12 Anx Dx m12 DBD Dx m12 ADHD 
Dx 
m12 Oth Dx m12 No Dx m24 Psychotic 
Dx 
m24 BP Dx 
m12 Psychotic Dx 1          
m12 BP Dx -.091* 1         
m12 Dep Dx -.053 -.205** 1        
m12 Anx Dx -.058 -.223** -.130** 1       
m12 DBD Dx -.079 -.295** -.179** -.194** 1      
m12 ADHD Dx -.076 -.294** -.171** -.187** -.256** 1     
m12 Oth Dx -.023 -.091* -.053 -.058 -.079 -.076 1    
m12 No Dx -.038 -.146** -.085 -.093* -.127** -.122** -.038 1   
m24 Psychotic Dx .523** -.080 .009 .000 -.072 -.025 -.021 -.034 1  
m24 BP Dx .026 .881** -.151** -.195** -.260** -.290** -.098* -.158** -.090 1 
m24 Dep Dx -.052 -.187** .335** .024 -.012 -.017 -.049 -.011 -.045 -.204** 
m24 Anx Dx -.016 -.219** .080 .584** -.110* -.132** -.011 -.093 -.051 -.234** 
m24 DBD Dx -.034 -.238** -.075 -.135** .509** -.055 .012 -.060 -.067 -.305** 
m24 ADHD Dx -.078 -.283** -.107* -.129** -.009 .533** .043 -.019 -.066 -.302** 
m24 Oth Dx -.021 -.033 .016 -.049 -.023 -.064 .346** .047 -.017 -.079 
m24 No Dx -.054 -.194** .038 -.009 -.061 .010 .000 .447** -.046 -.212** 
BL School Chall .016 .092* .039 -.019 -.062 -.042 .067 -.066 .103* .059 
m12 School Chall .076 .073 -.005 .079 -.050 -.047 -.004 -.110* .119* .082 
m24 School Chall .023 -.006 .065 .106* -.059 -.043 .034 -.070 .075 .015 
BL School Services .074 .057 -.005 .024 -.074 .007 .074 -.119** .040 .034 
m12 School Services .120** .043 .024 .007 -.075 -.004 .048 -.087 .109* .043 
m24 School Services .135** .023 .071 -.017 -.011 -.060 .017 -.087 .117* .050 
BL Inpatient .085 .153** -.020 -.084 -.028 -.043 -.034 -.055 .056 .077 
m12 Inpatient .117* .142** .010 -.061 .012 -.117* -.046 -.067 .108* .184** 
m24 Inpatient .108* .002 .017 -.061 .059 -.067 -.039 .026 .099* .120* 
BL Outpatient .035 .002 -.024 .078 -.066 .045 -.067 -.020 .024 .036 
m12 Outpatient -.027 .047 -.101* .028 .046 .016 -.027 -.066 -.047 .068 
m24 Outpatient .003 .076 .008 .076 .009 -.036 -.001 -.215** .046 .092* 
BL Inpatient Number .215** .135** -.027 -.047 -.054 -.078 -.029 -.046 .062 .174** 
m12 Inpatient Number .180** .112* .022 -.065 .003 -.110* -.041 -.060 .187** .178** 
m24 Inpatient Number .118* -.010 -.016 -.050 .072 -.060 -.026 .028 .032 .065 
BL Outpt Professionals -.025 .098* .127** -.006 -.065 -.077 .013 -.087* -.002 .098* 
m12 Outpt Profs .038 .112* .022 .058 -.039 -.065 -.052 -.130** .056 .177** 
m24 Outpt Profs -.025 .172** .037 .050 .011 -.117* -.066 -.192** .028 .160** 
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Table 12 continued 
  
m24 Dep Dx m24 Anx Dx m24 DBD Dx m24 ADHD Dx m24 Oth Dx m24 No Dx BL School Chall 
m12 School 
Chall 
m24 School 
Chall 
m24 Dep Dx 1 
 
       
m24 Anx Dx -.116* 1        
m24 DBD Dx -.151** -.174** 1       
m24 ADHD Dx -.150** -.172** -.224** 1      
m24 Oth Dx -.039 -.045 -.059 -.058 1     
m24 No Dx -.105* -.121** -.157** -.156** -.041 1    
BL School Chall -.006 -.035 -.064 .009 .048 -.042 1   
m12 School Chall .008 -.014 -.121* .048 -.014 -.074 .338** 1  
m24 School Chall .027 .042 .040 -.041 -.007 -.125** .266** .418** 1 
BL School Services -.023 .015 -.001 -.040 .012 -.016 .396** .270** .204** 
m12 School Services .036 -.065 -.061 .036 .075 -.083 .348** .418** .263** 
m24 School Services .074 -.040 .032 -.040 -.014 -.143** .312** .294** .332** 
BL Inpatient .017 -.071 -.004 -.003 -.024 -.064 .048 .044 -.007 
m12 Inpatient -.048 -.064 .018 -.103* -.032 -.087 .057 .104* .008 
m24 Inpatient .058 -.092 -.046 -.095 .044 -.022 -.005 .006 .027 
BL Outpatient -.009 .029 -.115* .043 .011 .001 .071 .183** .075 
m12 Outpatient -.082 .046 .042 -.035 .027 -.070 .032 .065 .027 
m24 Outpatient .050 .046 .000 -.080 .040 -.174** .070 .042 .103* 
BL Inpatient Number -.043 -.059 -.034 -.064 -.022 -.053 .064 .038 .005 
m12 Inpatient Number -.051 -.066 -.007 -.101* -.030 -.082 .063 .097* .010 
m24 Inpatient Number .135** -.060 -.058 -.068 .010 -.017 -.063 -.019 -.020 
BL Outpt Professionals .076 -.040 -.045 -.042 .012 -.070 .116** .133** .181** 
m12 Outpt Profs -.036 .016 -.013 -.103* .010 -.129** .153** .149** .150** 
m24 Outpt Profs .041 .061 -.014 -.150** .012 -.149** .136** .126* .193** 
  BL School 
Services 
m12 School 
Services 
m24 School 
Services 
BL Inpatient m12 Inpatient m24 Inpatient BL Outpatient m12 Outpatient m24 Outpatient 
BL School Services 1         
m12 School Services .333** 1        
m24 School Services .210** .435** 1       
BL Inpatient .011 .040 .100* 1      
m12 Inpatient .038 .150** .077 .206** 1     
m24 Inpatient -.023 .082 .139** .101* .156** 1    
BL Outpatient .061 .137** .103* .026 .019 .022 1   
m12 Outpatient .074 .107* .036 .045 .065 .056 .191** 1  
m24 Outpatient .007 .071 .193** .060 .018 .086 .003 .237** 1 
BL Inpatient Number .066 .093* .134** .455** .213** .157** .025 .039 .047 
m12 Inpatient Number .042 .142** .112* .258** .911** .262** .041 .059 .031 
m24 Inpatient Number -.062 .103* .105* .095 .132** .695** .015 .037 .056 
BL Outpt Professionals .120** .097* .039 .063 .044 .042 .095* .078 .118** 
m12 Outpt Profs .130** .228** .231** .101* .189** .163** .261** .434** .351** 
m24 Outpt Profs .100* .189** .291** .153** .112* .202** .128** .214** .525** 
  BL Inpt Num m12 Inpt Num m24 Inpt Num BL Outpt Profs m12 Outpt Profs m24 Outpt Profs 
BL Inpatient Number 1      
m12 Inpatient Number .265** 1     
m24 Inpatient Number .196** .180** 1    
BL Outpt Professionals .140** .050 .011 1   
m12 Outpt Profs .146** .190** .117* .190** 1  
m24 Outpt Profs .173** .119* .140** .155** .598** 1 
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Table 12 continued 
Note. BL = Baseline; m12 = 12-Month assessment; m24 = 24-Month assessment; KINDL = Revididerter KINDer Lebensqualiatsfragebogen; CGI = Clinical Global Impression Scale – 
Severity; NoMeds = No medication; AnyMed = An medication; Antipsychotic = Antipsychotic medication; Antidep = Antidepressant medication; Anxiolytic = Anxiolytic medication; 
OthMeds = Other Medication; MoodStab = Mood stabilizer; Stim = Simulant medication; PSS_Num Stress = Parent Stress Survey -  Number of Stressors; PSS_Tot Stress= Parent Stress 
Survey – Total Stress; NumDx = Number of diagnoses; PGBI10 = Parent General Behavior Inventory – 10-Item Mania Scale; ESM+ = Elevated symptoms of mania – Positive; alifeprimary 
= Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up Evaluation – Primary caregiver; alifesecondary = Psychosocial Schedule of the Adolescent Longitudinal Interval 
Follow-Up Evaluation – Secondary caregiver; alifepeer = Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up Evaluation – Peers; Sig Health Prob = Significant health 
problems; Psychotic Dx = Psychotic disorder diagnostic category; Bp Dx = Bipolar spectrum disorder diagnostic category; Dep Dx = Depressive Spectrum Disorder diagnostic category; Anx 
Dx = Anxiety Disorder diagnostic category; DBD Dx = Disruptive behavior disorder diagnostic category; ADHD Dx = Attention-Deficit/Hyperactivity Disorder diagnostic category; Oth Dx 
= Other diagnoses diagnostic category; No Dx = No diagnosis; School Chall = School challenges; Outpt Profs = Number of outpatient professionals seen. *Correlation is significant at the 
0.05 level (2-tailed); **Correlation is significant at the 0.01 level (2-tailed).  
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Table 13 
Pearson’s correlations between level-1 and leveld-2 predictors and among level-2 predictors 
  
BL C-KINDL 
Total 
m12 C-KINDL 
Total 
m24 C-KINDL 
Total 
BL P-KINDL 
Total 
m12 P-KINDL 
Total 
m24 P-KINDL 
Total 
BL CGI m12 CGI m24 CGI 
IQ .041 -.056 -.007 .050 -.011 .033 -.065 -.166 -.093 
Sex -.024 -.061 -.089 -.116** -.135** -.128** -.003 -.033 .038 
Hispanic .003 -.020 -.056 -.002 .025 .041 -.060 -.068 -.057 
White -.057 -.095* -.094 -.126** -.113* -.051 .056 .031 .053 
Parents: No Dx -.047 .022 -.015 .001 .090 .074 -.049 -.077 -.051 
Parents: ADHD -.057 -.008 .028 -.026 .012 .017 .116** .075 .043 
Parents: Mania -.049 -.110* -.067 -.158** -.217** -.166** .075 .081 .082 
Parents: Depression -.048 -.134** -.106* -.068 -.176** -.120* .044 .125** .114* 
Parents: Psychosis .025 -.046 .055 -.060 -.092 -.069 .064 .091* .012 
Parents: Anxiety -.025 -.084 -.041 .001 -.086 -.036 .111** .087* .075 
Parents: Suicidality -.030 -.020 -.042 -.121** -.130** -.083 .133** .170** .148** 
Parents: Substance Use .030 -.011 -.044 .003 -.031 -.030 .073 .083 .067 
Parents: Disruptive Behavior .000 .040 .069 .007 -.041 .072 .075 .135** .071 
Parents: Total Dx -.025 -.034 -.043 -.094* -.159** -.098* .179** .190** .189** 
Live with both parents .029 -.057 -.028 -.033 -.062 .002 -.020 -.021 -.009 
Live with one parent -.038 .049 -.018 .061 .002 .001 -.023 -.036 -.043 
Live in blended family -.004 .036 .029 -.040 .034 .024 .021 .013 .031 
Live with other .016 -.031 .018 -.006 .044 -.051 .046 .075 .046 
Family: No Dx .008 .043 -.035 .037 .067 -.041 -.109** -.053 -.015 
Family: ADHD .015 .045 -.003 -.035 .039 .009 .153** .074 .134** 
Family: Mania -.005 -.013 .000 -.099* -.051 -.003 .040 -.026 -.051 
Family: Depression -.011 .006 -.034 -.178** -.093* -.072 .114** .062 .090 
Family: Psychosis .049 .096* .039 -.073 -.017 -.084 .147** -.045 .046 
Family: Anxiety .084* .100* .069 -.073 -.029 -.011 .169** .070 .114* 
Family: Suicidality -.044 -.054 .011 -.095* -.114* -.071 .104** .128** .056 
Family: Substance .012 -.008 .032 -.038 -.026 .004 .168** .170** .117* 
Family: Disruptive Behavior .016 .128** .146** -.010 .050 .058 .220** .165** .137** 
BL Income: < $19,999 -.041 .074 -.062 .009 .059 .021 .070 .015 .056 
BL Income: $20,000-$39,999 .031 -.043 .086 .038 -.017 .037 -.067 -.067 -.037 
BL Income: $40000-$49999 -.018 .034 .018 -.032 -.093* .013 -.043 -.015 -.076 
BL Income: > $200000 .004 -.039 -.001 -.078 -.040 -.041 -.042 -.008 -.045 
Site -.056 .086 -.051 .122** .202** .094 .092* .173** .160** 
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Table 13 continued 
  BL Age m12 Age m24 Age 
BL Non-
Medicaid 
m12 Non-
Medicaid 
m24 Non-
Medicaid 
BL NoMeds BL AnyMed 
BL 
Antipsychotic 
BL Antidep 
IQ .015 .025 .025 .018 .018 .238 .241 .216 -.073 .073 
Sex .105** .091* .121** .061 .071 .036 .098* -.098* -.064 .047 
Hispanic -.031 -.004 -.030 -.009 .013 -.025 .033 -.033 -.111** .035 
White -.008 .025 -.016 .421** .435** .417** -.209** .209** .177** .160** 
Parents: No Dx .057 .047 .013 .141** .121** .150** -.024 .024 .082* -.015 
Parents: ADHD -.113** -.113** -.129** -.070 -.051 -.080 -.009 .009 -.031 -.094* 
Parents: Mania .010 .011 .012 -.010 -.005 -.040 .031 -.031 .009 -.081* 
Parents: Depression .043 .074 .073 .031 .112* .023 .008 -.008 -.051 .067 
Parents: Psychosis .006 -.005 -.022 -.142** -.117** -.188** .064 -.064 -.033 -.077* 
Parents: Anxiety -.034 -.010 -.030 -.142** -.096* -.088 .066 -.066 -.098* -.019 
Parents: Suicidality -.014 -.058 -.049 -.148** -.155** -.133** .066 -.066 .021 -.066 
Parents: Substance Use -.023 -.022 -.036 -.233** -.197** -.189** .072 -.072 -.040 -.036 
Parents: Disruptive Behavior -.076* -.097* -.103* -.381** -.371** -.287** .110** -.110** -.058 -.130** 
Parents: Total Dx -.077* -.086 -.087 -.310** -.246** -.278** .128** -.128** -.073 -.081* 
Live with both parents -.019 .006 -.039 .410** .421** .398** -.124** .124** .136** .182** 
Live with one parent -.056 -.075 -.027 -.249** -.254** -.198** .073 -.073 -.102** -.111** 
Live in blended family .023 .009 .023 -.081* -.095* -.107* .038 -.038 -.046 -.056 
Live with other .089* .094* .074 -.153** -.162** -.189** .039 -.039 .003 -.039 
Family: No Dx .031 .036 .017 .003 -.020 -.047 -.017 .017 .058 .011 
Family: ADHD .036 .017 -.023 .053 -.015 -.020 -.030 .030 .010 .075 
Family: Mania -.003 .013 .014 .118** .116** .109* .026 -.026 .050 .024 
Family: Depression .031 .029 .040 .119** .171** .144** -.062 .062 .024 .082* 
Family: Psychosis -.026 -.035 -.040 -.035 -.030 -.039 .006 -.006 .020 .010 
Family: Anxiety -.016 -.018 -.046 -.035 -.032 -.056 .017 -.017 -.026 .059 
Family: Suicidality -.045 -.026 .003 -.102** -.116** -.106* .062 -.062 .028 -.042 
Family: Substance -.054 -.060 -.062 -.148** -.172** -.109* .079* -.079* -.063 -.029 
Family: Disruptive Behavior -.103** -.105* -.129** -.178** -.200** -.243** .081* -.081* -.066 -.066 
BL Income: < $19,999 .021 .049 .039 -.265** -.269** -.305** .002 -.002 .033 -.001 
BL Income: $20,000-$39,999 .012 -.005 .016 .102** .082 .151** .030 -.030 -.048 -.050 
BL Income: $40000-$49999 -.072 -.075 -.083 .143** .158** .156** -.021 .021 .007 -.013 
BL Income: > $200000 .011 .000 .023 .261** .296** .258** -.080* .080* .048 .077* 
Site -.079* -.076 -.060 -.238** -.319** -.347** .204** -.204** -.219** -.191** 
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Table 13 continued 
  BL Anxiolytic BL OthMeds BL MoodStab BL Stim m12 NoMeds m12 AnyMed 
m12 
MoodStab 
m12 Antidep m12 Antidep m12 Anxio 
IQ -.037 -.023 -.022 .050 -.037 .037 -.013 .042 -.036 .006 
Sex .018 -.058 -.010 -.087* .042 -.042 .006 .038 -.015 .009 
Hispanic .026 -.032 -.053 .001 .002 -.002 -.105* .080 -.072 -.017 
White .064 .157** .119** .040 -.301** .301** .131** .163** .225** .048 
Parents: No Dx -.033 -.026 -.027 -.046 -.017 .017 -.012 -.009 .025 -.041 
Parents: ADHD .007 .052 -.001 .103** .008 -.008 .037 -.071 -.033 .009 
Parents: Mania -.024 .054 .058 -.031 -.023 .023 .112* -.015 .138** -.002 
Parents: Depression .015 .059 -.006 .006 .002 -.002 -.059 .097* -.008 -.034 
Parents: Psychosis -.006 -.034 -.006 -.046 .086 -.086 .028 .010 .000 -.020 
Parents: Anxiety .040 -.027 .032 -.014 .058 -.058 -.051 .027 -.054 .078 
Parents: Suicidality -.039 .074 .087* -.069 -.013 .013 .070 -.028 .019 -.038 
Parents: Substance Use -.038 -.024 .036 -.018 -.013 .013 -.005 -.014 .032 -.051 
Parents: Disruptive Behavior .019 .011 .006 -.028 .093* -.093* .031 -.157** -.001 -.073 
Parents: Total Dx -.010 .007 .049 -.058 .098* -.098* .020 -.038 -.015 -.010 
Live with both parents .112** .055 .055 -.030 -.109* .109* .132** .138** .088* .082 
Live with one parent -.034 -.042 -.022 .029 .109* -.109* -.102* -.083 -.111* -.032 
Live in blended family -.064 -.027 -.045 -.011 .016 -.016 -.025 .007 -.050 -.081 
Live with other -.040 .010 .010 .016 -.005 .005 -.024 -.101* .088* .022 
Family: No Dx -.009 .006 -.017 .079* -.010 .010 .027 .020 .004 .006 
Family: ADHD .001 .087* .059 -.029 .012 -.012 .057 -.018 .024 -.031 
Family: Mania -.020 -.034 .006 -.043 .009 -.009 .026 -.028 .077 -.043 
Family: Depression .046 .036 .028 .041 -.069 .069 -.007 .068 .060 .061 
Family: Psychosis -.023 -.012 .057 -.037 -.029 .029 .052 .080 .048 -.046 
Family: Anxiety .044 -.001 .047 -.055 -.012 .012 .001 .047 .005 .095* 
Family: Suicidality .040 .039 .074 -.083* -.031 .031 .056 -.010 .062 .015 
Family: Substance -.003 .013 .031 -.030 .021 -.021 .010 -.042 -.004 .020 
Family: Disruptive Behavior .038 .018 -.007 -.063 .094* -.094* -.015 -.084 -.103* .090* 
BL Income: < $19,999 .051 -.007 -.017 .014 -.002 .002 -.015 -.062 .042 .029 
BL Income: $20,000-$39,999 -.073 -.014 -.024 -.004 .043 -.043 -.046 .007 -.078 -.045 
BL Income: $40000-$49999 -.030 .015 -.043 .021 -.050 .050 -.048 .028 .022 .013 
BL Income: > $200000 .005 .021 .016 .020 -.042 .042 .069 .057 .055 .026 
Site -.068 -.014 -.032 -.036 .151** -.151** -.113** -.086* -.227** .000 
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Table 13 continued 
  m12 OthMeds m12 Stim m24 NoMeds 
m24 
AnyMeds 
m24 
MoodStab 
m24 Antidep m24 Anxio m24 OthMeds 
m24 
Antipsychotic 
m24 Stim 
IQ .017 .029 .009 -.009 -.018 .059 -.029 -.001 .053 -.054 
Sex -.109* -.088* .084 -.084 .003 .038 -.043 -.129** .006 -.163** 
Hispanic .004 -.016 .058 -.058 -.108* -.077 -.033 .057 -.062 -.007 
White .159** .064 -.235** .235** .132** .113* .050 .165** .197** .047 
Parents: No Dx .024 .026 -.079 .079 .013 .092* .027 .002 .045 .085 
Parents: ADHD .053 .067 .064 -.064 .031 -.147** -.024 .045 -.013 -.014 
Parents: Mania .053 -.101* -.041 .041 .121* -.006 -.015 .055 .091 -.084 
Parents: Depression .043 -.016 .032 -.032 -.015 .068 -.029 .089 .002 -.121** 
Parents: Psychosis -.077 -.125** .045 -.045 -.001 .008 -.005 -.037 .021 -.111* 
Parents: Anxiety -.056 -.094* .036 -.036 -.044 -.006 .038 -.071 -.042 -.076 
Parents: Suicidality .029 -.045 .051 -.051 .084 .013 -.083 .071 -.018 -.134** 
Parents: Substance Use .051 -.032 .038 -.038 -.005 -.016 -.041 .061 .041 -.091* 
Parents: Disruptive Behavior .022 -.028 .124** -.124** -.047 -.125** -.082 -.014 -.059 -.033 
Parents: Total Dx -.014 -.100* .083 -.083 .024 -.044 -.011 -.009 .003 -.140** 
Live with both parents .045 -.008 -.103* .103* .066 .040 .032 .041 .070 .035 
Live with one parent -.086 -.027 .151** -.151** -.076 -.048 -.034 -.041 -.109* -.120** 
Live in blended family .014 .023 -.017 .017 -.043 .074 -.073 -.042 -.025 .049 
Live with other .041 .017 -.036 .036 .066 -.082 .095* .043 .090 .054 
Family: No Dx .046 .056 -.071 .071 -.031 .059 .030 .003 .069 .057 
Family: ADHD .033 .017 .066 -.066 .095* .019 .028 .013 .009 -.062 
Family: Mania .024 -.034 .000 .000 .010 -.041 -.027 .014 .058 .043 
Family: Depression .045 .041 -.054 .054 .045 .007 -.010 .085 .020 .017 
Family: Psychosis -.028 -.027 -.010 .010 .022 -.021 .009 -.008 .022 -.030 
Family: Anxiety -.010 -.067 .071 -.071 -.025 -.050 .060 -.003 -.062 -.071 
Family: Suicidality .028 -.008 .009 -.009 .033 -.057 .055 .054 -.034 -.022 
Family: Substance .041 .002 .064 -.064 .028 -.103* .036 .078 -.010 -.053 
Family: Disruptive Behavior .036 -.032 .038 -.038 .011 -.060 .112* .063 -.092* .010 
BL Income: < $19,999 .045 .045 .002 -.002 .007 -.022 .003 -.008 .022 .002 
BL Income: $20,000-$39,999 .011 -.019 .047 -.047 -.058 -.069 .009 .016 -.114* .010 
BL Income: $40000-$49999 -.034 .034 -.026 .026 .007 .041 -.036 -.015 .088 .045 
BL Income: > $200000 -.038 -.009 -.078 .078 .036 .085 .057 .010 .042 -.020 
Site .015 -.055 .203** -.203** -.095* -.099* .111* -.028 -.119* -.142** 
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Table 13 continued 
  
BL 
PSS_NumStre
ss 
BL PSS_Tot 
Stress 
m12 
PSS_Num 
Stress 
m12 PSS_Tot 
Stress 
m24 
PSS_Num 
Stress 
m24 PSS_Tot 
Stress 
BL 
PSLES_Num 
Stress 
BL 
PSLES_Tot 
Stress 
m12 
PSLES_Num 
Stress 
m12 
PSLES_Tot 
Stress 
IQ .106 .066 .095 .060 .073 .083 -.030 -.020 -.045 -.057 
Sex -.004 .004 .075 .074 .092 .082 .044 .059 .118** .132** 
Hispanic -.040 -.050 -.028 -.042 -.097* -.076 -.023 -.055 -.001 .003 
White .152** .125** .068 .078 .075 .057 -.120** -.082* -.059 -.043 
Parents: No Dx -.078* -.102** -.057 -.074 -.076 -.052 -.120** -.110** -.107* -.087* 
Parents: ADHD .102** .117** .074 .096* .019 .028 .038 .051 .056 .069 
Parents: Mania .132** .166** .055 .075 .069 .079 .189** .217** .186** .210** 
Parents: Depression .128** .167** .124** .163** .167** .146** .133** .162** .104* .124** 
Parents: Psychosis .077* .079* .023 .093* -.021 .029 .178** .168** .086 .106* 
Parents: Anxiety .122** .138** .169** .193** .164** .144** .169** .150** .148** .150** 
Parents: Suicidality .137** .146** .090* .104* .046 .023 .166** .184** .135** .139** 
Parents: Substance Use .079* .074 .049 .018 .004 -.010 .172** .165** .111* .082 
Parents: Disruptive Behavior -.004 .014 -.001 .018 .011 .005 .186** .163** .158** .118** 
Parents: Total Dx .160** .195** .157** .217** .143** .155** .302** .294** .247** .258** 
Live with both parents .042 -.007 .121** .107* .128** .082 -.164** -.133** -.078 -.053 
Live with one parent -.024 .018 -.037 -.023 -.083 -.039 .062 .051 .057 .047 
Live in blended family .041 .035 -.036 -.019 -.002 .004 .060 .026 .012 .013 
Live with other -.083* -.062 -.084 -.104* -.072 -.073 .094* .107** .031 .003 
Family: No Dx -.044 -.033 -.090* -.097* -.094* -.073 -.059 -.050 -.040 -.043 
Family: ADHD .065 .093* .028 .064 .087 .100* .007 .030 .000 .026 
Family: Mania .059 .025 -.010 -.036 -.013 -.037 .024 .027 .006 .029 
Family: Depression .137** .103** .138** .121** .131** .126** .120** .141** .047 .075 
Family: Psychosis .082* .078* .093* .117** .103* .109* .074 .082* .002 .011 
Family: Anxiety .091* .118** .170** .164** .144** .138** .085* .088* .086 .081 
Family: Suicidality .069 .065 .087 .076 .071 .041 .133** .145** .181** .205** 
Family: Substance .051 .066 .030 .064 .092 .056 .159** .136** .104* .096* 
Family: Disruptive Behavior .032 .013 .035 .053 .084 .045 .100** .098* .096* .078 
BL Income: < $19,999 .008 .055 .088* .097* .072 .072 .127** .118** .180** .176** 
BL Income: $20,000-$39,999 -.091* -.128** -.107* -.082 -.129** -.138** -.100** -.109** -.087* -.096* 
BL Income: $40000-$49999 .062 .039 .025 .001 .032 .067 -.052 -.047 -.054 -.037 
BL Income: > $200000 .049 .037 -.008 -.017 .000 -.009 -.019 .014 -.083 -.078 
Site -.012 -.006 -.001 -.007 .026 .061 .083* .048 .094* .075 
Continued 
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Table 13 continued 
  
BL 
PSS_NumStre
ss 
BL PSS_Tot 
Stress 
m12 
PSS_Num 
Stress 
m12 PSS_Tot 
Stress 
m24 
PSS_Num 
Stress 
m24 PSS_Tot 
Stress 
BL 
PSLES_Num 
Stress 
BL 
PSLES_Tot 
Stress 
m12 
PSLES_Num 
Stress 
m12 
PSLES_Tot 
Stress 
IQ .106 .066 .095 .060 .073 .083 -.030 -.020 -.045 -.057 
Sex -.004 .004 .075 .074 .092 .082 .044 .059 .118** .132** 
Hispanic -.040 -.050 -.028 -.042 -.097* -.076 -.023 -.055 -.001 .003 
White .152** .125** .068 .078 .075 .057 -.120** -.082* -.059 -.043 
Parents: No Dx -.078* -.102** -.057 -.074 -.076 -.052 -.120** -.110** -.107* -.087* 
Parents: ADHD .102** .117** .074 .096* .019 .028 .038 .051 .056 .069 
Parents: Mania .132** .166** .055 .075 .069 .079 .189** .217** .186** .210** 
Parents: Depression .128** .167** .124** .163** .167** .146** .133** .162** .104* .124** 
Parents: Psychosis .077* .079* .023 .093* -.021 .029 .178** .168** .086 .106* 
Parents: Anxiety .122** .138** .169** .193** .164** .144** .169** .150** .148** .150** 
Parents: Suicidality .137** .146** .090* .104* .046 .023 .166** .184** .135** .139** 
Parents: Substance Use .079* .074 .049 .018 .004 -.010 .172** .165** .111* .082 
Parents: Disruptive Behavior -.004 .014 -.001 .018 .011 .005 .186** .163** .158** .118** 
Parents: Total Dx .160** .195** .157** .217** .143** .155** .302** .294** .247** .258** 
Live with both parents .042 -.007 .121** .107* .128** .082 -.164** -.133** -.078 -.053 
Live with one parent -.024 .018 -.037 -.023 -.083 -.039 .062 .051 .057 .047 
Live in blended family .041 .035 -.036 -.019 -.002 .004 .060 .026 .012 .013 
Live with other -.083* -.062 -.084 -.104* -.072 -.073 .094* .107** .031 .003 
Family: No Dx -.044 -.033 -.090* -.097* -.094* -.073 -.059 -.050 -.040 -.043 
Family: ADHD .065 .093* .028 .064 .087 .100* .007 .030 .000 .026 
Family: Mania .059 .025 -.010 -.036 -.013 -.037 .024 .027 .006 .029 
Family: Depression .137** .103** .138** .121** .131** .126** .120** .141** .047 .075 
Family: Psychosis .082* .078* .093* .117** .103* .109* .074 .082* .002 .011 
Family: Anxiety .091* .118** .170** .164** .144** .138** .085* .088* .086 .081 
Family: Suicidality .069 .065 .087 .076 .071 .041 .133** .145** .181** .205** 
Family: Substance .051 .066 .030 .064 .092 .056 .159** .136** .104* .096* 
Family: Disruptive Behavior .032 .013 .035 .053 .084 .045 .100** .098* .096* .078 
BL Income: < $19,999 .008 .055 .088* .097* .072 .072 .127** .118** .180** .176** 
BL Income: $20,000-$39,999 -.091* -.128** -.107* -.082 -.129** -.138** -.100** -.109** -.087* -.096* 
BL Income: $40000-$49999 .062 .039 .025 .001 .032 .067 -.052 -.047 -.054 -.037 
BL Income: > $200000 .049 .037 -.008 -.017 .000 -.009 -.019 .014 -.083 -.078 
Site -.012 -.006 -.001 -.007 .026 .061 .083* .048 .094* .075 
Continued 
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Table 13 continued 
  
m24 
PSLES_Nu
m Stress 
m24 
PSLES_To 
Stress 
BL 
CSLES_Nu
m Stress 
BL 
CSLES_Tot 
Stress 
m12 
CSLES_Nu
m Stress 
m12 
CSLES_Tot 
Stress 
m24 
CSLES_Nu
m Stress 
m24 
CSLES_Tot 
Stress 
BL Num Dx 
m12 Num 
Dx 
m24 Num 
Dx 
IQ -.028 -.004 -.016 -.043 -.038 -.060 -.041 -.041 -.098 -.116 -.136 
Sex .088 .118* .067 .062 .133** .153** .085 .095* -.057 -.025 -.019 
Hispanic -.073 -.079 .005 .001 -.030 -.021 .055 .014 -.019 .000 -.042 
White -.090 -.064 -.167** -.138** -.075 -.075 -.157** -.111* .089* .097* .012 
Parents: No Dx -.109* -.091 -.073 -.079* -.034 -.058 -.016 -.017 -.030 -.089* -.118* 
Parents: ADHD .106* .088 .015 .021 .046 .051 .058 .068 .155** .156** .117* 
Parents: Mania .116* .131** -.008 -.009 -.008 -.019 -.007 .006 .113** .054 .090 
Parents: Depression .122** .150** .059 .081* .068 .077 .030 .034 .070 .138** .157** 
Parents: Psychosis .139** .121** .069 .036 .030 .031 .017 .045 .052 .028 .030 
Parents: Anxiety .173** .155** .090* .104** .070 .096* .025 .020 .072 .104* .090 
Parents: Suicidality .132** .122** .122** .123** .039 .044 .041 .094* .113** .170** .117* 
Parents: Substance Use .105* .104* .106** .121** .038 .034 .113* .104* -.001 .043 .086 
Parents: Disruptive Behavior .141** .107* .148** .163** .045 .084 .128** .120* .048 .080 .091 
Parents: Total Dx .260** .246** .168** .179** .067 .080 .099* .112* .186** .196** .216** 
Live with both parents -.058 -.016 -.200** -.178** -.101* -.106* -.082 -.099* .050 -.011 -.017 
Live with one parent .037 .023 .119** .109** .096* .128** .085 .108* -.021 .004 -.023 
Live in blended family -.004 -.039 .035 .023 .019 -.017 -.028 -.042 -.037 -.027 .002 
Live with other .051 .051 .094* .090* -.006 .000 .046 .054 .007 .047 .061 
Family: No Dx -.075 -.064 -.052 -.077* -.032 -.029 .032 -.007 -.016 -.038 .022 
Family: ADHD .031 .012 -.005 .002 .054 .048 -.010 .003 .092* .055 .110* 
Family: Mania .000 .004 -.055 -.035 -.019 -.010 -.054 -.009 .015 -.009 -.052 
Family: Depression .089 .092* -.024 -.011 -.041 -.030 -.009 -.004 .068 .085 .034 
Family: Psychosis .057 .042 .068 .085* -.025 -.016 .055 .090 .102** .026 .135** 
Family: Anxiety .147** .126** .112** .141** .001 .020 -.103* -.072 .129** .105* .107* 
Family: Suicidality .218** .182** .103** .112** .061 .070 .036 .069 .080* .113** .057 
Family: Substance .166** .135** .148** .168** .110* .126** .080 .099* .099** .109* .108* 
Family: Disruptive Behavior .109* .086 .075 .110** -.002 .018 .026 .028 .102** .148** .137** 
BL Income: < $19,999 .152** .149** .108** .083* .094* .066 .034 .066 .022 .022 .054 
BL Income: $20,000-$39,999 -.116* -.137** -.014 .019 -.024 .006 .066 .036 -.037 -.052 -.058 
BL Income: $40000-$49999 -.046 -.059 -.087* -.102** -.096* -.092* -.076 -.098* -.075 .051 -.021 
BL Income: > $200000 -.051 -.019 -.043 -.038 -.007 -.017 -.063 -.079 .015 -.063 -.073 
Site .167** .144** .103** .141** .096* .106* .101* .045 .154** .164** .202** 
Continued 
2
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9
 
  
 
 
 
Table 13 continued 
  BL PGBI10 Tot BL ESM+ 
m12 PGBI10 
Tot 
m12 ESM+ 
m24 PGBI10 
Tot 
m24 ESM+ BL GBI-P Tot m24 GBI-P Tot m24 GBI-P Tot 
IQ -.123 -.052 -.175 -.159 -.152 -.109 -.082 -.097 -.095 
Sex .064 .087* .084 .108* .075 .074 .032 .098* .004 
Hispanic -.085* -.068 -.089* -.093* -.118* -.120* -.073 -.005 -.104* 
White .007 .020 -.036 -.055 -.028 -.032 -.051 -.094* -.060 
Parents: No Dx -.064 -.067 -.179** -.143** -.103* -.068 -.176** -.155** -.132** 
Parents: ADHD .027 -.001 .051 .048 .067 .042 .151** .130** .080 
Parents: Mania .235** .176** .202** .165** .169** .088 .307** .216** .203** 
Parents: Depression .064 .071 .089* .078 .119* .095* .278** .244** .207** 
Parents: Psychosis .132** .102** .066 .048 .131** .069 .135** .181** .210** 
Parents: Anxiety .051 .061 .063 .031 .099* .076 .208** .205** .242** 
Parents: Suicidality .102** .118** .083 .092* .095* .062 .235** .176** .201** 
Parents: Substance Use .030 .025 .087* .072 .120* .060 .107** .069 .095* 
Parents: Disruptive Behavior .090* .099* .197** .203** .133** .106* .121** .144** .108* 
Parents: Total Dx .148** .142** .202** .170** .243** .163** .382** .364** .376** 
Live with both parents -.074 -.091* -.074 -.121** -.098* -.117* -.091* -.079 -.061 
Live with one parent .008 .014 -.031 .002 -.041 -.025 .062 .091* .035 
Live in blended family .038 .070 .095* .128** .102* .121* .035 -.007 .042 
Live with other .050 .023 .037 .025 .080 .062 -.004 -.005 -.011 
Family: No Dx .026 .015 -.042 -.093* -.002 .002 -.065 -.114* -.104* 
Family: ADHD .022 -.001 .053 .016 .059 .017 .095* .092* .085 
Family: Mania .076 .092* .054 .076 -.032 -.045 .024 .031 .010 
Family: Depression -.003 .017 .066 .072 .020 -.031 .069 .070 .068 
Family: Psychosis .056 .083* .069 .079 .097* .076 .099* .095* .108* 
Family: Anxiety .062 .061 .034 .040 .105* .066 .079* .113* .178** 
Family: Suicidality .076 .073 .070 .097* .090 .042 .151** .067 .190** 
Family: Substance .041 .026 .083 .080 .070 .011 .126** .139** .166** 
Family: Disruptive Behavior .067 .070 .047 .074 .067 .064 .133** .113* .163** 
BL Income: < $19,999 .051 .035 .012 -.017 .044 -.030 .133** .163** .133** 
BL Income: $20,000-$39,999 -.073 -.063 -.018 .010 -.092* -.062 -.104** -.130** -.096* 
BL Income: $40000-$49999 .025 .025 .056 .023 .055 .030 -.031 .002 .046 
BL Income: > $200000 .020 .028 -.037 -.028 .010 .055 -.099* -.138** -.139** 
Site -.100** -.095* -.051 -.002 -.038 -.005 .091* .093* .114* 
Continued 
2
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Table 13 continued 
  BL CGAS m12 CGAS m24 CGAS BLalifeprimary 
BLalifesecondar
y 
BLalifepeer m12alifeprimary 
m12alifesecond
ary 
m12alifepeer 
IQ .150 .204 .193 .036 .041 .177 .093 -.006 .137 
Sex .040 -.006 -.011 -.105** -.078 .059 -.163** -.125* .040 
Hispanic .009 .082 .052 -.024 -.024 .011 .019 -.008 .022 
White -.021 .010 .035 -.008 -.024 -.010 .067 .038 .013 
Parents: No Dx .058 .153** .117* .011 .048 .034 .048 .025 .026 
Parents: ADHD -.074 -.122** -.105* .065 .042 -.031 .033 .040 -.024 
Parents: Mania -.113** -.056 -.072 -.071 -.018 -.074 -.056 .006 -.029 
Parents: Depression -.082* -.112* -.167** -.065 -.072 -.084* -.108* -.119* -.029 
Parents: Psychosis -.091* -.110* -.084 -.048 -.028 -.044 -.079 -.083 -.094* 
Parents: Anxiety -.088* -.171** -.130** -.029 .037 -.029 -.035 -.040 -.049 
Parents: Suicidality -.156** -.197** -.228** -.079* -.067 -.093* -.100* -.036 -.150** 
Parents: Substance Use -.061 -.127** -.131** .008 -.059 .028 -.064 -.044 -.018 
Parents: Disruptive Behavior -.130** -.205** -.199** .028 -.004 -.003 -.052 .014 -.055 
Parents: Total Dx -.200** -.265** -.301** -.052 -.034 -.073 -.104* -.019 -.087 
Live with both parents .013 .035 .050 .088* .049 -.022 .079 .104* -.050 
Live with one parent .006 .013 -.010 -.070 -.105* -.047 -.042 -.065 .013 
Live in blended family .011 .021 -.030 -.035 .043 .058 -.079 -.031 .049 
Live with other -.047 -.108* -.031 .018 .002 .041 .031 -.056 -.002 
Family: No Dx .065 .074 .071 .008 .029 .036 .000 -.034 .045 
Family: ADHD -.123** -.098* -.133** -.012 -.052 -.085* -.026 .034 -.022 
Family: Mania -.025 .007 .050 -.031 .030 -.034 .039 .065 .002 
Family: Depression -.070 -.088* -.065 -.079* -.102* -.069 -.039 -.087 -.098* 
Family: Psychosis -.138** -.038 -.104* -.035 -.068 -.029 .022 -.061 -.076 
Family: Anxiety -.126** -.094* -.144** .066 -.020 .026 .052 .007 -.021 
Family: Suicidality -.127** -.157** -.131** -.041 -.014 -.060 -.020 -.039 -.092* 
Family: Substance -.124** -.171** -.176** -.027 -.038 -.066 -.034 .048 -.047 
Family: Disruptive Behavior -.181** -.187** -.229** .026 .037 -.095* .009 .084 -.076 
BL Income: < $19,999 -.088* -.031 -.123** -.024 -.009 -.076* -.021 .069 -.012 
BL Income: $20,000-$39,999 .045 .092* .084 .055 .079 .016 .025 -.011 .032 
BL Income: $40000-$49999 .058 .000 .059 -.030 -.082 .049 .043 .007 .028 
BL Income: > $200000 .072 .035 .095* -.031 -.069 .030 .043 -.027 .012 
Site -.145** -.147** -.241** .014 .085* .033 .041 .056 .075 
Continued 
2
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Table 13 continued 
  
m24alifepri
mary 
m24alifesec
ondary 
m24alifepee
r 
BL Sig 
Health Prob 
m12 Sig 
Health Prob 
m24 Sig 
Health Prob 
BL 
Psychotic 
Dx 
BL BP Dx BL Dep Dx BL Anx Dx BL DBD Dx 
IQ .070 -.037 .114 .060 -.045 .055 -.020 -.034 .032 .032 -.076 
Sex -.162** -.118* -.017 -.077* .019 .063 .022 .126** .020 -.003 -.089* 
Hispanic -.004 .047 .048 .047 .057 .004 -.065 -.031 .042 -.014 -.001 
White .033 -.091 -.041 .154** .027 -.012 -.015 .076* -.005 .084* -.074 
Parents: No Dx .070 .060 .080 .010 -.028 .046 -.042 -.059 .009 .119** -.017 
Parents: ADHD -.018 -.054 .016 .012 .048 .027 .027 -.015 .028 .038 -.022 
Parents: Mania -.030 -.006 -.060 .023 .100* .027 .048 .201** .004 -.010 -.100* 
Parents: Depression -.121** -.134* -.121** .034 .055 .008 .008 .075 .010 .024 -.079* 
Parents: Psychosis -.054 .057 -.025 -.026 .017 -.004 .017 .061 .013 -.016 -.045 
Parents: Anxiety -.063 .036 -.103* .058 .118** .055 .019 .011 .055 -.009 -.019 
Parents: Suicidality -.081 -.099 -.156** .021 .103* .041 .059 .050 .050 .021 -.073 
Parents: Substance Use -.053 -.066 -.062 -.082* .100* -.004 -.020 .001 .042 -.086* .070 
Parents: Disruptive Behavior -.023 -.048 -.080 -.079* .095* -.011 .012 .082* -.069 -.067 .060 
Parents: Total Dx -.115* -.042 -.143** -.023 .127** .026 .056 .083* .029 -.010 -.037 
Live with both parents .073 .004 -.042 .127** -.026 -.068 -.009 .039 -.012 .094* -.051 
Live with one parent -.021 -.009 .023 -.024 -.062 .146** .044 -.094* .013 -.039 .033 
Live in blended family -.062 .009 .012 -.078* .061 -.045 -.005 .068 -.005 -.044 .002 
Live with other -.008 -.017 .013 -.059 .050 -.048 -.049 -.012 .010 -.028 .031 
Family: No Dx .016 -.010 .028 .004 -.009 .000 -.026 .018 .001 .023 -.048 
Family: ADHD .045 -.025 -.035 .047 .041 .068 .077* .026 .036 .017 -.031 
Family: Mania .107* .063 -.030 .026 .058 -.057 .099** .104** -.043 -.030 -.030 
Family: Depression .020 -.023 -.032 .026 -.017 -.044 .087* .039 .067 .008 -.102** 
Family: Psychosis -.032 -.060 -.094* -.051 .023 -.013 .090* .108** .003 -.032 -.085* 
Family: Anxiety .013 .018 -.085 .049 .046 -.014 .064 .017 .075* .043 -.096* 
Family: Suicidality .015 .042 -.077 .032 .045 -.039 .026 .064 .001 .017 -.076* 
Family: Substance -.033 .019 -.136** -.066 -.002 -.068 .058 .002 .013 -.051 .088* 
Family: Disruptive Behavior .064 .077 -.124** -.015 .073 -.044 .093* -.028 .023 .013 .006 
BL Income: < $19,999 -.044 -.008 -.071 .034 .089* -.035 .053 -.005 -.005 -.016 .005 
BL Income: $20,000-$39,999 .048 .102 .113* -.010 -.085 .045 -.023 -.051 .017 .017 .045 
BL Income: $40000-$49999 .030 -.092 -.065 .030 -.040 -.095* -.037 -.019 -.014 -.010 .000 
BL Income: > $200000 .026 -.015 -.012 -.009 -.081 .055 -.011 .045 -.021 .065 -.108** 
Site .044 .030 .045 -.057 .072 .037 -.062 -.237** .065 .076* .133** 
Continued 
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Table 13 continued 
  
BL ADHD 
Dx 
BL Oth Dx BL No Dx 
m12 
Psychotic 
Dx 
m12 BP Dx m12 Dep Dx m12 Anx Dx 
m12 DBD 
Dx 
m12 ADHD 
Dx 
m12 Oth Dx m12 No Dx 
IQ .052 .007 .046 -.075 .000 -.042 .025 -.072 .079 .027 .042 
Sex -.083* -.038 .065 -.054 .183** .057 .005 -.046 -.186** -.027 .018 
Hispanic .006 .035 .032 -.141** -.005 -.035 .006 .053 .025 -.024 .019 
White -.064 .026 -.056 -.048 .124** .047 .094* -.123** -.030 -.021 -.112* 
Parents: No Dx -.029 .061 -.042 -.043 -.061 -.026 .056 .020 -.003 -.043 .095* 
Parents: ADHD -.006 -.019 -.048 -.034 -.003 -.003 .104* -.005 -.065 -.063 .040 
Parents: Mania -.097* -.038 -.051 .051 .199** .036 -.028 -.150** -.060 .025 -.043 
Parents: Depression -.041 .028 -.013 .036 .092* .024 .017 -.043 -.081 -.018 -.020 
Parents: Psychosis -.041 -.031 .071 .064 .035 .068 -.006 -.025 -.118** -.016 .065 
Parents: Anxiety -.044 .006 -.022 -.034 .019 .128** .087* -.127** -.035 .018 -.046 
Parents: Suicidality -.056 -.069 .035 .093* .057 .085 -.022 -.013 -.099* -.027 -.043 
Parents: Substance Use -.027 -.078* .064 -.032 .032 .007 -.046 .086 -.054 .006 -.035 
Parents: Disruptive Behavior -.002 -.120** .054 .098* .053 -.103* -.095* .131** -.028 -.087* -.011 
Parents: Total Dx -.058 -.095* .001 .054 .091* .081 -.019 -.044 -.094* -.042 -.015 
Live with both parents -.057 .036 -.051 -.048 .041 -.008 .098* -.039 -.041 .015 -.053 
Live with one parent .103** -.032 -.020 .067 -.102* .043 -.029 .032 .056 -.009 -.019 
Live in blended family -.056 .009 .044 -.009 .048 -.074 -.063 .010 .020 -.037 .070 
Live with other .000 -.019 .055 -.010 .031 .046 -.031 -.014 -.040 .038 .025 
Family: No Dx .011 -.034 .065 -.022 -.025 -.044 .059 .062 -.037 -.060 .025 
Family: ADHD -.038 -.047 -.054 .011 .049 .070 -.032 -.031 -.052 -.017 .018 
Family: Mania -.064 .028 -.011 .067 .114** -.009 -.016 -.084 -.071 .033 .020 
Family: Depression -.017 -.022 -.033 .015 .083 .051 .027 -.138** .010 .041 -.082 
Family: Psychosis -.032 -.027 .011 .028 .063 .063 -.040 -.058 -.069 .061 .013 
Family: Anxiety -.048 .012 -.035 -.051 .025 .160** .051 -.142** -.006 .025 -.066 
Family: Suicidality -.011 .008 -.019 .090* .045 .017 .000 -.089* .007 .001 -.027 
Family: Substance -.034 -.056 -.085* -.026 -.005 .078 -.024 -.022 -.003 .051 -.026 
Family: Disruptive Behavior -.015 -.056 -.021 .026 .036 .077 -.038 .004 -.031 -.062 -.053 
BL Income: < $19,999 .009 .004 -.027 .082 .028 -.001 .064 -.096* -.046 .056 .008 
BL Income: $20,000-$39,999 -.039 .025 .022 -.063 -.068 -.025 -.055 .053 .096* -.005 .020 
BL Income: $40000-$49999 .062 -.001 .006 .022 -.020 .059 -.009 -.014 -.007 .022 -.020 
BL Income: > $200000 .050 .014 -.046 -.050 .084 -.030 .013 -.059 .015 -.050 .030 
Site .039 -.045 -.026 -.036 -.199** .067 .033 .153** .027 -.071 -.016 
Continued 
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Table 13 continued 
  
m24 
Psychotic 
Dx 
m24 BP Dx m24 Dep Dx m24 Anx Dx 
m24 DBD 
Dx 
m24 ADHD 
Dx 
m24 Oth Dx m24 No Dx 
BL School 
Chall 
m12 School 
Chall 
m24 School 
Chall 
IQ -.074 .013 -.057 .008 -.053 .058 -.012 .058 -.302 -.217 -.254 
Sex -.067 .142** .103* -.007 -.057 -.159** -.050 .023 -.059 -.088* -.050 
Hispanic -.038 -.043 .041 -.005 -.015 .009 .029 .044 -.028 -.074 -.096* 
White -.023 .103* -.098* .125** -.146** -.012 .020 .011 -.074 -.116** -.092* 
Parents: No Dx -.039 -.029 -.089 .005 -.024 .088 -.035 .075 -.043 .016 .014 
Parents: ADHD -.016 -.024 .072 .044 .014 -.052 -.076 .008 .060 .087* .131** 
Parents: Mania .002 .202** .045 -.047 -.124* -.067 -.063 -.029 .007 -.017 .015 
Parents: Depression .037 .142** .104* .001 -.084 -.128** .016 -.067 -.020 -.088* -.007 
Parents: Psychosis .042 .006 .129** -.034 -.024 -.075 -.047 .029 -.007 .035 .072 
Parents: Anxiety -.009 .021 .025 .063 -.054 -.025 .081 -.051 .093* .046 .127** 
Parents: Suicidality .069 .045 .119* -.047 -.028 -.080 .014 -.032 .030 .075 .040 
Parents: Substance Use .034 .051 .004 -.061 .090 -.079 -.037 -.029 .050 .057 .019 
Parents: Disruptive Behavior .112* .026 .023 -.095* .037 -.032 .012 -.020 .095* .087* .124** 
Parents: Total Dx .087 .113* .108* -.075 -.034 -.094* -.043 -.052 .127** .105* .197** 
Live with both parents -.018 -.001 -.046 .113* -.052 -.006 -.028 .018 -.050 -.069 -.085 
Live with one parent .009 -.072 .047 -.070 .107* .058 -.044 -.059 .037 .012 .052 
Live in blended family .011 .101* .014 -.094* .001 -.071 .030 .007 -.043 -.012 -.033 
Live with other .003 -.016 -.012 .049 -.087 .006 .074 .055 .084* .114** .105* 
Family: No Dx -.054 -.025 .030 .016 .045 -.002 -.048 -.022 -.049 .001 .001 
Family: ADHD .073 .015 -.039 .040 -.022 -.031 .069 -.021 .124** .084 .147** 
Family: Mania .144** .063 -.045 .012 -.096* -.109* -.009 .138** .002 -.009 -.093* 
Family: Depression .099* .040 .029 .021 -.089 -.050 .044 .005 -.025 -.014 -.037 
Family: Psychosis .099* .026 -.011 .041 -.001 -.130** .082 .017 .073 .119** .072 
Family: Anxiety .048 .051 .024 .089 -.118* -.047 .054 -.027 .130** .073 .111* 
Family: Suicidality .031 .059 -.005 -.003 -.060 -.005 .055 -.034 .090* .114** .111* 
Family: Substance .056 .049 .016 .015 -.021 -.049 -.002 -.039 .120** .094* .121** 
Family: Disruptive Behavior .057 .052 .027 .021 -.035 -.020 .006 -.085 .055 .187** .181** 
BL Income: < $19,999 .018 .012 .028 .040 .020 -.096* -.015 .006 .099** .048 .139** 
BL Income: $20,000-$39,999 .019 -.087 -.063 .014 .030 .108* .043 -.026 -.023 -.035 -.116* 
BL Income: $40000-$49999 -.034 .009 -.013 -.031 -.067 .079 .047 .014 .002 .023 -.001 
BL Income: > $200000 .010 .062 .029 -.045 -.053 -.032 -.039 .047 -.084* -.063 -.061 
Site .024 -.162** .092* .101* .107* -.003 -.101* -.056 .018 .081 .188** 
Continued 
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Table 13 continued 
 
BL School 
Services 
m12 School 
Services 
m24 School 
Services 
BL Inpatient 
m12 
Inpatient 
m24 
Inpatient 
BL 
Outpatient 
m12 
Outpatient 
m24 
Outpatient 
BL Inpatient 
Number 
m12 
Inpatient 
Number 
IQ -.106** -.261** -.134** .042 -.087 .047 -.031 -.042 -.054 -.056 -.072 
Sex -.073 -.091* -.057 .021 -.001 .095 -.056 -.039 .049 -.043 .002 
Hispanic .017 -.037 -.004 -.054 -.006 -.023 -.040 -.003 -.069 -.035 -.014 
White -.020 -.061 -.043 .048 .000 -.049 -.016 .040 .163** -.010 -.025 
Parents: No Dx -.064 -.014 -.007 -.061 .042 -.037 .064 .057 -.001 -.035 .010 
Parents: ADHD .128** .060 .075 -.028 -.085 -.061 -.007 -.055 -.043 -.028 -.068 
Parents: Mania -.010 .016 .023 .111** .057 -.001 -.126** -.055 .034 .105** .039 
Parents: Depression -.038 -.029 -.012 .065 -.055 .098* -.078* -.086* .055 .024 -.060 
Parents: Psychosis -.018 .005 .005 .031 .062 .003 -.022 -.035 .027 .025 .042 
Parents: Anxiety .089* .024 -.004 -.003 -.052 .089 .050 -.079 .042 -.018 -.042 
Parents: Suicidality .046 .058 .015 .113** .106* -.056 -.045 -.031 .031 .134** .096* 
Parents: Substance Use .024 .034 .082 .034 .044 .031 .016 .031 .014 -.016 .046 
Parents: Disruptive Behavior .038 .092* .124** .008 .060 .075 .004 -.003 .006 .041 .090 
Parents: Total Dx .082* .056 .063 .025 .034 .056 -.012 -.061 -.013 .025 .041 
Live with both parents .003 -.069 -.055 -.018 -.069 -.108* -.015 .028 .098* -.042 -.053 
Live with one parent -.010 .038 .035 .012 -.034 .027 -.001 -.025 -.110* .009 -.039 
Live in blended family .005 -.001 -.024 .007 .037 -.001 .018 -.013 .020 .057 .024 
Live with other -.001 .055 .061 .002 .116* .131** .007 .008 -.019 -.025 .111* 
Family: No Dx -.099** -.079 -.041 .043 .052 -.074 .052 .052 -.010 .003 .011 
Family: ADHD .145** .062 .066 -.038 -.023 .058 .022 -.073 .001 -.058 -.031 
Family: Mania .074 -.031 .018 -.002 -.001 -.018 -.133** -.091* .002 .005 -.013 
Family: Depression .097* -.031 .025 .037 -.091* .096* .041 -.007 .073 -.039 -.049 
Family: Psychosis .083* .063 .097* .009 .040 -.018 .031 .074 .050 .019 .086 
Family: Anxiety .082* -.018 .023 -.022 -.050 .024 .071 -.035 .050 -.004 -.049 
Family: Suicidality .035 .136** .024 .028 .022 .024 .016 .001 .053 .058 .048 
Family: Substance .096* .079 .081 -.022 -.085 .069 .056 .006 .048 -.016 -.029 
Family: Disruptive Behavior .088* .037 .131** -.021 -.012 .002 .038 -.014 -.002 -.026 -.005 
BL Income: < $19,999 .038 .019 .092* -.064 .021 -.023 -.010 .030 .026 -.027 -.010 
BL Income: $20,000-$39,999 -.029 .014 -.013 .023 -.026 -.009 -.044 -.054 -.005 -.015 -.030 
BL Income: $40000-$49999 .066 .032 .003 -.054 -.068 -.065 .044 .015 -.047 .000 -.061 
BL Income: > $200000 -.046 -.056 -.158** .029 -.041 .018 -.012 .035 .028 -.010 -.049 
Site .005 .063 .072 -.061 -.015 .105* -.003 .001 -.091* -.055 .004 
Continued 
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Table 13 continued 
 m24 Inpatient Number BL Outpatient Professionals m12 Outpatient Professionals m24 Outpatient Professionals 
IQ -.003 .001 -.002 -.020 
Sex .095 -.008 -.021 .076 
Hispanic .004 -.026 -.020 -.054 
White -.013 .098* .117* .130** 
Parents: No Dx -.032 -.012 .046 .045 
Parents: ADHD -.059 .079* -.039 -.062 
Parents: Mania .057 .081* .008 .010 
Parents: Depression .071 .014 .001 -.001 
Parents: Psychosis .006 -.018 -.040 .001 
Parents: Anxiety .027 .028 -.020 -.027 
Parents: Suicidality .000 .051 -.024 .038 
Parents: Substance Use .006 .016 .010 .087 
Parents: Disruptive Behavior .019 -.019 -.066 .004 
Parents: Total Dx .034 .045 -.035 .005 
Live with both parents -.033 .055 .054 .075 
Live with one parent .027 -.043 -.102* -.127** 
Live in blended family -.039 -.038 -.013 .026 
Live with other .062 .031 .087 .034 
Family: No Dx -.054 -.067 -.018 .018 
Family: ADHD .047 .046 -.033 .012 
Family: Mania -.013 .000 -.047 -.002 
Family: Depression .056 .018 .007 -.002 
Family: Psychosis -.034 -.002 .065 .129** 
Family: Anxiety -.003 .012 .080 .061 
Family: Suicidality .009 .091* .018 .075 
Family: Substance -.035 .041 .050 .093 
Family: Disruptive Behavior .004 -.008 .005 .025 
BL Income: < $19,999 .048 .024 .006 .054 
BL Income: $20,000-$39,999 -.048 -.057 -.090* -.045 
BL Income: $40000-$49999 -.042 .035 -.009 -.048 
BL Income: > $200000 -.011 .018 .027 -.042 
Site .035 -.022 -.007 .021 
Continued 
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Table 13 continued 
 
  Sex Hispanic White 
Parents: No 
Dx 
Parents: ADD 
Parents: 
Mania 
Parents: 
Depression 
Parents: 
Psychosis 
Parents: 
Anxiety 
Parents: 
Suicidality 
IQ -.040 .025 .246** .015 -.010 .010 .109** -.071 -.034 -.064 
Sex 1 .029 -.027 .014 -.054 .018 .045 .052 -.014 .050 
Hispanic .029 1 .051 -.034 -.017 .021 .059 -.068 -.014 -.021 
White -.027 .051 1 .071 .011 .070 .116** -.121** .005 -.022 
Parents: No Dx .014 -.034 .071 1 -.176** -.150** -.384** -.102** -.308** -.157** 
Parents: ADHD -.054 -.017 .011 -.176** 1 .139** .141** .093* .157** .129** 
Parents: Mania .018 .021 .070 -.150** .139** 1 .339** .274** .110** .259** 
Parents: Depression .045 .059 .116** -.384** .141** .339** 1 .134** .270** .282** 
Parents: Psychosis .052 -.068 -.121** -.102** .093* .274** .134** 1 .237** .265** 
Parents: Anxiety -.014 -.014 .005 -.308** .157** .110** .270** .237** 1 .173** 
Parents: Suicidality .050 -.021 -.022 -.157** .129** .259** .282** .265** .173** 1 
Parents: Substance Use .009 .067 -.103** -.261** .103** .192** .207** .127** .148** .234** 
Parents: Disruptive Behavior .025 .039 -.253** -.373** .129** .098* .157** .155** .174** .296** 
Parents: Total Dx .020 -.033 -.106** -.347** .385** .474** .466** .468** .510** .531** 
Live with both parents -.039 .049 .331** .095* .011 -.038 .020 -.090* -.017 -.142** 
Live with one parent .009 .003 -.241** -.087* .001 -.032 -.059 -.010 .033 .057 
Live in blended family .010 -.019 -.021 -.032 .019 .058 .082* .107** .069 .122** 
Live with other .032 -.061 -.116** .031 -.051 .036 -.053 .015 -.117** -.033 
Family: No Dx .066 -.049 -.055 .268** -.152** -.039 -.224** -.078* -.221** -.114** 
Family: ADHD -.029 -.048 .041 -.019 .144** .023 .043 .020 .069 .037 
Family: Mania .026 .015 .104** -.042 .011 .189** .113** .011 -.016 .017 
Family: Depression .022 .019 .163** -.149** .128** .097* .309** .067 .131** .071 
Family: Psychosis -.008 -.035 -.043 -.050 .042 .029 .084* .202** .081* .052 
Family: Anxiety -.038 .008 .064 -.153** .133** -.016 .144** .127** .384** .096* 
Family: Suicidality -.015 -.054 .022 -.061 .119** .102* .141** .115** .107** .222** 
Family: Substance -.033 .064 -.019 -.191** .173** .057 .165** .076* .152** .104** 
Family: Disruptive Behavior -.099** -.035 -.054 -.154** .157** .028 .082* .103** .188** .110** 
BL Income: < $19,999 .034 .038 -.047 -.030 .037 .046 .003 .081* .107** .101** 
BL Income: $20,000-$39,999 -.024 -.016 -.030 .016 -.063 -.016 -.013 -.121** -.066 -.092* 
BL Income: $40000-$49999 -.025 -.040 .050 .007 -.006 -.046 -.037 -.050 -.032 -.031 
BL Income: > $200000 .024 -.009 .089* -.001 .033 .004 .042 -.030 -.109** -.061 
Site -.059 .018 -.094* -.069 .103** -.010 .066 .116** .164** .097* 
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Table 13 continued 
 
Parents: 
Substance Use 
Parents: 
Disruptive 
Behavior 
Parents: Total 
Dx 
Live with both 
parents 
Live with one 
parent 
Live in 
blended 
family 
Live with 
other 
Family: No 
Dx 
Family: 
ADHD 
Family: Mania 
IQ -.009 -.206** -.100* .131** -.126** .002 -.008 -.007 -.026 .043 
Sex .009 .025 .020 -.039 .009 .010 .032 .066 -.029 .026 
Hispanic .067 .039 -.033 .049 .003 -.019 -.061 -.049 -.048 .015 
White -.103** -.253** -.106** .331** -.241** -.021 -.116** -.055 .041 .104** 
Parents: No Dx -.261** -.373** -.347** .095* -.087* -.032 .031 .268** -.019 -.042 
Parents: ADHD .103** .129** .385** .011 .001 .019 -.051 -.152** .144** .011 
Parents: Mania .192** .098* .474** -.038 -.032 .058 .036 -.039 .023 .189** 
Parents: Depression .207** .157** .466** .020 -.059 .082* -.053 -.224** .043 .113** 
Parents: Psychosis .127** .155** .468** -.090* -.010 .107** .015 -.078* .020 .011 
Parents: Anxiety .148** .174** .510** -.017 .033 .069 -.117** -.221** .069 -.016 
Parents: Suicidality .234** .296** .531** -.142** .057 .122** -.033 -.114** .037 .017 
Parents: Substance Use 1 .398** .531** -.268** .095* .097* .151** -.103** .048 .035 
Parents: Disruptive Behavior .398** 1 .520** -.308** .157** .115** .090* -.174** .094* -.029 
Parents: Total Dx .531** .520** 1 -.182** .060 .118** .041 -.225** .148** .041 
Live with both parents -.268** -.308** -.182** 1 -.529** -.393** -.243** .046 .007 .037 
Live with one parent .095* .157** .060 -.529** 1 -.364** -.225** -.054 -.035 -.011 
Live in blended family .097* .115** .118** -.393** -.364** 1 -.167** -.065 -.014 -.021 
Live with other .151** .090* .041 -.243** -.225** -.167** 1 .095* .069 -.011 
Family: No Dx -.103** -.174** -.225** .046 -.054 -.065 .095* 1 -.245** -.164** 
Family: ADHD .048 .094* .148** .007 -.035 -.014 .069 -.245** 1 .075 
Family: Mania .035 -.029 .041 .037 -.011 -.021 -.011 -.164** .075 1 
Family: Depression .065 .014 .178** .070 -.041 -.010 -.034 -.385** .101** .282** 
Family: Psychosis .044 .027 .155** .005 -.029 .017 .018 -.172** .126** .214** 
Family: Anxiety .081* .146** .279** .035 -.015 .024 -.060 -.390** .206** .084* 
Family: Suicidality .155** .144** .258** -.057 .083* -.013 -.025 -.221** .077* .155** 
Family: Substance .267** .237** .304** -.067 .021 .053 .003 -.472** .165** .093* 
Family: Disruptive Behavior .128** .228** .284** -.008 -.037 .011 .063 -.224** .252** .068 
BL Income: < $19,999 .004 .063 .161** -.033 .058 -.032 .000 .057 .040 .022 
BL Income: $20,000-$39,999 -.024 -.020 -.118** -.032 .010 .026 .004 -.057 -.004 .017 
BL Income: $40000-$49999 .003 -.011 -.074 .003 .007 -.017 .010 -.016 .005 -.021 
BL Income: > $200000 -.003 -.098* -.090* .094* -.016 -.059 -.046 .024 .001 -.022 
Site .129** .158** .229** -.119** .068 .046 .028 -.099** .076* -.070 
Continued 
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Table 13 continued 
 
Family: 
Depression 
Family: 
Psychosis 
Family: 
Anxiety 
Family: 
Suicidality 
Family: 
Substance 
Family: 
Disruptive 
Behavior 
BL Income: 
< $19,999 
BL Income: 
$20,000-
$39,999 
BL Income: 
$40000-
$49999 
BL Income: 
> $200000 
Site 
IQ .075 -.045 -.025 -.117** -.066 -.091* -.120** .018 .033 .135** .057 
 
Sex .022 -.008 -.038 -.015 -.033 -.099** .034 -.024 -.025 .024 -.059 
Hispanic .019 -.035 .008 -.054 .064 -.035 .038 -.016 -.040 -.009 .018 
White .163** -.043 .064 .022 -.019 -.054 -.047 -.030 .050 .089* -.094* 
Parents: No Dx -.149** -.050 -.153** -.061 -.191** -.154** -.030 .016 .007 -.001 -.069 
Parents: ADHD .128** .042 .133** .119** .173** .157** .037 -.063 -.006 .033 .103** 
Parents: Mania .097* .029 -.016 .102* .057 .028 .046 -.016 -.046 .004 -.010 
Parents: Depression .309** .084* .144** .141** .165** .082* .003 -.013 -.037 .042 .066 
Parents: Psychosis .067 .202** .127** .115** .076* .103** .081* -.121** -.050 -.030 .116** 
Parents: Anxiety .131** .081* .384** .107** .152** .188** .107** -.066 -.032 -.109** .164** 
Parents: Suicidality .071 .052 .096* .222** .104** .110** .101** -.092* -.031 -.061 .097* 
Parents: Substance Use .065 .044 .081* .155** .267** .128** .004 -.024 .003 -.003 .129** 
Parents: Disruptive Behavior .014 .027 .146** .144** .237** .228** .063 -.020 -.011 -.098* .158** 
Parents: Total Dx .178** .155** .279** .258** .304** .284** .161** -.118** -.074 -.090* .229** 
Live with both parents .070 .005 .035 -.057 -.067 -.008 -.033 -.032 .003 .094* -.119** 
Live with one parent -.041 -.029 -.015 .083* .021 -.037 .058 .010 .007 -.016 .068 
Live in blended family -.010 .017 .024 -.013 .053 .011 -.032 .026 -.017 -.059 .046 
Live with other -.034 .018 -.060 -.025 .003 .063 .000 .004 .010 -.046 .028 
Family: No Dx -.385** -.172** -.390** -.221** -.472** -.224** .057 -.057 -.016 .024 -.099** 
Family: ADHD .101** .126** .206** .077* .165** .252** .040 -.004 .005 .001 .076* 
Family: Mania .282** .214** .084* .155** .093* .068 .022 .017 -.021 -.022 -.070 
Family: Depression 1 .214** .255** .214** .173** .130** -.036 -.010 .001 .086* -.030 
Family: Psychosis .214** 1 .262** .192** .126** .177** .018 -.031 .005 -.073 .065 
Family: Anxiety .255** .262** 1 .219** .257** .301** .008 -.006 -.003 -.042 .126** 
Family: Suicidality .214** .192** .219** 1 .229** .167** .100** -.076* .000 -.064 .049 
Family: Substance .173** .126** .257** .229** 1 .317** -.029 .021 -.037 -.007 .138** 
Family: Disruptive Behavior .130** .177** .301** .167** .317** 1 .030 -.021 -.003 -.079* .157** 
BL Income: < $19,999 -.036 .018 .008 .100** -.029 .030 1 -.591** -.240** -.303** .069 
BL Income: $20,000-$39,999 -.010 -.031 -.006 -.076* .021 -.021 -.591** 1 -.148** -.187** -.025 
BL Income: $40000-$49999 .001 .005 -.003 .000 -.037 -.003 -.240** -.148** 1 -.076* -.088* 
BL Income: > $200000 .086* -.073 -.042 -.064 -.007 -.079* -.303** -.187** -.076* 1 -.147** 
Site -.030 .065 .126** .049 .138** .157** .069 -.025 -.088* -.147** 1 
Continued 
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Table 13 continued 
Note. BL = Baseline; m12 = 12-Month assessment; m24 = 24-Month assessment; IQ = Intelligence Quotient; KINDL = Revididerter KINDer Lebensqualiatsfragebogen; CGI = Clinical 
Global Impression Scale – Severity; NoMeds = No medication; AnyMed = An medication; Antipsychotic = Antipsychotic medication; Antidep = Antidepressant medication; Anxiolytic = 
Anxiolytic medication; OthMeds = Other Medication; MoodStab = Mood stabilizer; Stim = Simulant medication; PSS_Num Stress = Parent Stress Survey -  Number of Stressors; PSS_Tot 
Stress= Parent Stress Survey – Total Stress; NumDx = Number of diagnoses; PGBI10 = Parent General Behavior Inventory – 10-Item Mania Scale; ESM+ = Elevated symptoms of mania – 
Positive; alifeprimary = Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up Evaluation – Primary caregiver; alifesecondary = Psychosocial Schedule of the Adolescent 
Longitudinal Interval Follow-Up Evaluation – Secondary caregiver; alifepeer = Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up Evaluation – Peers; Sig Health 
Prob = Significant health problems; Psychotic Dx = Psychotic disorder diagnostic category; Bp Dx = Bipolar spectrum disorder diagnostic category; Dep Dx = Depressive Spectrum Disorder 
diagnostic category; Anx Dx = Anxiety Disorder diagnostic category; DBD Dx = Disruptive behavior disorder diagnostic category; ADHD Dx = Attention-Deficit/Hyperactivity Disorder 
diagnostic category; Oth Dx = Other diagnoses diagnostic category; No Dx = No diagnosis; School Chall = School challenges. *Correlation is significant at the 0.05 level (2-tailed); 
**Correlation is significant at the 0.01 level (2-tailed). 
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Table 14 
Parameter estimates for hypothesized and exploratory time-varying (Level 1) covariates with parent-reported QoL as outcome 
Outcome: P-KINDL 
Time-Varying (Level 1) Predictor 
(Slope) 
  
 
Unconditional 
Means Model 
Unconditional 
Growth Model 
Growth Model 
with CGI as 
Predictor (“Base 
Model”) 
A-LIFE – Primary 
Caregiver
H 
A-LIFE- 
Secondary 
Caregiver
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 58.98 (0.43)*** 58.97 (0.43)*** 65.16 (0.68)*** 64.22 (0.73)*** 64.27 (0.73)*** 
  
Time-Varying 
Predictor Slope
1
 
γ01 -- -- -- -0.59 (2.13)ns -0.78 (2.22)ns 
 
Rate of Change 
(Age
2), π1i 
Intercept γ10 -- -0.064 (0.22)ns
3
 -0.23 (0.21)ns -0.26 (0.19)ns -0.15 (0.19)ns 
  
Time-Varying 
Predictor Slope 
γ11 -- -- -- 4.08 (0.52)*** 3.34 (0.54)*** 
 
Slope of Symptom 
Severity (CGI
4), π2i 
Intercept γ20 -- -- -2.76 (0.25)*** -2.35 (0.28)*** -2.37 (0.27)*** 
  
Time-Varying 
Predictor Slope 
γ21 -- -- -- 0.11 (0.77)ns 0.24 (0.79)ns 
Variance Components 
 Level 1 Within-person εij 76.39 (3.98)*** 76.14 (3.88)*** 69.84 (4.34)*** 79.81 (4.42)*** 79.59 (4.19)*** 
 Level 2 In Initial Status ζ0i 68.61 (6.48)*** 67.09 (7.22)** 62.73 (12.68)*** -- -- 
  In Rate of Change ζ1i -- 0.34 (0.89)ns
5
 -- 2.92 (0.82)* 3.36 (0.85)* 
  
In Slope of Symptom 
Severity 
ζ2i -- -- 0.39 (1.43)ns
6
 5.59 (0.80)*** 5.69 (0.84)*** 
Continued 
                                                 
1
 Slopes of Time-Varying Predictors were extracted by running separate models with Time-Varying Predictors as the outcome variable and Age as a Level-1 Predictor. Individual 
slopes were extracted for each child, averaged across imputations, and entered as Level-2 Predictors in the current models.  
2
 Age was centered at the grand mean. 
3
 This effect (fixed effect of Age) was retained in subsequent models to preserve the longitudinal nature of the study design and data structure.  
4
 CGI was centered at the lowest rating of 1 (“Normal”). 
5
 This effect (random effect of Age) was removed from subsequent models due to its non-significant statistic. 
6
 This effect (random effect of CGI) was removed from subsequent models due to its non-significant statistic. 
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Table 14 continued 
Outcome: P-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 A-LIFE – Peers
H
 
Number of 
Diagnoses
H
 
No Medication
H
 
Antipsychotic 
Medication
H
 
Antidepressant 
Medication
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 63.95 (0.80)*** 63.77 (0.80)*** 64.54 (0.76)*** 64.53 (0.76)*** 64.74 (0.79)*** 
  
Time-Varying 
Predictor Slope 
γ01 0.52 (1.92)ns 1.55 (1.23)ns 0.75 (3.51)ns 5.61 (3.56)ns -3.99 (4.32)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.49 (0.20)* -0.47 (0.20)* -0.26 (0.20)ns -0.24 (0.19)ns -0.23 (0.20)ns 
  
Time-Varying 
Predictor Slope 
γ11 3.31 (0.53)*** -1.44 (0.39)** 1.13 (1.06)ns -1.69 (0.97)~ -1.07 (1.23)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.26 (0.30)*** -2.17 (0.30)*** -2.48 (0.29)*** -2.47 (0.28)*** -2.59 (0.30)*** 
 
 
Time-Varying 
Predictor Slope 
γ21 -0.20 (0.66)ns -0.49 (0.45)ns 0.62 (1.31)ns -2.50 (1.21)ns 2.09 (1.70)ns 
Variance Components 
 Level 1 Within-person εij 79.39 (4.21)*** 70.10 (4.34)*** 78.84 (4.32)*** 78.6 (4.35)*** 78.76 (4.33)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 3.39 (0.85)* 3.98 (0.89)** 4.21 (0.90)** 4.24 (0.90)** 4.24 (0.90)** 
  
In Slope of 
Symptom Severity 
ζ2i 5.62 (0.84)*** 5.71 (0.85)*** 5.96 (0.87)*** 5.87 (0.86)*** 5.98 (0.87)*** 
Continued 
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Table 14 continued 
Outcome: P-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 
Anxiolytic 
Medication
H7
 
Stimulant 
Medication
H
 
Mood Stabilizer 
Medication
H
 
Other 
Medication
H
 
School Services
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 -- 64.64 (0.77)*** 64.57 (0.76)*** 64.58 (0.76)*** 64.41 (0.78)*** 
  
Time-Varying 
Predictor Slope 
γ01 -- -1.78 (3.45)ns 3.47 (5.59)ns -2.26 (4.46)ns -1.33 (3.58)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -- -0.26 (0.19)ns -0.24 (0.19)ns -0.26 (0.20)ns -0.28 (0.20)ns 
  
Time-Varying 
Predictor Slope 
γ11 -- 0.68 (0.96)ns -2.18 (1.62)ns 0.50 (1.26)ns -1.83 (1.04)~ 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -- -2.52 (0.29)*** -2.50 (0.28)*** -2.49 (0.28)*** -2.44 (0.29)*** 
 
 
Time-Varying 
Predictor Slope 
γ21 -- 0.41 (1.27)ns -1.03 (1.87)ns 1.35 (1.68)ns 0.34 (1.28)ns 
Variance Components 
 Level 1 Within-person εij -- 78.73 (4.34)*** 78.92 (4.31)*** 78.79 (4.32)*** 78.68 (4.31)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i -- 4.33 (0.90)** 4.24 (0.91)** 4.28 (0.90)** 4.25 (0.89)** 
  
In Slope of 
Symptom Severity 
ζ2i -- 5.94 (0.86)*** 5.92 (0.87)*** 5.97 (0.87)*** 5.95 (0.86)*** 
Continued 
 
 
                                                 
7
 Model run to extract slope for Anxiolytic Medication did not converge. Hence, its effect on symptom severity was unable to be examined.  
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Table 14 continued 
Outcome: P-KINDL Time-Varying (Level 1) Predictor (Slopes) 
  
 
Inpatient 
Hospitalization
H
 
Number of 
Inpatient 
Hospitalizations
H
 
Outpatient 
Services
H
 
Number of 
Outpatient 
Professionals
H
 
CGAS
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 64.68 (0.76)*** 64.67 (0.75)*** 64.74 (0.76)*** 64.34 (0.79)*** 63.64 (0.86)*** 
  
Time-Varying 
Predictor Slope 
γ01 -10.57 (7.91)ns -6.43 (2.88)* -9.01 (4.41)* -0.07 (1.04)ns 0.15 (0.14)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.25 (0.19)ns -0.26 (0.19)ns -0.28 (0.19)ns -0.21 (0.20)ns -0.42 (0.21)~ 
  
Time-Varying 
Predictor Slope 
γ11 -0.88 (2.68)ns -0.81 (0.64)ns -0.57 (1.60)ns -0.80 (0.28)** 0.18 (0.05)** 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.52 (0.29)*** -2.52 (0.28)*** -2.53 (0.28)*** -2.39 (0.30)*** -2.18 (0.32)*** 
 
 
Time-Varying 
Predictor Slope 
γ21 2.63 (2.31)ns 1.82 (0.63)** 1.74 (1.78)ns -0.39 (0.40)ns -0.004 (0.05)ns 
Variance Components 
 Level 1 Within-person εij 78.70 (4.26)*** 78.71 (4.24)*** 78.49 (4.31)*** 78.98 (4.31)*** 78.66 (4.28)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 4.20 (0.91)** 4.11 (0.91)** 4.26 (0.90)** 4.06 (0.88)** 4.00 (0.92)** 
  
In Slope of 
Symptom Severity 
ζ2i 6.02 (0.87)*** 5.96 (0.87)*** 5.91 (0.86)*** 5.83 (0.86)*** 5.85 (0.86)*** 
Continued 
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Table 14 continued 
Outcome: P-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 
Significant 
Physical Health 
Problems
E8
 
Psychotic Disorder 
Diagnosis
E9
 
Bipolar Spectrum 
Disorder 
Diagnosis
E
 
Depressive 
Spectrum Disorder 
Diagnosis
E
 
Anxiety Disorder 
Diagnosis
E
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 -- 64.51 (0.76)*** 64.55 (0.76)*** 64.39 (0.74)*** 64.61 (0.78)*** 
  
Time-Varying 
Predictor Slope 
γ01 -- -3.32 (13.39)ns -0.18 (4.01)ns -11.18 (6.31)~ 1.98 (4.88)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -- -0.28 (0.19)ns -0.24 (0.19)ns -0.30 (0.19)ns -0.27 (0.20)ns 
  
Time-Varying 
Predictor Slope 
γ11 -- -6.54 (4.29)ns -1.20 (0.98)ns -5.91 (1.60)** -1.14 (1.38)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -- -2.48 (0.29)*** -2.449 (0.28)*** -2.44 (0.28)*** -2.51 (0.29)*** 
 
 
Time-Varying 
Predictor Slope 
γ21 -- 1.26 (3.96)ns 0.68 (1.38)ns 3.22 (2.30)ns -0.99 (1.83)ns 
Variance Components 
 Level 1 Within-person εij -- 78.63 (4.29)*** 78.99 (4.33)*** 79.41 (4.49)*** 78.71 (4.28)*** 
 Level 2 In Initial Status ζ0i -- -- -- --  -- 
  In Rate of Change ζ1i -- 4.26 (0.90)** 4.25 (0.90)** 3.95 (0.87)** 4.27 (0.90)** 
  
In Slope of Symptom 
Severity 
ζ2i -- 5.99 (0.87)*** 5.90 (0.86)*** 5.57 (0.83)*** 6.01 (0.88)*** 
Continued 
                                                 
8
 Model run to extract slope for Significant Physical Health Problems did not converge. Hence, its effect on symptom severity was unable to be 
examined. 
9
 This and subsequent diagnoses based on hierarchically-formed diagnostic groups.  
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Table 14 continued 
Outcome: P-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 
Disruptive 
Behavior Disorder 
Diagnosis
E
 
ADHD Diagnosis
E
 Other Diagnosis
E10
 No Diagnosis
E11
 
Parent Stress 
Survey – Number 
of Stressors
H 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 64.80 (0.76)*** 64.35 (0.74)*** -- -- 64.15 (0.74)*** 
  
Time-Varying 
Predictor Slope 
γ01 5.74 (3.99)ns -4.84 (4.53)ns -- -- 0.04 (0.39)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.27 (0.19)ns -0.21 (0.19)ns -- -- -0.41 (0.19)* 
  
Time-Varying 
Predictor Slope 
γ11 0.35 (1.15)ns 7.49 (1.40)*** -- -- -0.88 (0.10)*** 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.59 (0.28)*** -2.41 (0.28)*** -- -- -2.31 (0.28)*** 
 
 
Time-Varying 
Predictor Slope 
γ21 -2.70 (1.53)~ 1.74 (1.89)ns -- -- 0.07 (0.15)ns 
Variance Components 
 Level 1 Within-person εij 78.71 (4.31)*** 79.60 (4.38)*** -- -- 79.60 (4.35)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 4.19 (0.89)** 3.47 (0.86)* -- -- 2.98 (0.79)* 
  
In Slope of Symptom 
Severity 
ζ2i 6.00 (0.87)*** 5.57 (0.83)*** -- -- 5.39 (0.81)*** 
Continued 
 
                                                 
10
 Model to extract slope for Other Diagnosis did not converge. Hence, its effect on symptom severity was unable to be examined. 
11
 Model to extract slope for No Diagnosis did not converge. Hence, its effect on symptom severity was unable to be examined. 
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Table 14 continued 
Outcome: P-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 
Parent Stress 
Survey – Total 
Stress
H
 
Stressful Life 
Events Schedule 
(Parent) – Number 
of Stressors
H
 
Stressful Life 
Events Schedule 
(Parent) – Total 
Stress
H
 
Stressful Life 
Events Schedule 
(Child/Adolescent
) – Number of 
Stressors
H12
 
Stressful Life 
Events Schedule 
(Child) – Total 
Stress
H12 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 63.96 (0.74)*** 64.21 (0.75)*** 64.09 (0.75)*** 63.65 (0.78)*** 63.68 (0.76)*** 
  
Time-Varying 
Predictor Slope 
γ01 0.02 (0.12)ns -0.53 (0.30)~ -0.21 (0.10)* 0.05 (2.51)ns -0.97 (2.02)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.16 (0.18)ns -0.28 (0.20)ns -0.29 (0.19)ns -0.11 (0.18)ns -0.13 (0.18)ns 
  
Time-Varying 
Predictor Slope 
γ11 -0.26 (0.03)*** -0.41 (0.09)*** -0.18 (0.03)*** -0.66 (0.51)ns -0.81 (0.49)~ 
 Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.28 (0.28)*** -2.35 (0.28)*** -2.31 (0.28)*** -1.96 (0.29)*** -1.97 (0.28)*** 
  
Time-Varying 
Predictor Slope 
γ21 0.01 (0.05)ns 0.20 (0.11)~ 0.08 (0.04)* 0.25 (0.85)ns 0.43 (0.69)ns 
Variance Components 
 Level 1 Within-person εij 79.64 (4.36)*** 79.01 (4.34)*** 79.25 (4.28)*** 70.09 (3.90)*** 70.09 (3.91)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 2.86 (0.80)~ 3.82 (0.88)** 3.52 (0.86)** 3.58 (0.87)** 3.54 (0.87)** 
  
In Slope of Symptom 
Severity 
ζ2i 5.42 (0.82)*** 5.75 (0.86)*** 5.62 (0.85)*** 7.00 (0.79)*** 7.01 (0.80)*** 
Continued 
 
                                                 
12
 Slope of this variable is based on standardized scores to allow for child and adolescent versions to be combined.  
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Table 14 continued 
Outcome: P-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 
General Behavior 
Inventory – 
10item Mania 
Scale Total
E
 
Elevated 
Symptoms of 
Mania – PositiveE 
General Behavior 
Inventory (Parent 
Report) – TotalE 
Non-Medicaid
H
 
School 
Challenges
E
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 63.85 (0.78)*** 64.34 (0.78)*** 64.25 (0.75)*** 64.75 (0.76)*** 64.56 (0.75)*** 
  
Time-Varying 
Predictor Slope 
γ01 -0.28 (0.24)ns 0.82 (4.06)ns -0.03 (0.05)ns 4.28 (3.42)ns 2.53 (3.3.64)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.48 (0.20)* -0.43 (0.20)* -0.34 (0.19)ns -0.28 (0.19)ns -0.28 (0.20)ns 
  
Time-Varying 
Predictor Slope 
γ11 -0.41 (0.07)*** -4.96 (1.07)*** -0.06 (0.01)*** -1.99 (0.95)* -1.97 (1.00)* 
 Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.22 (0.29)*** -2.36 (0.28)*** -2.35 (0.28)*** -2.58 (0.28)*** -2.49 (0.28)*** 
  
Time-Varying 
Predictor Slope 
γ21 0.08 (0.09)ns 0.24 (1.47)ns 0.02 (0.02)ns -1.84 (1.32)ns -0.97 (1.32)ns 
Variance Components 
 Level 1 Within-person εij 79.29 (4.34)*** 78.83 (4.31)*** 78.74 (4.36)*** 78.85 (4.33)*** 78.49 (4.28)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 3.52 (0.89)** 3.94 (0.90)** 3.88 (0.88)* 4.29 (0.89)** 4.18 (0.90)** 
  
In Slope of Symptom 
Severity 
ζ2i 5.66 (0.83)*** 578 (0.86)*** 5.76 (0.84)*** 5.78 (0.86)*** 6.08 (0.88)*** 
Continued 
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Table 14 continued 
Outcome: P-KINDL Time-Varying (Level 1) Predictor (Slope) 
   Suicidality
E
 Psychosis
E
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 64.41 (0.77)*** 64.51 (0.76)*** 
  
Time-Varying 
Predictor Slope 
γ01 0.33 (9.16)ns -3.32 (13.39)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.27 (0.20)ns -0.28 (019)ns 
  
Time-Varying 
Predictor Slope 
γ11 -3.92 (1.80)* -6.54 (4.29)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.43 (0.29)*** -2.48 (0.29)*** 
  
Time-Varying 
Predictor Slope 
γ21 0.88 (2.98)ns 1.26 (3.96)ns 
Variance Components 
 Level 1 Within-person εij 78.88 (4.29)*** 78.63 (4.29)*** 
 Level 2 In Initial Status ζ0i -- -- 
  In Rate of Change ζ1i 4.17 (0.90)** 4.26 (0.90)** 
  
In Slope of Symptom 
Severity 
ζ2i 5.89 (0.86)*** 5.99 (0.87)*** 
Continued 
Note.  
H
= Covariate hypothesized to moderate the time-linked relationship between symptom severity and QoL; 
E
 = Covariate explored for potential 
moderating effects on the time-linked relationship between symptom severity and QoL; QoL = Quality of life; KINDL = Revididerter KINDer  
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Table 14 continued 
Lebensqualiatsfragebogen; P-KINDL = KINDL – Parent Report; CGI = Clinical Global Impression Scale – Overall current severity; A-LIFE = 
Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up Evaluation; CGAS= Children’s Global Assessment Scale; ADHD = 
Attention-Deficit/Hyperactivity Disorder. ~ p < .10; * p < .05; ** p < .01; *** p < .001; ns = non-significant.
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Table 15 
Parameter estimates for hypothesized and exploratory time-invariant (Level 2) covariates with parent-reported QoL as 
outcome 
Outcome: P-KINDL Time-Invariant (Level 2) Predictor 
  
 
Unconditional 
Means Model 
Unconditional 
Growth Model 
Growth Model with 
CGI as Predictor 
(“Base Model”) 
Site IQ
H 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 58.98 (0.43)*** 58.97 (0.43)*** 65.16 (0.68)*** 61.34 (1.55)*** 61.80 (4.91)*** 
  
Time-Invariant 
Predictor 
γ01 -- -- -- 1.44 (0.59)** 0.03 (0.05)ns 
 
Rate of Change 
(Age
1), π1i 
Intercept γ10 -- -0.064 (0.22)ns
2
 -0.23 (0.21)ns -0.15 (0.42)ns -0.96 (1.04)ns 
 
 
Time-Invariant 
Predictor 
γ11 -- -- -- -0.03 (0.15)ns 0.007 (0.01)ns 
 
Slope of Symptom 
Severity (CGI
3), π2i 
Intercept γ20 -- -- -2.76 (0.25)*** -2.85 (0.63)*** -1.57 (1.72)ns 
  
Time-Invariant 
Predictor 
γ21 
 
-- -- -- 0.07 (0.23)ns -0.01 (0.02)ns 
Variance Components 
 Level 1 Within-person εij 76.39 (3.98)*** 76.14 (3.88)*** 69.84 (4.34)*** 78.38 (4.33)*** 78.03 (4.12)*** 
 Level 2 In Initial Status ζ0i 68.61 (6.48)*** 67.09 (7.22)** 62.73 (12.68)*** -- -- 
  In Rate of Change ζ1i -- 0.34 (0.89)ns
4
 -- 4.13 (0.88)** 4.19 (0.88)** 
  
In Slope of 
Symptom Severity 
ζ2i -- -- 0.39 (1.43)ns
5
 5.64 (0.85)*** 5.96 (0.87)*** 
Continued 
                                                 
1
 Age was centered at the grand mean. 
2
 This effect (fixed effect of Age) was retained in subsequent models to preserve the longitudinal nature of the study design and data structure.  
3
 CGI was centered at the lowest rating of 1 (“Normal”). 
4
 This effect (random effect of Age) was removed from subsequent models due to its non-significant statistic. 
5
 This effect (random effect of CGI) was removed from subsequent models due to its non-significant statistic. 
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Table 15 continued 
Outcome: P-KINDL Time-Invariant (Level 2) Predictor 
  
 Sex (Female)
E 
Caucasian
E
 Hispanic
E
 
Parental 
Psychiatric 
History: No 
Diagnosis
E
 
Parental 
Psychiatric 
History: ADHD
E
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.45 (0.90)*** 66.00 (1.18)*** 66.89 (2.63)*** 64.79 (0.85)*** 64.34 (0.92)*** 
  
Time-Invariant 
Predictor 
γ01 -2.53 (1.45)~ -2.28 (1.47)ns -2.41 (2.83)ns 1.91 (2.35)ns 2..33 (1.73)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.29 (0.23)ns -0.19 (0.30)ns -0.08 (0.80)ns -0.21 (0.21)ns -0.13 (0.22)ns 
 
 
Time-Invariant 
Predictor 
γ11 0.18 (0.36)ns -0.112 (0.39)ns -0.19 (0.81)ns -0.11 (0.72)ns -0.31 (0.44)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.49 (0.35)*** -2.54 (0.43)*** -3.18 (1.05)** -2.60 (0.32)*** -2.34 (0.34)*** 
  
Time-Invariant 
Predictor 
γ21 
 
-0.11 (0.54)ns 0.10 (0.54)ns 0.71 (1.12)ns -0.25 (0.95)ns -1.06 (0.62)~ 
Variance Components 
 Level 1 Within-person εij 78.68 (4.31)*** 78.50 (4.27)*** 78.77 (4.31)*** 79.52 (4.56)*** 79.21 (4.60)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 4.09 (0.88)** 4.22 (0.90)** 4.29 (0.91)** 6.94 (0.94)* 3.93 (0.94)** 
  
In Slope of 
Symptom Severity 
ζ2i 5.84 (0.85)*** 5.92 (0.88)*** 5.96 (0.87)*** 6.26 (1.07)*** 6.32 (1.08)*** 
Continued 
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Table 15 continued 
Outcome: P-KINDL Time-Invariant (Level 2) Predictor 
  
 
Parental 
Psychiatric 
History: Mania
E
 
Parental 
Psychiatric 
History: 
Depression
E
 
Parental 
Psychiatric 
History: 
Anxiety
E
 
Parental 
Psychiatric 
History: 
Disruptive 
Behavior
E
 
Parental 
Psychiatric 
History: 
Substance Use
E
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.37 (0.93)*** 66.05 (1.32)*** 66.49 (1.03)*** 65.29 (1.16)*** 65.74 (1.02)*** 
  
Time-Invariant 
Predictor 
γ01 -2.20 (1.94)ns -1.77 (1.57)ns -3.08 (1.41)ns -0.52 (1.45)ns -1.88 (1.66)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.31 (0.22)ns -0.74 (0.30)* -0.34 (0.28)ns -0.36 (0.36)ns -0.27 (0.25)ns 
 
 
Time-Invariant 
Predictor 
γ11 0.51 (0.43)ns 0.85 (0.37)* 0.27 (0.39)ns 0.25 (0.44)ns 0.15 (0.36)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.44 (0.36)*** -2.52 (0.51)*** -3.09 (0.39)*** -2.86 (0.46)*** -2.80 (0.42)*** 
  
Time-Invariant 
Predictor 
γ21 
 
-0.69 (0.71)ns -0.14 (0.60)ns 0.95 (0.53)~ 0.37 (0.55)ns 0.42 (0.64)ns 
Variance Components 
 Level 1 Within-person εij 79.49 (4.59)*** 79.18 (4.50)*** 79.03 (4.49)*** 79.54 (4.58)*** 79.48 (4.53)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 3.87 (0.95)* 3.93 (0.95)* 3.82 (0.94)* 3.87 (0.93)* 3.82 (0.93)* 
  
In Slope of 
Symptom Severity 
ζ2i 5.91 (1.03)*** 6.12 (1.07)*** 6.39 (1.08)*** 6.32 (1.07)*** 6.33 (1.07)*** 
Continued 
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Table 15 continued 
Outcome: P-KINDL Time-Invariant (Level 2) Predictor 
  
 
Parental 
Psychiatric 
History: 
Suicidality
E
 
Parental 
Psychiatric 
History: 
Psychosis
E
 
Parental 
Psychiatric 
History: Total 
Diagnoses
E
 
Baseline Family 
Structure: Live 
with Both 
Parents
H
 
Familial 
Psychiatric 
History: No 
Diagnosis
E
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.14 (0.91)*** 65.15 (0.86)*** 65.98 (1.22)*** 64.18 (0.94)*** 64.43 (0.79)*** 
  
Time-Invariant 
Predictor 
γ01 -1.17 (2.07)ns -1.76 (2.36)ns 0.23 (0.19)*** 0.91 (1.44)ns 1.06 (1.75)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.33 (0.22)ns -0.20 (0.22)ns -0.42 (0.29)ns -0.16 (0.23)ns -0.17 (0.21)ns 
 
 
Time-Invariant 
Predictor 
γ11 0.54 (0.43)ns -0.04 (0.60)ns -0.04 (0.04)ns -0.31 (0.39)ns -0.66 (0.50)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.43 (0.36)*** -2.56 (0.34)*** -2.52 (0.46)*** -2.30 (0.34)*** -2.47 (0.30)*** 
  
Time-Invariant 
Predictor 
γ21 
 
-0.64 (0.72)ns -0.38 (0.84)ns 001 (0.06)ns -0.55 (0.54)ns -0.20 (0.70)ns 
Variance Components 
 Level 1 Within-person εij 79.12 (4.51)*** 79.58 (4.56)*** 79.42 (4.52)*** 79.20 (4.40)*** 78.62 (4.27)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 4.06 (0.95)* 3.91 (0.94)* 3.88 (0.93)* 4.27 (0.90)** 4.24 (0.90)** 
  
In Slope of 
Symptom Severity 
ζ2i 6.09 (1.05)*** 6.16 (1.03)*** 6.16 (1.06)*** 5.96 (0.89)*** 6.04 (0.88)*** 
Continued 
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Table 15 continued 
Outcome: P-KINDL Time-Invariant (Level 2) Predictor 
  
 
Familial 
Psychiatric 
History: ADHD
E
 
Familial 
Psychiatric 
History: Mania
E
 
Familial 
Psychiatric 
History: 
Depression
E
 
Familial 
Psychiatric 
History: 
Anxiety
E
 
Familial 
Psychiatric 
History: 
Conduct
E
  
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 63.93 (0.90)*** 64.59 (0.85)*** 65.15 (1.04)*** 65.06 (0.94)*** 63.96 (0.83)*** 
  
Time-Invariant 
Predictor 
γ01 2.89 (1.47)~ -0.11 (1.45)ns -1.31 (1.47)ns -1.06 (1.46)ns 3.85 (1.74)* 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.15 (0.23)ns -0.32 (0.21)ns -0.54 (0.27)* -0.26 (0.24)ns -0.18 (0.22)ns 
 
 
Time-Invariant 
Predictor 
γ11 -0.45 (0.37)ns 0.42 (0.45)ns 0.60 (0.35)~ 0.03 (0.36)ns -0.29 (0.39)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.34 (0.34)*** -2.39 (0.31)*** -2.23 (0.40)*** -2.61 (0.36)*** -2.42 (0.32)*** 
  
Time-Invariant 
Predictor 
γ21 
 
-0.76 (0.53)ns -0.67 (0.53)ns -0.46 (0.56)ns 0.26 (0.51)ns -0.83 (0.61)ns 
Variance Components 
 Level 1 Within-person εij 78.45 (4.36)*** 78.65 (4.32)*** 78.47 (4.23)*** 78.66 (4.27)*** 78.42 (4.31)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 4.29 (0.89)** 4.31 (0.90)** 4.22 (0.89)** 4.26 (0.90)** 4.26 (0.90)** 
  
In Slope of 
Symptom Severity 
ζ2i 5.95 (0.85)*** 5.93 (0.86)*** 5.84 (0.87)*** 6.02 (0.88)*** 5.92 (0.87)*** 
Continued 
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Table 15 continued 
Outcome: P-KINDL Time-Invariant (Level 2) Predictor 
  
 
Familial 
Psychiatric 
History: 
Substance Use
E
 
Familial 
Psychiatric 
History: 
Suicidality
E
 
Familial 
Psychiatric 
History: 
Psychosis
E
 
Baseline Family 
Income: < 
$19,999
H
 
Baseline Family 
Income: 
$20,000-
$39,999
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.74 (1.02)*** 64.65 (0.89)*** 64.46 (0.89)*** 64.39 (1.04)*** 64.80 (0.88)*** 
  
Time-Invariant 
Predictor 
γ01 -1.88 (1.66)ns -0.48 (1.55)ns 0.58 (1.93)ns 0.44 (1.41)ns -0.70 (1.58)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.27 (0.25)ns -0.31 (0.21)ns -0.28 (0.20)ns -0.22 (0.27)ns -0.41 (0.22)~ 
 
 
Time-Invariant 
Predictor 
γ11 0.15 (0.3)ns 0.17 (0.38)ns 0.08 (0.40)ns -0.09 (0.35)ns 0.53 (0.37)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.80 (0.42)*** -2.34 (0.36)*** -2.41 (0.34)*** -2.59 (0.39)*** -2.60 (0.33)*** 
  
Time-Invariant 
Predictor 
γ21 
 
0.42 (0.64)ns -0.50 (0.57)ns -0.49 (0.66)ns 0.15 (0.54)ns 0.31 (0.58)ns 
Variance Components 
 Level 1 Within-person εij 79.78 (4.53)*** 78.72 (4.27)*** 78.83 (4.31)*** 78.71 (4.34)*** 78.71 (4.30)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 3.82 (0.93)* 4.28 (0.90)** 4.27 (0.90)** 4.30 (0.91)** 4.22 (0.90)** 
  
In Slope of 
Symptom Severity 
ζ2i 6.33 (1.07)*** 5.92 (0.86)*** 5.96 (0.88)*** 5.97 (0.87)*** 6.01 (0.86)*** 
Continued 
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Table 15 continued 
Outcome: P-KINDL Time-Invariant (Level 2) Predictor 
  
 
Baseline Family Income: $40,000-
$49,999
H
 
Baseline Family Income: $50,000-More than 
$200,000
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 64.74 (0.77)*** 64.53 (0.80)*** 
  
Time-Invariant 
Predictor 
γ01 -2.32 (2.79)ns 0.64 (2.26)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.28 (0.20)ns -0.21 (0.20)ns 
  
Time-Invariant 
Predictor 
γ11 0.14 (0.73)ns -0.52 (0.64)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.51 (0.28)*** -2.40 (0.29)*** 
 
 
Time-Invariant 
Predictor 
γ21 
 
0.00 (1.22)ns -1.14 (0.82)ns 
Variance Components 
 Level 1 Within-person εij 78.93 (4.33)*** 78.89 (4.31)*** 
 Level 2 In Initial Status ζ0i -- -- 
  In Rate of Change ζ1i 4.16 (0.89)** 4.17 (0.89)** 
  
In Slope of 
Symptom Severity 
ζ2i 5.96 (0.88)*** 5.95 (0.87)*** 
Continued 
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Table 15 continued 
Note.  
H
= Covariate hypothesized to moderate the time-linked relationship between symptom severity and QoL; 
E
 = Covariate explored for potential 
moderating effects on the time-linked relationship between symptom severity and QoL; QoL = Quality of life; KINDL = Revididerter KINDer 
Lebensqualiatsfragebogen; P-KINDL = KINDL – Parent Report; CGI = Clinical Global Impression Scale – Overall current severity; IQ = Intelligence 
Quotient; A-LIFE = Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up Evaluation; CGAS= Children’s Global Assessment 
Scale; ADHD = Attention-Deficit/Hyperactivity Disorder. ~ p < .10; * p < .05; ** p < .01; *** p < .001; ns = non-significant. 
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Table 16 
Site differences on key demographic variables and ratings of symptom severity and 
QoL 
 
Case Western 
(%) 
Cincinnati 
(%) 
Ohio State 
(%) 
Pittsburgh 
(%) 
χ
2
 or F-value 
Baseline Medicaid 
Status 
53.3
a 
16.6
b 
65.3
c 
72.0
c χ
2
 = 
125.74*** 
12-Month Medicaid 
Status 
47.1
a 
19.0
b 
64.1
c 
78.6
d χ
2
 = 
108.15*** 
24-Month Medicaid 
Status 
46.1
a
 20.0
b 
61.0
c 
79.8
d χ
2
 =  
98.80*** 
Sex (Female) 37.6
a 
36.7
a 
25.0
b 
33.1
ab 
χ
2
 = 7.70~ 
Hispanic 5.5
a 
3.0
a
 5.7
a
 3.4
a
 χ
2
 = 2.36ns 
Caucasian 53.3
a 
88.8
b 
69.9
c 
46.9
a 
χ
2
 = 78.60*** 
Baseline CGI -- 
F(3,680) = 
32.85***
1
 
12-Month CGI -- 
F(3,521) = 
14.45***
2
 
24-Month CGI -- 
F(3,460) = 
19.52***
3
 
Baseline P-KINDL -- 
F(3,584) = 
3.51*
4
 
12-Month P-
KINDL 
-- 
F(3,452) = 
7.22***
5
 
24-Month P-
KINDL 
-- 
F(3,425) = 
2.02ns 
Baseline C-KINDL -- 
F(3,585) = 
3.72*
6
 
12-Month C-
KINDL 
-- 
F(3,438) = 
4.62**
7
 
24-Month C-
KINDL 
-- 
F(3,409) = 
3.17*
8
 
Continued 
                                                 
1
 OSU > Case Western  > Cincinnati; OSU > Pittsburgh 
2
 OSU > Pittsburgh ~ Cincinnati > Case Western  
3
 OSU > Pittsburgh ~ Cincinnati > Case Western  
4
 Pittsburgh > Cincinnati ~ Case Western 
5
 Pittsburgh ~ OSU > Case Western ~ Cincinnati 
6
 Case Western > Cincinnati ~ OSU 
7
 OSU ~ Pittsburgh > Cincinnati 
8
 Case Western > Cincinnati 
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Table 16 continued 
Note. Same superscripts indicate no significant differences between sites; different superscripts indicate 
significant site differences. QoL = Quality of life; CGI = Clinical Global Impression Scale – Overall 
current severity; KINDL = Revididerter KINDer Lebensqualiatsfragebogen; P-KINDL = KINDL – 
Parent Report; C-KINDL = KINDL – Youth Report. ~p < .10; *p < .05; **p < .01; ***p < .001; ns = 
non-significant.
  
 
Table 17 
 
Parameter estimates for hypothesized and exploratory time-varying (Level 1) covariates with youth-reported QoL as outcome 
Outcome: C-KINDL 
Time-Varying (Level 1) Predictor 
(Slope) 
  
 
Unconditional 
Means Model 
Unconditional 
Growth Model 
Growth Model 
with CGI as 
Predictor (“Base 
Model”) 
ALIFE – Primary 
CaregiverH 
ALIFE- 
Secondary 
CaregiverH 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 61.22 (0.45)***  61.17 (0.44)*** 65.76 (0.72)*** 65.38 (0.71)*** 65.26 (0.69)*** 
  
Time-Varying 
Predictor Slope 
γ01 -- -- -- -2.31 (2.34)ns -0.02 (2.19)ns 
 
Rate of Change 
(Age1), π1i 
Intercept γ10 -- -0.18 (0.21)ns -0.28 (0.20)ns -0.23 (0.20)ns -0.18 (0.21)ns 
 
 
Time-Varying 
Predictor Slope 
γ11 -- -- -- 1.89 (0.67)** 2.30 (0.62)*** 
 
Slope of Symptom 
Severity (CGI2), π2i 
Intercept γ20 - -- -2.05 (0.30)*** -1.87 (0.30)*** -1.82 (0.29)*** 
  
Time-Varying 
Predictor Slope 
γ21 
 
-- -- -- 0.67 (0.81)ns 0.44 (0.79)ns 
Variance Components 
 Level 1 Within-person εij 131.50 (6.75)*** 128.54 (6.91)*** 125.28 (6.87)*** 128.01 (6.18)*** 128.38 (6.21)*** 
 Level 2 In Initial Status ζ0i 43.79 (6.52)*** 33.46 (7.11)*** 32.94 (7.03)*** -- -- 
  In Rate of Change ζ1i -- 2.90 (1.45)** 2.40 (1.32)* 3.33 (1.32)* 3.36 (1.27)* 
  
In Slope of 
Symptom Severity 
ζ2i -- -- --
3 3.91 (0.86)*** 3.72 (0.84)*** 
Continued 
                                                 
1
 Age was centered at the grand mean. 
2
 CGI was centered at the lowest rating of 1 (“Normal”). 
3
 When the random effect of CGI was included in the model, there were insufficient degrees of freedom to estimate the within-person variance component. Given that the random 
effect of CGI was non-significant (p = .28) when entered as the sole random effect, it was removed in subsequent models while the random effect of Age was retained.  
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Table 17 continued 
Outcome: C-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 ALIFE – Peers
H
 
Number of 
Diagnoses
H
 
No Medication
H
 
Antipsychotic 
Medication
H
 
Antidepressant 
Medication
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.04 (0.72)*** 64.84 (0.80)*** 65.47 (0.70)*** 65.50 (0.70)*** 65.38 (0.71)*** 
  
Time-Varying 
Predictor Slope 
γ01 -0.82 (1.90)ns 0.39 (1.21)ns -0.78 (3.25)ns -0.38 (3.11)ns 2.34 (3.90)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.39 (0.21)~ -0.39 (0.22)~ -0.25 (0.20)ns -0.26 (0.20)ns -0.21 (0.20)ns 
  
Time-Varying 
Predictor Slope 
γ11 2.44 (0.60)*** -1.28 (0.47)** 0.95 (1.21)ns 0.08 (1.16)ns -1.56 (1.35)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -1.73 (0.30)*** -1.69 (0.32)*** -1.91 (0.29)*** -1.91 (0.29)*** -1.90 (0.30)*** 
 
 
Time-Varying 
Predictor Slope 
γ21 
 
0.19 (0.64)ns 0.15 (0.44)ns 0.94 (1.42)ns -1.03 (1.21)ns -0.53 (1.60)ns 
Variance Components 
 Level 1 Within-person εij 127.31 (6.21)*** 127.68 (6.25)*** 127.77 (6.22)*** 127.91 (6.24)*** 127.74 (6.22)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 33.33 (1.27)* 3.46 (1.28)* 3.72 (1.30)* 3.71 (1.30)** 3.73 (1.29)* 
  
In Slope of 
Symptom 
Severity 
ζ2i 3.94 (0.87)*** 3.93 (0.86)*** 3.92 (0.85)*** 3.87 (0.85)*** 3.92 (0.85)*** 
Continued 
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Table 17 continued 
Outcome: C-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 
Anxiolytic 
Medication
H4
 
Stimulant 
Medication
H
 
Mood Stabilizer 
Medication
H
 
Other 
Medication
H
 
School Services
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 -- 65.48 (0.69)*** 65.45 (0.70)*** 65.49 (0.70)*** 65.39 (0.73)*** 
  
Time-Varying 
Predictor Slope 
γ01 -- 1.57 (3.10)ns 8.59 (5.72)ns 4.00 (4.13)ns 0.30 (3.19)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -- -0.26 (0.20)ns -0.23 (0.20)ns -0.26 (0.20)ns -0.26 (0.20)ns 
  
Time-Varying 
Predictor Slope 
γ11 -- -0.34 (1.05)ns -2.74 (2.03)ns -1.42 (1.39)ns -1.16 (1.27)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -- -1.92 (0.29)*** -1.91 (0.29)*** -1.91 (0.30)*** -1.89 (0.30)*** 
 
 
Time-Varying 
Predictor Slope 
γ21 
 
-- -0.62 (1.27)ns -3.04 (1.89)ns -0.31 (1.58)ns -0.81 (1.30)ns 
Variance Components 
 Level 1 Within-person εij -- 127.85 (6.18)*** 127.90 (6.19)*** 127.53 (6.20)*** 127.74 (6.20)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i -- 3.68 (1.29)* 3.68 (1.28)* 3.73 (1.31)* 3.70 (1.29)* 
  
In Slope of 
Symptom 
Severity 
ζ2i -- 3.95 (0.85)*** 3.84 (0.86)*** 3.91 (0.85)*** 3.93 (0.85)*** 
Continued 
                                                 
4
 Model run to extract slope for Anxiolytic Medication did not converge. Hence, its effect on symptom severity was unable to be examined.  
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Table 17 continued 
Outcome: C-KINDL Time-Varying (Level 1) Predictor (Slopes) 
  
 
Inpatient 
Hospitalization
H
 
Number of 
Inpatient 
Hospitalizations
H
 
Outpatient 
Services
H
 
Number of 
Outpatient 
Professionals
H
 
CGAS
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.35 (0.69)*** 65.42 (0.69)*** 65.47 (0.70)*** 65.36 (0.70)*** 64.20 (0.85)*** 
  
Time-Varying 
Predictor Slope 
γ01 5.06 (8.47)ns 2.09 (2.93)ns -0.09 (0.57)ns -0.37 (1.08)ns 0.03 (0.14)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.17 (0.20)ns -0.24 (0.20)ns -0.25 (0.20)ns -0.23 (0.20)ns -0.43 (0.22)~ 
  
Time-Varying 
Predictor Slope 
γ11 -6.08 (2.88)* -0.47 (0.82)ns -1.07 (1.96)ns -0.32 (0.34)ns 0.26 (0.06)*** 
 Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -1.88 (0.30)*** -1.91 (0.29)*** -1.92 (0.30)*** -1.87 (0.31)*** -1.39 (0.35)*** 
  
Time-Varying 
Predictor Slope 
γ21 
 
-1.22 (2.69)ns -0.23 (0.73)ns -0.13 (1.31)ns -0.24 (0.43)ns 0.02 (0.05)ns 
Variance Components 
 Level 1 Within-person εij 128.23 (6.21)*** 127.92 (6.18)*** 127.82 (6.21)*** 127.83 (6.19)*** 127.07 (6.14)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 3.56 (1.24)* 3.72 (1.28)* 3.70 (1.29)* 3.69 (1.28)* 3.05 (1.27)* 
  
In Slope of 
Symptom 
Severity 
ζ2i 3.81 (0.84)*** 3.86 (0.85)*** 3.93 (0.85)*** 3.91 (0.85)*** 4.10 (0.89)*** 
Continued 
 
2
9
4
 
  
 
 
Table 17 continued 
Outcome: C-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 
Significant 
Physical Health 
ProblemsE5 
Psychotic 
Disorder 
DiagnosisE6 
Bipolar Spectrum 
Disorder 
DiagnosisE 
Depressive 
Spectrum 
Disorder 
DiagnosisE 
Anxiety Disorder 
DiagnosisE 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 -- 65.39 (0.70)*** 65.46 (0.70)*** 65.31 (0.70)*** 65.52 (0.70)*** 
  
Time-Varying 
Predictor Slope 
γ01 -- -23.10 (14.65)ns 2.21 (4.01)ns -3.68 (6.17)ns 1.04 (5.38)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -- -0.29 (0.20)ns -0.25 (0.21)ns -0.25 (0.21)ns -0.25 (0.20)ns 
  
Time-Varying 
Predictor Slope 
γ11 -- -4.00 (4.53)ns -0.24 (1.27)ns -4.62 (1.93)* 0.59 (1.54)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -- -1.90 (0.29)*** -1.92 (0.30)*** -1.87 (0.29)*** -1.94 (0.29)*** 
 
 
Time-Varying 
Predictor Slope 
γ21 
 
-- 4.45 (3.79)ns -0.74 (1.42)ns 0.08 (2.23)ns -0.14 (2.09)ns 
Variance Components 
 Level 1 Within-person εij -- 127.46 (6.36)*** 127.87 (6.23)*** 127.91 (6.17)*** 127.90 (6.20)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i -- 3.66 (1.28)* 3.66 (1.29)* 3.57 (1.25)* 3.69 (1.29)* 
  
In Slope of 
Symptom Severity 
ζ2i -- 3.97 (0.85)*** 3.95 (0.86)*** 3.81 (0.84)*** 3.93 (0.85)*** 
Continued 
                                                 
5
 Model run to extract slope for Significant Physical Health Problems did not converge. Hence, its effect on symptom severity was unable to be 
examined. 
6
 This and subsequent diagnoses based on hierarchically-formed diagnostic groups.  
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Table 17 continued 
Outcome: C-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 
Disruptive 
Behavior 
Disorder 
Diagnosis
E
 
ADHD 
Diagnosis
E
 
Other 
Diagnosis
E7
 
No Diagnosis
E8
 
Parent Stress 
Survey – 
Number of 
Stressors
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.63 (0.72)*** 65.33 (0.70)*** -- -- 65.34 (0.75)*** 
  
Time-Varying 
Predictor Slope 
γ01 3.30 (4.70)ns -4.00 (4.40)ns -- -- 0.12 (0.39)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.27 (0.21)ns -0.21 (0.20)ns -- -- -0.30 (0.20)ns 
  
Time-Varying 
Predictor Slope 
γ11 -0.58 (1.34)ns 3.86 (1.51)* -- -- -0.38 (0.13)** 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -1.98 (0.30)*** -1.86 (0.30)*** -- -- -1.84 (0.32)*** 
 
 
Time-Varying 
Predictor Slope 
γ21 
 
-1.22 (1.88)ns 1.90 (2.13)ns -- -- 0.06 (0.16)ns 
Variance Components 
 Level 1 Within-person εij 127.71 (6.25)*** 127.6 (6.25)*** -- -- 127.57 (6.21)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  
In Rate of 
Change 
ζ1i 3.66 (1.30)* 3.44 (1.28)* -- -- 3.49 (1.30)* 
  
In Slope of 
Symptom 
Severity 
ζ2i 3.98 (0.87)*** 4.01(0.86)*** -- -- 3.90 (0.84)*** 
Continued 
                                                 
7
 Model to extract slope for Other Diagnosis did not converge. Hence, its effect on symptom severity was unable to be examined. 
8
 Model to extract slope for No Diagnosis did not converge. Hence, its effect on symptom severity was unable to be examined. 
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Table 17 continued 
Outcome: C-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 
Parent Stress 
Survey – Total 
Stress
H
 
Stressful Life 
Events Schedule 
(Parent) – 
Number of 
Stressors
H
 
Stressful Life 
Events Schedule 
(Parent) – Total 
Stress
H
 
Stressful Life 
Events Schedule 
(Child/Adoles) – 
Number of 
Stressors
H9
 
Stressful Life 
Events Schedule 
(Child/Adoles) – 
Total Stress
H10
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.24 (0.70)*** 65.22 (0.70)*** 65.12 (0.69)*** 64.73 (0.69)*** 64.66 (0.70)*** 
  
Time-Varying 
Predictor Slope 
γ01 -0.04 (0.12)ns -0.36 (0.31)ns -0.16 (0.10)ns -3.71 (1.59)* -3.92 (1.93)* 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.20 (0.20)ns -0.26 (0.20)ns -0.26 (0.20)ns -0.09 (0.20)ns -0.11 (0.20)ns 
  
Time-Varying 
Predictor Slope 
γ11 -0.10 (0.04)** -0.27 (011)* -0.12 (0.04)** -2.16 (0.77)** -2.43 (0.72)** 
 Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -1.85 (0.30)*** -1.81 (0.29)*** -1.78 (0.29)*** -1.59 (0.29)*** -1.56 (0.29)*** 
  
Time-Varying 
Predictor Slope 
γ21 
 
0.01 (0.05)ns 0.15 (0.12)ns 0.06 (0.04)ns 1.75 (0.62)** 1.83 (0.70)* 
Variance Components 
 Level 1 Within-person εij 127.91 (6.22)*** 127.64 (6.22)*** 127.67 (6.22)*** 111.77 (6.14)*** 111.28 (6.06)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  
In Rate of 
Change 
ζ1i 3.44 (1.29)* 3.48 (1.29)* 3.34 (1.27)* 3.73 (1.10)** 3.72 (1.11)** 
  
In Slope of 
Symptom 
Severity 
ζ2i 3.89 (0.84)*** 3.96 (0.85)*** 3.93 (0.85)*** 4.67 (0.85)*** 4.69 (0.84)*** 
Continued 
                                                 
9
 Slope of this variable is based on standardized scores to allow for child and adolescent versions to be combined. 
10
 Slope of this variable is based on standardized scores to allow for child and adolescent versions to be combined. 
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Table 17 continued 
Outcome: C-KINDL Time-Varying (Level 1) Predictor (Slope) 
  
 
General 
Behavior 
Inventory – 
10item Mania 
Scale Total
E
 
Elevated 
Symptoms of 
Mania – 
Positive
E
 
General 
Behavior 
Inventory 
(Parent Report) – 
Total
E
 
Non-Medicaid
H
 
School 
Challenges
E
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.35 (0.79)*** 65.50 (0.79)*** 65.26 (0.71)*** 65.54 (0.70)*** 65.78 (0.74)*** 
  
Time-Varying 
Predictor Slope 
γ01 0.02 (0.24)ns 2.09 (3.89)ns -0.07 (0.05)ns 1.33 (3.44)ns 3.32 (3.66)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.31 (0.21)ns -0.31 (0.21)ns -0.30 (0.20)ns -0.28 (0.20)ns -0.21 (0.21)ns 
  
Time-Varying 
Predictor Slope 
γ11 -0.15 (0.09)~ -2.24 (1.40)ns -0.02 (0.01)ns -0.50 (1.07)ns 1.41 (1.26)ns 
 Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -1.95 (0.33)*** -1.96 (0.3)*** -1.82 (0.30)*** -1.95 (0.29)*** -2.04 (0.30)*** 
  
Time-Varying 
Predictor Slope 
γ21 
 
-0.12 (0.10)ns -1.52 (1.47)ns 0.03 (0.02)~ -1.96 (1.30)ns -1.13 (1.40)ns 
Variance Components 
 Level 1 Within-person εij 127.50 (6.19)*** 127.66 (6.19)*** 127.37 (6.20)*** 128.06 (6.24)*** 127.99 (6.21)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 3.63 (1.29)* 3.55 (1.30)* 3.64 (1.28)* 3.76 (1.29)* 3.67 (1.29)* 
  
In Slope of 
Symptom 
Severity 
ζ2i 3.90 (0.87)*** 4.00 (0.86)*** 3.98 (0.85)*** 3.73 (0.85)*** 3.87 (0.84)*** 
Continued 
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Table 17 continued 
Outcome: C-KINDL Time-Varying (Level 1) Predictor (Slope) 
   Suicidality
E
 Psychosis
E11
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.17 (0.72)*** -- 
  
Time-Varying 
Predictor Slope 
γ01 0.57 (7.00)ns -- 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.27 (0.20)ns -- 
  
Time-Varying 
Predictor Slope 
γ11 -6.63 (2.22)** -- 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -1.83 (0.30)*** -- 
 
 
Time-Varying 
Predictor Slope 
γ21 
 
-0.31 (2.28)ns -- 
Variance Components 
 Level 1 Within-person εij 127.85 (6.11)*** -- 
 Level 2 In Initial Status ζ0i -- -- 
  In Rate of Change ζ1i 3.33 (1.28)* -- 
  
In Slope of 
Symptom 
Severity 
ζ2i 3.95 (0.85)*** -- 
Continued 
 
                                                 
11
 Model to extract slope for Psychosis did not converge. Hence, its effect on symptom severity was unable to be examined. 
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Table 17 continued 
Note.  
H
= Covariate hypothesized to moderate the time-linked relationship between symptom severity and QoL; 
E
 = Covariate explored for potential moderating 
effects on the time-linked relationship between symptom severity and QoL; QoL = Quality of life; KINDL = Revididerter KINDer Lebensqualiatsfragebogen; 
C-KINDL = KINDL – Youth Report.CGI = Clinical Global Impression Scale – Overall current severity; A-LIFE = Psychosocial Schedule of the 
Adolescent Longitudinal Interval Follow-Up Evaluation; CGAS= Children’s Global Assessment Scale; ADHD = Attention-Deficit/Hyperactivity 
Disorder. ~ p < .10; * p < .05; ** p < .01; *** p < .001; ns = non-significant.
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Table 18 
Parameter estimates for hypothesized and exploratory time-invariant (Level 2) covariates with youth-reported QoL as outcome 
Outcome: C-KINDL Time-Invariant (Level 2) Predictor 
  
 
Unconditional 
Means Model 
Unconditional 
Growth Model 
Growth Model 
with CGI as 
Predictor (“Base 
Model”) 
Site IQH 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 61.22 (0.45)***  61.17 (0.44)*** 65.76 (0.72)*** 65.04 (1.52)*** 67.81 (5.04)*** 
  
Time-Invariant 
Predictor 
γ01 -- -- -- 0.20 (0.58)ns -0.02 (0.05)ns 
 
Rate of Change 
(Age1), π1i 
Intercept γ10 -- -0.18 (0.21)ns -0.28 (0.20)ns -0.33 (0.46)ns 0.06 (1.17)ns 
  
Time-Invariant 
Predictor 
γ11 -- -- -- 0.03 (0.16)ns -0.00 (0.01)ns 
 Slope of Symptom 
Severity (CGI2), π2i 
Intercept γ20 - -- -2.05 (0.30)*** -1.90 (0.64)** -2.18 (2.00)ns 
  
Time-Invariant 
Predictor 
γ21 
 
-- -- -- -0.02 (0.24)ns 0.00 (0.02)ns 
Variance Components 
 Level 1 Within-person εij 131.50 (6.75)*** 128.54 (6.91)*** 125.28 (6.87)*** 127.87 (6.23)*** 127.63 (6.35)*** 
 Level 2 In Initial Status ζ0i 43.79 (6.52)*** 33.46 (7.11)*** 32.94 (7.03)*** -- -- 
  In Rate of Change ζ1i -- 2.90 (1.45)** 2.40 (1.32)* 3.70 (1.29)* 3.74 (1.30)* 
  
In Slope of 
Symptom Severity 
ζ2i -- -- --
3 3.93 (0.85)*** 3.89 (0.85)*** 
Continued 
                                                 
1
 Age was centered at the grand mean. 
2
 CGI was centered at the lowest rating of 1 (“Normal”). 
3
 When the random effect of CGI was included in the model, there were insufficient degrees of freedom to estimate the within-person variance 
component. Given that the random effect of CGI was non-significant (p = .28) when entered as the sole random effect, it was removed in subsequent 
models while the random effect of Age was retained.  
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Table 18 continued 
Outcome: C-KINDL Time-Invariant (Level 2) Predictor 
  
 Sex (Female)
E 
Caucasian
E
 Hispanic
E
 
Parental 
Psychiatric 
History: No 
Diagnosis
E
 
Parental 
Psychiatric 
History: ADHD
E
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.42 (0.88)*** 66.60 (1.25)*** 70.80 (2.98)*** 65.59 (0.82)*** 65.34 (0.86)*** 
  
Time-Invariant 
Predictor 
γ01 0.23 (1.59)ns -1.80 (1.77)ns -5.55 (3.05)~ 0.68 (2.64)ns 1.11 (1.85)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.20 (0.26)ns -0.19 (0.29)ns -1.63 (0.98)~ -0.27 (0.23)ns -0.46 (0.26)~ 
  
Time-Invariant 
Predictor 
γ11 -0.12 (0.40)ns -0.09 (0.40)ns 1.43 (1.04)ns -0.29 (0.73)ns 0.66 (0.49)ns 
 Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -1.72 (0.36)*** -2.06 (0.51)*** -3.41 (1.18)** -1.88 (0.34)*** -1.84 (0.36)*** 
  
Time-Invariant 
Predictor 
γ21 
 
-0.62 (0.58)ns 0.24 (0.65)ns 1.56 (1.23)ns -0.76 (1.20)ns -0.30 (0.71)ns 
Variance Components 
 Level 1 Within-person εij 127.94 (6.18)*** 127.48 (6.38)*** 127.86 (6.26)*** 130.51 (6.85)*** 130.24 (6.91)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 3.57 (1.28)* 3.72 (1.29)* 3.50 (1.30)* 3.39 (1.31)* 3.34 (1.28)* 
  
In Slope of 
Symptom Severity 
ζ2i 3.94 (0.85)*** 3.88 (0.85)*** 3.95 (0.86)*** 3.92 (0.86)*** 3.97 (0.86)*** 
Continued 
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Table 18 continued 
Outcome: C-KINDL Time-Invariant (Level 2) Predictor 
  
 
Parental 
Psychiatric 
History: Mania
E
 
Parental 
Psychiatric 
History: 
Depression
E
 
Parental 
Psychiatric 
History: 
Anxiety
E
 
Parental 
Psychiatric 
History: 
Disruptive 
Behavior
E
 
Parental 
Psychiatric 
History: 
Substance Use
E
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.53 (0.84)*** 66.52 (1.30)*** 65.99 (1.08)*** 66.11 (1.15)*** 66.79 (0.93)*** 
  
Time-Invariant 
Predictor 
γ01 0.24 (1.89)ns -1.49 (1.74)ns -0.79 (1.64)ns -0.77 (1.60)ns -2.76 (1.72)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.26 (0.24)ns -0.49 (0.35)ns -0.35 (0.31)ns -0.40 (0.35)ns -0.17 (0.26)ns 
 
 
Time-Invariant 
Predictor 
γ11 -0.15 (0.50)ns 0.32 (0.40)ns 0.11 (0.41)ns 0.17 (0.42)ns -0.27 (0.39)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -1.78 (0.37)*** -1.84 (0.61)** -1.88 (0.47)*** -2.32 (0.50)*** -2.38 (0.42)*** 
  
Time-Invariant 
Predictor 
γ21 
 
-0.60 (0.67)ns -0.10 (0.74)ns -0.04 (0.66)ns 0.60 (0.65)ns 1.02 (0.71)ns 
Variance Components 
 Level 1 Within-person εij 130.64 (6.85)*** 130.48 (6.86)*** 130.49 (6.87)*** 130.37 (6.86)*** 130.22 (6.95)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 3.29 (1.30)* 3.33 (1.31)* 3.37 (1.32)* 3.43 (1.30)* 3.35 (1.32)* 
  
In Slope of 
Symptom Severity 
ζ2i 3.93 (0.86)*** 3.87 (0.85)*** 3.93 (0.88)*** 3.91 (0.86)*** 3.93 (0.86)*** 
Continued 
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Table 18 continued 
Outcome: C-KINDL Time-Invariant (Level 2) Predictor 
  
 
Parental 
Psychiatric 
History: 
Suicidality
E
 
Parental 
Psychiatric 
History: 
Psychosis
E
 
Parental 
Psychiatric 
History: Total 
Diagnoses
E
 
Baseline Family 
Structure: Live 
with Both 
Parents
EH
 
Familial 
Psychiatric 
History: No 
Diagnosis
E
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.65 (0.86)*** 65.51 (0.82)*** 65.84 (1.16)*** 64.95 (0.92)*** 65.40 (0.75)*** 
  
Time-Invariant 
Predictor 
γ01 -0.18 (2.28)ns 0.84 (2.12)ns 0.05 (0.21)ns 1.44 (1.41)ns 0.75 (2.05)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.29 (0.24)ns -0.32 (0.23)ns -0.36 (0.33)ns -0.12 (0.27)ns -0.23 (0.21)ns 
 
 
Time-Invariant 
Predictor 
γ11 0.01 (0.45)ns 0.26 (0.60)ns -0.01 (0.05)ns -0.36 (0.41)ns -0.19 (0.52)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -1.92 (0.39)*** -1.89 (0.35)*** -1.90 (0.50)*** -1.64 (0.37)*** -1.89 (0.31)*** 
  
Time-Invariant 
Predictor 
γ21 
 
-0.02 (0.84)ns -0.30 (0.77)ns 0.00 (0.07)ns -0.77 (0.57)ns -0.34 (0.84)ns 
Variance Components 
 Level 1 Within-person εij 130.43 (6.85)*** 130.41 (6.87)*** 130.51 (6.86)*** 127.64 (6.26)*** 127.82 (6.20)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 3.41 (1.33)* 3.42 (1.33)* 3.37 (1.31)* 3.42 (1.28)* 3.68 (1.28)* 
  
In Slope of 
Symptom Severity 
ζ2i 3.95 (0.86)*** 3.94 (0.86)*** 3.95 (0.87)*** 3.95 (0.86)*** 3.95 (0.86)*** 
Continued 
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Table 18 continued 
Outcome: C-KINDL Time-Invariant (Level 2) Predictor 
  
 
Familial 
Psychiatric 
History: ADHD
E
 
Familial 
Psychiatric 
History: Mania
E
 
Familial 
Psychiatric 
History: 
Depression
E
 
Familial 
Psychiatric 
History: 
Anxiety
E
 
Familial 
Psychiatric 
History: 
Conduct
E
  
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.43 (0.85)*** 65.53 (0.80)*** 65.05 (1.05)*** 65.74 (0.98)*** 65.01 (0.77)*** 
  
Time-Invariant 
Predictor 
γ01 0.54 (1.77)ns -0.20 (1.83)ns 0.92 (1.56)ns -0.33 (1.53)ns 3.23 (1.80)~ 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.19 (0.24)ns -0.33 (0.22)ns -0.33 (0.30)ns -0.22 (0.27)ns -0.28 (0.23)ns 
 
 
Time-Invariant 
Predictor 
γ11 -0.27 (0.42)ns 0.47 (0.52)ns 0.13 (0.38)ns -0.07 (0.37)ns 0.19 (0.48)ns 
 
Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.04 (0.35)*** -1.95 (0.35)*** -1.78 (0.47)** -2.50 (0.42)*** -1.97 (0.34)*** 
  
Time-Invariant 
Predictor 
γ21 
 
0.22 (0.65)ns 0.14 (0.74)ns -0.31 (0.62)ns 0.99 (0.62)ns -0.36 (070)ns 
Variance Components 
 Level 1 Within-person εij 127.86 (6.23)*** 127.92 (6.19)*** 127.85 (6.21)*** 128.06 (6.18)*** 127.57 (6.21)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 3.74 (1.29)* 3.60 (1.29)* 3.66 (1.29)* 3.59 (1.27)* 3.61 (1.27)* 
  
In Slope of 
Symptom Severity 
ζ2i 3.85 (0.83)*** 3.97 (0.86)*** 3.95 (0.85)*** 3.76 (0.83)*** 3.87 (0.84)*** 
Continued 
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Table 18 continued 
Outcome: C-KINDL Time-Invariant (Level 2) Predictor 
  
 
Familial 
Psychiatric 
History: 
Substance Use
E
 
Familial 
Psychiatric 
History: 
Suicidality
E
 
Familial 
Psychiatric 
History: 
Psychosis
E
 
Baseline Family 
Income: < 
$19,999
H
 
Baseline Family 
Income: 
$20,000-
$39,999
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.65 (1.06)*** 65.48 (0.81)*** 65.26 (0.78)*** 64.97 (1.02)*** 65.29 (0.84)*** 
  
Time-Invariant 
Predictor 
γ01 -0.16 (1.56)ns 0.01 (1.83)ns 1.62 (1.65)ns 1.07 (1.41)ns 0.73 (1.59)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.42 (0.30)ns -0.27 (0.22)ns -0.27 (0.23)ns -0.36 (0.29)ns -0.27 (0.23)ns 
  
Time-Invariant 
Predictor 
γ11 0.27 (0.0)ns 0.05 (0.41)ns 0.07 (0.53)ns 0.20 (0.36)ns 0.05 (0.40)ns 
 Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.32 (0.46)*** -1.88 (0.36)*** -1.95 (0.35)*** -1.73 (0.43)*** -1.88 (0.33)*** 
  
Time-Invariant 
Predictor 
γ21 
 
0.57 (0.61)ns -0.16 (0.72)ns 0.02 (0.69)ns -0.40 (0.56)ns -0.20 (0.61)ns 
Variance Components 
 Level 1 Within-person εij 127.79 (6.19)*** 127.84 (6.21)*** 127.67 (6.22)*** 127.84 (6..21)*** 127.91 (6.20)*** 
 Level 2 In Initial Status ζ0i -- -- -- -- -- 
  In Rate of Change ζ1i 3.67 (1.30)* 3.68 (1.29)* 3.73 (1.29)* 3.67 (1.28)* 3.66 (129)* 
  
In Slope of 
Symptom Severity 
ζ2i 3.89 (0.85)*** 3.95 (0.85)*** 3.89 (0.84)*** 3.94 (0.85)*** 3.94 (0.85)*** 
Continued 
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Table 18 continued 
Outcome: C-KINDL Time-Invariant (Level 2) Predictor 
  
 
Baseline Family Income: $40,000-
$49,999
H
 
Baseline Family Income: $50,000-More than 
$200,000
H
 
Effects  Parameter  
Fixed Effects 
 Initial Status, π0i Intercept γ00 65.64 (0.71)*** 65.65 (0.75)*** 
  
Time-Invariant 
Predictor 
γ01 -2.47 (3.89)ns -1.48 (2.36)ns 
 
Rate of Change 
(Age), π1i 
Intercept γ10 -0.30 (0.20)ns -0.20 (0.21)ns 
  
Time-Invariant 
Predictor 
γ11 0.72 (0.81)ns -0.70 (0.61)ns 
 Slope of Symptom 
Severity (CGI), π2i 
Intercept γ20 -2.00 (0.31)*** -1.96 (0.31)*** 
  
Time-Invariant 
Predictor 
γ21 
 
1.40 (1.58)ns 0.28 (1.07)ns 
Variance Components 
 Level 1 Within-person εij 127.87 (6.20)*** 127.97 (6.16)*** 
 Level 2 In Initial Status ζ0i -- -- 
  In Rate of Change ζ1i 3.58 (1.31)* 3.59 (1.25)* 
  
In Slope of 
Symptom Severity 
ζ2i 3.96 (0.86)*** 3.93 (0.85)*** 
Continued 
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Table 18 continued 
Note.  
H
= Covariate hypothesized to moderate the time-linked relationship between symptom severity and QoL; 
E
 = Covariate explored for potential 
moderating effects on the time-linked relationship between symptom severity and QoL; QoL = Quality of life; KINDL = Revididerter KINDer 
Lebensqualiatsfragebogen; C-KINDL = KINDL – Child Report.CGI = Clinical Global Impression Scale – Overall current severity; IQ = Intellience 
Quotient; A-LIFE = Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up Evaluation; CGAS= Children’s Global Assessment 
Scale; ADHD = Attention-Deficit/Hyperactivity Disorder. ~ p < .10; * p < .05; ** p < .01; *** p < .001; ns = non-significant. 
  
  
3
0
8
 
  
 
 
Table 19 
Significance of interaction effects moderating the time-linked relationship between symptom severity and specific QoL domains 
KINDL Domain 
P-KINDL: Number of 
Inpatient Hospitalizations 
P-KINDL:  
P-SLES Total Stress 
C-KINDL: K-SLES 
Number of Stressors 
C-KINDL: K-SLES 
Total Stress 
Total Yes** Yes* Yes** Yes* 
Physical No Yes* No No 
Emotional Yes** No No No 
Esteem Yes* Approach Sig Yes* Yes** 
Family Yes* Yes* Yes* Approach Sig 
Friends Approach Sig No Yes* Yes* 
School No Approach Sig Yes** Yes** 
Note. Results based on original, non-imputed dataset. KINDL = Revididerter KINDer Lebensqualiatsfragebogen; P-KINDL = KINDL – Parent Report; 
C-KINDL = KINDL – Youth Report; Approach Sig = Approaching significance (p < .10). *p < .05; **p < .01. 
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Table 20 
Intra-class correlation coefficients for parent- and youth-reported KINDL domain 
scores 
 Baseline 12-Month 24-Month 
Domain     
 ICC ICC ICC 
Physical 0.39*** 0.33*** 0.33*** 
Emotional 0.27*** 0.22*** 0.30*** 
Esteem 0.13** 0.15** 0.28*** 
Family 0.24*** 0.30*** 0.29*** 
Friends 0.36*** 0.39*** 0.33*** 
School 0.26*** 0.22*** 0.20*** 
Total 0.34*** 0.33*** 0.38*** 
Note. KINDL = Revididerter KINDer Lebensqualiatsfragebogen; ICC = Intraclass correlation 
coefficient. **p < .01; ***p < .001. 
  
  
 
Table 21 
Pearson’s correlations, mean differences and mean biases between parent- and youth-reported KINDL domain scores 
 Baseline 12-Month 24-Month 
Domains             
 r 
Mean 
Biases
1
 
Mean 
Difference
2
 
t-value r 
Mean 
Biases 
Mean 
Difference 
t-value r 
Mean 
Biases 
Mean 
Difference 
t-value 
Physical 0.39*** 0.66 0.32 1.99* 0.33*** -0.07 -0.10 -0.67ns 0.36*** 0.01 -0.02 -0.14ns 
Emotional 0.27*** 0.36 0.08 0.52ns 0.22*** 0.34 0.32 2.14* 0.30*** 0.46 0.44 3.07** 
Esteem 0.14** -0.88 -1.25 -5.52*** 0.16** -0.62 -0.56 -2.45* 0.29*** -0.40 -0.40 -1.82~ 
Family 0.24*** -1.41 -1.61 -9.24*** 0.30*** -1.46 -1.55 -9.56*** 0.29*** -0.52 -1.55 -8.99*** 
Friends 0.36*** -0.62 -0.84 -4.82*** 0.39*** -0.82 -0.80 -5.01*** 0.33*** -1.21 -0.57 -3.24** 
School 0.26*** 0.71 0.81 4.46*** 0.22*** 0.46 0.66 3.13** 0.14* 0.65 0.46 2.07* 
Total 0.35*** -2.35 -2.20 -3.41** 0.33*** -2.63 -3.18 -4.90*** 0.38*** -1.41 -1.57 -2.34* 
Note. Positive mean biases and t-values indicate that parent-reported scores were greater than child-reported scores; negative mean biases and t-values 
indicate that child-reported scores were greater than parent-reported scores. KINDL = Revididerter KINDer Lebensqualiatsfragebogen. ~p < .10; *p < 
.05; **p < .01; ***p < .001; ns = non-significant. 
 
                                                 
1
 Mean biases are based on mean scores of each parent- and child-reported domain or total score.  
2
 Mean differences are based on paired scores. 
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Table 22 
Results from modified Pearson-Filon tests of dependent correlations between parent- 
and youth-reported KINDL domain scores 
  Baseline 12-Month 24-Month 
Domain 1 Domain 2       
  z p z p z p 
Physical        
 Emotional 2.22* 0.03 1.81 0.07 1.04 0.30 
 Esteem 4.09*** 0 2.75** 0.006 1.13 0.26 
 Family 2.47* 0.01 0.50 0.62 1.16 0.25 
 Friends 0.48 0.63 -1.01 0.31 0.59 0.56 
 School 2.15* 0.03 1.56 0.12 2.47* 0.01 
 Total 0.94 0.35 0.05 0.96 -0.44 0.66 
Emotional        
 Esteem 2.08* 0.04 1.05 0.29 0.15 0.88 
 Family 0.44 0.66 -1.29 0.20 0.21 0.84 
 Friends -1.65 0.10 -1.08 0.28 -0.41 0.68 
 School 0.13 0.90 -0.08 0.94 1.59 0.11 
 Total -1.69 0.09 -2.10* 0.04 -1.74 0.08 
Esteem        
 Family -1.70 0.09 -2.23* 0.03 0.05 0.96 
 Friends -3.90*** 0 -3.94*** 0 -0.56 0.58 
 School -1.92 0.06 -1.04 0.30 1.40 0.16 
 Total -4.26*** 0 -2.84** 0.005 -1.84 0.07 
Family        
 Friends -2.14* 0.03 -1.56 0.12 -0.60 0.55 
 School -0.30 0.76 1.06 0.29 1.34 0.18 
 Total -2.03* 0.04 -0.51 0.61 -1.76 0.079 
Friends        
 School 1.77 0.08 2.56* 0.01 1.98* 0.05 
 Total 0.43 0.67 1.29 0.20 -1.24 0.22 
School        
 Total -1.69 0.09 -1.81 0.07 -3.50*** 0.00 
Note. Significant values (p < .05) indicate significant differences in parent-child agreement between 
KINDL domain scores. Positive z-values indicate that parent-child agreement in Domain 1 is greater 
than agreement in Domain 2; Negative z-values indicate that parent-child agreement in Domain 1 is less 
than agreement in Domain 2. KINDL = Revididerter KINDer Lebensqualiatsfragebogen. * p < .05; ** p 
< .01; *** p < .001.  
  
Table 23 
Summary table of results with level-1 covariates examined for their effects on parent- and youth-reported QoL 
Level 1 Covariate (slope) 
Effect on  
P-QoL at Mean 
Age 
Effect on  
Y-QoL at Mean 
Age 
Effect on 
Change in  
P-QoL 
Effect on 
Change in  
Y-QoL 
Interaction 
Effect with 
Severity on  
P-QoL 
Interaction 
Effect with 
Severity on  
Y-QoL 
A-LIFE-Primary ns ns Positive
C
 Positive
C
 ns ns 
A-LIFE-Secondary ns ns Positive
C 
Positive
C
 ns ns 
A-LIFE-Peers ns ns Positive
C
 Positive
C
 ns ns 
Number of Diagnoses ns ns Negative
C
 Negative
C
 ns ns 
No Medication ns ns ns ns ns ns 
Antipsychotic ns ns 
Negative
- 
(Approach sig) 
ns ns ns 
Antidepressant ns ns ns ns ns ns 
Anxiolytic (not slope) ns ns -- -- -- -- 
Stimulant ns ns ns ns ns ns 
Mood Stabilizer ns ns ns ns ns ns 
Other Medication ns ns ns ns ns ns 
School Services ns ns 
Negative
- 
(Approach sig) 
ns ns ns 
Inpatient Hospitalization – 
Any  
ns ns ns Negative
C
 ns ns 
Number of Hospitalizations Negative
C
 ns ns ns Significant
C
 ns 
Outpatient Services – Any  NegativeI ns ns ns ns ns 
Continued 
 
 
 
                                                 
C
 Consistent with hypothesis. 
I
 Inconsistent with hypothesis. 
-
 No a priori hypothesis. 
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Table 23 continued  
 
Level 1 Covariate  
(slope) 
Effect on  
P-QoL at Mean 
Age 
Effect on  
Y-QoL at Mean 
Age 
Effect on 
Change in  
P-QoL 
Effect on 
Change in  
Y-QoL 
Interaction 
Effect with 
Severity on  
P-QoL 
Interaction 
Effect with 
Severity on  
Y-QoL 
Number of Outpatient 
Professionals 
ns ns Negative
I
 ns ns ns 
CGAS ns ns Positive
C 
Positive
C
 ns ns 
Significant Health 
Problems (not slope) 
ns Negative
C 
-- -- -- -- 
Psychotic Disorder 
Diagnostic Category 
ns ns ns ns ns ns 
Bipolar Spectrum 
Diagnostic Category 
ns ns ns ns ns ns 
Depressive Spectrum 
Diagnostic Category 
Negative
 C
 
(Approach sig)
 ns Negative 
C 
Negative
C
 ns ns 
Anxiety Disorder 
Diagnostic Category 
ns ns ns ns ns ns 
Disruptive Behavior 
Disorder Diagnostic 
Category 
ns ns ns ns Approach sig ns 
ADHD Diagnostic 
Category 
ns ns Positive
I 
Positive
I
 ns ns 
Other Diagnosis (not 
slope) 
ns ns -- -- -- -- 
No Diagnosis (not slope) Positive
C 
ns -- -- -- -- 
Parent Stress – Number  ns ns NegativeC NegativeC ns ns 
Continued 
                                                 
C
 Consistent with hypothesis. 
I
 Inconsistent with hypothesis. 
-
 No a priori hypothesis. 
3
1
4
 
  
 
 
 
 
Table 23 continued 
 
Level 1 Covariate 
(slope) 
Effect on  
P-QoL at Mean 
Age 
Effect on  
Y-QoL at 
Mean Age 
Effect on 
Change in  
P-QoL 
Effect on 
Change in  
Y-QoL 
Interaction 
Effect with 
Severity on  
P-QoL 
Interaction 
Effect with 
Severity on  
Y-QoL 
Parent Stress – Total  ns ns NegativeC NegativeC ns ns 
Number of Stressful Life 
Events – Parent  
Negative
 C
 
(Approach Sig) 
ns Negative
C
 Negative
C
 Approach Sig
I
 ns 
Total Impact of Stressful 
Life Events – Parent  
Negative
C
 ns Negative
C
 Negative
C
 Significant
I
 ns 
Number of Stressful Life 
Events – Youth  
ns Negative
C 
ns Negative
C 
ns Significant
I 
Total Impact of Stressful 
Life Events – Youth 
ns Negative
C
 
Negative
C 
(Approach Sig)
 Negative
C
 ns Significant
I
 
PGBI-10M ns ns Negative
C 
Negative
C 
(Approach 
Sig)
 
ns ns 
ESM+ ns ns Negative
C
 ns ns Approach Sig
- 
GBI – Parent  ns ns NegativeC ns ns ns 
Non-Medicaid ns ns Negative
C
 ns ns ns 
School Challenges ns ns Negative
C
 ns ns ns 
Suicidality ns ns ns
 
Negative
C
 ns ns 
Psychosis (not slope) ns ns Ns -- ns -- 
Continued 
Note. P-QoL = Parent-reported quality of life; Y-QoL = Youth-reported quality of life; ns = non-significant; Approach sig = Approaching significance; 
A-LIFE = Psychosocial Schedule of the Adolescent Longitudinal Interval Follow-Up Evaluation; CGAS = Children’s Global Assessment Scale; ADHD  
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Table 23 continued 
= Attention-Deficit/Hyperactivity Disorder; PGBI-10M = Parent General Behavior Inventory – 10-Item Mania Scale; ESM+ = Elevated symptoms of 
mania – Positive; GBI = General Behavior Inventory.   
3
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Table 24  
Summary table of results with level-2 covariates examined for their effects on parent- and youth-reported QoL 
Level 2 Covariate 
Effect on P-QoL 
at Mean Age 
Effect on Y-QoL 
at Mean Age 
Effect on Change 
in P-QoL 
Effect on Change 
in Y-QoL 
Interaction 
Effect with 
Severity on P-
QoL 
Interaction 
Effect with 
Severity on Y-
QoL 
Site PositiveI ns ns ns n ns 
IQ ns ns ns ns ns ns 
Sex (Female) 
Negative- 
(Approach sig) 
ns ns ns ns ns 
Caucasian ns ns ns ns ns ns 
Hispanic ns 
Negative- 
(Approach sig) 
ns ns ns ns 
Parents: No Psychiatric 
History 
ns ns ns ns ns ns 
Parents: ADHD ns ns ns ns Approach sig ns 
Parents: Mania ns ns ns ns ns ns 
Parents: Depression ns ns PositiveI  ns ns ns 
Parents: Anxiety ns ns ns ns Approach sig ns 
Parents: Disruptive Behavior ns ns ns ns ns ns 
Parents: Substance Use ns ns ns ns ns ns 
Parents: Suicidality ns ns ns ns ns ns 
Parents: Psychosis ns ns ns ns ns ns 
Continued 
                                                 
C
 Consistent with hypothesis. 
I
 Inconsistent with hypothesis. 
-
 No a priori hypothesis.hypothesis. 
 
  
 
 
Table 24 continued 
 
Level 2 Covariate 
Effect on P-QoL 
at Mean Age 
Effect on Y-QoL 
at Mean Age 
Effect on Change 
in P-QoL 
Effect on Change 
in Y-QoL 
Interaction 
Effect with 
Severity on P-
QoL 
Interaction 
Effect with 
Severity on Y-
QoL 
Parents: Total Diagnoses NegativeC ns ns ns ns ns 
Baseline Family Structure ns ns ns ns ns ns 
Family: No Psychiatric 
History 
ns ns ns ns ns ns 
Family: ADHD 
PositiveI 
(Approach sig) 
ns ns ns ns ns 
Family: Mania ns ns ns ns ns ns 
Family: Depression ns ns 
PositiveI 
(Approach sig) 
ns ns ns 
Family: Anxiety ns ns ns ns ns ns 
Family: Conduct PositiveI 
PositiveI 
(Approach sig) 
ns ns ns ns 
Family: Substance Use ns ns ns ns ns ns 
Family: Suicidality ns ns ns ns ns ns 
Family: Psychosis ns ns ns ns ns ns 
Baseline Family Income < 
$19,999 
ns ns ns ns ns ns 
Baseline Family Income 
$20,000-$39,999 
ns ns ns ns ns ns 
Baseline Family Income 
$40,000-$49,999 
ns ns ns ns ns ns 
Baseline Family Income 
$50,000-More Than $200,000 
ns ns ns ns ns ns 
Note. P-QoL = Parent-reported quality of life; Y-QoL = Youth-reported quality of life; ns = non-significant; Approach sig = Approaching significance; 
IQ = Intelligence Quotient; ADHD = Attention-Deficit/Hyperactivity Disorder.
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Appendix F: Figures 
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continued 
Figure 1. Scatterplots displaying the non-significant relationship between age and 
QoL. P-KINDL = Revididerter KINDer Lebensqualiatsfragebogen – Parent report; C-KINDL = 
Revididerter KINDer Lebensqualiatsfragebogen – Youth report; QoL = Quality of life. 
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Figure 1 continued 
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continued  
Figure 2. Scatterplots displaying the negative relationship between symptom severity 
and QoL. P-KINDL = Revididerter KINDer Lebensqualiatsfragebogen – Parent report; C-KINDL = 
Revididerter KINDer Lebensqualiatsfragebogen – Youth report; QoL = Quality of life; CGI = Clinical 
Global Impression Scale – Overall current severity. 
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Figure 2 continued 
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Figure 3. Scatterplot displaying the relationship between age and symptom severity; 
no clear relationship is observed. CGI = Clinical Global Impression Scale – Overall current 
severity.  
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Figure 4. Interaction effect of slope of number of inpatient hospitalizations with 
symptom severity on parent-reported QoL. P-KINDL = Revididerter KINDer 
Lebensqualiatsfragebogen – Parent report; QoL = Quality of life; CGI = Clinical Global Impression 
Scale – Overall current severity.  
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Figure 5. Interaction effect of slope of parent-reported total stress on Stressful Life 
Events Scale with symptom severity on parent-reported QoL. P-KINDL = Revididerter 
KINDer Lebensqualiatsfragebogen – Parent report; QoL = Quality of life; CGI = Clinical Global 
Impression Scale – Overall current severity.  
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Figure 6. Interaction effect of slope of standardized youth-reported number of 
stressors on Stressful Life Events Scale with symptom severity on youth-reported 
QoL. C-KINDL = Revididerter KINDer Lebensqualiatsfragebogen – Youth report; QoL = Quality of 
life; CGI = Clinical Global Impression Scale – Overall current severity. 
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Figure 7. Interaction effect of slope of standardized youth-reported total stress on 
Stressful Life Events Scale with symptom severity on youth-reported QoL. C-KINDL = 
Revididerter KINDer Lebensqualiatsfragebogen – Youth report; QoL = Quality of life; CGI = Clinical 
Global Impression Scale – Overall current severity. 
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continued 
 
Figure 8. Site differences in symptom severity ratings. Different subscripts indicate 
significant site differences. BL = Baseline; M12 = 12-Month Assessment; M24 = 24-Month Assessment; CGI = Clinical Global 
Impression Scale – Overall current severity; CWRU = Case Western Reserve University; OSU = The Ohio State University.  
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Figure 8 continued 
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         continued 
 
Figure 9. Site differences in parent-reported QoL. Different subscripts indicate significant site 
differences. P-KINDL = Revididerter KINDer Lebensqualiatsfragebogen – Parent report; QoL = Quality of life; CGI = 
Clinical Global Impression Scale – Overall current severity; BL = Baseline; M12 = 12-Month Assessment; M24 = 24-Month 
Assessment; CGI = Clinical Global Impression Scale – Overall current severity; CWRU = Case Western Reserve University; 
OSU = The Ohio State University. 
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Figure 9 continued 
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         continued 
 
Figure 10. Site differences in youth-reported QoL. Different subscripts indicate 
significant site differences. C-KINDL = Revididerter KINDer Lebensqualiatsfragebogen – Youth report; QoL = 
Quality of life; CGI = Clinical Global Impression Scale – Overall current severity; BL = Baseline; M12 = 12-Month Assessment; 
M24 = 24-Month Assessment; CGI = Clinical Global Impression Scale – Overall current severity; CWRU = Case Western 
Reserve University; OSU = The Ohio State University. 
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Figure 10 continued 
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continued 
 
Figure 11. Site differences in parent-reported number of stressful life events.  
Different subscripts indicate significant site differences. BL = Baseline; M12 = 12-Month assessment; M24 = 24-
Month assessment; P-SLES = Stressful Life Events Schedule – Parent Report; CWRU = Case Western Reserve University; OSU = 
The Ohio State University. 
  
335 
 
Figure 11 continued 
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continued 
Figure 12. Site differences in parent-reported total impact of stressful life events.  
Different subscripts indicate significant site differences. BL = Baseline; M12 = 12-Month assessment; M24 = 24-
Month assessment; P-SLES = Stressful Life Events Schedule – Parent Report; CWRU = Case Western Reserve University; OSU = 
The Ohio State University. 
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Figure 12 continued 
 
 
 
 
 
